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Abstract:  
 
The mbfA (membrane bound ferritin A) gene is carried by all Brucella species and is 
widely conserved in α-Proteobacteria. mbfA encodes a novel iron-export protein 
comprising an N-terminal peroxide reductase (erythrin) domain and a C-terminal, 
membrane-embedded, iron-export domain (vacuolar iron transport, VIT).  In this thesis, 
for the first time, the role of mbfA in Brucella suis 1330 and Brucella melitensis 16M 
was investigated, and the contributions of the two domains towards a novel mechanism 
of oxidative-stress resistance was considered. In addition, any part played by MbfA in 
enhancing Brucella survival within the macrophage ‘Brucella-containing vacuole’ 
(BCV) was investigated.   
 
The isolated erythrin domain was shown to bind two iron atoms (as expected) or zinc 
which stabilized the protein, but no substantive peroxidase activity was exhibited, 
presumably due to lack of a reduction partner.  mbfA complemented an E. coli mutant 
that was devoid of catalases/alkyl-hydroperoxidases, enhanced growth of a fur mutant 
with deregulated iron uptake, and impaired growth of a mutant lacking iron-uptake 
capacity.  These findings support a role for MbfA in peroxide resistance and iron 
export.  MbfA was shown to export 55Fe when expressed in E. coli, and this activity was 
found to be O2 and H2O2 dependent.  Similar results were obtained using a 
Burkholderia multivorans mbfA mutant. In addition, MbfA mediated the decomposition 
of exogenous H2O2, which was mainly achieved by degradation of exogenous peroxide 
by exported iron.  MbfA provided peroxide resistance in wildtype E. coli but only when 
endogenous catalases/peroxidases were inhibited by NO.  Thus, MbfA is not markedly 
NO inhibited.  MbfA iron export was found to be partly dependent on the presence of 
iron stores, in the form of bacterioferritin. 
 
A naturally-occurring single-nucleotide substitution in the proximal coding region of 
the mbfA gene renders this gene cryptic in B. melitensis (although mbfA appears 
functional in all other Brucella spp.).  Thus, a B. melitensis mbfA mutant exhibited no 
observable phenotype whereas a B. suis mbfA mutant displayed enhanced sensitivity to 
both Fe2+- and H2O2-mediated oxidative stress. It is hypothesized that MbfA exports 
ferric iron into the luminal space of the endosomal Brucella-containing vacuole (eBCV) 
to counteract both the respiratory burst generated by NADPH oxidase as well as the 
export of iron into the macrophage cytoplasm by NRAMP1.  Exported iron causes 
 
 
iv 
disproportionation of peroxide externally, thus reducing the potential for harmful 
oxygen- and nitrogen-radical formation within the bacterial cell.  Macrophage survival 
assays show that the absence of functional mbfA decreases intracellular survival during 
the early colonization phase in the eBCV, suggesting a reduced capacity to resist the 
redox stress of the endosomal and transient lysosomal compartments in the macrophage, 
which precede transition to the replicative BCV. Additionally, in vivo, mbfA contributes 
significantly to the maintenance of chronic infection within the murine liver and 
spleen.  Further, MbfA provided a greater advantage in NRAMP1+ macrophages, than 
in NRAMP1- macrophages.  This finding supports a role for MbfA in countering the 
iron export role of NRAMP1 within the phagolysosome, such that the purpose of this 
NRAMP1 actiy would be to preserve peroxide against iron-catalysed degradation. In 
summary, the results are therefore consistent with a role for mbfA in intracellular 
survival and redox stress resistance in Brucella.  
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Chapter 1:  Introduction 
 
1.1: Biological Importance of Iron 
Iron is an essential nutrient required for growth, replication and survival; its acquisition 
in sufficient quantities is paramount for the propagation of nearly all organisms, 
including both pathogenic and non-pathogenic bacteria.  This importance of iron in 
cellular biology is due to its role as a co-factor for proteins involved in numerous 
essential cellular processes.  For instance, enzymes such as aconitase, part of the 
tricarboxylic acid cycle, and cytochromes, essential components of respiratory electron 
transport chains, require iron for their activity.  Iron, as a co-factor, is incorporated into 
proteins in various forms, mostly as: the ‘free’ metal in mono- or di-nuclear form; as 
part of an iron-sulphur cluster; or combined with a protoporphyrin ring in the form of 
haem.  The usefulness of iron as a co-factor component is largely dependent on its 
ability to readily switch between, and maintain, alternative redox states (ferrous - 
Fe2+/ferric - Fe3+) and adopts a wide range of redox potentials, allowing iron to mediate 
a variety of cellular redox reactions.  However, this property can also be deleterious as it 
enables free iron within the cell to engage in illicit redox processes with molecular 
oxygen (and derived species) to generate toxic, reactive oxygen species (ROS: 
superoxide, O2-; hydrogen peroxide, H2O2 and the hydroxyl radical, ·HO) through 
Fenton and Haber-Weiss chemistry (Koppenol 2001), indicated below: 
Haber-Weiss:  Fe3+ + O2- à Fe2+ + O2 
Fenton:  Fe2+ + H2O2 + H+ à Fe3+ + HO· + H2O 
Net Radical Production: O2- + H2O2 à HO· + OH- + O2 
 
Such ROS can cause uncontrolled damage to various cell components, in particular 
lipid membranes, proteins and nucleic acids, leading to loss of cell viability. Thus, the 
deployment of iron within the cell must be carefully balanced to avoid iron toxicity 
whilst ensuring iron sufficiency.  
 
In addition to its potential toxicity, iron presents problems of poor availability despite 
its abundance as the 4th most common element in the Earth’s crust.  This is caused by 
the very low solubility (1.4x10-9 M at pH 7; (Ratledge and Dover 2000)) of the 
environmentally predominant oxidised, ferric iron.  Reduced, ferrous iron is soluble (0.1 
M at pH 7.0), but is readily oxidised by molecular oxygen and so does not persist under 
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atmospheric conditions at neutral pH or higher. An effective and efficient mechanism 
for the acquisition of iron is an essential feature of a successful pathogen.  Upon entry 
of a pathogen into the host, the bacterial cell experiences an environment in which iron 
is limited, this process is termed nutritional immunity.  
 
1.2: Iron Acquisition by Pathogenic Bacteria 
Under aerobic conditions, which prevail within the tissues of the mammalian host, iron 
primarily exists in the oxidized ferric form at a concentration below that required to 
support and maintain microbial growth. The host maintains free iron levels in the serum 
at even lower levels (10-24 M) as part of its innate resistance to microbial infection.  
This selective pressure has led pathogenic bacteria to develop mechanisms to counteract 
the iron withdrawal strategy of the host.  These mechanisms can assimilate both the 
ferrous and ferric forms of iron from a wide range of host sources.  Pathogenic bacteria 
often possess iron uptake systems that are also deployed by non-pathogens 
(siderophore-dependent systems and free metal transporters) but in many cases they rely 
upon iron transporters that are specific for host iron sources (Figure 1.1). Such 
mechanisms include: 
• the rupture of iron-rich erythrocytes to enable retrieval of iron in the form of 
haem; 
• secretion of high-affinity iron-chelating compounds called siderophores, which 
allow scavenging of iron from host sources such as transferrin; 
• direct binding of host iron-proteins (e.g. transferrin, lactoferrin, haemoglobin, 
haemopexin and haptoglobin), using specific surface receptors, to allow 
acquisition of the iron that they hold;  
• utilisation of free iron within host niches where free iron is sufficiently available 
(e.g. low oxygen, low pH or reducing conditions such as the gut, the cytosol and 
the phagosome); and 
• release of iron from cytosolic ferritin.    
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Figure 1.1: Schematic representation of iron transport in Bacteria. 
Iron transport systems in selected pathogenic Gram-negative (Yersinia pestis and 
Brucella suis) and Gram-positive bacteria (Bacillus anthracis). Purple - outer 
membrane transport proteins, blue – periplasmic binding proteins, orange – inner 
membrane transport proteins, green – TonB complex, yellow – cytoplasmic reductase.  
 
Table 1.1: Iron transport systems in Yersinia pestis, Brucella suis and Bacillus 
anthracis. 
 Iron Import System 
Organism Siderophore Fe3+ Fe2+ Haem 
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FhuBCD YiuABC FeoABC HmuRTUV 
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FatBCDE SfuABCD1 FtrABCD BhuTUV 
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Bacillus anthracis 
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1.3: Introduction to Brucella and Brucellosis 
Brucellosis is a zoonotic infection caused by the bacterial genus Brucella; a small (0.5 x 
0.6 µm) Gram-negative, facultatively intracellular aerobic cocco-bacilli.  The disease 
has been known by numerous names, including Mediterranean fever, Malta fever, 
Bang’s disease, gastric remittent fever, and undulant fever. The bacteria are transmitted 
from animals to humans by ingestion of contaminated food products (unpasteurized 
milk and related dairy products), direct contact with an infected material (e.g. 
percutaneous needlestick), or inhalation of aerosols.  Slaughterhouse workers are at 
most risk of contracting Brucellosis where aerosolization of fluids, contamination of 
skin abrasions, and splashing of mucous membranes can occur.  
 
Fever is the most common symptom of Brucellosis, occurring in 80-100% of cases, 
alongside additional symptoms including malaise and weight loss (>90% of cases). 
Death from Brucellosis is rare, occurring in approx. 2% of cases, but the economic loss 
associated with Brucella infection is substantial.  This unfortunately, has resulted in 
Brucella spp. being incorporated into bioweapons, first developed by the United States 
military in the 1950’s (Franz et al. 1997). It is estimated that the economic impact of a 
bioterrorist attack with Brucella spp. would cost hundreds of millions of dollars per 
100,000 people exposed (Kaufmann et al. 1997). 
 
To date, 10 Brucella species have been identified: B. melitensis (goat), B. suis (swine), 
B. abortus (cattle), B. canis (dog), B. ovis (sheep), B. ceti (porpoise), B. pinipedialis 
(seal), B. neotomae (desert woodrat), B. microti (common vole) and B. inopinata 
(unknown).  The genomes of B. melitensis (DelVecchio et al. 2002), B. abortus (Halling  
et al. 2005), and B. suis (Paulsen et al. 2002) were the first to be sequenced and 
highlighted a high degree of similarity between biovars.  Each species is named 
primarily from their source animal, with classical smooth O-lipopolysaccharide 
expressing B. melitensis, B. suis and B. abortus presenting with the highest human 
pathogenicity.  
 
Brucellosis remains a major public health concern worldwide and is the most common 
zoonotic infection with more than 500,000 infections per year worldwide.  Effective 
public and animal health programs limit the geographic distribution of Brucella 
infections, and the prevalence of the disease varies widely between countries.  The 
heaviest disease burden lies in countries of the Mediterranean basin and Arabian 
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Peninsula, but the disease is also common in India, Mexico, and South and Central 
America.  
 
Brucellosis can be effectively managed with long-course (6 weeks plus) treatments with 
antibiotics.  Mono-antibiotic therapies with doxycycline can be effective in clearance of 
infection, but relapse rates approach 40%, therefore the World Health Organization 
(WHO) recommend a combination treatment of doxycycline for 6 weeks alongside IM 
streptomycin for 2-3 weeks. 
 
Brucella organisms localise in the reproductive organs of host animals, causing 
abortions and sterility. This is caused by replication within intracellular compartments 
associated with the rough endoplasmic reticulum of trophoblasts (Anderson et al. 1986), 
a layer of cells at the outer surface of the blastocyst, which develops into a large 
percentage of the placenta.  Infection of this tissue and subsequent accumulation of 
extremely large numbers (1013) of bacteria (Alexander et al. 1981) promotes abortion. 
Bacterial replication to such extreme concentrations has been linked to the growth 
stimulatory factor erythritol (Smith et al. 1962), a four-carbon sugar found in the 
placenta and fetal tissues of Brucella hosts. The affinity of Brucella for erythritol is 
such that in vitro experimentation determined that Brucella abortus would preferentially 
utilize erythriol over glucose (Sperry and Robertson 1975).  
 
Brucellae are shed in large numbers in the animal’s urine, milk, placental fluid as well 
as other fluids. However, humans experience limited risk of contracting Brucellosis 
from wild animals, due to a lack of proximity, contact and infrequent use of milk and 
meat products from these animals.  Instead infection is mainly acquired from domestic 
animals.  It is likely that humans are accidental hosts of Brucella infection, due to the 
fact that humans are unable to transmit the disease either vertically or horizontally.   
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1.4: Brucella Intracellular Lifestyle 
In incidences of human infection with Brucella, entry is gained to the body through 
breaks in the skin, mucous membranes, conjunctivae, and the respiratory and 
gastrointestinal tract. Once in the bloodstream, the organisms quickly become 
internalized by circulating polymorphonuclear cells (PMNs) and macrophages, which 
results in a large reduction of viable bacteria but replication and survival within host 
phagocytic cells is possible (Smith and Ficht 1990). It is of note that Brucella have a 
relatively low pyrogenicity, making them poor inducers of some inflammatory 
cytokines and the adaptive immune response and do not activate the alternative 
complement system. Phagocytosed Brucellae are first located within an early 
endosomal vacuole termed the early Brucella containing vacuole (eBCV) (Celli et al. 
2003), characterised by the acquisition of RAB5, its effector EEA1 and the transferrin 
receptor (Pizarro-Cerda et al. 1998, Celli et al. 2003, Bellaire et al. 2005) before 
acidification and maturation into late endosomes, characterised by the additional 
acquisition of late endocytic markers (LAMP1 and CD63), making the endosome 
competent for fusion with lysosomes (Pizarro-Cerda et al. 1998, Celli et al. 2003, 
Bellaire et al. 2005). The maturation of the eBCV along the endocytic pathway is 
deleterious to Brucellae cellular viability; the viable bacterial load within the 
macrophage is reduced throughout this period.  Up to 90% of ingested bacteria are 
killed rapidly by the macrophage within the first 4 hours of infection (Celli et al. 2003).  
Fusion with the lysosome serves to further acidify the eBCV; Brucellae adapt to the 
lowering pH and reduce carbon anabolism to counter nutrient deprivation.  Both stimuli 
activate expression of the VirB, Type 4 Secretion System (T4SS), of which maximal 
expression is achieved after 5 h post infection (Sieira et al. 2004).  The VirB operon is 
Brucella’s major virulence determinant (O'Callaghan et al. 1999, Boschiroli et al. 2002) 
and the encoded VirB apparatus is essential for escape from the endocytic pathway and 
trafficking towards the replicative BCV (rBVC) (Lestrate et al. 2000, Delrue et al. 2001, 
Celli et al. 2003) (Figure 1.2).  
 
During transit through the eBCV, when Brucella spp. have a reduced replication 
capacity and are exposed to oxidative stress (Jiang et al. 1993) it is expected that the 
Brucella cell is rich in intracellular iron, acquired during systemic circulation, prior to 
phagocytosis by the macrophage (Baldwin et al. 1993).  The combination of high iron 
concentrations within an oxidising environment presents a major risk of loss of bacterial 
viability through acquiring ROS mediated damage. To combat this, Brucella encode 
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two superoxide dismutases (SodA and SodC), a catalase (KatE) and an alkyl 
hydroperoxidease (AhpC) (Gee et al. 2005, Steele et al. 2010, Martin et al. 2012), all 
functioning to reduce ROS associated damage.  
 
In contrast to the high iron concentrations observed within the Brucella cell, the 
phagosome is considered a low-iron compartment due to the activity of NRAMP1 
(natural-resistance against macrophage pathogens), which is present within the 
phagosomal membrane, and exports di-valent metal cations from the phagosome, 
including ferrous iron. Imposition of iron-restriction functions to prevent bacterial iron 
acquisition, a process called nutritional immunity, preventing replication and growth of 
intracellular pathogens.  Mutation, specifically a G169D point mutation, in the NRAMP1 
gene is associated with enhanced susceptibility to infection by intracellular pathogens 
(Garcia-del Portillo et al. 1992, Pope et al. 1996, Blackwell 2001), through the inability 
of the phagolysosome to become iron limited. Failure to remove iron from this lumenal 
space makes availble a source of iron for bacterial aquistion. A second key mechanism 
for limiting the replication of intracellular pathogens is mitigated through interferon 
gamma (IFN-γ), which also acts to reduce intracellular iron concentrations (Byrd and 
Horwitz 1989).  IFN-γ causes a reduction in macrophage iron uptake by decreasing 
expression of the transferrin receptor 1 (a major cellular iron importer) and increasing 
the expression of iron efflux proteins such as ferroportin 1. This results in decreased 
free iron availability in the macrophage, which, in turn, leads to decreased phagosomal 
iron concentrations (Nairz et al. 2008).   
 
Additional features of the innate immune response which function to prevent bacteria 
colonization of the host and which are specific to Brucella infection include the 
oxidative burst mechanism of macrophages mediated by NADPH oxidase.  The 
presence of NRAMP1 within the phagolysosomal membrane, nitric oxide synthase, 
NADPH oxidase and superoxide dismutase function to generate reactive oxygen species 
within the phagolysosome.  Nitric oxide synthase catalyses the generation of nitric 
oxide from L-arginine, NADPH oxidase (nicotinamide adenine dinucleotide phosphate-
oxidase) acts to generate superoxide from molecular oxygen, whilst super oxide 
dismutase dismutates superoxide to hydrogen peroxide.  The sole purpose of these 
activities is to generate a bactericidal concentration of oxygen radicals, to prevent 
bacterial colonisation. In addition to these mechanisms, neutrophils produce 
myeloperoxidase (MPO) which functions to generate hypochlorous acid from hydrogen 
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peroxide and the chloride anion, and is the most potent mediator of redox stress in 
biological systems.  It should be noted however, that Brucella species are not thought to 
colonise neutrophils. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Model of Brucella intracellular trafficking in mammalian cells. 
Brucella spp. reside within a vacuole termed the Brucella containing vacuole (BCV) 
which traffics along the endocytic pathway interacting with early endosome (EE), late 
endosomes (LE) and lysosomes (Lys).  Interaction with the lysosome provides cues for 
induction of the VirB T4SS, from which VirB type IV effector proteins redirect the 
BCV to fuse with the endoplasmic reticulum (ER) creating the rBCV.  
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1.5: Brucella iron acquisition 
Establishment of the rBCV sees replication of intracellular Brucellae that have adapted 
to a reduced oxygen respiratory system (Carrica Mdel et al. 2013), with an increased 
dependency in the use of amino acids as carbon sources (Roop et al. 2009).  It is only 
within the rBCV that genes involved in iron acquisition are activated (Roop et al. 2009); 
Brucella species encode two TonB-dependent outer-membrane protein homologues that 
transport siderophore-iron complexes (2,3-dihydroxybenzoic acid (2,3-DHBA) (Lopez-
Goni et al. 1992) and brucebactin (Gonzalez Carrero et al. 2002)) across the outer 
membrane; membrane protein functionality is based upon sequence homology to the E. 
coli outer membrane proteins Cir (Griggs et al. 1987) and Fiu (Hantke 1990).  
Siderophore iron complexes are internalised by two periplasmic binding protein 
dependent ABC transporters, FatBCDE and FepBCD, homologues of which are present 
in Escherichia and Vibrio species (Koster et al. 1991) (Shea and McIntosh 1991, 
Stephens et al. 1995).  A further two ferric-chelate uptake systems, SfuABC1/2 
homologues of the Serratia marcescens SfuABC complex (Angerer et al. 1992), import 
ferric iron.  Ferrous iron is imported via a haem uptake system, BhuATUV; BhuA is a 
TonB dependant outer membrane haem transporter and homologue of the Shigella 
ShuA (Mills and Payne 1997) and Yersinia HmuA (Thompson et al. 1999) proteins 
whilst the BhuTUV proteins are homologues of the Shigella dysenteriae ShuTUV 
proteins (Wyckoff et al. 1998) which allow passage of haem across the cytoplasmic 
membrane. Once haem is internalised, ferrous iron can be liberated via degradation of 
haem into biliverdin and carbon monoxide via the haem oxygenase BhuQ (Ojeda et al. 
2012). Finally, ferrous iron is also acquired via a ferrous-iron uptake system, FtrABCD 
(Elhassanny et al. 2013) which has functional similarities to the Escherichia coli 
O157:H7 EfeUOB system (Cao et al. 2007).  Of these four distinct systems, the heam 
and ferrous iron transporters are the only systems shown to be essential during infection 
of both macrophage and mice (Paulley et al. 2007, Elhassanny et al. 2013).  Schematic 
representation of these iron transport systems is displayed in Figure 1.1. 
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1.6: Novel redox stress resistance mechanisms in Brucella  
Although multiple routes for iron import have been identified, two of which are crucial 
for in vivo mouse infection, no iron export system, that might ameliorate iron-induced 
redox stress in the phagosome, has been described to date.  Interestingly, Brucella 
species possess an uncharacterised gene ‘membrane-bound bacterioferritin’, mbfA 
(Brucella melitensis: BMEI0354, Brucella abortus: BAB1_1691, Brucella suis: 
BS1330_I1673) that might specify a system fulfilling such a function.   
 
The MbfA protein consists of two predicted domains: a cytosolic, N-terminal, diiron 
erythrin; and a C-terminal, vacuolar iron transporter (VIT1) domain that is integral to 
the inner-membrane. The diiron erythrin domain is related to rubrerythrins of anaerobic 
bacteria.  Rubrerythrins consist of two domains, a diiron erythrin and a Cys4-Fe 
rubredoxin domain, and act as peroxide reductases affording resistance against exposure 
to redox stress.  Reduction of peroxide is coupled to oxidation of the diiron centre, 
which is subsequently re-reduced by a rubredoxin-NAD+ reductase system that employs 
NADH as the reducing source (Lumppio et al. 2001).  A reducing system is expected to 
be required for MbfA for the N-terminal erythrin domain of MbfA, which re-reduces 
the diiron centre allowing for continual reduction of hydrogen peroxide.  The VIT1 
domain is homologous with the VIT1 protein of Arabidopsis and ‘calcium cross-
complementor 1’ (CCC1) of Saccharomyces cerevisiae.  VIT1 and CCC1 are located in 
vacuolar compartments and are involved in the intracellular trafficking of Fe2+ and/or 
Mn2+ (Li et al. 2001, Kim et al. 2006). However, it is speculation that these transport 
systems are truly importing ferrous iron into the vacuole; the experimentation 
conducted relied upon inductively coupled plasma – optical emission spectroscopy 
(ISP-OES) to quantitate vacuolar metal contents.  This technique is not specific to either 
the ferric or ferrous ion and instead quantitates a combined concentration of iron.  
 
It is suggested that the functions of the erythrin and VIT1 domains are combined in 
MbfA such that reduction of peroxide is coupled to the oxidation and export of ferric 
iron in order to minimise iron-induced peroxide stress (Andrews 2010). With regards to 
the influence that MbfA has upon Brucella spp. survival within their intra-macrophage 
niche, it is proposed that MbfA is utilised to minimise ROS and iron-induced oxidative 
stress (Andrews 2010) during passage of Brucellae towards the rBCV.  
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The first phenotypic analysis of MbfA was conducted by Ruangkiattikul et al. 2012 in 
Agrobacterium tumefaciens.  mbfA mutants were found to be more sensitive to 
hydrogen peroxide and iron stress, and have greater cellular iron contents than their 
respective wild types, as determined by ICP-OES, suggesting that MbfA is involved in 
decomposition of H2O2 and iron export.  Structural work expanding on this was 
conducted by Bhubhanil et al. (Bhubhanil et al. 2014), confirming the presumed 
orientation of MbfA within the A. tumerfaciens inner membrane.  Work by Sankari and 
O'Brian (Sankari and O'Brian 2014) examined functional and biochemical aspects of 
MbfA from Bradyrhizobium japonicum. The apo-form of the erythrin domain of B. 
japonicum was purified as a homo-dimer and found to exhibit ferroxidase activity, but 
is restricted to two molar equivalents of ferrous iron, indicating that a di-ferric iron site 
is formed by the erythrin domain. 
 
1.7: Regulation of Iron Genes in Brucella species 
The iron response regulator (Irr) is the predominant regulator of iron metabolism, 
acquisition and storage genes in α-proteobacteria including Brucella (Martinez et al. 
2005) rather than the Fur (ferric uptake regulator) transcriptional repressor protein 
(Rodionov et al. 2006), observed in many other proteobacteria.  Irr was first identified 
in Bradyrhizobium japonicum (Hamza et al. 1998) where it acts as a repressor of the 
haem biosynthesis gene, hemB, when cellular iron concentrations are low. Upon high 
intracellular iron conditions, Irr is degraded via ferrochelatase (Qi and O'Brian 2002) 
resulting in hemB repression being relieved.  This regulation mechanism has been 
shown to control mbfA expression, mbfA is induced in response to high intracellular iron 
concentrations as well as through hydrogen peroxide stress mediated through Irr-
dependent repression control (Ruangkiattikul et al. 2012, Bhubhanil et al. 2014, Sankari 
and O'Brian 2014). mbfA mutants are more sensitive to hydrogen peroxide and iron 
stress, and have greater cellular iron contents than their respective wild types, 
suggesting that MbfA is involved in decomposition of H2O2 and iron export.Recent 
research also shows that Irr is an activator of iron acquisition genes.  Irr has been shown 
to up-regulate siderophore production (Martinez et al. 2006), the haem transporter 
BhuA (Anderson et al. 2011), the haem oxygenase BhuQ (Ojeda et al. 2012) and the 
ferrous iron uptake operon FtrABCD (Elhassanny et al. 2013) when cellular iron levels 
are low.  In this way, Irr acts to both activate iron acquisition genes and repress iron 
metabolism and the iron storage gene in low iron conditions, allowing for regulation of 
iron homeostasis. The positive or negative regulation of genes by Irr is dependent upon 
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the location of the ICE-box (iron control element), the DNA binding site for Irr.  The 
consensus motif of the ICE-box is: TTTAGAA–N3–TTCTAAA, a 21 base pair, A/T 
rich, inverted repeat sequence which is shown to be highly conserved within the mbfA 
promoter region (Rudolph et al. 2006a, Rudolph et al. 2006b).  
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1.8: Aims and Objectives 
Studying the MbfA system from Brucella spp. will provide insight into a novel 
mechanism of iron transport across biological membranes.   In particular, not only is the 
MbfA system unique in terms of sequence and arrangement, but also in terms of the 
proposed direction and mechanism of iron transport with respects to other systems 
known in prokaryotes.  If substantiated, MbfA would represent the first dedicated iron 
export system described in bacteria.  
 
The primary aim of this project is to investigate the role that MbfA plays in terms of 
iron transport within Brucella spp. and how this may influence survival within the 
Brucella containing vacuole (BCV).  To understand this, the mechanism by which iron 
is transported across the membrane will be determined through analyzing phenotypic 
effects that the expression of mbfA has upon E. coli mutants, as well as by measuring 
the export of iron from the bacterial cell, and the effect of mutations and environment 
on this activity. 
 
To add context to the role that MbfA plays in Brucella virulence and survival, and the 
impact that nutritional immunity may play upon Brucella, an assessment of the ability 
B. melitensis, B. suis and corresponding mbfA deletion mutants to withstand exposure to 
hydrogen peroxide and ferrous iron will be conducted. Additionally, the survival in 
vitro within cultured murine macrophages (NRAMP1+/-) as well as in vivo within a 
murine model of wildtype Brucella and mbfA mutants will be examined.  The effect of 
mbfA inactivation in Burkholderia multivorans iron export capacity will also be tested, 
and the mechanism of iron export for a VIT1 system (from plant) will also be analysed 
as a comparator to MbfA. 
 
Furthermore, experimentation will be undertaken to overexpress, purify and perform 
biochemical analysis, including metal content analysis, mass spectroscopy and 
crystallization trials upon the N terminal erythrin domain of MbfA.  Spectroscopic 
measurements of the erythrin domain will provide insight into the iron binding 
capability of the domain and its ability to reduce hydrogen peroxide.  Crystallization of 
the domain will enable structure solution by x-ray diffraction allowing models to be 
generated of the erythrin’s structure.  Together, these experiments will aid in the 
understanding of the biochemistry occurring at the erythrin domain during iron export.   
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Chapter 2: Methods 
 
2.1: Bacterial Propagation 
 
2.1.1: Bacterial Strains and Growth Conditions 
Escherichia coli strains were grown on Lysogeny broth agar (LA) or in Lysogeny broth 
(LB) or minimal medium.  Brucella suis bv.1 str. 1330 and Brucella melitensis bv. 1 str. 
16M and derivative strains were grown on Brucella agar, Tryptone soya agar or in 
Brucella broth. All cultures were maintained at 37 °C with continual shaking at 200 rpm 
when required. Bacterial strains and plasmids used in this study are detailed in Table 1.  
 
All bacteriological media were prepared with distilled (18.2 Ω) water and sterilised by 
autoclaving at 121 °C at 15 psi for 15 min.  Heat labile substances were filter sterilised 
using a 0.2 µm filter (Millipore).  Additions to molten media were made at 55 °C. 
• LB:  10 g l-1 tryptone, 5 g l-1 yeast extract and 5 g l-1 NaCl.  
o LA was prepared by addition 1.5% agar to LB.  
• Defined minimal media: M9 salts 0.2% v/v glycerol, 2 mM MgCl2, 100 µM 
CaCl2 and 1 mM thiamine 
• Brucella broth: 10 g l-1 pancreatic digest of casein, 10 g l-1 peptic digest of 
animal tissue, 2 g l-1 yeast extract, 5 g l-1 NaCl, 0.1 g l-1 sodium bisulfite 
(NaHSO3) and 1 g l-1 dextrose  
o Brucella agar was prepared by addition 1.5% agar to Brucella broth.  
• Typtone soy agar (TSA): 15 g l-1 pancreatic digest of casein, 5 g l-1 enzymatic 
digest of soya bean, 5 g l-1 NaCl and 15 g l-1 agar.  
 
2.1.2: Antibiotics 
The antibiotics used routinely during experimentation with E. coli and Brucella spp. are 
described in Table 2.1, ampicillin, kanamycin and gentamycin are dissolved in water; 
chloramphenicol is dissolved in ethanol.  All dissolved antibiotics are filter sterilised 
through a 0.2 µm filter (Millipore) and stored at -20 °C. 
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Table 2.1.: Concentrations of antibiotics.  
Antibiotic Abbreviation Stock concentration 
Working concentration 
(Brucella spp.) 
Ampicillin Amp 100 mg ml-1 100 µg ml-1 
Chloramphenicol Cm 50 mg ml-1 50 µg ml-1 
Kanamycin Km 50 mg ml-1 25 µg ml-1 (45 µg ml-1) 
Gentamycin Gm 50 mg ml-1 50 µg ml-1 
 
 
2.1.3: Bacterial growth curve  
An overnight culture form a single isolated E. coli or Brucella spp. colony was washed 
once with phosphate buffered saline pH 7.2 and adjusted to a final OD of 1. A micro-
titre plate was prepared with 200 µl of media per well and the standardised bacterial 
cultures used to inoculate individual wells to a starting OD of 0.01. E. coli and Brucella 
growth curves were monitored every 30 minutes for up to 48 h using a Bioscreen C 
(Labsystems) or MultiSkan FC (Thermo-Fisher) incubated spectrophotometer, 
respectively. 
 
  
Chapter 2 
 
 
16 
2.2: Cell Culture 
 
2.2.1: Macrophage Cell Lines and Growth Conditions  
J774.A1 and RAW264.7 murine macrophages were used for intracellular survival 
assays of Brucella spp. and were passaged and maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) with addition of 5% fetal calf serum and 2 mM L-glutamate 
and incubated at 37 °C with 5% CO2.  In the absence of an increased CO2 atmosphere 
(infection assays with Brucella within containment level 3 laboratory). Leibovitz's L-15 
medium was used to maintain infected macrophages. 
 
2.2.2: Thawing cryo-preserved cells 
Liquid-nitrogen-stored cells were thawed at room temperature and immediately added 
to warm (37 °C) DMEM in a 75 cm2 flask.  After 6 h incubation at 37 °C with 5% CO2, 
once cells had adhered to the flask, spent medium was aspirated and replaced with 15 
ml fresh media. 
 
2.2.3: Cellular Passage 
Cells were observed under the light microscope to determine confluence and passaged 
at 70-80% confluence (once every 2/3 days).  Spent medium was aspirated and cells 
washed twice with 1x DPBS.  Adherent cells were scraped from the flask and re-
suspended in 5 ml of DMEM with FCS and glutamate.  The number of live cells was 
determined via addition of 10 µl trypan blue to 10 µl of cell suspension and enumeration 
of live white cells was achieved with a hemacytometer.  Then, 2.5x106 cells were 
dispensed into 75 cm2 flasks with 10 ml of supplemented DMEM and incubated at 37 
°C with 5% CO2. 
 
2.2.4: Cyro-preservation 
A total of 1x106 of 70% confluent cells were detached and collected by centrifuged at 
1000 rpm for 5 min, spent medium was removed and the cells were re-suspended in 3.6 
ml FCS.  Then, 400 µl of DMSO were added dropwise and 1 ml aliquots were frozen to 
-80 °C overnight before being transferred to liquid nitrogen for long term storage. 
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2.3: Molecular Cloning 
 
2.3.1: Polymerase Chain Reaction (PCR) 
Primers were purchased from Eurofins MWG Operon, and were supplied as lyophilised 
oligonucleotides, which were re-hydrated with sterile ultrapure H2O to give a stock 
concentration of 100 pmol/µl.  Stock primers were diluted 1:10 to produce a working 
stock of 10 pmol/µl. Once re-hydrated, primers were stored at -20 °C.  
 
2.3.2: PCR reactions 
For high-fidelity cloning of genes from plasmid and chromosomal DNA and generation 
of Gibson assembly components, Q5 or Phusion  (New England Biolabs) DNA 
polymerases were used. Reaction mixtures of 25 µl were assembled on ice and 
comprised of 5 µl 5x reaction buffer, 0.5 µl of 10 mM dNTPs, 1.25 µl of forward and 
reverse primers, 1 ng-1 µg of template DNA and 0.25 µl (0.2 U/µl) of DNA polymerase, 
made to the final volume with sterile ultrapure H2O. The reaction mix was gently mixed 
and briefly pulse centrifuged before being transferred to a pre-heated thermocycler (98 
°C; BioRad T100).  Typical thermocycling parameters are outlined below: 
Step Cycles Temperature Time 
Initial denature 1 98 °C 30 s 
Denature 
30 
98 °C 10 s 
Anneal 50-72 °C 30 s 
Extension 72 °C 30 s/kb of plasmid length 
Final extension 1 72 °C 2 min 
 
For screening of recombinant DNA, colony PCR was employed with the use of low-
fidelity thermostable DNA polymerases (Taq/DreamTaq; New England Biolabs).  
Putative recombinant DNA containing colonies were taken from an agar plate with a 10 
µl pipette tip and inoculated into 50 µl of sterile ultrapure water in a 0.5 ml centrifuge 
tube. Remaining bacterial suspension was used to subculture into fresh LB with 
appropriate antibiotic, colonies that presented with a positive PCR result when analysed 
by agarose gel electrophoresis. A 20 µl reaction mix was assembled on ice comprising 
of 2.5 µl 10x buffer, 2.5 µl of 2 mM dNTPs, 1 µl of forward and reverse primers, 1 µl of 
DNA and 0.125 µl (1.25 U/µl) DNA polymerase, made to the final volume with sterile 
ultrapure H2O. The reaction mix was gently mixed and briefly pulse centrifuged before 
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being transferred to a pre-heated thermocycler (95 °C).  Typical thermocycling 
parameters are outlined below: 
 
Step Cycles Temperature Time 
Initial denature 1 95 °C 3 min 
Denature 
30 
95 °C 30 s 
Anneal Tm –5 °C 30 s 
Extension 72 °C 1 min/kb of plasmid length 
Final extension 1 72 °C 10 min 
 
 
2.3.3: Site-directed mutagenesis  
(Agilent QuikChange II Site-Directed Mutagenesis kit) 
Mutagenic primers were designed with the aid of the QuikChange primer design 
program (www.agilent.com/genomics/qcpd), with the following properties: 25 to 45 bp 
in length, with the desired mutation base in the middle of the primer and a Tm of ≥78 ˚C. 
The PCR reaction mix was set up on ice to a final volume of 25 µl, comprised of 2.5 µl 
of 10x reaction buffer, 10 ng of template dsDNA, 31.25 ng of forward and reverse 
primers, 0.5 µl of deoxyribonucleotide triphosphates (dNTPs), 1.5 µl QuikSolution and 
1 µl of PfuUltra HF DNA polymerase (2.5 U/µl).  The thermocycler was pre-heated to 
95 °C before samples were added.  Thermocycling parameters are outlined below: 
 
Step Cycles Temperature Time 
Initial denature 1 95 °C 30 s 
Denature 
18 
95 °C 30 s 
Anneal 55 °C 1 min 
Extension 68 °C 1 min/kb of plasmid length 
Final extension 1 68 °C 7 min 
  
Following thermocycling, reaction mixtures were placed on ice to cool the reaction.  A 
0.5 µl volume of DpnI (10 U/µl) was added per reaction mix, the solution was gently 
vortexed and pulse centrifuged, and was then incubated at 37 °C for 1 h to digest 
parental, non-mutated template DNA. XL-10 Gold ultra-competent cells (45 µl) where 
used to transform 1 µl of the DpnI-treated DNA, with the addition of 2 µl of β-
mercaptoethanol, with a heat shock time of 30 s.   
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2.3.4: Plasmid and PCR digestion 
Digestion of plasmids with one or two restriction endonucleases (New England Biolabs) 
was conducted in a final volume of 20 µl.  Restriction endonuclease digestions were 
prepared with the required volume of ultrapure water first, followed by 2 µl of digestion 
buffer, 1 µl of plasmid DNA and 1 µl of each restriction endonuclease. The reaction 
mixtures were briefly vortexed and pulse centrifuged to pool the reaction mixture to the 
base of the reaction vessel, before incubation at 37 °C for 15 min.  For digestion of PCR 
products, a final reaction volume of 30 µl was used.  In each case, 10 µl of PCR product 
were added to 16 µl of sterile ultrapure water, 2 µl of digestion buffer and 1 µl of each 
restriction endonuclease.  The reaction mixture was briefly vortexed and pulse 
centrifuged before incubation at 37 °C for 1 h. Addition of fast alkaline phosphatase 
was included in some reactions to prevent unwanted self-ligation of the digested 
plasmid.  The alkaline phosphatase (1 µl) was added to the final reaction after 
incubation at 37 °C; an additional 5 min incubation step at 75 °C was included to 
inactive the alkaline phosphatase. 
 
2.3.5: Blunting reaction 
To blunt the sticky ends of a digestion reaction (for use in a blunt-end ligation 
reactions), the Fermentas blunting enzyme was used (enzyme removes 3’ overhangs and 
fills in 5’ overhangs). Following the digestion of the plasmid, a 20 µl final volume 
reaction mixture comprising of 10 µl of reaction buffer, 0.15 pmols of sticky-end DNA 
fragment and 1 µl DNA-blunting enzyme were briefly vortexed and centrifuged.  The 
reaction mixture was incubated at 70 °C for 5 min and used directly in the ligation 
reaction. 
 
2.3.6: Agarose gel electrophoresis  
Typically, 0.8% agarose gels were used for visualising 500 bp – 10 kb fragments after 
electrophoretic separation with addition of GelRed (Biotin) or ethidium bromide 
(Sigma) in 0.5x TBE buffer (5x: 445 mM Tris base, 217 mM borate, 10 mM 
ethylenediaminetetraacetic acid (EDTA) pH 8.0). DNA samples were prepared in 6 or 
12 µl volumes (dependent upon the number of wells used in the gel) with 6x loading 
buffer (30% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol), sterile ultra-
pure water and 0.5-2 µl of DNA (supercoiled or digested DNA, respectively) per 
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sample.  Gels were submerged in 0.5x TBE buffer and subjected to electrophoresis with 
a constant 60 V for approx. 2 h in a horizontal gel tank.  DNA fragments were 
visualised with a UV transluminator (G-Box, Syngene).  
 
2.3.7: Molecular weight markers - DNA marker  
GeneRuler 1kb and Roche X DNA molecular weight markers (Appendix 9.1) were used 
to estimate the size and quantity of DNA following agarose gel electrophoresis, using 
either UV-induced fluorescence of Gel-Red (Biotin) or ethidium bromide at a 
concentration of 0.5 mg/ml. 
 
2.3.8: Gel extraction and PCR purification  
(Thermo GeneJET/Qiagen QIAquick gel extraction/PCR purification kit)  
Gel extraction was used to excise a specific band from an agarose gel after digestion 
with a restriction endonuclease.  The fragment of agarose gel containing the DNA 
fragment was excised using a clean, sterile scalpel blade and placed into a pre-weighed 
1.5 ml centrifuge tube.  Binding buffer was added in a 100 µl:100 mg ratio and 
incubated at 55 °C for 10 min to dissolve the agarose gel fragment, releasing the 
enclosed DNA. Up to 800 µl of DNA containing solution were then added to the centre 
of a centrifugation column and centrifuged for 1 min at 12000 x g (Eppendorf 5453) 
and the flow-through discarded.  The column was washed with an ethanol-based wash 
solution and centrifuged for an addition minute to remove residual ethanol, before 20-
50 µl of elution solution were added to the centre of the column and centrifuged again 
for 1 min.  The eluent containing the linear DNA fragments was stored at -20 °C.  
 
PCR purification was used to remove residual oligonucleotides, polymerases or 
restriction endonucleases after PCR or digestion reactions.  Equivalent volumes of 
binding buffer were added to the PCR or digestion reaction in a 1:1 ratio, up to 800 µl 
was then added to the centre of the centrifugation column.  Washing and eluting of 
bound DNA follows the protocol described above for gel-extracted fragments. 
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2.3.9: Ligation 
All ligation reactions were conducted with the T4 ligase (New England BioLabs), in a 
final volume of 20 µl comprising of 2 µl T4 ligase buffer, 1:3 vector:insert, DNA ratio 
and 1 µl of T4 ligase.  Sticky end ligations were incubated at room temperature for 10 
min whereas blunt end ligations were incubated at room temperature for 1 h. In both 
cases the entire 20 µl reaction was used for transformation into 200 µl of chemically 
competent cells. 
 
2.3.10: Gibson Assembly  
(ClonTech In-Fusion HD cloning kit)  
The In-Fusion cloning procedure was used with gel extracted purified products. 
Between 50 and 200 ng of each fragment were used with no parental DNA or non-
specific background bands present, when analysed by agarose gel electrophoresis. 
Purified insert fragment (10-200 ng) and 50-200 ng of the linearised vector were added 
to 2 µl of 5x In-Fusion HD enzyme premix (containing a T5 exonuclease, DNA 
polymerase and a T4 ligase), made up to a 10 µl total reaction volume.   The assembled 
reaction was incubated for 15 min at 50 °C in a BioRad T100 thermocycler (to allow 
reliable incubation temperature and rapid cooling to 4 °C when reaction was complete), 
which was then placed on ice.  A 2.5 µl volume of the reaction mix was then used to 
transform competent cells; Stellar ultra-competent cells were used to ensure high-
transformation efficiencies (>1x108 cfu/µg). Method 2.27 was followed for 
transformation. 
 
2.3.11: Chemically competent cells 
For preparation of 20 aliquots of 200 µl of competent cells, a 5 ml overnight culture, 
inoculated with the required strain, was added to pre-warmed, pre-shaken 50 ml LB in a 
250 ml Erlenmeyer flask. The culture was monitor until an OD600 of 0.4 to 0.5 was 
achieved at which point the entire 50 ml culture was centrifuged at 3250 x g for 10 mins 
at 4 °C (Eppendorf 5804R with A-4-44 rotor). The supernatant was removed and the 
cell pellet resuspended in 30 ml ice cold 0.1 M MgCl2 and incubated on ice for 10 min.  
The solution was centrifuged (same conditions), the supernatant removed and the pellet 
resuspended in 30 ml ice cold 0.1 M CaCl2 and incubated on ice for 30 min.  The cells 
were centrifuged for a final time (same conditions), the supernatant removed and the 
pellet resuspended in 4 ml ice cold 0.1 M CaCl2 and 20% glycerol. Aliquots of 200 µl 
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were made, flash frozen in liquid nitrogen and stored at -80 °C.  
 
2.3.12: Transformation 
Typically 1-2 µl of plasmid DNA (approximately 100 ng/µl) was used in transformation 
reactions, unless the transformed DNA was from a ligation reaction, in which case the 
entire reaction mix was transformed into 200 µl of chemically competent cells.  
Competent cells were defrosted on ice and plasmid DNA added, mixed gently and 
incubated on ice for 30 min before being heat shocked at 42 °C for 1 min.  Heat-
shocked cells were incubated on ice for 5 min then 900 µl of pre-warmed LB were 
added followed by incubation at 37 °C with 250 rpm shaking for 90 min.  Cells were 
centrifuged at 12000 x g (Eppendorf 5453) for 5 min and 1 ml of supernatant removed.  
The pellet was resuspended in the remaining 100 µl of supernatant and plated onto LA 
with appropriate antibiotic(s). 
 
2.3.13: Electroporation 
Electroporation was used to introduce plasmid DNA into Brucella spp. Competent 
Brucella cells were prepared by harvesting Brucella from a Brucella agar plate into 1 ml 
H2O.  The cells were washed three times with 1 ml H2O via centrifugation (3 min, 
20°C, 13,000 rpm), re-suspended in 200 µl of water before dividing into 50 µl aliquots.  
Up to 5 µl of plasmid DNA (~ 1 µg) were added to 50 µl of competent Brucella cells in 
a cooled 0.2 mm electroporation cuvette and electroporated (BioRad XCell 
electroporation system) at 400 Ω, 25 µF and 2.5 kV for 10 ms.  Electroporated cells 
were allowed to recover in 1 ml SOC-B at 37 °C overnight before plating onto TSA 
with appropriate antibiotics and incubated at 37°C for up to 5 days.  
 
2.3.14: Plasmid extraction  
(Thermo GeneJET mini prep kit; Qiagen QIAprep Spin Miniprep kit) 
A 5 ml liquid culture (LB), with appropriate antibiotic, of E. coli harbouring the 
plasmid required for extraction was grown for a maximum of 16 h at 37 °C with 
250 rpm shaking.  Following incubation, the entire culture was centrifuged at 3250 x g 
(Eppendorf 5804R with A-4-44 rotor) for 10 min at 4 °C.  The supernatant was removed 
and the pellet re-suspended in 250 µl resuspension solution, (QIAprep includes addition 
of 10 µl alkaline phosphatase with incubation at room temperature for 5 mins) 250 µl 
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lysis solution and 350 µl of neutralisation solution were added and the centrifuged for 5 
min at 12000 x g (Eppendorf 5453).  A 850 µl volume of supernatant was added to the 
centrifugation column and centrifuged for 1 min at 12000 x g (Eppendorf 5453), the 
flow-through was discarded and the column washed twice with an ethanol-containing 
wash solution.  The column was centrifuged for an additional 1 min at 12000 x g 
(Eppendorf 5453) to remove residual ethanol, before 50 µl of elution solution were 
added to the centre of the column, incubated at room temperature for 2 min and 
centrifuged at 12000 x g (Eppendorf 5453) for 2 min.  The eluent containing the 
plasmid was stored at -20 °C. 
 
2.3.15: Estimation of DNA concentration 
Prior to ligation and sequencing reactions the concentration of the plasmid DNA was 
estimated using the Nanodrop spectrophotometer.  Plasmid DNA (2 µl) was placed onto 
the spectrophotometer’s pedestal and the absorbance of the sample at 260 nm was 
determined, with a read out of DNA concentration in ng/µl given. Considerations to the 
purity of the DNA were undertaken though the ratio of 260/280 nm absorbance.   
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2.4: Recombinant protein manipulation 
 
2.4.1: Induction of recombinant protein  
A single isolated colony of E. coli BL21 (DE3) harbouring an overexpression plasmid 
(pET series) engineered to express a 6xHis tagged recombinant protein was inoculated 
into LB with ampicillin and incubated overnight at 37 °C with 250 rpm shaking (starter 
culture). This starter culture was used to inoculate pre-warmed and pre-shaken LB with 
ampicillin at a ratio of 1:100 (starter culture; fresh LB).  The optical density of the 
culture was monitored until an OD600 of 0.5 was achieved, at which point 0.5 mM IPTG 
was added to induce protein expression.  During preliminary expression experiments, 
0.5 OD units of cells were collected by centrifugation (7 min at 12000 x g; Eppendorf 
5453) every hour for 5 h after induction, with an additional sample taken after overnight 
growth. The supernatant was removed and dry pellets stored temporarily on ice or 
overnight at -20 °C.  For larger scale overexpression 5 L of culture were harvested by 
centrifugation at 6000 x g (Sorval RC5B+ with SLA-3000 rotor) for 30 min at 4 °C, 5 h 
after induction. The resulting pellet was re-suspended in 25 ml ice-cold PBS and 
centrifuged for 20 min at 4000 x g (Sorval RC5B+ with SS-34 rotor), the supernatant 
was removed and the pellet frozen to -80 °C prior to lysis (Method 2.5).   
 
2.4.2: Protein solubility 
To determine the solubility of expressed recombinant protein, samples of whole cells 
were solubilized with BugBuster (5 ml/g of cells) and incubated at room temperature 
for 20 min with gentle shaking.  Lysed cells were centrifuged at 12000 x g (Eppendorf 
5453) for 20 min at 4 °C, the supernatant was removed and stored in a sterile 1.5 ml 
centrifuge tube (soluble fraction), the cell debris was resuspended in SDS-sample 
loading buffer (insoluble fraction).  Samples of each soluble and insoluble fraction were 
applied alongside each other during separation by SDS-PAGE and the relative 
concentration of the protein in each band determined.  
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2.4.3: Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE) 
Pelleted whole cells were re-suspended in 100 µl of 1x SDS sample loading buffer 
whilst solutions containing protein required the addition of one volume of 2x SDS 
sample loading buffer (1x sample loading buffer: 50 mM Tris-HCl pH 6.8, 2% SDS, 
10% glycerol, 1% β-mercaptoethanol or dithiothreitol, 12.5 mM EDTA and 0.02% 
bromophenol blue) and denatured by heating at 100 °C for 10 min. To disrupt cell 
membranes to isolate integral membrane proteins an addition of 8 M urea was made to 
1x SDS sample-loading buffer (urea sample loading buffer), whole cell samples were 
resuspended in urea sample loading buffer and incubated at 37 °C for 1 h. 
 
A 10 µl volume of denatured protein sample was loaded per well of a polymerized 
polyacrylamide gel (12 or 16% acrylamide concentration) which was subjected to 
electrophoresis for approx. 1 h with a constant 30 mA per gel in SDS-PAGE running 
buffer (25 mM Tris base, 192 mM glycine and 0.1% (w/v) SDS, pH 8.3) or until the 
loading dye had migrated to the bottom of the gel. For visualisation of total protein 
Coomassie blue stain (1.2 mM Coomassie Brilliant Blue R-250, 50% (v/v) methanol, 
10% (v/v) glacial acetic acid) was applied for 2 h, the stain was removed and the gel 
washed with cold water to remove excess stain.   The gel was then submerged in de-
stain (10% (v/v) acetic acid, 30% (v/v) methanol) initially for 30 min and then for an 
additional 2 h minimum, until the gel had little or no blue background staining.  Upon 
complete de-staining, the gel was equilibrated in water, and visualised with the G-Box 
(Syngene).   
 
2.4.4: Molecular weight markers - Protein marker 
PageRuler plus prestained protein ladder and BioRad precision plus kaleidoscope 
marker (Appendix 9.1) were used to estimate the size and quantity of protein following 
gel electrophoresis.  
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2.4.5: Western Blotting 
Samples for Western blotting follow Method 2.25 but are not stained with Coomassie 
blue, after gel electrophoresis the gel with separated protein was removed from the glass 
plates, equilibrated in 1x Tris-glycine transfer buffer (Novex – Invitrogen) for 15 min 
and transferred to a polyvinylidene fluoride (PVDF) membrane.  The PVDF membrane 
was prepared by soaking in methanol for 10 s, followed by distilled water for 2 min and 
15 min in 1x Tris-glycine transfer buffer.  A Bio-Rad Trans Blot SD semi-dry transfer 
cell was used to transfer protein from the SDS-PAGE gel to the PVDF membrane.  A 
transfer buffer soaked sheet of filter paper was applied to the anode of the transfer cell, 
ensuring that all air bubbles were removed, followed by the prepared PVDF membrane, 
the equilibrated SDS-PAGE gel and a final sheet of transfer buffer soaked filter paper.  
The cathode was attached and proteins transferred for 1-2 h with a continuous 400 mA. 
 
Following transfer, the PVDF membrane and the SDS-PAGE gel were removed from 
the transfer apparatus.  The PVDF membrane was stained with Ponceau S (0.1% (w/v) 
Ponceau S in 1% (v/v) acetic acid) to ensure that proteins had been transferred to the 
membrane.  Ponceau S was applied directly to the membrane and shaken for 5 min; 
excess stain was removed by washing with 5% acetic acid or water.  The stain is 
reversible and blocking of the membrane commenced after visualisation of bound 
proteins to the membrane.  In addition, the post-transfer polyacrylmide gel was stained 
with Coomassie blue to determine the efficiency of the transfer. 
 
The PVDF membrane was blocked with 5% dried skimmed milk powder in Tris-
buffered saline (TBS: 50 mM Tris-Cl pH 7.5 and 150 mM NaCl) for 1 h at room 
temperature with shaking or over-night at 4 °C.  Blocking reagent was removed through 
washing three times for 5 min each with 0.01% skimmed milk powder and 0.05% 
Tween 20 in TBS.  After washing, primary polyclonal antibody was applied at 1:1000 
dilution to the membrane and shaken at room temperature for 1 h.  The wash step was 
repeated and secondary antibody (anti-rabbit horse-radish peroxidase) was applied for 
45 min with shaking. The wash step was repeated and 10 ml of DAB (50 µM 3,3′-
diaminobenzidine tetrahydrochloride in H2O) with metal enhancer is applied to the 
membrane and left to develop for 5-10 min.  Following development, the membrane 
was washed with PBS and dried at 50 °C. 
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2.4.6: Cell lysis by sonication 
Frozen, pelleted cells harvested from a large scale overexpression (Method 2.15) were 
defrosted overnight at 4 °C and re-suspended in 14 ml buffer A1 (50 mM Tris, 15 mM 
mannitol and 15 mM imidazole, pH 8.0). Cell lysis was initiated by addition of 1 mg/ml 
lysozyme which was incubated at 22 °C for 1 h.  The cells were cooled on ice for 30 
min before sonication at 60% amplitude with a 6 mm diameter tip for 15 min (Sonics 
Libra Cell).  The resulting cell lysate was centrifuged three times at 3250 x g 
(Eppendorf 5810R with A-4-81 rotor) for 20 min at 4 °C and the supernatant filtered 
through a 0.45 µm sterile filter. 
 
2.4.7: Chromatography 
Nickel affinity chromatography 
Prior to separation of recombinant protein the nickel-affinity chromatography column 
was washed with two column volumes (CV) of degassed 30% ethanol, all solutions to 
be applied to all chromatography columns are degassed via exposure to a negative 
pressure achieved through vacuum pressure. The column was stripped of bound nickel 
via washing with 2 CV of 0.5 M EDTA (pH 8.0) followed by a 2 CV wash with 
ultrapure H2O.  The stripped column was re-charged with nickel via washing with 2 CV 
0.5 M NiSO4 followed by a 2 CV wash with H2O to remove unbound nickel.  The 
column was then equilibrated by washing first with 1 CV of buffer B1 (buffer A1 with 1 
M imidazole) then 3 CV of buffer A1.  Filtered cell lysate (Method 2.5) in buffer A1 
was then loaded onto the buffer-A1-equilibrated nickel-affinity column.  Excess un-
bound protein was removed from the column by washing with 2 CV of buffer A1, and 
the flow-through was collected for subsequent SDS-PAGE analysis. All subsequent 
eluant was collected into plastic test tubes containing 7 ml fractions, and the UV 
absorbance at 280 nm was measured throughout.  A further 2 CV of buffer A1 was used 
to wash residual unbound protein from the column; the UV reading of the eluent was to 
0 and a linear gradient of 0-100% of buffer B1 was applied over 8 CVs. To ensure all 
protein was eluted, a further 2 CV of buffer B1 was applied followed by 2 CV of buffer 
A1 and 2 CV of 30% ethanol to preserve the column.  A 10 µl volume of all collected 
fractions displaying elevated UV absorbance (suggesting presence of purified 
recombinant protein) were analysed by SDS-PAGE through solubilisation with 2x SDS-
PAGE loading buffer. 
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Diethylaminoethanol (DEAE) anion-exchange chromatography 
DEAE anion exchange chromatography was used as a secondary purification technique, 
further purifying recombinant protein from nickel-affinity chromatography.  Prior to 
loading the semi-purified recombinant protein from the nickel-affinity chromatography 
column, fractions with a high concentration of protein (as determined by SDS-PAGE) 
were pooled together. The anion-exchange column was washed with 2 CV of degassed 
H2O to removed preservative ethanol, the column was then equilibrated with 4 CV of 
buffer B2 (50 mM Tris, 1 mM dithiothreitol and 1 M NaCl) followed by 8 CV of buffer 
A2 (50 mM Tris and 1 mM dithiothreitol).  Semi-purified pooled protein fractions were 
loaded onto the column and excess un-bound protein was removed via washing with 2 
CV buffer A2, and the flow through was collected. All subsequent eluant was collected 
into 7 ml fractions; a further 4 CV of buffer A1 was run through the column, the A280nm 
of the eluent from the column was set to 0 and a linear gradient of 0-100% of buffer B2 
was applied over 4 CVs. To ensure all protein was eluted, a further 2 CV of buffer B2 
was applied followed by 2 CV of buffer A2 and 2 CV of 30% ethanol to preserve the 
column.  A 10 µl aliquot of all collected fractions displaying elevated UV absorbance 
suggesting presence of purified recombinant protein was analysed by SDS-PAGE 
through solubilisation with 2x SDS-PAGE loading buffer. 
 
2.4.8: Dialysis 
To exchange the buffer for the pooled fractions after purification (Method 2.9), dialysis 
using 33 mm diameter cellulose membrane dialysis tubing (Sigma Aldrich) was 
performed.  The solution to be dialysed was enclosed within the dialysis tubing, the 
sealed tube was placed into the required, pre-chilled, buffer and allowed to exchange by 
diffusion for 6 h with continuous stirring. Typically, the volume of solution required to 
ensure complete exchange of solute was 1:1000.  The buffer was exchanged three times 
during the procedure (18 h total dialysis time), after the third change, the protein 
containing solution was removed from the dialysis tubing and stored at -20/80 °C. 
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2.4.9: Estimation of protein concentration 
UV absorbance 
The concentration of recombinant protein was determined using the Nanodrop ND-1000 
spectrophotometer.  A 2 µl sample of protein was placed onto the spectrophotometer’s 
pedestal and the absorbance of the sample at 280 nm was determined, with a read out of 
protein concentration in mg/ml was reported. Considerations to the purity of the protein 
was undertaken though the ratio of 260/280 nm absorbance. 
 
Bradford Assay 
A standard curve of known concentrations of bovine serum albumin (BSA) was 
prepared in PBS, 10 µl of standard and 10 µl of un-diluted, 5x and 10x diluted protein 
were aliquoted into a 96 well plate.  A 200 µl volume of 1:4 diluted Bradford reagent 
(Bio-Rad) was added to each well and left to enable colour development for 5 min.  The 
absorbance of each well was measured at 595 nm using the Molecular Devices 
Spectramax 190 spectrophotometer.  The concentration of the unknown protein was 
then be calculated from the standard curve. 
 
2.4.10: Centrifugal concentration 
The eluent containing purified recombinant protein from liquid chromatography 
(Method 2.9) was concentrated using a Vivaspin 20 (30,000 MWCO) (Satorius Stedim 
Biotech) centrifugal concentrator.  Chromatography eluent was loaded into the top of 
the concentrator and centrifuged at 3250 x g for 20 min at 4 °C (Eppendorf 5804R with 
A-4-44 rotor), the flow through from the column was kept and analysed by SDS-PAGE 
to ensure the absence of the recombinant protein. Eluent can be continually applied to 
the top of the concentrator until the required concentration of protein is achieved. 
 
2.4.11: Reconstitution of recombinant protein with iron 
To remove bound metal from the as-isolated erythrin domain to create apo-erythrin, 1 
ml aliquots of 2 mg/ml protein solutions were incubated on ice for 1 h with addition of 
1 µM diethylenetriaminepentaacetic acid (DTPA), 1 µM 2,2’-dipyridyl and 2 µM 
sodium dithionite.   Metal chelates were subsequently removed through thorough 
dialysis against 20 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) 
pH 7.0, generating apo-erythrin. Adventitiously bound iron was removed by dialysis of 
the protein-metal complex through thorough dialysis against 20 mM HEPES pH 7.0. 
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Typically the UV-visible spectrum of 500 µl of 10 µM apo-protein, anaerobically 
prepared (N2 purged) 20 mM HEPES pH 7.0, was measured pre and post addition of 
anaerobically prepared 20 µM ferrous ammonium sulphate, to ensure reconstitution 
with iron. 
 
2.4.12: Thermal shift assay method: 
A 1 mg/ml solution of apo-erythrin was prepared in 20 mM HEPES pH 7.0, to which, 
SYPRO orange was diluted to a final x2 concentration. A 10 µl volume of the desired 
screening reagent (for screening assay 1 and 2 profiles see appendix 9.5) was added to 
each well of a 96-well PCR plate before 10 µl of the SYPRO orange-erythrin solution.  
The fluorescence emission signal data (567–596 nm) was collected with an Applied 
Biosystems 7500 FAST RealTime PCR System (excitation range: 510–530 nm), whilst 
the temperature was increased from 24 to 94 °C at a rate of 1°C/min. The temperature 
of hydrophobic exposure at which half of the protein population was unfolded, Th, was 
determined with NAMI algorithm (Groftehauge et al. 2015).  
 
 
2.5: Assays 
 
2.5.1: 55Fe Transport Assay: 
A transformant E. coli MG1655 colony was grown overnight in 5 ml LB, from which 1 
ml was used to inoculate 25 ml of fresh LB with addition of 10 µl 55Fe3+ (0.185 mBq). 
Cells were allowed to grow until mid-log phase (2 h), at which time cells were induced 
with 0.1 mM rhamnose and incubated for a further 1 h. Induced cells were harvested by 
centrifugation (5000 x g 4 °C 10 min) and the supernatant discarded, the cells were 
washed three times with 10 ml cold transport buffer (TB: 50 mM MES, 50 mM TAPS 
pH 7.0, 0.4% glucose, 0.2 mM CaCl2, 2 mM MgCl2). The cell pellet was re-suspended 
in 1.5 ml ice cold TB and 300 µl aliquots created. One aliquot at a time was diluted in to 
3 ml pre-warmed (37 oC) TB in the reaction cell, maintained with continual stirring. A 
250 µl aliquot of cells was removed from the reaction cell for every time point taken 
and filtered through a 0.22 µm syringe driven filter, followed by washing with 2.5 ml 
cold wash buffer (WB: 10 mM EDTA, pH 8.0). then, 2 ml of filtrate were added to 4 ml 
Ultima Gold XR scintillant (Perkin Elmer) and inverted until mixed. All samples were 
left for 24 h to allow for a reduction in background chemi-luminescence, before liquid 
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scintillation counting (0.2 – 6.2 KeV) with the Beckman LS-6500 multi-purpose 
scintillation counter for 3 min per sample.  Results were standardised per mg of protein 
determined via a Bradford assay. Additions of hydrogen peroxide, catalase 
(Micrococcus lysodeikticus) and CCCP (3.3 mM stock; DMSO) were made 
immediately prior to addition of cells to the reaction chamber. 
 
2.5.1.1: Principles for using radio-labelled iron for iron export experimentation 
Iron-55 (55Fe) is a synthetic radioactive isotope of iron and has a half-life of 2.7 years. 
The nucleus of 55Fe contains 26 protons and 29 neutrons (compared to the stable 56Fe 
atom which contains 26 protons and 30 neutrons) and decays by electron capture to 
stable manganese-55 (25 protons and 30 neutrons).  Decay via electron capture (k-
electron capture) is a process by which a proton rich nucleus of an electrically neutral 
atom absorbs an electron from the k electron shell. This process changes the nuclear 
proton to a neutron as well as emitting an electron neutrino (ve).  
 
p + e- = n + ve 2629𝐹𝑒 + 𝑒! →  2530𝑀𝑛 +  𝑣!  
 
If the daughter nuclide is in an excited state, it transitions to its ground state, usually 
through emission of a gamma ray.  After capture of an inner electron into the nucleus, 
an outer electron replaces it and one or more X-ray photons are emitted in the process.  
Alternatively, electron capture can result in the Auger effect; the energy released when 
the outer electron replaces the inner electron is transferred to another outer electron, 
resulting in this electron’s ejection from the atom, leaving a positive ion. 
 
The decay energy of the transition of 55Fe to 55Mn is 2.31 keV (kilo-electronvolts); 
generated by both X-rays and Auger electrons, and is detected by liquid scintillation 
counting (LSC). The collected samples containing the radioactive isotope are suspended 
in a scintillation ‘cocktail’ (Ultima Gold XR – Perkin Elmer) containing a solvent, 
surfactant and scintillator, within a translucent plastic scintillation vial.  Emitted energy 
during the radioactive decay is transferred to the aromatic ring of the solvent; the 
energized solvent molecules transfer the captured energy to other solvent molecules, 
until the energy is transferred to the primary scintillator.  The primary scintillator emits 
photons, following the absorption of the transferred energy, which are detected by two 
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photo-multiplier tubes allowing the measurement of the radioactive decay in counts per 
minute (CPM/DPM). Analysis of a sample of 55Fe via liquid scintillation counting 
shows the decay energy of 2.31 KeV (Figure 2.1), this allows adjustment of the 
Beckman LS-6500 multi-purpose scintillation counter to observe photon emissions 
within defined channels (Figure 2.2). To facilitate conversion of DPM into pmol 55Fe 
first a conversion to Becquerels (Bq) is performed (1 Bq = 60 DPM), followed by 
multiplication by the specific activity of the 55Fe source (1.8703).  Additionally, through 
the analysis of known quantities of 55ferric citrate and discrepancies in the determined 
DPM, a quench factor  of 1.58 was included (Figure 2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Energy emission of 55Fe decay.   
Measurement of 55Fe energy emission via liquid scintillation counting as determined by 
counts per minute (CPM). Horizontal dashed lines represent the predefined high and 
low limits of detection. Beckman LS-6500 multi-purpose scintillation counter. 
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Figure 2.2: Channel range of energy emission from 55Fe decay.  
Measurement of 55Fe energy emission via liquid scintillation counting as determined by 
counts per minute (CPM). Horizontal dashed lines represent the predefined high and 
low limits of detection. Beckman LS-6500 multi-purpose scintillation counter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Calibration curve of 55Fe disintergrations per minute (DPM) to pmol 
55Fe.  
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2.5.2: Ferrozine assay 
A culture of 1 L was propagated and induced as for 55Fe transport assay, then cells were 
washed and re-suspended to a final 30 ml volume in TB.  10 ml of washed cells were 
diluted into 60 ml warm TB and 10 ml samples taken per time point.  Cellular 
supernatants were collected by centrifugation before 0.22 µm syringe driven filtration to 
remove residual cells.  Ferric iron concentration was determined with addition of a 1:1 
(v/v) ratio of supernatant to 1% ferrozine solution followed by measurement of 
absorbance at 562 nm. Detection of ferrous iron included addition of 10% acetic acid 
and 750 mM sodium sulphite to the ferrozine solution to promote reduction to ferrous 
iron. For determination of whole cell iron concentrations, the ferrous iron protocol was 
used, preparations were heated to 90 °C for 1 h to allow lysis of cells. 
 
2.5.3: Hydrogen peroxide assay 
Measurements of hydrogen peroxide concentrations were made with Amplex Red 
(Thermo).  Transformant E. coli MG1655 was inoculated into 5 ml LB (starting OD: 
0.05), induced for 1 h at OD600nm 0.5 with 100 µM rhamnose, washed once with 10 ml 
cold WB, then twice with TB followed by dilution to 1 OD unit ml-1. For each 
measurement of H2O2 concentration, 100 µl of cell-free solution were added to 100 µl 
Amplex Red reagent and absorbance at 560 nm determined, then compared to a 
standard curve generated with known concentrations of H2O2. For each assay, a 
measurement prior to addition (Pre) of 15 µM H2O2 (T0) was made to ensure 
endogenous H2O2 concentrations were minimal, then every 2 min after H2O2 addition 
during the assay. When used, desferrioxamine was added prior to addition of cells or 
iron.  The pH of TB was adjusted as required. 
 
2.5.4: Streptonigrin assay 
Transformant E. coli strains were inoculated into 200 µl LB (starting at OD 0.05) 
containing up to 4 µg/ml streptonigrin (1 mg/ml stock in DMSO) and 75 µM 
diethylamine NONOate (nitric oxide liberator; PBS pH 7.4). Bacterial growth was 
monitored every 30 min by Labsystems Bioscreen C incubated spectrophotometer.  
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2.5.5: Macrophage survival assay  
Macrophages were seeded at a concentration of 1x105 in 24 well plates in Dulbecco’s 
modified Eagle’s medium with 5% fetal bovine serum and 2 mM L-glutamate and 
incubated at 37 °C with 5% CO2.  After 24 h, macrophages were infected with Brucella 
at a multiplicity of infection (MOI) of 100:1 and incubated at 37 °C for 1.5 h to allow 
phagocytosis. Extracellular bacteria were killed by treatment with gentamicin (50 
µg/ml) for 1 h and maintained in Leibovitz's L-15 medium with gentamicin (2 µg/ml) 
thereafter. At 0, 4, 24 and 48 h after infection, macrophages were washed with PBS and 
lysed with 0.1% (v:v) Triton X-100 in H2O.  The number of intracellular bacteria was 
determined by serial dilutions of macrophage lysates and plated on Brucella agar.   
 
2.5.6: Cellular fractionation 
A single isolated E. coli colony transformed with a controllable expression plasmid 
(pSU or pBAD) capable of expressing an a mbfA isoform was inoculated into 5 ml LB 
containing appropriate antibiotic and incubated over-night at 37 °C with 250 rpm 
shaking.  The over-night culture was diluted 1:10 into fresh LB with appropriate 
antibiotic; the OD600nm was measured until a value of 0.5 was achieved, upon which, the 
culture was induced (0.5 mM IPTG or 0.1 mM rhamnose).  The cells were harvested by 
centrifugation at 4000 x g (Sorval RC5B+ with SS-34 rotor) at 4 °C for 10 min after 2 h 
a growth post-induction and the supernatant removed. One OD unit of cells was taken 
and kept as whole cells.  The periplasm was extracted via osmotic shock through 
resuspending the remaining cells in 20% w/v sucrose, 30 mM Tris (pH 8.0) and 1 mM 
EDTA and incubated on ice for 30 min, after which the cells were pelleted via 
centrifugation at 3250 x g for 20 min (Eppendorf 5810R with A-4-81 rotor). The 
supernatant was kept as the sucrose fraction and the pellet resuspended in 10 mM 
MgCl2 and incubated on ice for 30 min.  The cells were pelleted via centrifugation at 
3250 x g for 20 min (Eppendorf 5810R with A-4-81 rotor) and the resulting supernatant 
kept as the MgCl2 fraction.  The resulting pellet was resuspended in PBS and the 
spheroblasts were lysed by sonication using a 6mm diameter tip at 60% amplitude for 
15mins (Method 2.5).  Unlysed cells were removed through multiple centrifugations at 
4500 x g at 4°C for 10 mins (Sorval RC5B+ with SS-34 rotor), the resulting supernatant 
was kept as spheroplasts lysate.  The lysed spheroplasts were subjected to 
ultracentrifugation at 130,000 x g at 4 °C for 1 h (Beckman Coulter L-90K with SW40 
Ti rotor and 14x89 ml centrifuge tubes) to separate the cytoplasm (supernatant) from 
the cellular membranes (pellet).  The pelleted membranes were resuspended in PBS, 3 
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mM EDTA and 0.5% sarcosyl and incubated at room temperature for 30 min.  The total 
membrane fraction was centrifuged again at 130,000 x g at 4 °C for 1 h to separate the 
outer-membrane (supernatant) from the inner membranes (pellet), the pellet was 
resuspended in 50 mM Tris (pH 8.0) with 10 mM EDTA.  The resulting membrane 
fractions were analysed by SDS-PAGE and Western blotting. 
 
 
2.6: Removal of Biological Materials from Containment Level 3 Facilities 
 
2.6.1: Removal of PCR amplified DNA  
 
To conduct agarose gel electrophoresis on PCR amplified DNA at containment level 2 
from DNA samples originating at containment level 3 the following protocol was 
followed (DSTL-DOC-30515: The Growth, Manipulation and Inactivation of Brucella 
spp.) to ensure the complete inactivation of Brucella cells.   
 
A single Brucella melitensis colony was resuspended in 100 µl of H2O and heated to 96 
°C for 10 min (demonstrated previously to inactivate 100% of Brucella melitensis cells 
- February 2010 lab book 33/2009).  The PCR reaction was prepared with 2 µl of the 
Brucella boilate within a class III safety cabinet which was wiped out of the cabinet 
using a 10% Chloros soaked cloth before being subjected to the required PCR cycling 
conditions outside of primary containment.   For PCR reactions using genomic DNA an 
extended 10 min initial denaturation step at 96° C must be included and witnessed by an 
independent observer, to further ensure sterility of the PCR sample.  Upon completion 
of the thermocycling, the PCR vessels were wiped again with a 10% chloros soaked 
cloth, removed from the containment suite and analysed immediately at containment 
level 2 within a class II safety cabinet. 
 
NOTE: 96 °C for 10 min heat inactivation of Brucella suis strains had not been 
previously demonstrated, thus prevented the removal of B. suis PCR samples from the 
containment level 3 facility.  
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2.6.2: Removal of heat inactivated cells 
 
To remove heat inactivated Brucella samples for downstream processes such as SDS-
PAGE and Western blotting the heat inactivation and sterility / inactivation checks were 
conducted as described in DSTL-DOC-30515: The Growth, Manipulation and 
Inactivation of Brucella spp. 
 
 
A 5 ml Brucella sample in a 30 ml container was placed in a 60 °C water bath within a 
class III microbiological safety cabinet for at least 2 hours to ensure complete 
inactivation. On completion, the water will be allowed to cool, decanted into a Duran 
bottle and added to Chloros to give a final concentration of 10% v/v. 
 
To determine sterility of the inactivated material 10% of the inactivated bacterial 
suspension was inoculated into Brucella broth, the broth volume being in excess, at 
least 10x that of the inoculum, and incubated for a minimum of seven days at 37 ºC. 
10% of the broth was plated out onto Brucella agar (250 µl per plate) and the plates 
incubated for a further seven days at 37 ºC in sealed containers.  Preparations cleared by 
this method were released upon completion of a ‘production and issue of biological 
materials’ form and used at containment level 2. Every sterility check included a 
positive control to show that the media supports growth of Brucella spp.  
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Table 2.2: Bacterial Strains.  
E. coli Strains Genotype Reference/Source 
MG1655 F-  wild-type  Lab Stock 
LC106 MG1655: ΔahpCF’ kan::’ahpF Δ(katG17::Tn10)1 Δ(katE12::Tn10)1 L.Seaver (2004) 
W3110 F–  λ–  IN(rrnD-rrnE)1 rph-1 Lab Stock 
JC28 W3110  ΔfecABCDE ΔzupT ΔmntH ΔentC ΔfeoABC J. Cao (2007) 
MC4100 F-, (araD139)B/r, Δ(argF-lac)169,  λ
– , e14-, flhD5301, Δ(fruK-yeiR)725(fruA25), 
relA1, rpsL150(strR), rbsR22,  Δ(fimB-fimE)632(::IS1), deoC1 Lab Stock 
H1941 MC4100 Δfur K. Hantke (2001) 
BW25113 lacI rrnB ΔlacZ hsdK ΔaraBAD ΔrhaBAD  Datsenko and Wanner (2000) 
AS01 BW25113 Δbfr A. Salman (2016) 
AS02 BW25113 Δdps A. Salman (2016) 
AS03 BW25113 ΔftnA A. Salman (2016) 
AS04 BW25113 Δdps ΔftnA A. Salman (2016) 
AS05 BW25113 Δbfr ΔftnA A. Salman (2016) 
AS06 BW25113 Δdps Δbfr A. Salman (2016) 
AS07 BW25113 Δdps Δbfr ΔftnA A. Salman (2016) 
  BW25113 Δbfd  Lab stock 
  BW25113 Δbfr Δbfd  Lab stock 
EM1055 MG1655Δ(lacI-ZYA)X74  E. Masse (2002) 
EM1256 MG1655 - Δfur::kan E. Masse (2002) 
EM1238 MG1655 - ΔryhB::cat E. Masse (2002) 
EM1257 MG1655 - Δfur::kan  ΔryhB::cat E. Masse (2002) 
BL21(DE3) F– ompT hsdSB(rB–, mB–) gal dcm(λDE3) Invitrogen 
BL21(DE3) Star F– ompT hsdSB(rB–, mB–) gal dcm rne131 (λDE3) Invitrogen 
BL21(DE3) Rosetta F– ompT hsdSB(rB–, mB–) gal dcm (λDE3) pRARE2 (CamR) Novagen 
   
Brucella Strains Genotype Reference/Source 
B. suis 1330 WT Laboratory Stock 
B. suis  ΔmbfA B. suis 1330 ΔmbfA This study 
B. suis pmbfA B. suis ΔmbfA carrying pBBR4mbfAsuis This study 
B. suis pmbfAmel B. suis ΔmbfA carrying pBBR4mbfAmelitensis This study 
B. melitensis 16M WT Laboratory Stock 
B. melitensis ΔmbfA B. melitensis 16M ΔmbfA This study 
B. melitensis pmbfA B. melitensis ΔmbfA  carrying pBBR4mbfAsuis This study 
B. melitensis 
pmbfAmel 
B. melitensis ΔmbfA carrying pBBR4mbfAmelitensis This study 
      
Burkholderia 
Strains Genotype Reference/Source 
B. multivorans ATCC 
17616 WT Laboratory Stock 
B. multivorans  
ΔmbfA B. multivorans ΔmbfA F. Izza (2015) 
B. multivorans pmbfA B. multivorans ΔmbfA carrying pBBR4mbfA F. Izza (2015) 
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Table 2.3: Plasmids. 
Plasmid name Genotype Antibiotic resistance Source 
pJET1.2blunt Cloning vector from which DNA fragments are inserted into Eco32I site within the eco47IR gene Amp Fermentas 
pJETmbfA271 B. melitensis 16M mbfA with 0.5kb 5’/3’ flanking sequence Amp This work 
pJETmbfA306 B. melitensis 16M mbfA with 0.5kb 5’/3’ flanking sequence.  SDM - c64a to create MbfA306 Amp This work 
pJETmbfA327 B. melitensis 16M mbfA with 0.5kb 5’/3’ flanking sequence.  SDM - t55c to create wild-type Brucella MbfA327 Amp This work 
pJETmbfA B. melitensis 16M mbfA with 1kb 5’/3’ flanking sequence Amp This work 
pJETΔmbfA::kn B. melitensis 16M mbfA with 1kb 5’/3’ flanking sequence.  mbfA coding sequence removed, Kn cassette insertion. Amp/Kn This work 
        
pCR2.1  Cloning vector Amp	 ThermoFisher 
pCR16M B. melitensis 16M mbfA with 0.5kb 5’/3’ flanking sequence Amp This work 
pCR16MΔmbfA B. melitensis 16M ΔmbfA with 0.5kb 5’/3’ flanking sequence Amp/Kn This work 
pCR1330 B. suis 1330 mbfA with 0.5kb 5’/3’ flanking sequence Amp This work 
pCR1330ΔmbfA B. suis 1330 ΔmbfA with 0.5kb 5’/3’ flanking sequence Amp/Kn This work 
        
pEX100T Suicide vector, sacB negative selection gene Amp Martin Roop 
pEXΔmbfA::kn ΔmbfA with 1kb 5’/3’ flanking sequence Amp/Kn This work 
        
pBBR1-MSC4 Broad host range vector, MCS, lac promoter and lacZa Amp Michael Kovach 
pBBR4mbfA271 mbfA271 with 0.5kb 5’/3’ flanking sequence Amp This work 
pBBR4mbfA327 mbfA327 with 0.5kb 5’/3’ flanking sequence Amp This work 
        
pSU18 High copy number vector, MCS, lac promoter and lacZa Cm Lab Stock 
pSUmbfA271 mbfA271 cloned into MCS site  Cm This work 
pSUmbfA306 mbfA306 cloned into MCS site  Cm This work 
pSUmbfA327 mbfA327 cloned into MCS site  Cm This work 
        
pBADrham Low copy number vector, MCS, rhamnose promoter Cm 
Ford, Ireland 
2014 
pBADmbfA271 mbfA271 cloned into MCS  Cm This work 
pBADmbfA306 mbfA306 cloned into MCS  Cm This work 
pBADmbfA327 mbfA327 cloned into MCS  Cm This work 
pBADmbfA327D191 mbfA327 cloned into MCS - SDM D191G Cm This work 
pBADmbfA327M228 mbfA327 cloned into MCS - SDM M228G Cm This work 
pBADmbfA327E232 mbfA327 cloned into MCS - SDM E232G Cm This work 
pBADmbfA327Y268 mbfA327 cloned into MCS - SDM Y268G Cm This work 
pBADAT_VIT Synthetic AT_VIT cloned into MCS  Cm This work 
pBADery mbfA - erythrin domain cloned into MCS  Cm This work 
pBADVIT mbfA - Vit domain cloned into MCS  Cm This work 
		
	
    
pBADHisA Cloning vector, arabinose promoter Amp Invitrogen 
pARAmbfA mbfA327 cloned into MCS  Amp This work 
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Plasmid name Genotype Antibiotic resistance Source 
pET21a T7 promoter and terminator, MCS, N terminal 6xHis Amp Novagen 
pETery271 ery271cloned into MCS site Amp This work 
pETery306 ery306 cloned into MCS site Amp This work 
pETery327 ery327 cloned into MCS site Amp This work 
pETeryCO eryCO cloned into MCS site of pET21a Amp This work 
        
pHP45ΩKn High copy number vector, x2 MCS Amp/Kn Fellay 1987 
        
pMA-mbfA Synthetic, codon optimised mbfA327 Amp Invitrogen 
pMA-AT_VIT Synthetic, codon optimised Arabidopsis thaliana VIT1 Amp Invitrogen 
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Table 2.4: PCR primers. 
Name Sequence 5’-3’ GC (%) Length 
Tm 
(oC) 
Knockout construction 
mbfA0.5kb 
F ACACGAAGATGATGAAATCGTAA 35 23 51 
mbfA0.5kb 
R CGACAACGATCCCGTGCTGGCCT 65 23 68 
mbfA1kb F GTGCCGAACATCAGGAACAATGT 48 23 66 
mbfA1kb R ACCTATTTCGAGCATATGGCCTTTG 44 25 65 
mbfAKn F CACCGCGCAGCACTGCCGGAATTGCCAGCTGGG 70 33 68 
mbfAKn R CGCCGCCAGGACGAGTCAGAAGAACTCGTCAAGAA 57 35 58 
ΔmbfA F CTC GTC CTG GCG GCG GGC ATA 67 21 74 
ΔmbfA R CAG TGC TGC GCG GTG GTC GTG 71 21 75 
Site directed mutagenesis 
t55c F CTCTTTCGATTCGCTTTCTGAACAGGAAATTCTGGCGC 47 38 79 
t55c R GCGCCAGAATTTCCTGTTCAGAAAGCGAATCGAAAGAG 47 38 79 
c64a F CGATTCGCTTTCTGAATAGGAAATTATGGCGCTTGCCAT 44 39 80 
c64a R ATGGCAAGCGCCATAATTTCCTATTCAGAAAGCGAATCG 44 39 80 
D191G F CTTGCGGGCCTGATGGGCGGCTCCGTCTCGAC 72 32 88 
D191G R GTCGAGACGGAGCCGCCCATCAGGCCCGCAAG 72 32 88 
M228G F GCCGGTATTTCGGGGGGCTTTACAGAAGC 59 29 81 
M228G R GCTTCTGTAAAGCCCCCCGAAATACCGGC 59 29 81 
E232G F CGATGGGCTTTACAGGAGCCGTGCATGACG 60 30 83 
E232G R CGTCATGCACGGCTCCTGTAAAGCCCATCG 60 30 83 
Y268G F GGTCACAGCCTGCCCGGTCTGATCAAGGATTTC 58 33 84 
Y268G R GAAATCCTTGATCAGACCGGGCAGGCTGTGACC 58 33 84 
pSU18 cloning 
mbfA271 F GACGAATTCAGGAGGATCTAGATGGCCGCAGAGGAA 53 36 61 
mbfA306 F GACGAATTCAGGAGGATCTAGATGGCGCTTGCCATA 50 36 58 
mbfA327 F GACGAATTCAGGAGGATCTAGATGTTCAGCCGATTC 47 36 52 
mbfA R GTCGGATCCTCAGGCGCTGCCGATCAA 63 27 68 
pBADrham cloning 
mbfA271 F2 GTGCATATGGCCGCAGAGGAACACG 60 25 61 
mbfA306 F2 GTGCATATGGCGCTTGCCATATCCTC 54 26 60 
mbfA327 F2 GTGCATATGTTCAGCCGATTCTTCC 48 25 55 
pBADara cloning 
mbfA For GGAATTAACCATGGGATGTTCAGCCGATTC 47 30 67 
mbfA Rev TGATGATGAGAACCCTCAGGCGCTGCCGATC 58 30 74 
Vector For GAATCGGCTGAACATCCCATGGTTAATTCC 47 30 67 
Vector Rev GATCGGCAGCGCCTGAGGGTTCTCATCATCA 58 30 74 
 
 
 
 
 
 
 
Chapter 2 
 
 
42 
Name Sequence 5’-3’ GC (%) Length Tm (
oC) 
pET cloning 
ery271 F CACCATATGGCCGCAGAGGAA 57 21 61 
ery306 F CACCATATGGCGCTTGCCATATC 52 23 60 
ery327 F CACCATATGTTCAGCCGATTCTTC 46 24 57 
ery R GTGAAGCTTCTTGCGCTCGGC 62 21 57 
eryCO F CACCATATGTTTAGCCGCTTT 43 21 51 
eryCO R GTGAAGCTTTTTGCGTTCTGCTGCACG 52 27 65 
Sequencing 
T7 F TAATACGACTCACTATAGG 37 19 47 
pJET R AAGAACATCGATTTTCCATGGCAG 42 24 69 
pBADrha F GAAGGTCGCGAATTCAGG 56 18 56 
pBAD R GATTTAATCTGTATCAGG 33 18 45 
colony PCR 
KnF GATCGTTTCGCATGATTGAACAAG 42 24 60 
KnR CAAGAAGGCGATAGAAGGCG 55 20 60 
mbfAOutF GCGACGCCGAAGAAAATG 56 18 56 
mbfAOutR AGTATTTCCAATGACGACACGC 46 22 58 
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Chapter 3: Bioinformatics analysis of mbfA of Brucella 
 
3.1: Analysis of the coding sequence of mbfA in Brucella suis bv. 1 str. 1330  
Analysis of the mbfA gene (BS1330_I1673) and translated amino acid sequence from 
Brucella suis 1330 revealed information regarding the potential activity and mechanism 
of function of the MbfA protein (the nucleotide and amino acid sequences, and amino 
acid frequency are in Appendix 9.2 and iron related gene locations in Appendix 9.4).  
 
The N-terminal erythrin domain of MbfA contains four iron-binding motifs, two ExxH 
and two E-6-Y motifs (Figure 3.1), which are predicted (on the basis of homology to 
rubrerythrin) to co-ordinate two iron atoms.  These iron-binding motifs are well 
conserved within di-iron carboxylate proteins (Nordlund and Eklund 1995) (Figure 3.1).  
Substitution of the glutamic acid residues of the E-6-Y motifs to alanine in MbfA of B. 
japonicum (Sankari and O'Brian 2014) results in loss of ferrioxdase activity and failure 
to form a di-iron centre.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1:  Amino acid sequence of B. suis MbfA. 
Location of iron-binding motifs (orange) and predicted transmembrane helices (red) in 
Brucella suis MbfA.  Annotation conducted in Geneious 7.0.6. 
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Figure 3.2: Di-iron carboxylate protein binding sites 
Co-ordination of iron atoms by the two E-6-Y (green and yellow) and two ExxH (red 
and blue) iron-binding motifs in di-iron carboxylate proteins. The Tyr residues do not 
act as iron ligands but are highly conserved in the superfamily. 
 
The N-terminal erythrin domain bares similarity to the rubrerythrin protein of anaerobic 
bacteria.  Rubrerythrins consist of two domains, a diiron erythrin and a Cys4-Fe 
rubredoxin domain, and act as peroxide reductases affording resistance against exposure 
to redox stress (Lumppio et al. 2001).  Multiple sequence alignment of the conserved N-
terminal erythrin domains displays the conservation of the iron binding motifs within 
the erythrin domain (Figure 3.3a).  Differences in the respective C-terminal domain 
organizations are shown schematically in Figure 3.3b.  
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Figure 3.3: Alignment of the amino acid sequences of the erythrin domains of 
MbfA and rubrerythrin proteins from selected bacterial species 
A: Multiple sequence alignment of Brucella suis 1330 MbfA and rubrerythin from 
selected anaerobic bacteria (Desulfovibrio vulgaris and Clostridium perfringens) 
displaying conservation of E-6-Y (AA: 29-36 and 115-123) and ExxH (AA: 62-65 and 
148-152) iron binding motifs. Alignment performed and displayed using MUSCLE 
option of Geneious 7.0.6. B: Schematic representation of domain organisation in 
Desulfovibrio vulgaris rubrerythrin and Brucella suis MbfA.  
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The C-terminal Vit1 domain of MbfA is predicted to be embedded in the inner 
membrane based upon sequence similarity to Saccharomyces cerevisiae CCC1 and 
Arabidopsis thaliana VIT1 (Figure 3.4), and membrane prediction tools (see below) 
(Figure 3.5).  CCC1 and VIT1 facilitate the transport of cytosolic free iron into storage 
vacuoles and hence are located within the vacuolar membrane (Li et al. 2001, Kim et al. 
2006).  More recently, a VIT1 protein was identified in Plasmodium spp. as well as 
other Apicomplexa and Kinetoplastida parasites (Toxoplasma gondii and Trypanosoma 
brucei respectivly) (Slavic and Krishna 2016), and has been reported to be located in 
the vacuole for P. falciparum.  
 
  
 
 
 
 
 
 
 
Figure 3.4: Alignment of Brucella suis MbfA Vit domain with eukaryotic VIT1 
proteins 
Multiple sequence alignment of Brucella suis MbfA Vit domain with VIT1/CCC1 
proteins from A. thaliana, S. cerevisiae and P. falciparum, conserved five 
transmembrane helices are marked in red.  
 
The localization of MbfA to the bacterial inner membrane is further evidenced by the 
examination of the membrane topology of MbfA in Agrobacterium tumefaciens 
(Bhubhanil et al. 2014).  LacZ and PhoA fusions identified that amino acid 180, located 
after the erythrin domain but before the Vit1 domain, is located cytoplasmically, 
whereas the terminal amino acid 327 is located periplasmically. Analysis of the B. suis 
MbfA protein sequence with Phobius - a combined transmembrane topology and signal 
peptide predictor (Kall et al. 2004) predicts five transmembrane helices with the N-
terminal erythrin domain locating within the bacterial cytosol (Figure 3.5). The average 
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length of the predicted transmembrane helices is 20 amino acid residues and 
periplasmic regions is 5 amino acids. Whilst the predicted cytoplasmic loops are 
variable form 20 to 11 amino acids. 
 
 
 
 
 
 
 
 
 
 
 
 
Amino acid position Cellular location Length (AA) 
1 – 183 Cytoplasmic 183 
184 – 205 Transmembrane 22 
206 – 210 Periplasmic 5 
211 - 230 Transmembrane 20 
231 – 250 Cytoplasmic 20 
251 – 270 Transmembrane 20 
271 - 275 Periplasmic 5 
276 – 294 Transmembrane 19 
295 – 305 Cytoplasmic 11 
306 – 325 Transmembrane 20 
326 - 327 Periplasmic 1 
 
Figure 3.5: Trans-membrane helix prediction of B. suis MbfA 
Prediction of membrane spanning regions of Brucella suis MbfA with Phobius 
transmembrane topology prediction. Grey bars: transmembrane, green line: 
cytoplasmic, blue line periplasmic, red line signal peptide.  
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3.2: Examples of MbfA and MbfA-like proteins  
It is of note that the eukaryotic VIT1 proteins examined in Figure 3.4 possess an 
elongated cytoplasmic loop (approx. 70 AA in length). Alignment of 70 MbfA/VIT1 
sequences (52 prokaryotic and 18 eukaryotic) (Figure 3.6) displays that this feature is 
not unique to eukaryotes, but select prokaryotes also exhibit a conserved cytoplasmic 
loop between transmembrane helices 2 and 3. (More detailed alignments of erythrin, Vit 
and loop segments in Appendix 9.3).  This multiple species alignment allows for the 
determination of the complete conservation of an aspartic acid within transmembrane 
helix 1 and that five TMH are present in all cases.  In addition, the alignment allows the 
differentiation of MbfA-like sequences into 5 discrete sub-families denoted: Ia, Ib, Ic, 
IIp and IIe.  
Sub-families Ia-c represent MbfA-like sequences, these proteins contain 2 domains, 
with the VIT1 domain located downstream from the erythrin domain.  Sub-family Ia 
comprises sequences with uncharacterised N terminal domains, solely Bartonella spp.. 
Subfamily Ib represents the MbfA sequence present within Brucella spp. and is 
characterized by the absence of a cytoplasmic loop between TMH2 and 3.  Subfamily Ic 
represents MbfA sequences characterized by the presence of a cytoplasmic loop 
between TMH2 and 3) (Location of loop shown schematically in Figure 3.7).  Both of 
these sub-families comprise proteins with two pairs of highly conserved iron binding 
motifs – ExxH and E-6-Y – which are present within the N-terminal cytoplasmic 
erythrin domain of all MbfA proteins, allowing co-ordination of two iron atoms.  One 
notable exception is the Burkholderia cepacia spp., which possess a unique 41 AA 
truncation at the N terminus of erythrin domain resulting in one of the four iron binding 
motifs being absent, potentially compromising the di-iron site and peroxide reductase 
activity of this domain. In addition, mbfA in Burkholderia spp. is limited to the 
Burkholderia cepacia complex strains, as it is encoded on the non-essential virulence 
plasmid C3 (Agnoli et al. 2012). 
Type II subfamilies can be differentiated into either prokaryotic or eukaryotic grouping, 
but in either case they lack an N-terminal domain, therefore only consist of a VIT1 
domain.  All examples contain the cytoplasmic loop insertion between TMH2 and 3.  
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Figure 3.6: Alignment of prokaryotic and eukaryotic MbfA and VIT1-like proteins 
A: Multiple sequence alignment of prokaryotic and eukaryotic MbfA and VIT1-like 
proteins displaying conservation of five transmembrane helices and aspartic acid (green 
TMH1). B: Schematic representation of the separation of mbfA-like sequences into sub-
families denoted: Ia, Ib, Ic, IIp and IIe. TMH and cytoplasmic loop locations indiucted 
with boxes within the Vit domain.   
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Figure 3.7: 2D plot of Brucella suis and Burkholderia multivorans MbfA membrane 
topology.   
Brucella suis (A) and Burkholderia multivorans (B) MbfA membrane topology.  
Bacterial membrane (pink), TMH number (blue).  Transmembrane helix location 
determined by Phobius prediction.  
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To examine the relationship and evolution of the MbfA-like proteins phylogenetic 
analysis (Geneious) was conducted on the conserved trans-membrane helix regions 
from the 70 MbfA/VIT1 sequences analysed previously (Figure 3.8).  The phylogenetic 
arrangement of the MbfA proteins displays a distinct separation into previously denoted 
MbfA subfamilies, suggesting evolution of the protein to facilitate a common function 
within these bacterial species.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Phylogenetic analysis of prokaryotic and eukaryotic MbfA and VIT1-
like proteins 
Phylogenetic analysis of prokaryotic and eukaryotic MbfA and VIT1-like proteins 
displaying corresponding assignment to MbfA sub-families.  
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Multiple sequence alignment and phylogenetic analysis show that type Ib/c MbfA-like 
proteins are widely spread across bacterial phyla. Attention should be drawn to the high 
number of sequences observed within the alpha-proteobacteria, in particular, mbfA 
sequences are present within all Brucella spp., both classical (B. suis, B. melitensis and 
B. abortus) as well as non-classical strains (B. ovis and B. microti) and display a high 
sequence similarity (321/327 AA – 98.2% identical sites).  However, the mbfA coding 
sequence of Brucella melitensis bv.1 str. 16M and Brucella melitensis bv. 3 str. Ether 
display a CàT point mutation at nucleotide 55 resulting in an amber stop codon (UAG) 
in place of a glutamate codon (CAG) at the 18th codon (Figure 3.9).  The inclusion of 
this stop codon is predicted to result in a cryptic version of the gene resulting in no 
translation of the MbfA protein.  In addition, a second glutamate to amber stop codon 
SNP (C634T) is present in the C terminal end of all clade I B. melitensis strains (B. 
melitensis UK31/99, B. melitensis Ether, B. melitensis F15/06-7 and B. melitensis 
F5/07-239A), suggesting that the mbfA gene has accumulated nullifying mutation in B. 
melitensis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Cryptic mbfA in Brucella melitensis strains.   
Gene context tool analysis (GeConT 3 - (Martinez-Guerrero et al. 2008)) of mbfA from 
B. microti (BMI_I1700), B. ovis (BOV_1623), B. abortus 2308 (BAB1_1691), B. suis 
1330 (BSUIS_B1154) and B. melitensis 16M (BMEI0354) and multiple sequence 
alignment of Brucella mbfA highlighting disruptive SNP locations in B. melitensis 16M 
and B. melitensis Ether (*) compared to classical and non-classical Brucella isolates.  
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It is of additional interest that there are just two B. melitensis strains that lack the SNP at 
nucleotide 55 and thus encode non-cryptic versions of mfA.  B. melitensis bv. 1 str. 
16M13W and B. melitensis S66 both possess a T at position 55 of the mbfA gene, 
restoring the wildtype sequence of the gene. B. melitensis bv. 1 str. 16M13W is 
experimentally derived from B. melitensis bv. 1 str. 16M following a 13-week period of 
mouse infection (Ke et al. 2012), whilst, B. melitensis S66 was isolated from the blood 
of a human patient suffering from Brucellosis (Ke et al. 2012). However, the validity of 
these observations is questionable as analysis of the genomes of these two isolates (Tan 
et al. 2015) suggests that both segregate into a group that does not belong to other B. 
melitensis strains raising concern that the Chinese Brucella melitensis 16M strain may 
not be the same B. melitensis strain used worldwide isolates. 
 
A wider analysis of the sequence identity of MbfA outside of the Brucella spp., but 
remaining within the rhizobiale α-proteobacteria reveals maintenance of conservation. 
As described previously, MbfA has been studied in Agrobacterium tumefaciens 
(ATCR1_17048) (Ruangkiattikul et al. 2012, Bhubhanil et al. 2014) but also within 
Bradyrhizobium japonicum (BJ6T_85830) (Sankari and O'Brian 2014). The sequence 
identity of these two organisms with Brucella suis MbfA are displayed in Table 3.1.  
 
 A. tumefaciens B. japonicum 
B. suis 224 AA (68.5%) 186 AA (57.6%) 
A. tumefaciens  191 AA (59.1%) 
Table 3.1: Sequence identity of B. suis, A. tumefaciens and B. japonicum 
 
As highlighted previously, MbfA sub-family Ia comprises sequences with 
uncharacterised N terminal domains, which solely comprises Bartonella spp.. 
Bartonella are closely related to Brucella spp. phylogentically and inhabit a similar 
intracellular niche, from which the requirement of MbfA might originate.   Although 
Bartonella spp. encode an N-terminal domain, it shares no sequence identity to the B. 
suis erythrin domain or any other sequences in protein databases, however, the C-
terminal VIT domain is highly conserved (Figure 3.10).  The loss of the erythrin domain 
in Bartonella spp. may represent an iron export system that is not dependent on the 
reduction of hydrogen peroxide to facilitate the export or iron via the VIT domain, 
although examination of the Bartonella N-terminal domain would be required to test 
this hypothesis.    
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Figure 3.10: Sequence alignment of α-proteobacteria mbfA 
Multiple sequence alignment of B. suis, A. tumefaciens, B. japonicum and B. quintana 
MbfA. Orange: iron binding motifs, Red: transmembrane helices. 
 
  
Chapter 3 
 
 
55 
3.3: Prediction of B. suis MbfA tertiary Structure 
 
A prediction of tertiary structure of the erythrin domain was generated using the protein 
homology/analogy recognition engine (Phyre 2) (Kelley and Sternberg 2009). 
Alignment of the erythrin domain to the ferritin of Magnetospirillum magnetotacticum 
(PDB: d2oh3a1) reveals 145 residues from amino acid 18 to 165 (44% of the total 
MbfA protein, 83% of the erythrin domain) can be modelled with 89.7% confidence to 
the ferritin protein.  This prediction further suggests that the erythrin domain assembles 
into a four alpha helical bundle, with each helix similar in length and carrying a single 
di-iron motif (E-6-Y or ExxH) located at the centre of the helix. In addition, the amino 
acid side chains predicted to coordinate the di-iron centre are orientated inwards 
towards the expected location of the di-iron species (Figure 3.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11:  B. suis MbfA tertiary structure prediction 
Prediction of tertiary structure of the MbfA erythrin domain displaying 4 alpha helices, 
labeled A-D, (green) and di-iron binding motifs E-6-Y and ExxH (red) from Phyre 2, 
image annotation with Pymol.  
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3.4: Regulation of mbfA 
Analysis of the upstream DNA sequence from the mbfA gene has led to insight into its 
regulation.  A region of DNA highly homologous to the consensus ICE-box is found 
located directly overlapping the transcription initiation site (-10 promoter region) 
(Figure 3.10). The location of the ICE-box suggests that Irr is negatively regulating 
mbfA transcription under low iron conditions and repression will be relieved under high 
iron conditions, this fits with the assumption that MbfA is acting as an iron efflux 
protein as the trigger of increased iron concentration would thus drive export of iron. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: ICE box location - regulation of mbfA.  
A: ICE-box location covering -10 box that would be expected to mediate negative 
regulation of mbfA under low iron concentrations through Irr control. B: ICE consensus 
aligned with mbfA ICE – 19/21 bp match, mismatch is within the least conserved region 
with respect to the ICE Box consensus sequence. -10 and -35 sites identified through 
sequence conservation. 
 
  
TGCAGGGCCGCGTTGCAGGTTGTCGTGACGCCAAACCATAAGTTAATGCGTCACGACAGCCTAATGCGCCAAATGCGCCCGTTCTGCA
AGACTTGACTTCCGCCCGCCGAGGCATATTTTAGAATTATTCTAAATTAATGGATTTAAGATATGTTCAGCCGATTCTTCCGTAATGA
CCGACGCTCTTTCGATTCGCTTTCTGAACAGGAAATTCTGGCGCTTGCCATATCCTCCGAGGAGGATGATGCCCGCATCTATCTGGCT
TATGCCGATGGCCTGCGCGACGAGTTTCCGCAATCGGCGAAGATTTTCGAGCAGATGGCCGCAGAGGAACACGACCACCGCGCAGCAC
TGATTGAGCGGCATAAGGCCCGCTTTGGCGACCGGATTCCGCTGATCCGCCGCGAGCATGTCAGTGGCTATTATGATCGCAAGCCGGA
CTGGCTGGTGCGTCCGCTCGGCATCGACAAGGTGCGTGAGGCCGCCTCCGAGATGGAGGAACAGGCTTATCGTTTCTATGTCGAGGCG
GCCAAGCGCGTCAGCGATGCAGACACGCGCAAACTGCTGGGTGACCTTGCCCAGCAGGAAAAACAGCACGAAGCCAAGGCTGAATCGC
TGGAACACACGCTGACACCGGATAATGTGCAGGATGAGGAACGCGCCGCCGAGCGCAAGCAATTCATCCTCACCTACATCCAGCCTGG
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Rudolph et al. (2006) showed that in B. japonicum’s ICE-like motifs are located 
upstream of bll6680 (bacterioferritin) and blr7895 (rubrerythrin) genes, at the respective 
-10 boxes and that these sites mediate negative regulation by Irr.  These findings 
provide precedence for the impact of an ICE box at the -10 site.  Furthermore, 
Ruangkiattikul et al. (2012) showed that mbfA is regulated by Irr in A. tumerfaciens.  
With Irr present, mbfA expression was repressed at low iron concentrations, whilst 
expression was increased under high iron concentrations and also in an isogenic irr 
mutant.  These findings demonstrate that Irr represses mbfA in this α-proteobacterium, 
which supports the likelihood that Irr also controls mbfA in Brucella species.  Further 
details of relevant B. suis 1330 iron metabolism and redox stress genes supplied in 
appendix 9.4. 
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3.5: Discussion 
To summarize, bioinformatical analysis of the MbfA sequence from Brucella suis 1330 
has enabled a detailed hypothesis of the mechanism of action of MbfA.  The presence of 
4 iron-binding motifs within the erythrin domain suggests it has the capability of 
binding 2 iron atoms per protein monomer.  This, along with the similarity of the 
erythrin domain to the rubrerythrin protein suggests that an involvement in hydrogen 
peroxide reduction may occur at the di-iron center.   In addition,  the membrane 
topology, 5 conserved TMH and single aspartic acid residue within TMH1 suggest that 
the C terminal VIT1 domain of MbfA is likely to function in a similar manner to 
examples of VIT1/CCC1 observed in A. thaliana, S. cerevisiae and P. falciparum. In 
addition, analysis of the region of DNA upstream of the coding sequence has allowed 
hypothesis that Irr regulates MbfA in response to intracellular iron and hydrogen 
peroxide concentrations through the conservation of the ICE-box spanning the -10 
transcription initiation site.  
 
Multiple sequence alignment enabled the in depth evaluation of the distribution of 
MbfA and MbfA-like genes within nature.  The MbfA variant observed within B. suis is 
well conserved across the alpha-proteobacteria, but is also present in wider phyla.  It is 
possible to sub-divide the MbfA-like sequences observed into 4 distinct sub-families 
based upon the presence of an N-terminal erythrin domain, as well as the presence or 
absence of a 70 AA cytoplasmic loop between TMH2 and 3.   
 
Despite MbfA being widespread across both prokaryotes and eukaryotes suggesting that 
the expression of MbfA affords a distinct advantage, presumably during periods of 
redox stress, B. melitensis strains may present a differing view. The observation that B. 
melitensis strains have accumulated possible nullifying mutations throughout the mbfA 
gene, promotes questions to be asked as to the importance of a potential iron export 
protein.  Although export of potentially toxic iron, during residence within a redox 
active environment presents as a valid mechanism of cellular preservation; the process 
of iron export nonetheless depletes stores of an essential micronutrient.  The acquisition 
of nullifying mutations, thus preventing iron export may be evidence of the adaption of 
B. melitensis strains to their host species, but would require specific experimentation to 
prove.  
Chapter 4 
 
 
59 
Chapter 4: Construction of Genetic Reagents 
 
4.1: Introduction 
MbfA has not yet been studied in Brucella although characterisation in other bacteria 
has shown a role in resistance to iron toxicity and hydrogen peroxide (Ruangkiattikul et 
al. 2012, Bhubhanil et al. 2014, Sankari and O'Brian 2014). MbfA is suggested to 
function as an iron exporter, although this has yet to be proven.  Thus, to study the 
mechanism of iron export by MbfA, and to understand how this confers resistance to 
oxidative stress and might aid intracellular survival of Brucella spp., the mbfA gene was 
cloned from Brucella melitensis.  The mbfA gene is 984 bp in length in all Brucella 
spp.; the small size of this gene and monocistronic nature of the transcribed mRNA 
product allow for straightforward manipulations of the DNA sequence. mbfA DNA 
sequences from Brucella suis 1330 (functional) and Brucella melitensis 16M (cryptic – 
non-functional) were ulitised during this project. During initial experimentation, only B. 
melitensis 16M gDNA was available, from which the B. suis 1330 mbfA variant was 
constructed through SDM.  
 
In summary, the mbfA sequence was amplified from B. melitensis 16M genomic DNA 
by PCR and ligated into the pJET1.2 plasmid, permitting propagation in E. coli and 
allowing the subsequent construction of engineered plasmids for specific purposes.  
From the pJET1.2 plasmid, the mbfA sequence was manipulated to represent the coding 
sequence observed in Brucella suis and other mbfA expressing Brucella spp.. This 
modified mbfA gene was then used as a source for cloning into inducible expression 
plasmids (pSU18, pBADrham and pBADara) as well as an over-expression (pET), 
suicide (pEX100T) and complementation plasmids (pBBR1-MSC4), all designed 
specifically to allow investigation into precise aspects of Brucella and mbfA function. 
Details of the constructions generated are provided below. 
 
4.2: Cloning of mbfA from Brucella melitensis bv.1 str. 16M 
The mbfA gene with 0.5 kb of up and downstream flanking sequence was amplified by 
PCR (primers mbfA0.5kbF/R; Table 2.4) from a preparation of genomic DNA isolated 
from B. melitensis bv. 1 str. 16M. The single, blunt-end PCR product (Figure 4.1A) was 
ligated into pre-linearized pJET1.2 (ThermoFisher) with T4 DNA ligase in a 3:1 molar 
ratio (insert:vector), in order to generate pJETmbfA (Figure 4.1C).  The ligation reaction 
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was transformed into E. coli Top10 chemically competent cells and recombinant 
colonies selected for via resistance to ampicillin (additional selection is achieved when 
using pJET1.2 due to inserts disrupting the lethal restriction enzyme gene, eco47IR, 
enabling positive selection of recombinants).  Plasmids from presumptive recombinant 
colonies were extracted and digested with XhoI and XbaI, unique restriction sites 
outside of the inserted mbfA fragment, and SacI, which is unique to the inserted 
fragment (Figure 4.1B).  Upon confirmation of mbfA insertion into pJET1.2 through 
release of the mbfA-containing fragment, Sanger sequencing (Primers T7F and pJETR; 
Table 2.4) was used to confirm the mbfA sequence within the pJET1.2 vector. Sanger 
sequencing additionally confirmed the presence of the C to T SNP within the B. 
melitensis nucleotide sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Cloning of mbfA into pJET  
A: 0.8% agarose gel of the PCR product (1680 bp). B: Restriction confirmation of the 
pJETmbfA plasmid.  Tracks left to right: 1, undigested plasmid; 2, SacI digested 
plasmid (incomplete digestion) resulted in an approx. 4.5 kb linear fragment, together 
with uncut plasmid; 3, XhoI and XbaI double digestion plasmid resulted in two linear 
fragments of approx. 1.7 and 3 kb,. C: Vector map of pJETmbfA.    
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4.3: Correction of SNP in Brucella melitensis mbfA sequence  
From bioinformatic analysis, it is expected that the C to T nucleotide substitution at 
position 55 of the mbfA gene in B. melitensis strains (that results in a stop codon in 
place of glutamate) will prevent translation of mbfA, rendering mbfA cryptic in B. 
melitensis.  It is however; possible that translation may occur at a downstream start 
codon to give a truncated MbfA polypeptide. Downstream of the C to T point mutation, 
there are two potential alternate start codons that would permit translation of 
polypeptides of 271 and 306 amino acids respectively (MbfA271 and MbfA306) (Figure 
4.2). MbfA271 would be translated from mRNA at the next available, in-frame ATG. It 
is unlikely that MbfA271 would be fully functional as one of the four di-iron binding 
motifs would not be present in the polypeptide sequence, preventing iron binding to the 
protein and thus failure to generate a catalytic centre capable of peroxide reductase 
activity.  Alternatively, a translation product yielding MbfA306 may result if translation 
initiated from the uncommon start CTG codon (O'Donnell and Janssen 2001). If this 
peptide were produced, the first di-iron site would be present within the amino acid 
sequence affording the ability to bind iron at the di-iron centre.  
 
These suggested alternate mbfA translation products for B. melitensis strains are 
speculative; thus, to determine if mbfA is indeed rendered cryptic by the SNP at position 
55 in B. melitensis, site directed mutagenesis (SDM) was used to repair the mutation.  
This would then allow comparison of the ‘cryptic’ and ‘non-cryptic’ versions of mbfA. 
SDM was used to correct the C to T point mutation (primers t55cF/R; Table 2.4) in the 
B. melitensis mbfA sequence (pJETmbfA), converting it to the sequence observed in B. 
suis and other Brucella spp..  Reversion of the point mutation was confirmed by Sanger 
sequencing (primers: T7F and pJETR) and the resulting plasmid named pJETmbfAsuis.  
In addition, a second point mutation (C64A) was introduced to the B. melitensis mbfA 
(pJETmbfA) sequence by SDM (primers: c64aF/R), changing the potential start CTG to 
ATG.  This mutation would allow for the subsequent generation of a cloned construct 
able to efficiently express the MbfA306 polypeptide. The presumptively mutated plasmid 
was isolated from transformants, confirmed by Sanger sequencing and named 
pJETmbfA306. 
 
The original cloned mbfA sequence, pJETmbfA, was subsequently used to generate the 
MbfA271 polypeptide and was thus re-named pJETmbfA271. 
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Figure 4.2: Translations from Sanger sequencing reads of MbfA isoforms.  
Alignment of translated mbfA nucleotide Sanger sequencing reads from pJETmbfA271, 
pJETmbfA306 and pJETmbfAsuis (pJETmbfA327), showing differences in gene length 
though truncations from the N terminus. 
 
The mbfA genes encoding the two potential MbfA polypeptides will be cloned into 
inducible expression vectors, alongside the corrected B. suis variant, to allow 
assessment of their ability to functionally complement specified E. coli mutants.  It is of 
note that even if a phenotype is observed with expression of a truncated MbfA peptide 
when expressed in E. coli, that these isoforms may not be expressed in B. melitensis 
strains due to the lack of an apparent corresponding Shine-Dalgarno sequence.   
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4.4: Construction of controllable expression plasmids 
To enable the determination of the functional effects of MbfA, the mbfA gene from each 
pJETmbfA variant was cloned into the pSU18 (p15A origin, ~10 copies per cell, lac 
promoter) and pBADrham (p15A origin, ~10 copies per cell, rhamnose promoter) 
plasmids to enable the controllable induction of mbfA within specific E. coli mutant 
strains.   
 
To enable effective transcription of the mbfA gene from the lac promoter in pSU18, a 
ribosome-binding site (RBS) was introduced 7 bp upstream of each mbfA isoform start 
codon.  The RBS, EcoRI and BamHI restriction sites required for cloning into pSU18 
were introduced by PCR (primers mbfA271F, mbfA306F, mbfA327F and mbfAR; Table 
2.4) using the high fidelity Q5 DNA polymerase.  The vector and PCR fragments were 
digested with EcoRI and BamHI, and ligated with T4 DNA ligase in a 3:1 molar ratio 
(insert:vector).  The ligation mix was transformed into chemically competent Top10 
cells, and recombinant colonies were selected on LA with chloramphenicol with 
blue/white screening using 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (XGal) 
and isopropyl β-D-1-thiogalactopyranoside (IPTG).  Confirmation of Lac- colonies was 
achieved by plasmid extraction and digestion with EcoRI and BamHI to excise the 
inserted fragment (Figure 4.3).  The nucleotide sequence confirmed mbfA containing 
plasmids were then used for phenotypic analysis. The constructs created were 
designated pSUmbfA271, pSUmbfA306 and pSUmbfA327, respectively.  Similarly, mbfA 
variants were cloned into the pBADrham plasmid through PCR amplification (primers 
mbfA271F2, mbfA306F2, mbfA327F2 and mbfAR; Table 2.4) of the target gene sequence 
with addition of NdeI and BamHI restriction sites (addition of RBS not required as 
located on plasmid). Ligation of digested DNA fragments, selection and confirmation of 
transformants was achieved using the same procedure as described for pSU18 cloning 
(XGal selection omitted) (Figure 4.3).  The constructs created were designated 
pBADmbfA271, pBADmbfA306 and pBADmbfA327, respectively. 
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Figure 4.3: Cloning of mbfA271, mbfA306 and mbfA327 into pSU18 and 
pBADrham.  
A: Vector map of pSUmbfA327.  B: 0.8% agarose gel of restriction confirmation of the 
pSUmbfA variant plasmids. Tracks contain EcoRI and BamHI digested pSU18, the three 
EcoRI and BamHI digested mbfA variant PCR products (816, 921 and 984 bp, 
respectively), the EcoRI and BamHI digested pSUmbfA constructs showing the released 
insert and vector backbone fragments of equal size to the pre-ligation products and the 
molecular weight marker. C: Vector map of pBADmbfA327.  D: As B but for 
pBADmbfA variant constructs digested with NdeI and BamHI. 
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To clone the B. suis mbfA sequence into pBADara, Gibson assembly was used due to the 
lack of restriction endonuclease sites available to clone the mbfA gene in context with 
the arabinose promoter and RBS. This technique allows for assembly of multiple DNA 
fragments, regardless of fragment length or end compatibility (Gibson et al. 2009). The 
method includes three different enzymatic reactions: a T5 exonuclease that removes 
nucleotides from the 5’ end to create single-stranded 3’ overhangs that facilitate the 
annealing of fragments that share complementarity at one end (overlap region approx. 
15-80 bp); a DNA polymerase that fills in gaps within each annealed fragment; and the 
Taq DNA ligase that covalently seals the nicks in the assembled DNA.  First, PCR 
(primers araF, araR, mbfAaraF and mbfAaraR; Table 2.4) was used to introduce 15 bp 
regions of complementary DNA onto the 5’ and 3’ ends of the inserted mbfA fragment 
and linearized vector.  The amplified DNA fragments were separated via agarose gel 
electrophoresis and excised from the gel before combining 50 ng of mbfA insert with 
200 ng linearized pBADara vector with Gibson assembly reagents, and ligation was 
promoted through incubation at 50 °C for 15 min.  Reaction products were then 
transformed into Top10 competent cells.  Colony PCR (primers mbfAaraF and 
mbfAaraR) was used as a first line screen for the identification of presumptive mbfA 
containing transformants (77% false positive transformants present as pJETmbfA 
template DNA and pBADara plasmids are both AmpR).  PCR positive isolates were 
further confirmed to contain the mbfA insert via restriction digestions and Sanger 
sequencing. 
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4.5: Construction of over-expression plasmids 
To enable examination of the biochemistry of the N-terminal erythrin domain, 
specifically formation of the di-iron centre and resulting reactivity, this domain is 
required to be expressed in high concentrations to allow the purification of sufficient 
quantities of the protein for analysis.  This was achieved by cloning the erythrin domain 
into a vector containing the T7 RNA polymerase promoter (pET21a).  This vector, 
when transformed into an E. coli strain containing a prophage harboring the T7 RNA 
polymerase (BL21/DE3) under the control of the lac promoter allows the strong 
expression of the target gene in the presence of the inducer, IPTG.  
 
The gene fragment encoding the N-terminal erythrin domain of each variant of the mbfA 
gene (mbfA271: 1-524 bp, mbfA306: 1-356 bp and mbfA327: 1-461 bp) was amplified by 
PCR (primers ery271F, ery306F, ery327F and eryR; Table 2.4) designed to incorporate 
NdeI and HindIII restriction endonuclease sites.  The amplified fragments were gel 
extracted to avoid carryover of parental DNA when cloning into NdeI and HindIII 
digested pET21a as both parental and insertion vectors are ampicillin resistant. The 
pET21a vector and erythrin domain inserts were digested with NdeI and HindIII, and 
ligated with T4 ligase in a 3:1 molar ratio (insert:vector) before transformation into 
chemically competent Top10 cells.  Selection for recombinants was achieved with 
resistance to ampicillin. Sanger sequencing (primers T7F and pJETR) confirmed that 
the erythrin domain was present in the recombinant colonies. Further confirmation was 
achieved through NdeI and HindIII digestion of the extracted plasmid DNA releasing 
the desired inserted fragment (Figure 4.4). Confirmed constructs were named 
pETery271, pETery306 and pETery327, respectively. 
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Figure 4.4: Cloning of erythrin variants into pET21a  
A: Representative vector map of the pETery327 construct. B: 0.8% agarose gel of 
digested pETery vector variants.  Tracks from left to right: 1, gel extracted NdeI and 
HindIII digested pET21a (~4.6 kb); 2, 3 and 4, gel extracted NdeI and HindIII digested 
ery PCR products 356, 461 and 524 bp; 5, 7 and 9, undigested pETery constructs 
(supercoiled); 6, 8 and 10 NdeI and HindIII digested pETery constructs showing the 
released insert and vector backbone fragments of equal size to the pre ligation products. 
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4.6: Construction of Brucella mbfA knockout vector 
To allow the function of mbfA in resistance to oxidative stress to be determined and its 
role in Brucella suis and B. melitensis survival within the macrophage to be deduced, a 
suicide vector was designed to generate a non-polar gene excision of the mbfA gene in 
B. suis 1330 and B. melitensis 16M and replacement with a kanamycin resistance 
determinant.  The pEX100T suicide plasmid was utilized to remove the mbfA coding 
sequence from the Brucella genome as it encodes sacB (levansucrase) which, when 
expressed in the presence of sucrose, generates a toxic phenotype to the transformed 
cell allowing negative selection.  This function can be used to force a recombination 
event from the suicide plasmid to the bacterial genome, enabling the removal of the 
target gene. 
 
To construct the suicide vector, first, the mbfA gene with 1 kb of up- and down-stream 
flanking sequence was amplified from the genomic DNA of Brucella melitensis bv. 1 
str. 16M by PCR (primers mbfA1kbF/R; Table 2.4).  1 kb of flanking DNA sequence is 
used as standard within the published Brucella literature to provide sufficient base pair 
overlap to allow for successful recombination into the chromosome of Brucella spp 
(Elhassanny et al. 2013).  The size of the PCR product (3172 bp) was confirmed by 
agarose gel electrophoresis (Figure 4.6). The purified PCR fragment was blunt-end 
ligated into the pJET1.2 with T4 DNA ligase in a 3:1 molar ratio (insert:vector) and 
transformed into chemically competent Top10 cells.  The plasmid DNA of ampicillin 
resistant colonies was extracted; presumptive pJETmbfA plasmids were digested with 
HindIII, PstI and SacI restriction endonucleases (Figure 4.5). The resulting separation 
of DNA fragments by agarose gel electrophoresis allowed determination and 
confirmation of the insertion of the mbfA into the pJET1.2 vector.  Sanger sequencing 
(primers T7F and pJETR) confirmed the sequence and polarity of the inserted 
fragments.  
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Figure 4.5: Cloning of Brucella melitensis bv.1 str.16M mbfA into pJET 
A: Vector map of pJETmbfA1kb.  B: 0.8% agarose gel of restriction digest confirmation 
of pJETmbfA1kb. Tracks left to right: 1, PCR amplification of mbfA with 1 kb flanking 
DNA from the Brucella melitensis genome, 2, Supercoiled pJETmbfA1kb, 3, SacI 
digested pJETmbfA1kb (unique restriction site to inserted mbfA sequence), 4, EcoRI 
digested pJETmbfA1kb (unique restriction site to inserted pJET1.2 vector) 5, HindIII 
and PstI digested pJETmbfA1kb (release of inserted mbfA1kb 3486 and 301 bp 
fragments).   
 
To introduce the kanamycin resistance gene into the coding sequence of the mbfA gene, 
at the same time as removing the coding nucleotides, to create a non-polar gene 
excision, the Gibson assembly technique of molecular cloning was employed.  Inverse 
PCR (primers ΔmbfAF/R; Table 2.4) was used to amplify the flanking sequences of 
mbfA with the pJET vector backbone, excising the coding sequence of mbfA.  The 
resulting PCR product was excised from an agarose gel after electrophoretic separation, 
centrifugation column purified and estimates of the DNA concentration made through 
absorption measurement made at 260nm with a Nanodrop spectrophotometer.  The 
DNA fragment was designated pJETΔmbfA. The kanamycin resistance gene and its 
promoter (KanR cassette) were amplified from pHP45ΩKn (Fellay et al. 1987) 
(kanamycin cassette originates from the E. coli Tn5 transposon).  Primers 
(mbfAKnF/R) were designed to amplify the KanR cassette from pHP45ΩKn whilst 
incorporating additional DNA sequence complementary to the regions of DNA at the 
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up- and down-stream ends of the linearized pJETΔmbfA PCR fragment.  As the 
additional regions of complementary DNA provided by the primers would not anneal to 
the pHP45ΩKn template DNA in the first round of PCR a two-step PCR reaction was 
used (Methods 2.3.2).  The resulting PCR product was prepared as above and 
designated mbfAKnR. 
 
50 ng of the mbfAKnR insert and 200 ng of the pJETΔmbfA backbone vector were 
combined with the Gibson assembly enzymes and ligated at 50 °C for 15 mins.  The 
ligation mixtures were directly transformed into chemically competent E. coli and 
desired transformants were selected through ampicillin and kanamycin resistance.  
Restriction endonuclease digestion with PstI (an additional PstI restriction site was 
introduced into the plasmid within the inserted kanamycin cassette, allowing further 
confirmation of the plasmid) of the isolated plasmid DNA allowed confirmation of the 
construct, designated pJETΔmbfA::Kn (Figure 4.6). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Insertion of kanamycin resistance cassette into the coding sequence of 
mbfA  
A: Vector map of pJETΔmbfAKn. B: 0.8% agarose gel of restriction digest confirmation 
of pJETΔmbfAKn. Tracks left to right: 1, Supercoiled pJETΔmbfAKn; 2, EcoRI digested 
pJETΔmbfAKn (unique restriction site to inserted pJET vector); 3, PstI digested 
pJETΔmbfAKn (release of 4353 and 1982 bp fragments).   
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The next step involved PCR amplification of the ΔmbfA::KnR fragment of 
pJETΔmbfA::Kn using the same primers (mbfA1kbF/R) used to clone the 1 kb flanking 
regions from the B. melitensis chromosome.  The resulting PCR products were excised 
from an agarose gel after electrophoretic separation and centrifugation column purified. 
pEX100T (AmpR) was prepared to accept the ΔmbfA::KnR PCR fragment through 
digestion with SmaI (blunt end restriction endonuclease) and the linearised DNA was 
then excised from an agarose gel after electrophoretic separation, and was 
centrifugation column purified.  The DNA fragments were ligated with T4 DNA ligase, 
creating pEXΔmbfA::KnR. The resulting ligation mixture was transformed into 
chemically competent Top10 cells and plated onto LA with ampicillin and kanamycin. 
To ensure that transformants were pEX100T constructs and not carryover pJET 
constructs (both plasmid constructs are ampicillin and kanamycin resistance) the toxic 
activity required for a second recombination event in Brucella associated with SacB 
(levansucrase) was accessed (specific to pEX100T constructs). Transformant KnR, 
AmpR colonies were screened for sensitivity to sucrose through replica plating onto LA 
(with 100 µg/ml Amp, 50 µg/ml Kn) with and without 20% sucrose (Figure 4.8).  
Plasmid DNA was isolated from colonies that presented with the correct phenotypic 
profile (AmpR, KnR, SucS) and were digested with XhoI to confirm the size of the 
plasmid (Figure 4.7). 
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Figure 4.7:  Cloning of ΔmbfA::KnR fragment into pEX100T suicide plasmid.   
A: Vector map of pEXΔmbfAKn. B. Representative LA plate displaying the phenotypic 
characteristics of pEXΔmbfAKn transformant E. coli (AmpR, KnR, SucS) highlighted in 
red. C: 0.8% agarose gel of restriction digest confirmation of pEXΔmbfAKn. Tracks left 
to right: 1, SmaI linearised pEX100T (5846 bp); 2, supercoiled pEXΔmbfAKn; 3, XhoI 
linearised pEXΔmbfAKn (9238 bp).  
 
4.7: Construction of complementation vectors 
To confirm that phenotypes observed in the B. suis and melitensis mutants are truly a 
result of the deletion of the target gene, wild type activity must be shown to be restored 
with the target gene expressed in trans on a complementation plasmid.  Expression of 
genes in trans was conducted with the broad host range plasmid pBBR1MCS-4 
(ampicillin resistant).  Two constructs, representing the mbfA gene sequence observed 
in B. suis and B. melitensis strains, were created. The pattern of expression of these 
genes in trans from the complementation plasmid should match that of the wild type as 
they remain under control of their native promoter.  An increase in expression level 
through the multi-copy nature of plasmids will be limited due to the low copy number 
(10 copies per cell) of pBBR1MCS-4 in Brucella spp (Elzer et al. 1995). 
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Construction of the described complementation plasmids was achieved by digesting the 
pJETmbfA (B. suis and B. melitensis derived, with 0.5 kb of up- and down-stream 
flanking sequence) and pBBR1MCS-4 plasmid with XhoI and XbaI restriction enzymes. 
The resulting mbfA encoding 1680 bp fragments were excised from an agarose gel after 
electrophoretic separation, then centrifugation column purified and ligated with T4 
DNA ligase in a 3:1 molar ratio (insert:vector).  The ligation reactions were transformed 
into chemically competent Top10 cells and transformants screened for ampicillin 
resistance on LA. Additional screening with XGal was used to differentiate from 
pBBR1MCS-4 with no insert (Lac+) and pBBR4mbfA (Lac-). The pBBR4mbfA plasmids 
were extracted, digested with XhoI and XbaI to excise the inserted fragments (Figure 
4.8) and Sanger sequenced to confirm the presence/presence of the c55t SNP within the 
respective B. melitensis and B. suis sequences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Cloning of mbfAsuis and mbfAmelitensis into pBBR4 complementation 
plasmid. 
A: Vector map of pBBR4mbfAmel. B: 0.8% agarose gel of restriction digest confirmation 
of pBBR4mbfA. Tracks left to right, XhoI and XbaI digested: 1, pBBR4mbfAsuis 
(released fragment 1680 bp); and 2, pBBR4mbfAmelitensis (released fragment 1680 bp). 
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Chapter 5: Investigation of MbfA erythrin domain biochemistry 
 
5.1: Rationale - Generation and analysis of recombinant erythrin protein 
To enable investigation of the biochemistry mediated by the cytoplasmically located N-
terminal erythrin domain of the MbfA protein; the encoding sequence was expressed 
with tight control to allow the purification of sufficient quantities of the protein.  This 
was achieved by cloning the erythrin domain into a vector containing the T7 RNA 
polymerase promoter (pET21a) – detailed in Chapter 4.  In addition to maximizing 
expression, ideally, the protein should remain soluble in the cytoplasm of the expression 
strain, as the accumulation of insoluble polypeptides within inclusion bodies presents 
extra complications during subsequent purification steps.  To extract and purify the 
target protein from the bacterial cytosol, a x6 His tag was incorporated at the C-terminal 
end of the erythrin domain (engineered into the pET21a vector).  The affinity that 
histidine residues have for transition metals, especially nickel, was then used to retain 
the polyhistidine tagged protein to a nitrilotriacetic acid (NTA) agarose chromatography 
column saturated with Ni2+.  The NTA side chain binds nickel (II), forming an Ni-NTA 
complex, which has high affinity for polyhistidine-tagged proteins.  When a 
concentration gradient of imidazole is subsequently applied, polyhistidine binding to 
Ni-NTA is displaced, allowing elution of purified protein.  
 
Once the desired protein had been overexpressed and purified, biochemical analysis of 
the interactions of the protein with iron and hydrogen peroxide could be made, 
specifically the binding of iron to the erythrin as well as redox reactions at the di-iron 
centre.  In addition, techniques such as mass spectroscopy, protein crystallisation and 
generation of polyclonal antibodies can be conducted to enable more in-depth 
knowledge of MbfA. 
 
  
Chapter 5 
 
 
75 
5.2: Small-scale recombinant protein expression trials  
Three variants of the erythrin domain were cloned into the pET21a vector (detailed in 
Chapter 4) and were confirmed by Sanger sequencing to contain the desired nucleotide 
sequence. Each construct was transformed into BL21(DE3) chemically competent cells 
and transformants selected for by resistance to ampicillin. Before progressing to large-
scale production of the recombinant proteins, a preliminary study was conducted to 
ensure that each pET21a construct was generating His-tagged recombinant erythrin 
protein of the expected molecular weight. For this purpose, the expression profile of 
each pET21a transformant was examined in 50 ml of growth medium for a small-scale 
overexpression experiment.  
 
The growth of each strain was monitored to mid-log phase (0.5 OD units) whereupon 
the culture was induced with 0.5 mM IPTG. A total of 0.5 optical density units of whole 
cells were harvested every hour for 5 h as well as after overnight incubation.  Pelleted 
whole cells were solubilized in SDS loading buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 
10% glycerol, 12.5 mM EDTA, 1% dithiothreitol and 0.02 % bromophenol blue), 
heated to 100 °C for 10 min, centrifuged for 5 min at 12000 x g (Eppendorf 5452) and 
separated by SDS-PAGE.  The resulting polyacrylamide gel was stained with 
Coomassie blue, fixed with acetic acid (10%) and destained with ethanol (30%) (Figure 
5.1). No expression of recombinant protein was observed for any of the E. coli 
BL21(DE3) pET-ery transformants. The predicted molecular weights for each 
recombinant protein are; ery271: 15.5 kDa, ery306: 19.5 kDa and ery327: 21.9 kDa.   
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Figure 5.1: SDS-PAGE resolution of erythrin domain overexpression from pETery 
constructs in BL21(DE3).   
16% SDS-PAGE analysis of pETery271 (A), pETery306 (B) and pETery327 (C) 
expression in BL21(DE3), time after induction from which cells were harvested 
indicated.  Induced proteins expected at 15.5, 19.5 and 21.9 kDa, respectively.  
 
The lack of recombinant protein expression is predicted to be a result of codon bias 
(differences in tRNA usage) between Brucella and E. coli.  Two approaches were taken 
to address the lack of expression of recombinant protein. First, a synthetic, codon 
optimized, mbfA was synthesized which would eliminate those Brucella codons that are 
employed rarely by E. coli. Secondly, alternate E. coli cell types, which provide rare E. 
coli tRNA’s to increase translational efficiency, where used as expression host.  
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5.3: Codon optimisation of Brucella suis mbfA 
The nucleotide sequence of mbfA from B. suis was optimized for expression in E. coli 
by Gene Art, Life Technologies, Invitrogen.  The codon optimization manipulates the 
DNA sequence of the target gene, but preserves the encoded amino acids, therefore 
maintaining the amino acid sequence.  This methodology is employed to utilize the 
alternative codons that are used most frequently in E. coli enabling more efficient 
translation of non-E.coli originating genes in E. coli.  The native mbfA sequence was 
predicted to have less than optimal parameters for expression in E. coli; the average 
frequency of optimal codons for E. coli was 40%, suggesting that translation might stall 
during expression.  After optimization of each codon of the mbfA sequence, the use of 
optimal codons was predicted to be increased to 80%.  In addition, optimization reduced 
the average GC content from 59.39 to 47.52%, which closely matches that of the E. coli 
chromosome (Figure 5.2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Impact of codon optimisation on the nucleotide sequence and 
expression of mbfA.  A: Quality of used codons B: Percentage GC content C: Codon 
quality distribution. Native (blue) and synthetic (yellow) mbfA gene.  
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The synthetic B. suis mbfA gene was designed with NdeI and HindIII restriction 
endonuclease sites at the up- and down-stream ends, respectively, allowing excision 
from the pMA-T plasmid backbone (Figure 5.3A).  The excised fragment was ligated 
into NdeI and HindIII digested pET21a generating pETeryCO.  The pETeryCO 
construct was confirmed by comparison of the released eryCO fragment size by NdeI 
and HindIII digestion to that of the gel extracted NdeI and HindIII pMATeryCO 
fragment (Figure 5.3B). The confirmed pETeryCO construct was then transformed into 
chemically competent BL21(DE3) cells and transformants were selected through 
resistance to ampicillin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Cloning of the codon optimized erythrin domain from B. suis mbfA into 
pET21a.   
A: Vector map of pMA-TmbfA327. B: 0.8% agarose gel of pETeryCO cloning substrates 
and products. Tracks from left to right: 1, gel extracted NdeI and HindIII digested 
pET21a (~4.6 kb); 2, gel extracted eryCO PCR product 524 bp; 3, undigested 
pETeryCO (supercoiled DNA); and 4, NdeI and HindIII digested pETeryCO construct 
showing the released inserted fragment of equal size to the PCR product whilst the 
second fragment aligns with that of linearised pET21a. 
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The small-scale over-expression through induction with 0.5 mM IPTG was repeated and 
expression of recombinant protein was observed when 0.5 optical density units of 
solublised cell extracts were separated by SDS-PAGE and stained with Coomassie blue 
(Figure 5.4).  
 
The successful overexpression of recombinant protein through codon optimization of 
the erythrin coding sequence suggests that the lack of expression observed from the 
native Brucella constructs in E. coli BL21(DE3) was due to suboptimal codon usage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: SDS-PAGE analysis of codon optimized erythrin domain 
overexpression from the pETeryCO construct.   
16% SDS-PAGE of whole-cell extracts of BL21(DE3) transformed with pETeryCO  
and induced with IPTG at the time intervals indicated.  Induced protein expected mass 
of 21.9 kDa, indicated with arrow. 
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5.4: Expression of mbfA in E. coli BL21(DE3) Rosetta 
The second approach used to promote expression of mbfA from the T7 promoter, 
conducted alongside the codon optimization approach, was to transform the pET21a 
constructs into two genetically engineered E. coli strains designed to optimise protein 
expression.  These strains were: E. coli BL21(DE3)Star, which carries a mutated rne 
gene (rne131) that encodes a truncated RNase E enzyme that lacks the ability to 
degrade mRNA, resulting in an increase in mRNA stability; and BL21(DE3)Rosetta 
which encodes tRNAs for the codons AUA, AGG, AGA, CUA, CCC, GGA and CGG 
on a chloramphenicol-resistant pRARE2 plasmid, in E. coli BL21(DE3).  Small-scale 
over-expression was repeated and expression of erythrin was observed for all constructs 
in both E. coli BL21(DE3)Rosetta and E. coli BL21(DE3)Star (Figure 5.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: SDS-PAGE analysis of erythrin overexpression in E. coli 
BL21(DE3)Star/Rosetta.  
16% SDS-PAGE of whole-cell extracts of pETery271 (A), pETery306 (B), pETery327 (C) 
and pETeryCO (D) transformants of E. coli BL21(DE3)Star/Rosetta following 
induction with IPTG for the time periods indicated.  Overproduced proteins expected at 
14.1, 17.9 and 21.9 kDa, respectively, indicated with arrow.   
0	
hr
s	
	
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
La
dd
er
	
2	
hr
s	
pETery271	
BL21	Star	 BL21	Rose:a	
0	
hr
s	
	
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
2	
hr
s	
55kDa	
40kDa	
35kDa	
70kDa	
25kDa	
15kDa	
10kDa	
0	
hr
s	
	
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
La
dd
er
	
2	
hr
s	
pETery327	
BL21	Star	 BL21	Rose:a	
0	
hr
s	
	
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
2	
hr
s	
55kDa	
40kDa	
35kDa	
70kDa	
25kDa	
15kDa	
10kDa	
0	
hr
s		
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N	
La
dd
er
	
2	
hr
s	
pETery306	
BL21	Star	 BL21	Rose:a	
0	
hr
s		
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N	
2	
hr
s	
55kDa	
40kDa	
35kDa	
70kDa	
25kDa	
15kDa	
10kDa	
0	
hr
s		
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
La
dd
er
	
2	
hr
s	
pETeryCO	
BL21	Star	 BL21	Rose:a	
0	
hr
s		
1	
hr
s	
3	
hr
s	
4	
hr
s	
5	
hr
s	
O
N
	
2	
hr
s	
55kDa	
40kDa	
35kDa	
70kDa	
25kDa	
15kDa	
10kDa	
A	 B	
C	 D	
Chapter 5 
 
 
81 
With confirmation of expression of all erythrin constructs via small-scale over-
expression experimentation, through either codon optimization or alteration of E. coli 
expression strain, an estimation of the molecular weight (kDa) of the corresponding 
protein bands was conducted against a molecular weight marker. A digital image of a 
Coomassie stained polyacrylamide gel was used to calculate the retention values of each 
molecular weight marker and the recombinant protein bands, allowing calculation of the 
approximate molecular weights of the expressed protein (GeneSystem - GBox) (Figure 
5.6 and Table 5.1). The approximated molecular weight of each recombinant protein 
was within a maximum of 1.6 kDa of the predicted molecular weight, suggesting that 
the observed bands are those of the desired protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: SDS-PAGE analysis of erythrin overexpression from native and codon 
optimized pETery constructs.   
16% SDS-PAGE of whole-cell extracts of pETery271, pETery306, pETery327 and 
pETeryCO transformants of E. coli BL21(DE3)Star/Rosetta following induction with 
IPTG.  Estimated protein molecular weights displayed.   
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Table 5.1: Comparison of calculated molecular weights of recombinant protein to 
predicted molecular weight (kDa). 
 
Erythrin 
length (AA) 
Predicted MW 
(kDa) 
Average calculated 
MW (kDa) 
132 14.1 14.17 
167 17.9 17.38 
187 21.9 20.34 
187 21.9 20.30 
 
5.5: Solubility of recombinant erythrin domain proteins  
Before commitment to large-scale overexpression and purification of the erythrin 
domain variants, the solubility of each was determined.  A mild cell lysis reagent 
(BugBuster - Novagen) was used to rupture the cells, releasing the cytoplasmic 
contents, whilst not solubilising inclusion bodies.  The supernatant (soluble fraction) 
and pelleted cell debris (insoluble fraction) were collected for each pETery variant 
expressed in both E. coli BL21(DE3)Star and E. coli BL21(DE3)Rosetta strains (and E. 
coli BL21/DE3) for the codon optimized construct) after 5 h post induction with 0.5 
mM IPTG.  The samples were fractionated by SDS-PAGE and compared to whole-cell 
lysates of the respective transformant strains to compare the relative percentage of 
soluble and insoluble protein (Figure 5.7). 
 
The truncated erythrin proteins were present almost exclusively in the supernatant of the 
corresponding over-expressing E. coli BL21(DE3) strains, whereas the full length, non-
truncated, constructs presented with ~30% of the protein in the insoluble fractions.  The 
proportion of soluble protein obtained was considered acceptable for the purposes of 
purification.  
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Figure 5.7: SDS-PAGE analysis of relative solubility of recombinant erythrin 
domain proteins from native and codon optimized pETery constructs.   
16% SDS-PAGE of supernatant and pellet fractions of lysed E. coli BL21(DE3) strains 
transformed with pET-BM1ery, pET-BM2ery, pET-BSery and pET-BSeryCO 5 h post 
induction. Proteins expected at 14.1, 17.9 and 21.9 kDa, respectively, indicated with 
arrow. 
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5.6: Large-scale overexpression of recombinant protein 
Upon confirmation of recombinant protein expression and solubility, expression of the 
187 amino acid, full length erythrin construct was conducted at a larger scale.  Five 
litres of LB (50 ml in previous experiments) was inoculated with E. coli 
BL21(DE3)Rosetta transformed with pETery327.  Cells were harvested by 
centrifugation at 6000 x g (Sorval RC5B+ with SLA-3000 rotor) for 30 min at 4 °C, 5 h 
post induction with 0.5 mM IPTG. Pelleted cells were re-suspended in buffer A1 (50 
mM Tris and 15 mM imidazole pH 8.0) with 1 mg/ml lysozyme then incubated at room 
temperature for 1 h with 200 rpm shaking to enable degradation of peptidoglycan by 
lysozyme.  Cells were subsequently cooled on ice for 30 min before sonication (60% 
amplitude with a 6 mm diameter tip for 15 min) to lyse cells.  The cell lysate was 
centrifuged at 3250 x g (Eppendorf 5810r with A-4-81 rotor) for 20 min at 4 °C three 
times, collecting clear lysate between each centrifugation step, to remove unlysed cells.  
The collected lysate was filtered (0.45 µm pore size) before loading onto an equilibrated 
nickel affinity chromatography column.  Washing with buffer A1 facilitated removal of 
un-tagged proteins until the UV-absorbance of the flow-though had reached a minimal 
plateau.  After maximal removal of non-specific proteins, a linear gradient of buffer A2 
(50 mM Tris and 1.0 M imidazole pH 8.0) was applied to the column and 7 ml fractions 
collected. The eluted fractions displaying a high UV absorption, as displayed by the 
chromatogram from the nickel affinity column, were separated by SDS-PAGE and 
stained for total protein with Coomassie blue (Figure 5.8A).  
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Figure 5.8: Chromatograms and SDS-PAGE analysis of eluted fractions from 
nickel affinity and anion exchange chromatography.   
A: Chromatogram and 16% SDS-PAGE of nickel affinity chromatography purification 
of erythrin. SDS-PAGE of 0.5 optical density units of whole cells (WC) and cell lysate 
(L), and 10 µl of flow-through (FT) and fractions 15 to 21. B: Chromatogram and 16% 
SDS-PAGE of anion exchange chromatography purification of erythrin.  SDS-PAGE of 
10 µl of pooled fractions 15-21 (the loaded sample), flow-through (FT) and fractions 27 
to 36. Buffer gradient (black line), conductivity (mS/cm) (red line), A280 nm (blue line).  
Erythrin peak A/B labeled, pooled fractions indicate by black bar.   
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5.7: Differential separation of erythrin by anion-exchange chromatography 
Eluted fractions 15 to 21 from the nickel affinity column, which displayed a high 
recombinant protein content when analysed by SDS-PAGE, were pooled together to 
give a final volume of 49 ml.  The semi-purified sample was loaded onto an equilibrated 
diethylaminoethyl (DEAE) anion-exchange chromatography column (25 x 140 mm).  
The column was washed (buffer B1 – 50 mM Tris pH 8.0) and a linear gradient of 
buffer B2 (50 mM Tris and 1.0 M NaCl pH 8.0) was applied to the column over a 
volume of 240 ml, and 7 ml fractions collected. The chromatogram displayed a 
differential separation of the recombinant protein.  The first minor absorption peak 
corresponded to a larger quantity of eluted protein, as assessed by SDS-PAGE and 
Coomassie blue staining, whereas, the second, larger absorption peak surprising 
displayed a lower quantity of protein (Figure 5.8B).  The separated eluted proteins were 
pooled according to their respective peaks; peak A, fractions 27-31 (35 ml) and peak B, 
fractions 32-36 (35 ml).   
 
One explanation for the differential separation of the erythrin domain is that holo-
erythrin (metal bound) may result in alterations to the tertiary structure and/or surface 
charge of the protein due to metal binding, exposing more positively charged residues to 
the stationary phase of the anion-exchange column.  This would result in a higher ionic 
strength of eluent being required to dissociate the protein from the stationary phase, 
resulting in a delayed elution time from the DEAE column.  This hypothesis predicts 
that the high UV absorbance observed in peak B from DEAE chromatography is due to 
the binding of metals to the erythrin domain.  Transition metals, including iron and zinc, 
strongly absorb UV light (Table 5.2), and would therefore give artificially increased 
approximations to protein concentrations when calculated from 280 nm absorbance 
using spectroscopic analysis with a Nanodrop spectrophotometer.  Therefore, 
calculations of metal-bound erythrin concentrations were made via Bradford assay to 
approximate protein concentration dependent on the amino acid composition. 
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Table 5.2: UV absorption of Group four transition metals (provided by University of 
Reading, Department of Soil Sciences) 
 
Group 4 Transition Metal λmax (nm) 
Manganese (Mn) 257.610 
Iron (Fe) 238.204 
Cobalt (Co) 230.786 
Nickel (Ni) 231.604 
Copper (Cu) 324.752 
Zinc (Zn) 213.857 
 
Analysis of the protein concentration of each sample when determined 
spectroscopically with the Nanodrop ND-1000 or via a Bradford assay (BSA standard 
curve), before and after concentration using a Vivaspin-20 (3,000 MWCO, erythrin 
domain 21,989 MW) centrifugal concentrator (Satorius Stedim Biotech) (Table 5.3), 
demonstrated the excessively high estimations of peak B protein concentration by 280 
nm absorption. The concentration of protein in peak A (expected low metal content) 
displayed a difference of 3.8- and 2.9-fold, pre and post concentration, between 
Nanodrop and Bradford assays. In contrast, the concentration of peak B protein 
(expected high metal content) displayed a difference of 8.5- and 12.75-fold, pre and 
post concentration, between the Nanodrop and Bradford assays.  
  
Table 5.3: Concentration of recombinant protein before and after centrifugal 
concentration 
 Pre-concentration Post-concentration 
Volume 
ml 
ND 
mg/ml 
Bradford 
mg/ml 
Volume 
ml 
ND 
mg/ml 
Bradford 
mg/ml 
Ery Peak A 70 0.5 1.9 15 3.1 9.0 
Ery Peak B 70 0.34 0.04 15 2.55 0.2 
*ND – Nanodrop 
 
 
  
Chapter 5 
 
 
88 
5.8: Amino acid analysis (AAA) of His-tagged erythrin  
To add additional confirmation that the purified protein was His-tagged erythrin, amino 
acid analysis (Alta Bioscience) of the pooled fractions post nickel affinity and anion 
exchange chromatography was conducted.  Amino acid analysis is considered to be the 
golden standard analysis for accurate quantitation of proteins and can be used to very 
accurately determine the quantity of purified proteins in a manner that is not biased by 
differences in amino acid composition. 
 
A 5 ml aliquot of erythrin was dialysed into 20 mM HEPES pH 7.0 to allow removal of 
NaCl added during the anion exchange chromatography step and the concentration was 
then estimated via Bradford assay at 2.87 mg/ml.  To determine the amino acid 
composition of the sample, hydrolysis with 5.7 N HCl and a small amount of phenol 
under vacuum was conducted for 22-24 h at 110 °C.  Hydrolysis can have varying 
effects on different amino acids: asparagine and glutamine are converted to their 
corresponding acids (aspartic acid and glutamic acid), therefore cannot be measured 
independently within the sample, whereas tryptophan is completely destroyed by the 
hydrolysis process.  The sample was then dissolved in distilled water containing EDTA 
(to chelate metal ions) before commitment to derivatisation and high performance liquid 
chromatography (HPLC) by the amino acid analyzer.  Derivatisation reacts the free 
amino acids, under basic conditions, with phenylisothiocyanate (PITC) to produce 
phenylthiocarbamyl (PTC) amino acid derivatives that can be separated by HPLC; a 
reverse phase C18 silica column allows detection of the PTC chromophore at 254 nm. 
Chromatographic peaks are identified and quantitated allowing determination of the 
amount of amino acid (in nmole/ml) in the sample.  
 
The quantity of each amino acid in the sample was used to determine the percentage 
frequency of that amino acid as a percentage of the sum of the total protein 
concentration.  The quantity of each amino acid was subsequently used to calculate the 
molecular weight it contributes to the total molecular weight of the protein (Table 5.4).  
The concentration of protein in the submitted sample was 0.927 mg/ml, 3.1 fold lower 
than the estimate obtained by Bradford assay.  This discrepancy will be used in future 
parts of this thesis to correct protein concentrations obtained by Bradford assays to give 
a true estimate of protein concentration. The calculated MW of the erythrin protein was 
21.829 kDa, 122 Da less than the expected molecular weight (21.951 kDa).  
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Table 5.4:  Amino acid analysis.  Supplied data from amino acid analysis highlighted 
in grey. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Theore&cal		 AAA	Calcula&on	
	 Freq	(AA)	 MW	(Da)	 Sum	MW	(KDa)	 nmole/ml	 ug/ml	 	Freq	(%)	 Freq	(AA)	 MW	(KDa)	
Alanine	 22	 71.0779	 1.564	 988	 70.22	 12.35	 23.09	 1.641	
Asp/Asn	 18	 115.0874	 2.072	 762	 87.70	 9.52	 17.81	 2.050	
Glu/Gln	 30	 128.1292	 3.844	 1220	 156.32	 15.25	 28.52	 3.654	
Phenylalanine	 8	 147.1739	 1.177	 313	 46.07	 3.91	 7.32	 1.077	
Glycine	 5	 57.0513	 0.285	 259	 14.78	 3.24	 6.05	 0.345	
His=dine	 12	 137.1393	 1.646	 607	 83.24	 7.59	 14.19	 1.946	
Isoleucine	 8	 113.1576	 0.905	 534	 60.43	 6.67	 12.48	 1.412	
Lysine	 9	 128.1723	 1.154	 404	 51.78	 5.05	 9.44	 1.210	
Leucine	 15	 113.1576	 1.697	 737	 83.40	 9.21	 17.23	 1.949	
Methionine	 3	 131.1961	 0.394	 91.2	 11.97	 1.14	 2.13	 0.280	
Arginine	 22	 156.1857	 3.436	 802	 125.26	 10.02	 18.75	 2.928	
Proline	 6	 97.1152	 0.583	 210	 20.39	 2.62	 4.91	 0.477	
Serine	 13	 87.0773	 1.132	 424	 36.92	 5.30	 9.91	 0.863	
Threonine	 3	 101.1039	 0.303	 146	 14.76	 1.82	 3.41	 0.345	
Valine	 6	 99.1311	 0.595	 303	 30.04	 3.79	 7.08	 0.702	
Tyrosine	 6	 163.1733	 0.979	 200	 32.63	 2.50	 4.67	 0.763	
Tryptophan	 1	 186.2099	 0.186	 0	 0	 0	 0.00	 0.186	
Total	 187	 	 21.951	 8000.2	 925.90	 100.00	 187	 21.829	
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5.9: Identification and quantification of metals bound to erythrin and recreation of 
di-iron centred erythrin 
To determine the stoichiometric concentrations of metals bound to the purified erythrin 
domain, aliquots of peak A, peak B and apo-erythrin (metal free) were analysed by 
inductively-coupled plasma optical-emission spectroscopy (ICP-OES) and electrospray-
ionisation-coupled mass spectroscopy (ESI-MS). Apo-erythrin was generated by the 
removal of bound metals via chelation from peak A erythrin by treatment with 1 mM 
diethylenetriaminepentaacetic acid (DTPA - non-specific transition metal chelator), 1 
mM 2,2’-dipyridyl (specific ferrous iron chelator) and 2 mM sodium dithionite 
(reductant).  The metal chelates were subsequently removed through dialysis against 
20 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) pH 7.0.  
 
Di-iron carboxylate proteins, such as the erythrin domain, are able to bind iron atoms 
(as well as other group four transition metals including; manganese, cobalt, nickel, 
copper and zinc) with a stoichiometry of two (Nordlund and Eklund 1995).  It is 
therefore expected that divalent metals will associate with the di-iron binding motifs of 
the recombinant protein during expression in E. coli.  However, it is unclear whether 
iron will have been incorporated with the highest stoichiometry into the erythrin 
domain, due to the low concentration of free iron maintained within E. coli (10 µM) and 
potential binding to other metals. Additional divalent transition metals such as zinc, 
which, although present at lower concentrations within the cytoplasm compared to iron, 
are also able to bind metalloproteins when over-expressed in E. coli. As indicated by the 
Irving-Williams series (Irving and Williams 1953), zinc has a higher binding affinity 
than iron so is able to outcompete iron for iron binding sites within proteins. 
 
ICP-OES analysis was conducted with 0.0125 mg/ml (predicted metal ion concentration 
of 25 ppm - due to a predicted two metal atoms per protein monomer) of peak A, peak 
B and an apo-erythrin samples, using a Perkin Elmer Optima 7300 ICP-OES instrument 
in the School of Soil Sciences at the University of Reading (Figure 5.9).   
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Figure 5.9: ICP-OES analysis of peak A, peak B and apo-erythrin.  
Stoichiometric concentrations of transition metals bound to peak A, peak B and apo-
erythrin when analyzed via ICP-OES.  
 
Analysis of the three samples revealed that chelation and dialysis effectively removes 
bound metals from the peak A erythrin sample.  Peak A erythrin had a mixed occupancy 
of zinc and iron in equal stoichiometry (~0.6 and 0.6 per protein molecule), whilst zinc 
was bound with much higher stoichiometric levels in peak B erythrin with an 
approximate stoichiometry of two (with very little iron apparent), suggesting the 
formation of a di-zinc form of erythrin. These data support the suggestion that 
differential separation observed with DEAE chromatography is based upon metal 
occupancy and that the erythrin domain binds a maximum of 2 metal atoms per 
monomer.  
 
Upon creation of the apo-erythrin (originating from peak A) its binding capacity for 
ferrous iron was then determined.  Anaerobically prepared (N2 purged) 10 mM ferrous 
ammonium sulphate was titrated against 30 µM of apo-erythrin and measurements of 
UV-visible absorption (200-500 nm) at sub-stoichiometric iron concentrations were 
recorded with a Unicam Helios alpha spectrophotmoter (Figure 5.10A).  Titration with 
Fe2+ resulted in a linear increase in UV absorbance (λmax ~265 nm) up to two iron 
atoms per protein monomer (Figure 5.10B/C), suggesting the formation of the di-iron 
centre.  
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Figure 5.10: UV-visible spectroscopy of titration of apo-EryHis with ferrous iron. 
A: UV-visible spectrum from 200-500 nm of sub-stoichiometric concentrations of 
ferrous iron titrated against 30 µM apo-Ery. B: absorbance difference of apo-EryHis 
following iron addition. C: comparison of absorbance change at 265 nm with addition 
of ferrous iron.  A linear increase in A265 of ~0.125 A units per Fe atom equivalent is 
observed, for up to two atoms per protein, after which the degree of increase is 
diminished (to just ~0.0125 A unit per Fe atom equivalent) with further iron addition. 
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To generate substantial quantities of di-iron erythrin, a four-fold excess of ferrous 
ammounium sulphate was added to 10 ml of the apo-erythrin and incubated on ice for   
2 h.  Excess, unbound iron was then removed by dialysis against 20 mM HEPES pH 
7.0, and to ensure metal stoichiometry, an aliquot was submitted for ICP-OES analysis 
(Figure 5.11).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: ICP-OES analysis of diiron-erythrin.  
Stoichiometric concentrations of transition metals bound to Fe-erythrin analyzed by 
ICP-OES.  
 
A comparison of the UV-visible absorbance spectrum (200-400 nm) of 2 µM apo, 
diiron and dizinc (peak B) erythrin variants conducted with the Unicam Helios alpha 
spectrophotometer at room temperature in 20 mM HEPES pH 7.0 (Figure 5.12).  
Absorbance of apo-erythrin was consistently less than 0.1 absorbance units, whereas, 
saturation with iron and zinc resulted in increased absorption.  Di-Zn erythrin gave 
maxima of 0.48 at 210 and 0.12 at 260 nm whilst di-Fe erythrin gave maxima of 0.35 at 
210 and 0.18 at 260 nm. The absorbance of the iron-saturated erythrin at visible 
wavelengths was reflected by the observation of a clear yellow-coloured solution.  
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Figure 5.12: UV-visible spectroscopy of apo-, di-Fe- and di-Zn-erythrin (peak B).  
Spectra were recorded at 200-400 nm, with a 1 nm band width and scan rate of 1 nm/s.  
Proteins were at 2 µM in 20 mM HEPES pH 7.0.  
 
 
To accurately determine the intact mass of the peak A, peak B apo, diiron and dizinc 
forms of the recombinant erythrin protein and to confirm the presence of the bound 
metals, 50 µg (100 µl) samples of protein dialysed into 50 mM ammonium acetate were 
submitted for analysis with the Thermo Fisher Velos Orbitrap with Electron Transfer 
Dissociation at the Advanced Mass Spectroscopy Facility at the University of 
Birmingham.  Samples were analyzed via electro-spray ionization mass spectroscopy 
(ESI-MS) which allows the mass determination of macromolecules including proteins, 
as it is a 'soft ionization' technique which prevents the fragmentation of these molecules 
during ionization.  
 
Analysis of peak A (found to be largely metal free by ICP-OES) revealed three distinct 
mass/charge peaks, deconvolution of this data allowed determination of their masses as 
21988.09, 22052.00 and 22115.91 Da (Figure 5.13A).  The smallest mass (21988.08) 
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represents the apo-protein presenting as 1.56 Da less that the theoretical mass (21989.64 
Da) of the 188 amino acid His-tagged erythrin protein.  The second mass peak, 
22052.00 Da, of 80% relative abundance has a difference of 63.91 Da compared to the 
apo-protein, which represents the approximate weight of a single zinc atom (65.38 Da).  
The third mass peak, 2215.91 Da, of 45% relative abundance has a difference of 127.82 
Da compared to the apo-protein and represents the approximate weight of two zinc 
atoms (130.76 Da).  The selection of Zn as the metal associated with the erythrin is 
based upon the ICP-OES data suggests that high concentrations of zinc, and not other 
metals (such as copper and iron) are present within this sample. Together this data 
equates to the approximate stoichiometry of one metal atom per protein molecule which 
is consistent with that observed by ICP-OES.   
 
Mass spectroscopy analysis of peak B (suspected dizinc-erythrin according to the ICP-
OES data) indicated a single distinct mass/charge peak which upon deconvolution 
revealed a mass of 22115.89 Da (Figure 5.13B).  This mass is 127.8 Da greater than that 
of the apo-protein form identified for the peak A sample and again represents the 
approximate weight of two zinc atoms (0.02 Da difference between respective dizinc 
erythrins). It should be noted that the MS analysis gave no evidence of a dimeric (or any 
other multimer) form suggesting that the erythrin domain is monomeric in nature.  This 
is in contrast to the observations made by (Sankari and O'Brian 2014) for the equivalent 
domain of MbfA from B. japonicum, which was found to be dimeric according to gel 
filtration chromatography analysis. 
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Figure 5.13: ESI-MS analysis of peak A and peak B (dizinc).   
Electrospray ionization analysis of whole protein masses of protein-metal species 
present in peak A (A) and peak B (B).  
 
Lastly analysis of the diiron-reconstituted erythrin (anaerobic ferrous ammonium 
sulphate addition to previously chelated protein) by ESI-MS revealed a single distinct 
mass/charge peak, which upon deconvolution reveals a mass of 22101.82 Da (Figure 
5.14).  This mass is 113.73 Da greater than that of the apo-protein identified in the peak 
A sample.  This difference in mass represents the approximate weight of two iron atoms 
(Fe: 55.85 Da; 2 Fe: 111.7 Da) and suggests that two iron atoms are bound (matching 
the ICP-OES data), most likely at the di-iron binding site.  
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Figure 5.14: ESI-MS analysis of diiron-erythrin.  
Electrospray ionization analysis of whole protein masses of protein-metal species 
present in di-iron reconstituted erythrin. 
 
5.10: Reduction and oxidation of purified diFe-Erythrin 
The current model suggests that ferrous iron export from the cytosol of the bacterial cell 
by MbfA is facilitated by the movement of electrons from the exported iron atoms thus 
converting the iron to the ferric form. The released electrons are thought to reduce the 
iron atoms of the diiron centre of the erythrin domain generating a di-ferrous centre.  
The reduced iron centre can then be oxidized back to the ferric form, in the process 
reducing harmful cellular peroxides. In an attempt to provide support for this 
mechanism, the redox activity of the erythrin diiron centre was assessed 
spectroscopically through reduction with sodium dithionite followed by oxidation by 
hydrogen peroxide to the erythrin domain (Figure 5.15).  
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Figure 5.15: Spectroscopic measurement of erythrin reduction and oxidation.  
UV-visible spectroscopy of reduction (A) and oxidation (B) of 20 µM Fe-erythrin in   
20 µM HEPES pH. 7.0 through addition of sodium dithionite followed by addition of 
hydrogen peroxide respectively. Experimentation conducted at room temperature.  
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The absorbance of visible light between 380 and 480 nm was observed to decrease for 
each addition of sodium dithionite, resulting in the yellow protein becoming colourless 
as the di-ferric centred erythrin domain was presumed to be reduced to a di-ferrous 
state. The fully reduced protein was then titrated with hydrogen peroxide, which 
resulted in an increase in absorbance back to the original absorbance of the untreated 
protein as the di-ferric center was presumed to be re-formed. 
 
Interestingly, oxidation of the di-ferrous centred erythrin was also observed without the 
addition of hydrogen peroxide. Kinetic spectroscopy at 380 nm over a 10 min time 
course displayed that oxidation of the di-ferrous centre was possible with atmospheric 
oxygen as well as hydrogen peroxide (Figure 5.16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16: Oxidation of reduced erythrin with hydrogen peroxide or molecular 
oxygen.   
Change in absorbance at 380 nm over time arising from the oxidation of 20 µM reduced 
Fe-erythrin by hydrogen peroxide or oxygen, at room temperature.  
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The time taken for the fully reduced di-ferrous centre to become oxidized by 10 mM 
hydrogen peroxide was ~50 s, whereas oxidation via atmospheric oxygen took ~10 min, 
12 times slower.  In both, cases the absorbance of fully oxidized protein was equivalent 
to that of the control non-reduced sample which suggests that the di-Fe centre can 
undergo redox cycling without loss of integrity. 
 
The creation of a redox sensitive di-iron centered erythrin prompted analysis of the 
proposed peroxide reductase activity that this domain of the MbfA protein possesses 
and comparison to apo-EryHis and the as-isolated di-zinc erythrin (peak B).  Peroxide 
reductase activity was measured by kinetic UV-vis spectroscopy through reduction in 
absorbance at 240 nm (wavelength at which hydrogen peroxide strongly absorbs UV 
light) over time.  10 µM of each protein was exposed to excess (10 mM) hydrogen 
peroxide but no change in 240 nm absorbance was observed, suggesting that no 
peroxide reductase activity is present (data not shown).   
 
This in vitro examination of peroxide reductase activity was not successful due to the 
requirement of a source of electrons providing a route for re-reduction of the di-iron 
center, which would normally be supplied within the in vivo environment.  
 
 
   
Chapter 5 
 
 
101 
5.11: Additional purifications of recombinant erythrin protein 
The erythrin protein was purified a further two times during the course of this project to 
generate sufficient quantities and concentration of protein to allow for the completion of 
all conducted biochemical assays, including: recreation of a di-iron centre, UV-visible 
spectroscopy, ICP-OES studies and ESI-MS, thermal shift assays, crystallization trials 
and amino acid analysis.  
 
A second purification of the His-tagged erythrin domain of MbfA was conducted using 
the same methods described previously.  After collection of eluted protein from anion 
exchange chromatography, the as-isolated bound metals were removed from all protein 
via chelation, and the metal-chelates were removed by dialysis against 20 mM HEPES 
pH 7.0, as before.   
 
The generated apo-erythrin sample was split into two aliquots, one was left as apo-
erythrin the second was committed to generating a di-iron centred form.  To generate 
the di-iron centred erythrin, an estimate of the concentration of the apo-erythrin was 
determined via a Bradford assay and adjusted based upon variation between Bradford 
assay and amino acid analysis. Addition of a 10-fold excess of anaerobic ferrous 
ammonium sulphate was made to the protein solution. An increase in absorbance was 
apparent within seconds after addition of ferrous iron, with a yellow colour intensifying 
with incubation over two hours, suggesting oxidation of iron during incorporation into 
the iron binding site – an indication of ferroxidase activity. Excess unbound iron was 
removed by dialysis against 20 mM HEPES pH 7.0. 
 
To further facilitate purification and examine differences between the apo and di-iron 
erythrin; the apo- and diiron-erythrin samples were subjected to a second round of anion 
exchange chromatography (Figure 5.17). 
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Figure 5.17:  Chromatograms and SDS-PAGE analysis of eluted fractions from 
nickel affinity and anion exchange chromatography.  
A: Chromatogram and 16% SDS-PAGE analysis of nickel affinity chromatography 
purification of erythrin. SDS-PAGE resolution of cell lysate (L), flow-through (FT) and 
fractions 11 to 22. B: Chromatogram and 16% SDS-PAGE analysis of anion exchange 
chromatography purification of erythrin.  SDS-PAGE of pooled fractions 11-22, flow-
through (FT) and eluted fractions 10 to 19. Buffer gradient (black line), conductivity 
(mS/cm) (red line), A280 nm (blue line).  Erythrin peak A/B labeled, pooled fractions 
indicate by black bar.  
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Figure 5.18:  Chromatograms of DEAE anion exchange chromatography of apo- 
and diiron-erythrin.  
A: Chromatogram and 16% SDS-PAGE analysis of anion exchange chromatography 
purification of apo-erythrin. SDS-PAGE of flow-through (FT) and fractions 10 to 24. B: 
Chromatogram and 16% SDS-PAGE analysis of anion exchange chromatography 
purification of apo-erythrin. SDS-PAGE of flow-through (FT) and fractions 8 to 29.  
Photographs of fraction colour are provided. Buffer gradient (black line), conductivity 
(mS/cm) (red line), A280 nm (blue line).  Erythrin peak A/B labeled, pooled fractions 
indicate by black bar.  
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The relatively low absorbance for the three peaks seen in the chromatogram of apo-
erythrin (Figure 5.18A) suggest that all metal centres were removed, although it is 
unclear why the protein eluted in three peaks.  In contrast, the high intensity of Fe-
erythrin peak (absorbance at 280) on the chromatogram (Figure 5.18B) suggests that 
this protein is metallated, as is supported by the brown colouration of the fractions 
obtained. 
 
5.12: Thermal shift assay 
In order to assist crystallization trials with the erythrin domain (in an attempt generate 
X-ray diffraction data to solve the crystal structure), preliminary studies were 
conducted, by means of a thermal shift assay, to determine stabilizing conditions that 
may be beneficial to the generation of protein crystals in solution.  
 
A thermal shift assay (TSA) allows determination of the temperature at which half of 
the protein population is denatured (Th).  This measurement is useful within procedures 
designed to identify ligands which are stabilising to the protein’s tertiary structure, 
aiding attempts to generate protein crystals to conduct X-ray diffraction analysis.  The 
principle of the assay involves the addition of SYPRO orange (ThermoFisher) which 
exhibits a low fluorescence signal in polar environments (aqueous solutions) but a high 
fluorescence signal in non-polar environments, such as when in contact with the 
hydrophobic core of proteins (exposed upon denaturation).  The assay involves 
monitoring kinetically the fluorescence emission at 580 nm whilst the protein:SYPRO 
solution is heated from 24 °C to 94 °C at a rate of 1 °C/min.  As the temperature 
increases and the protein begins to denature; the hydrophobic core is exposed allowing 
binding of SYPRO orange increasing the fluorescence emission signal.  The 
fluorescence emission data generated was analyzed by the NAMI algorithm 
(Groftehauge et al. 2015) which identifies the temperature at which the emission data 
fits a linear regression with a correlation coefficient of r = 0.996. This reading is used to 
identify a Th as well as a maximum and minimum melting temperature. The thermal 
shift assay of erythrin in H2O (Figure 5.19) demonstrates the rapid linear increase in 
fluorescence emission upon denaturation of the protein which is used by the NAMI 
algorithm to determine the Th.  
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Figure 5.19: Thermal shift assay of apo-erythrin in H2O.   
Normalized fluorescence intensity data collected from 24 to 94 °C for apo-erythrin 
diluted into H2O. Dashed line represent minimum and maximum melting temperatures, 
solid line represents Th determined by NAMI.  
 
Firstly, an initial study was conducted with 1 mg/ml apo-erythrin to determine an 
optimal pH range in which apo-erythin is most stable, i.e. the pH at which Th is greatest.  
A pH screen matrix was created by Emily Cardew (University of Durham) which 
comprised 93 different pH conditions, ranging from pH 4.1 to 10.9, through 28 different 
buffers all at a concentration of 100 mM (Appendix 9.5). The fluorescence emission 
data collected from the RT-PCR machine was analysed by the NAMI algorithm and is 
displayed in Figure 5.20.   
 
The data show that the erythrin protein is more stable at acidic pH than at basic pH, 
with melting temperatures decreasing at a linear rate from approximately pH 6.0 to 9.0, 
with the lowest Th (27 °C) achieved when assayed in 100 mM CAPS pH 10.4.  The 
highest melting temperatures were achieved in buffers of pH 5.0 to 6.0, with a maximal 
Th of 51.5 °C in 100 mM succinate pH 5.4, a 6.8 °C increase over the same assay 
conducted in H2O.  
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Figure 5.20: Thermal shift assay of erythrin; pH screen.   
A: Th calculated via thermal shift assay for apo-erythrin for all assay conditions in pH 
screen matrix. B: Normalised intensity fluorescence emission readings of selected pH 
values of apo-erythrin. 
 
A second study examined the Th of apo-erythrin with addition of simple salt solutions. 
A salt screen matrix created by Emily Cardew comprised a titration of concentrations of 
six different salt solutions: sodium malonate, ammonium sulphate, sodium chloride, 
ammonium chloride, magnesium sulphate and sodium sulphate. In addition, 200 mM 
alkali metal chlorides were used in the screen, along with 100 mM sodium halides, 2 
mM lanthanide chlorides and 1 mM transition metal salts (Appendix 9.5). The data 
collected from the RT-PCR machine was analysed by the NAMI algorithm and is 
displayed in Figure 5.21.   
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Figure 5.21: Thermal shift assay, salt screen.   
A: Normalised intensity fluorescence emission data and Th bar graph representation of 
thermal shift assays of 1 mg/ml apo-erythrin with sodium malonate, ammonium 
sulphate, sodium chloride, ammonium chloride, magnesium sulphate, sodium sulphate, 
alkali metal chlorides, sodium halides and lanthanide chlorides. B: Normalised intensity 
fluorescence emission data and Th bar graph representation of thermal shift assays of 1 
mg/ml apo-erythrin with transition metal salts 
 
Titration of sodium malonate to apo-erythrin resulted in a concentration dependent 
decrease in Th, from 44.7 °C with no addition (H2O control) to 33.0 °C with 1.5 M 
sodium malonate. Titration of ammonium sulphate to apo-erythrin resulted in a 
concentration independent increase in Th, 0.2 M ammonium sulphate increased Th by 
4.9 °C over an H2O control to 49.6 °C, whereas 1.5 M ammonium sulphate only 
increased Th by 1.3 °C over an H2O control to 46.0 °C. Similar, relatively modest, 
concentration independent increases in Th, were observed for additions of sodium 
chloride and sodium sulphate. Titration of ammonium chloride and magnesium sulphate 
to apo-erythrin resulted in a concentration dependent increase in Th of 7.1 °C and 17.1 
°C at a 1 M respectively, compared to an H2O control. Thus, Mg2+ have a relatively 
large Th increase. 
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Comparison of 200 mM lithium to caesium alkali metal chlorides resulted in no 
difference in Th. Whereas, analysis of 400 mM sodium halides resulted in a decrease in 
Th as the halide descended in the group of the periodic table. Addition of NaF presented 
in no difference to the H2O control, but addition of NaI decrease Th by 12.6 °C to 32.1 
°C. Addition of 2 mM lanthanide chlorides resulted in a both increases and decreases to 
Th, with no trend across the series identified. La, Pr, Nd and Ho all increased Th, on 
average by 22.0 °C, whereas Sm, Yb and Lu presented no difference compared to a H2O 
control, whilst, Eu, Gd and Dy all decreased Th on average by 9.4 °C. 
 
Addition of transition metal salts resulted in the largest increases in Th.  This is not 
surprising as the di-iron carboxylate proteins such as erythrin require the binding of iron 
for their catalytic activity (iron was not included in this preliminary assay).  Addition of 
CuSO4, CoCl2 and NiCl2 resulted in very little difference in Th when compared to the 
H2O control, however, addition of CdSO4, ZnCl2 and MnCl2 increased Th markedly by 
43.3, 24.7 and 40.1 °C, respectively.  These large increases in Th can be observed 
clearly in the normalised intensity bar charts, where specifically, addition of cadmium 
and manganese salts results in the complete stabilisation of the protein complex to 
approximately 78 °C. 
 
In summary, addition of simple salts, alkali metal chlorides, and sodium halides provide 
marginal effects upon the Th of erythrin, especially in comparison to the addition of the 
transition metal salts, of CdSO4, ZnCl2 and MnCl2.  This result is not surprising given 
the evidence that the erythrin protein has the ability to bind two iron or zinc atoms.  
 
With the observation of a large increase in the Th of apo-erythrin with addition of Mn, 
Zn and Cd a third TSA was developed to determine the effect on Th with titration of the 
transition metals: V, Mn, Fe, Co, Ni, Cu, Zn, Mo, Cd and Pb.  Concentrations from 1 
µM to 2 mM were assayed which correspond to a protein:metal stoichiometry ranging 
from 0.01 to 10.  The fluorescence emission data of stabilizing salts collected from the 
RT-PCR machine was analysed by the NAMI algorithm generating Th values and is 
displayed against stoichiometry in Figure 5.22.  The Th values of transition metal salts 
which did not produce a stabilizing effect are displayed in Figure 5.23.   
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Figure 5.22: Thermal shift assay determination of Th with titration of transition 
metals.   
Th calculated via thermal shift assay for erythrin in titrated concentrations (20 µM to 2 
mM; 0.1 – 10 fold stoichiometry) of manganese, ferrous iron, zinc and cadmium. 
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Figure 5.23: Thermal shift assay determination of Th with titration of transition 
metals displaying weak effects.   
Th calculated via thermal shift assay for erythrin in titrated concentrations (2 µM to 2 
mM; 0.01 – 10 fold stoichiometry) of vanadium, copper, ferric iron, molybdenum, 
cobalt, lead and nickel.   
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5.13: Crystallization trials  
With the knowledge that the transition metals iron, zinc and manganese generate a 
stabilizing effect upon the erythrin protein’s tertiary structure, attempts were made to 
generate erythrin crystals in the presence of these three transition metals.  Each metal 
was added in a 10-fold molar excess as a sulphate salt to apo-erythrin (protein 
concentrations: iron-erythrin: 13.47 mg/ml, zinc-erythrin: 20.49 mg/ml, manganese 
erythrin: 19.37 mg/ml). 
 
Two crystallization trays were prepared per metal-protein solution; PACT primer and 
JCSG-plus (Molecular Dimensions) – details of the concentrations of the salts, buffers 
and precipitants in each well are detailed in Appendix 9.6.  Protein-erythrin samples 
were prepared as two parallel sitting drops (1: 200:200µl, 2: 100:200µl – protein:sample 
condition) and were left to at room temperature. 
 
Crystallization plates were first examined one month after preparation, iron containing 
samples presented with multiple brown precipitates suggesting precipitation and 
oxidation of iron, in contrast the Zn- and Mn-containing plates presented with no 
colouration and less precipitation. Drops A7 and A8 within the Zn containing PACT 
primier plate presented with the most promising crystals/precipitation, conditions 
displayed in Table 5.5. 
 
Table 5.5: Conditions in which most promising precipitate was present for Zn-erythrin.  
Well Conc Salt Conc Buffer pH Conc Precipitant 
A7 0.2 M Sodium 
chloride 
0.1 M Sodium 
acetate 
5.0 20 % (w/v) PEG 6000 
A8 0.2 M Ammonium 
chloride 
0.1 M Sodium 
acetate 
5.0 20 % (w/v) PEG 6000 
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5.14: Discussion  
In summary, the experimentation conducted in this chapter details the optimization of 
recombinant erythrin protein expressed from a pET21a expression vector in E. coli 
BL21(DE3).  Initial problems of achieving overproduction of recombinant erythrin 
were overcome through either codon optimization of the erythrin DNA coding sequence 
or transformation of the native Brucella sequence into alternate expression vectors; this 
then allowed purification and a preliminary assessment of the biochemistry of MbfA.  
Initially, the expression of soluble erythrin at high concentrations facilitated the 
generation of sufficient quantities of recombinant erythrin protein to enable its 
purification by chromatographic methods.  The incorporation of a C-terminal His-tag 
enabled initial purification of erythrin by nickel-affinity chromatography, which was 
followed by anion-exchange chromatography to yield high concentrations and 
homogeneity of erythrin.  Purification by anion-exchange chromatography resulted in a 
differential separation of erythrin protein into two distinct isomeric forms. The analysis 
of each form by ICP-OES and ESI-MS revealed differing stoichiometry and type of 
bound metal to each, a property used in subsequent purifications to generate high yields 
of di-iron centred erythrin. The differences in results obtained via ICP-OES and ESI-
MS techniques for the stoichiometry of iron and zinc bound to the erythrin protein is 
likely explain through the limitations of each spectroscopic method.  The high intensity 
measurements of di-Z erythrin compared to di-Fe erythrin for ESI-MS suggests that di-
Zn erythrin may be more stable (supported by TSA measurements – Figure 5.22) and 
hence result in better flight and detection by the mass spectrometer quadrupole, with the 
latter being more difficult to detect. It is also of note that ICP-OES measurements detect 
total concentrations of metals, not just metal ligands. Additional spectroscopic methods 
should be used in further examinations of the di-iron centre of erythrin including 
Mössbauer and electron paramagnetic resonance (EPR) spectroscopy.  As 57Fe is a 
Mössbauer-active isotope, incorporation of 57Fe into the di-iron center of erythrin would 
allow examination of the redox state of the iron atoms during reactions with hydrogen 
peroxide (Gupta et al. 1995) and would establish its di-iron status. Additionally, EPR 
spectrum analysis has been documented on the rubrerythrin from Desulfovibrio vulgaris 
(Ravi et al. 1993, Gupta et al. 1995) and shows that a characteristic spectrum of a di-
iron centre is observable despite limitations of the EPR-silent nature of ferrous iron. 
 
The purification to homogeneity of the erythrin protein allowed several subsequent 
analyses to be performed, including: the generation of polyclonal antibodies to be raised 
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in rabbits, facilitating the immune-detection of MbfA in E. coli and Brucella. As well 
as, the formation of apo-erythrin (metal free) through the chelation of bound metals, 
which were subsequently removed by dialysis, enabled the recreation of a di-iron centre 
erythrin through the titration of ferrous iron.  Experimentation determined that the di-
iron centre is oxidised by hydrogen peroxide, a process which is hypothesized to be 
linked to the export of a ferric iron atom (Chapter 6).  The system could be reduced 
artificially with strong reductant, but in vivo, a cellular reductase is hypothesized to be 
required to reduce the di-iron centre back to the ferrous form, to allow subsequent 
export of iron.  The requirement of a reductase system in vivo represents a challenge for 
the observation of peroxidase activity in vitro. Instead of a biological reductase system, 
a chemical reductant was employed in vitro during this analysis, but this poses 
difficulties in measuring the peroxide reductase functionality, as the reduction of H2O2 
by erythrin is outcompeted by the reduction of H2O2 by the chemical reductant. To 
allow monitoring of peroxide reductase by erythrin in vitro a biological reductase will 
be required, this provides a basis for additional experimentation. 
 
The metal-binding capacity of the erythrin domain was examined by thermal shift assay 
which showed that, in addition to iron, at least three other metals (zinc, manganese and 
cadmium) are also able to bind the di-iron binding site in a fashion that stabilizes the 
protein thus increasing its melting temperature.  This knowledge facilitated directed 
attempts to generate protein crystals; crystallization trials were conducted on iron, 
manganese and zinc centred erythrin. 
 
Experimentation conducted with the Brucella suis erythrin protein are largely in 
agreement with those observed with the erythrin domain of MbfA from Bradyrhizobium 
japonicum (Sankari and O'Brian 2014).  The B. japonicum erythrin domain (denoted 
ferritin like domain –FLD) was observed by Western blotting to be located on the 
cytoplasmic side of the inner membrane, and the FLD had a metal:peptide 
stoichiometry of two when titrated with ferrous iron.  The binding of iron at the di-iron 
centre was found to be reliant on the glutamic acid residues of the di-iron binding 
motifs, as mutation of these residues resulted in abolition of iron binding.  However, the 
FLD was purified as a homo-dimer by gel filtration chromatography, this experiment 
has not been conducted with the B. suis erythrin domain to date, but would warrant 
consideration due to the suggestion made her by MS that the Brucella erythrin domain 
is a homo-dimer which contrasts with the findings made for B. japonicum.   
Chapter 5 
 
 
115 
 
In addition to the analysis of the native erythrin domain of B. suis MbfA, 
experimentation was planned to also examine the potential for metal binding and 
subsequent biochemical activity of truncated erythrin proteins.  Truncated variants of 
the erythrin domain were generated which represented peptides that may have been 
translated from alternative start sites from the B. melitensis mbfA gene due to the 
location of a disruptive SNP at the proximal end of the gene.  This experimentation was 
not conducted for several reasons: firstly due to time limitations but more significantly, 
the lack of MbfA or truncated variants detected when probing B. melitensis with anti-
erythrin antibodies (Chapter 7.4) indicated that such variants are not generated 
naturally, thus there is little justification for examination of their biological activity.  
Subsequently, bioinformatic analysis showed that other bacterial species encode MbfA 
proteins with truncated N-terminal erythrin domains (Chapter 3.2), most notably 
Burkholderia multivorans, but its MbfA remains functional (Chapter 6.5) due to the 
maintenance of all four iron-binding motifs. Thus, the mbfA gene of B. melitensis would 
appear distinct from that of other bacteria since it is apparently cryptic in nature (not 
expressed).   
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Chapter 6: Characterization of MbfA function and mechanism of action 
 
6.1: Confirmation of mbfA expression in E. coli and sub-cellular location by 
immuno-detection  
A series of E. coli vectors (pSU18 and pBADrham/ara derived) containing the Brucella 
mbfA coding sequence under control of an inducible promoter was created previously 
(Chapter 4).  However, it remained unclear whether these vectors allowed production of 
the MbfA polypeptide.  Thus, the expression of mbfA from these inducible plasmids in 
E. coli was investigated.  Given the requirement for codon optimization or specific 
expression strains to obtain expression of the erythrin domain during recombinant 
protein overproduction, there was a good possibility that expression would not be easily 
achieved using the native gene.  However, the mbfA cloned into the above vectors for 
exploring the phenotype conferred by mbfA expression in E. coli was the codon 
optimized version, which increases the likelihood of successful expression.   Thus, 
expression from the lactose, rhamnose and arabinose promoters was assessed before 
initiation of the phenotype experiments with mbfA expressed in E. coli.  
 
Immuno-detection with polyclonal anti-erythrin antibodies, raised in New Zealand 
white rabbits by Proteogenix (France) using protein generated as in Chapter 5, was 
conducted on 0.5 OD units of whole cells collected from E. coli MG1655 pBADmbfA 
and pSUmbfA before and after induction, of an exponentially growing culture with 
rhamnose (0.1 mM) or IPTG (0.5 mM). Proteins were analysed by SDS-PAGE and 
transferred to a PVDF membrane, then immune-stained using anti-erythrin antibodies 
(Methods 2.4.5). The resulting Western blot showed that MbfA is indeed generated for 
both the pSUmbfA and pBADmbfA transformants but differences are apparent between 
the two plasmids (Figure 6.1).   
 
The clear increase in MbfA protein post-induction for the pBADmbfA transformant 
indicates regulation of mbfA gene expression from the rhamnose promoter. In contrast, 
MbfA levels for the pSUmbfA transformant show similar levels pre- and post-addition 
of inducer, suggesting leaky expression from the lac promoter. Importantly however, 
the Western blots demonstrate that MbfA is produced to give its expected mass from 
each of the two plasmids tested.  Thus, these plasmids can be used in future experiments 
exploring the effect of heterologous expression of mbfA in E. coli. 
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Figure 6.1: Western blot analysis of expression of pBADmbfA and pSUmbfA  
A: Immuno-detection of expression of mbfA from pBADmbfA in E. coli MG1655, lanes 
from left to right: vector control (pBADrha) before (0 h) and after induction (2 h); 
pBADmbfA before (0 h) and after induction (2 h). B: Immuno-detection of expression 
of mbfA from pSUmbfA in E. coli MG1655, lanes from left to right: vector control 
(pBADrha) before (0 h) and after induction (1-2 h); pSUmbfA before (0 h) and after 
induction (1-2 h). MbfA, 36.2 kDa indicated with arrow.  
A B 
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6.2: Cellular localisation of MbfA 
To further assess functional status of mbfA expression in E. coli, it was considered 
desirable to determine the subcellular location of the heterologously expressed MbfA.  
On the basis of membrane topology prediction, VIT1 homology and direct 
experimentation with mbfA from B. japonicum (Sankari and O'Brian 2014), it is very 
much anticipated that the B. suis MbfA would need to be incorporated into the inner 
membrane in order to be functional. 
 
Thus, E. coli MG1655 was transformed with pSUmbfA.  Induced cells were harvested 
and fractionated into the following fractions: whole cells, lysed spheroblasts, cytoplasm, 
periplasm, total membranes, inner membrane and outer membrane (Methods 2.5.6).  
The periplasm was extracted via osmotic shock, the resulting spheroplasts were lysed 
by sonication and the cytoplasm separated from the membranes via ultracentrifugation.  
Inner and outer membranes were further separated by incubation with sodium lauryl 
sarcosinate (solubilises inner membranes) and ultracentrifugation. Subcellular fractions 
were analysed by 16% PAGE and probed for the presence of MbfA with anti-erythrin 
antibodies via Western blotting (Figure 6.2). MbfA can be seen localized exclusively to 
the inner membrane (also present in whole cells, lysed spheroblasts, total membranes 
due to fractions containing inner membrane).  Thus, MbfA is associated with the 
expected subcellular compartment, which suggests that MbfA might exhibit 
functionality in E. coli. 
 
 
 
 
 
 
 
 
Figure 6.2: SDS-PAGE and Western blot analysis of MbfA subcellular location 
upon expression in E. coli.  
A: 16% SDS-PAGE analysis of expression of mbfA from pSUmbfA in E. coli in whole 
cells (WC), lysed spheroblasts (LS), cytoplasm (C), periplasm (P), total membranes 
(TM), outer membrane (OM) and inner membrane (IM) fractions. B: As (A) but 
Immuno-detection of expression MbfA. 36.2 kDa indicated with arrow.  
A B 
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6.3: Complementation of E. coli mutants with mbfA demonstrates a phenotype 
consistent with an iron export role for MbfA 
To provide evidence for the hypothesized iron export and peroxide reductase activities 
of MbfA, E. coli Δfur (H1941 - deregulated iron uptake), E. coli ΔfecABCDE ΔzupT 
ΔmntH ΔentC ΔfeoABC (JC28 - deficient in all known high affinity iron import 
systems), E. coli ΔahpCF’ kan::’ahpF Δ(katG17::Tn10)1 Δ(katE12::Tn10) (LC106 – 
oxidative stress sensitive) and corresponding parental wild-type strains were 
transformed with the B. suis mbfA gene (pBADmbfA plasmid) or empty vector control 
(pBADrham) under the control of an inducible rhamnose promoter and assayed for 
differences in cellular growth in L broth or minimal medium.  Cellular growth was 
assessed by measurement of OD of bacterial cultures with the LabSystems Bioscreen C. 
 
High cytosolic iron concentrations within the E. coli Δfur mutant (H1941), through un-
regulated iron uptake and lack of iron storage, render it more susceptible to oxidative 
stress than the parental E. coli stain (MC4100) (McHugh et al. 2003) as is observed by a 
0.51 OD unit, 60% reduction in final OD compared to the parent (Figure 6.6A). 
Complementation of E. coli Δfur with pBADmbfA resulted in a minimal increase (0.074 
OD units – 9.7%) in growth under oxidative stress conditions (400 µM H2O2) after 18 h, 
but major reduced time in lag phase (by 2 h; Figure 6.3).  Although a statistical 
difference in growth is not observed, as the differences in growth curves between mbfA 
expressing and vector control E. coli H1941 are too small, the slight growth 
enhancement (reduction in lag phase) of H1941 (pBADmbfA) under condition of 
oxidative stress is consistent with the notion that MbfA is able to export iron, but 
presumably not at a rate that exceeds that of iron import in the fur mutant where iron 
uptake is constitutive. 
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Figure 6.3: Growth of E. coli Δfur (H1941) transformed with pBADmbfA.   
Growth curve under aerobic conditions in L broth +/- 400 µM H2O2 for E. coli H1941 
transformed with pBADmbfA or vector control (VC, pBADrham). Data shown are the 
means of three independent experiments conducted in triplicate.  Rhamnose was 
included at 0.1 mM. 
 
An attempt to observe an E. coli growth phenotype consistent with iron export was next 
performed using E. coli JC28.  This strain harbours deletions to all known high affinity 
iron import systems (ΔfecABCDE ΔzupT ΔmntH ΔentC ΔfeoABC); the absence of iron 
import machinery and expression of the iron exporter mbfA within E. coli is expected to 
result in reduced growth when available iron is limited.  
 
Transformation of E. coli JC28 with pBADmbfA resulted in a decrease in growth in iron 
supplemented (20 µM ferric citrate) minimal media by 0.453 OD units (94%) after 48 h 
of aerobic growth in minimal medium (Figure 6.6B).  Addition of 1 µM 
diethylenetriaminepentaacetic acid (DTPA) to the minimal medium, further limiting 
iron availability, severely hindered the growth of E. coli JC28 (Figure 6.4), with 
pBADmbfA further decreasing the ability of E. coli JC28 to grow. These reduced-
growth mbfA-induced phenotypes are consistent with the removal of cellular iron by 
MbfA, further reducing cellular iron for E. coli JC28.  
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Figure 6.4: Growth of E. coli ΔfecABCDE ΔzupT ΔmntH ΔentC ΔfeoABC 
transformed with pBADmbfA.   
Growth under aerobic conditions in minimal medium with 20 µM ferric citrate or 1 µM 
DTPA for E. coli JC28 with pmbfA or vector control (pBADrham). Data shown are the 
means of three independent experiments conducted in triplicate. Rhamnose was 
included at 0.1 mM. 
 
The next E. coli strain used for phenotype analysis was E. coli LC106, which lacks 
catalases and alkyl-hydroperoxide reductases, and thus displays low resistance to 
oxidative stress (Seaver and Imlay 2004).  This strain was indeed observed to be 
sensitive to addition of 200 µM hydrogen peroxide to LB (Figure 6.6C).  
Transformation with pBADmbfA resulted in an increase in growth by 0.275 OD units 
(55%) after 18 h of growth compared to vector control (Figure 6.5).  In the presence of 
H2O2, induction of mbfA caused a decreased lag phase (~2.5 h) as well as a greater 
overall growth (~33% increase in OD at 18 h; Fig. 6.5). 
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Figure 6.5: Growth of E. coli ΔahpCF ΔkatG ΔkatE (LC106) transformed with 
pBADmbfA.  
Growth under aerobic conditions in L broth +/- 200 µM H2O2 of E. coli LC106 with 
pBADmbfA or vector control (VC).  Data shown are the means of three independent 
experiments conducted in triplicate. Rhamnose was included at 0.1 mM. 
 
Induction of mbfA also complemented the low resistance to oxidative stress of E. coli 
LC106 when exposed to organic peroxides and redox (Figure 6.6D). The pBADmbfA 
LC106 transformant out grew the vector control in the presence of t-butyl peroxide, 
dicumyl peroxide and methyl viologen by 0.44 (40%), 0.49 (49%) and 0.83 OD units 
(114%), respectively, at 18 h.   
 
The above observations show that MbfA provides resistance to alkyl hydroperoxides, 
hydrogen peroxide and a redox-cycling agent (superoxide inducer).   It is unclear if the 
predicted peroxide reductase activity of the erythrin domain is specific to hydrogen 
peroxide, or whether the tested organic peroxides are also able to serve as substrates for 
MbfA, and thus if such activity plays a role in detoxification of these peroxides.  
 
The resistance to MV provided by MbfA may arise due to its ability to degrade the 
raised levels of H2O2 that would be generated by superoxide dismutase in response to 
MV exposure.  In addition, the proposed ability of MbfA to export cellular iron would 
be expected to contribute to resistance to both alkylhydroperoxides and superoxide (as 
well as H2O2) through limiting iron-induced Fenton chemistry intracellularly, and 
possibly by promoting iron-induced peroxide degradation extracellularly. 
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Concentrations of hydrogen peroxide additions used during the above in vitro 
experiments range from 50- to tenfold higher than those expected to be found in the 
macrophage phagolysosome or eBCV (1-4 µM; (Slauch 2011), 30 µM; (Winterbourn et 
al. 2006)).  During in vitro experiments, H2O2 additions were provided as a single bolus, 
resulting in high level exposure initially followed by an expected gradual decreased 
exposure as the peroxide is degraded by the culture.  This is in contrast to the mode of 
peroxide exposure in the phagolysosome where hydrogen peroxide generation is 
continuous and thus concentrations can be expected to be maintained at a steady 
concentration.  In addition, the toxic effect exerted by H2O2 is enhanced in the 
phagolysosome by the generation of NO, leading to production of toxic peroxynitrite.  
Thus, the in vitro exposure of E. coli to peroxide applied above does not closely mimic 
the conditions within the phagolysosome (or early BCV) where MbfA may act to aid 
colonization of macrophages, but nevertheless clearly display a role for MbfA in redox 
stress resistance that would be expected to be of relevance during macrophage infection. 
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Figure 6.6: Phenotypes conveyed through expression of B. suis mbfA and A. 
thaliana VIT1, and the MbfA N-terminal erythrin and C-terminal Vit domains in 
E. coli mutant strains.   
A: Aerobic growth after 18 h in 400 µM H2O2 supplemented L broth of E. coli MC4100 
and H1941 transformed with B. suis mbfA (pBADmbfA) or vector control (pBAD).  B: 
Aerobic growth after 48 h in 20 µM ferric citrate supplemented minimal medium of E. 
coli W3110 and JC28 transformed as above.  C1: Aerobic growth after 18 h in 200 µM 
H2O2 supplemented LB of E. coli MG1655 and LC106 transformed as above, or with 
pBADery (N-terminal erythrin domain; pery), pBADvit (C-terminal Vit domain; pvit), 
pBAD_AtVIT1 (Arabidopsis thaliana VIT1, pVIT1).  D2: Aerobic growth after 18 h in 
150 µM t-butyl peroxide, 150 µM cumyl peroxide or 15 µM methyl viologen 
supplemented LB for E. coli LC106 transformed as in A. Data shown are the means ± 
standard deviation of three independent experiments conducted in triplicate and 
analysed using an unpaired, two tailed Student’s t-test; * P<0.05, ** P<0.01 *** 
P<0.001.  Growths included 0.1 mM rhamnose.  1 Figure 6.6C conducted by L. Wynne, 
under supervision, Final Year Project Student, 2015. 2 Figure 6.6D conducted by J. 
Lewis, under supervision, Final Year Project Student, 2016.  
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To determine whether the phenotypes conferred by mbfA require coupling of its two 
domains to allow reduction of hydrogen peroxide at the erythrin domain combined with 
export of iron via the vit domain, the two domains were cloned separately and 
introduced into E. coli LC106 (Figure 6.6C). Neither domain in isolation was able to 
restore the increased growth phenotype to E. coli LC106 as was seen with mbfA 
expression.  For the solo erythrin domain, this is presumably due to lack of iron export 
and oxidation capacity since the erythrin domain would be expected to lack the 
reduction pathway provided through Vit-domain-mediated export-oxidation of ferrous 
iron.  For the solo-Vit domain, a lack of a sink for electron transfer during its export of 
iron, coupled to ferroxidation, might be expected to debilitate its activity through 
inability to oxidise ferrous iron prior to transport. These findings are consistent with the 
notion that oxidation of the erythrin domain di-iron-centre by hydrogen peroxide drives 
the export process and that the two domains must be combined to elicit functionality.   
 
To address the nature of H2O2 degradation further (i.e. to determine to what degree iron 
export, as opposed to erythrin domain H2O2 reduction, are responsible for the mbfA 
phenotypes observed above), the vacuolar iron transport 1 (VIT1) gene from 
Arabidopsis thaliana was cloned and expressed in E. coli LC106 (pAt_VIT1).  VIT1 is a 
natural solo-Vit domain protein so would be expected to mediate iron export, but not 
peroxide reduction, when functionally expressed in E. coli. Expression of VIT1 resulted 
in an increase in culture density of 0.226 OD units (45%) after 18 h growth compared to 
the vector only control (Figure 6.7), an increase similar to that observed with mbfA. 
VIT1 acts as a transporter of ferrous iron into seed vacuoles (Kim et al. 2006, Cockrell 
et al. 2014) and the membrane organisation is such that when expressed in E. coli VIT1 
is expected to be localised to the inner-membrane, as is mbfA, where it would act to 
export iron from the bacterial cell into the periplasm. Due to the lack of a peroxide 
reducing erythrin domain in the VIT1 protein, it is likely that the observed resistance to 
H2O2 occurs through export of iron which would lower potential for iron-mediated 
Fenton reactions in the cytosol and might result in enhanced iron-mediated 
decomposition of extracellular H2O2.  Therefore, reduction of peroxide at the erythrin 
domain in MbfA may play a minimal role in peroxide detoxification, indicating 
importance for the physiological control of iron export in response peroxide exposure.   
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Figure 6.7: E. coli ΔahpCF ΔkatG ΔkatE transformed with pAt_VIT1 (A. thaliana 
VIT1) exhibits decreased oxidative stress sensitivity.   
Growth curve under aerobic conditions in L broth +/- 100 µM H2O2 for E. coli LC106 
transformed with pmbfA, pmbfA_VIT, pAt_VIT1 or vector control.  Data shown are the 
means of three independent experiments conducted in triplicate. Rhamnose was 
included at 0.1 mM. 
 
6.4: Expression of mbfA is directly related to streptonigrin resistance 
Streptonigrin is an aminoquinone antibiotic that induces bacterial killing in a manner 
that is dependent upon high intracellular iron concentrations.  This principle has been 
used as an assay to determine potential export of iron in Salmonella and Agrobacterium 
spp.  (Frawley et al. 2013, Bhubhanil et al. 2014).  Thus, the effect of MbfA on the 
viability of E. coli upon exposure to streptonigrin was examined, with the expectation 
that MbfA would provide resistance to this antibiotic.   
 
The resistance to streptonigrin killing of E. coli MG1655, H1941, LC106 and JC28 
transformed with either empty vector or pSUmbfA was assayed through growth against 
various streptonigrin concentrations (1, 2, 4, 8 and 16 µg/ml dissolved in DMSO). 
Figure 6.8A/B displays representative growth curves of E. coli JC28 pSU18 and 
pSUmbfA.  To allow comparison of multiple bacterial strains, final optical densities 
after 22 h displayed in Figure 6.9.   
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
1.4	
0	 2	 4	 6	 8	 10	 12	 14	 16	 18	
O
D 6
00
	
Time	(Hr)	
E.	coli	LC106:	LB	100	μM	H2O2	
pmbfA	
Vector		
control	
pmbfA_VIT	
pAT_VIT	
Chapter 6 
 
 
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8: Representative growth curves of E. coli JC28 resistance to 
streptonigrin.    
Aerobic growth in L broth with various levels of streptonigrin, (as displayed) for E. coli 
JC28 transformed with vector control (A) or pSUmbfA (B) or, with 0.5 mM IPTG. Data 
shown are the means ± standard deviation of three independent experiments conducted 
in triplicate.   
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Figure 6.9: Expression of mbfA confers resistance to E. coli strains against 
streptonigrin.   
Growth of vector control and pSUmbfA transformants after 22 h under aerobic 
conditions in L broth with 0-16 µg/ml of streptonigrin. A: E. coli MG1655, B: E. coli 
H1941, C: E. coli JC28 and D: E. coli LC106. Data shown are the means ± standard 
deviation of three independent experiments conducted in triplicate and analysed using 
an unpaired, two tailed Student’s t-test: * P<0.05, ** P<0.01 *** P<0.001. Rhamnose 
was included at 0.1 mM. 
 
Exposure of E. coli MG1655 (wildtype) to a range of streptonigrin concentrations 
resulted in an ~50% loss of growth a 2 µg/ml and complete loss at ≥4 µg/ml for both 
vector control and mbfA complemented strains (Figure 6.9A).  The OD of the vector 
control and pSUmbfA transformants with addition of 2 µg/ml were reduced by 52.2 and 
53.1% compared to those with no addition of streptonigrin, displaying no significant 
difference in cellular viability with expression of mbfA.  
 
In contrast, examination of E. coli H1941 (Δfur) using the same assay resulted in a 78.5 
and 93.3% reduction in OD with the addition of 1 and 2 µg/ml streptonigrin 
(respectively) to E.coli Δfur (VC) compared to zero addition, but only a 5.0 and 30.4% 
reduction for E. coli Δfur transformed with pSUmbfA (Figure 6.9B), thus indicating a 
significant and major increase in streptonigrin resistance mediated by MbfA.  This 
result extends the minor phenotypic observations of mbfA expression displayed 
previously in E. coli Δfur.  The results support the view that the deletion of fur increases 
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free, reactive cytosolic iron (Abdul-Tehrani et al. 1999), thus increasing sensitivity to 
streptonigrin, as indicated by the increased sensitivity for the VC seen at 1 and 2 µg/ml 
(Figure 6.9A & B).   In addition, the results suggest that expression of mbfA drives 
export of cytosolic free iron which protect against the bactericidal action of 
streptonigrin through lowering concentrations of available iron able to interact with 
streptonigrin.  It is interesting to note that the wildtype strain showed no gain in 
streptonigrin resistance when provided with mbfA which suggests that MbfA provides 
such an advantage for H1941 due to an ability to reverse the increase in free cytosolic 
iron caused by the fur mutation. 
 
The E. coli JC28 strain showed a clear increase in streptonigrin resistance with respect 
to the wildtype and H1941 (Figure 6.9C).  This was particularly apparent at 4 µg/ml 
where the JC28 vector control showed good growth (OD of 0.97 c.f. 0.10 for MG1655; 
Figure 6.9C).  This marked increase in resistance to streptonigrin is directly related to 
the genotype of the JC28 strain; removal of iron import machinery would be expected to 
limit accumulation of iron within the cell for reaction with streptonigrin.  It is of note 
that pSUmbfA further increased E. coli JC28 resistance to streptonigrin which is 
particularly evident at 16 µg/ml streptonigrin where MbfA increased growth from 0.10 
to 1.1 OD units).  These results thus suggest that the combined loss of iron uptake 
capacity and increase in iron export ability provide resistance to high levels of 
steptonigrin probably by driving very low intracellular iron concentrations.   
 
Finally, the effect of mbfA on resistance of E. coli LC106 to streptonigrin was assessed. 
The deletion of catalase and alkyl hydroperoxidase was expected to have large 
implications of the resistance to streptonigrin due to raised redox stress sensitivity.  The 
exact mechanism of action of streptonigrin is currently unknown but an involvement of 
reactive oxygen species is thought to contribute to its bactericidal effect (Lown 1983).  
The LC106 vector control grew less well than the wildtype by 0.67 OD units upon 
exposure to 2 µg/ml streptonigrin (Figure 6.9D).  Transformation with pSUmbfA 
increased growth by 0.25 OD units, but did not restore growth to wild type levels 
(requiring an increase of 0.64 OD units).  Nevertheless, mbfA provided significant 
protection (~threefold) against 2 and 4 µg/ml streptonigrin, where such protection was 
not seen in wild type E. coli.  This indicates that MbfA is able to compensate for lack of 
redox-stress resistance in LC106, either by provision of peroxide reductase activity or 
through iron export activity.  
Chapter 6 
 
 
130 
6.5: Quantitation of iron export by MbfA using a radioactive isotope of iron 
The above results support a role for MbfA in iron export, but provide no direct evidence 
for removal of iron from E. coli. Indeed, no direct evidence has yet been published 
demonstrating iron export by MbfA in any bacterium.  Thus, to determine conclusively 
that iron is exported by MbfA, current published literature was reviewed to determine a 
protocol for an iron export assay. However, at the time this work was conducted there 
was little information in the literature of any methodology for conducting such 
experiments.  Experiments conducted by Siva Sankari and Mark O’Brian (Sankari and 
O'Brian 2014) show the only “Iron export assay” in current literature.  In this assay 
55FeCl3 was added to an exponentially growing B. japonicum culture, in rich broth, 
before extracellular iron was chelated at 20 min. Samples of cells with internalised 55Fe 
were then taken at regular time points and the decrease in intracellular 55Fe, as measured 
by a LBK γ-counter, was reported as evidence of iron export.  However, this assay did 
not determine the export of intracellular iron as such, but instead measured the decrease 
in internal iron (in pmoles of 55Fe per mg of protein) over a 180 min duration.  Due to 
the fact that the original culture, at T0, was at mid-log phase, in rich medium, the 
decrease in internal iron/mg protein is likely be due to growth, in addition, the product 
of export (i.e. supernatant iron accumulation) was not reported.  
 
Radiolabeled iron transport experiments had also previously been conducted by Grass et 
al. (Grass et al. 2005) during the investigation of FieF (ferric iron efflux) iron transport 
in E. coli.  In this assay, bacterial cultures were propagated in iron deplete medium, fieF 
was induced 30 min prior to the addition of radiolabeled ferrous iron, cells were 
collected by filtration, analysed by LSC and cellular iron concentrations reported.  In 
similar respects to the experimentation conducted with B. japonicum, the effect of FieF 
expression was reported to prevent the accumulation of iron within the cell, rather than 
drive iron export from the cell.    
 
Lastly, a different approach to characterizing iron export was conducted by Frawley et 
al. (Frawley et al. 2013) in the investigation of Salmonella Typhimurium IceT (iron 
citrate efflux transporter).  S. Typhimurium ΔiceT was transformed with a plasmid 
harbouring the FeoAB ferrous iron transport system under a controllable expression 
promoter; the total cellular iron contents were determined via ICP-OES for this strain as 
well as an iceT transformant and compared.  The cellular iron content of the IceT 
expressing strain was half that of the non-expressing strain, leading to the deduction the 
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IceT prevents cellular iron accumulation through exporting iron.  Additionally, in the 
absence of constitutive expression of FeoAB in S. Typhimurium a reduction in cellular 
iron content of 10% was observed with expression of IceT.  
 
To expand upon these studies, a protocol for accurately measuring accumulation of 55Fe 
in the supernatant through export via MbfA was developed. A transformant E. coli 
MG1655 colony was grown overnight in 5 ml LB, from which 1 ml culture at an OD of 
1, was used to inoculate 25 ml of fresh LB (starting OD 0.04) with 10 µl 55Fe (0.185 
mBq). The cells were allowed to grow until early-log phase (2 h, OD ~0.5) (Figure 
6.10), during which time 55Fe will be imported into the cell. After this, cells were 
induced with 0.1 mM rhamnose and incubated for a further 1 h. Induced cells were 
harvested by centrifugation (5000 x g 4 °C 10 min), the supernatant discarded, and the 
cells were washed three times with 10 ml cold transport buffer (TB: 50 mM MES, 50 
mM TAPS pH 7.0, 0.4% glucose, 0.2 mM CaCl2, 2 mM MgCl2), ensuring the removal 
of extracellular 55Fe.  (N.B: transport buffer lacks essential nutrients, preventing growth 
during subsequent steps, but contains salts, for membrane integrity and glucose as an 
energy source to maintain cellular metabolism). The cell pellet was re-suspended in 1.5 
ml ice cold TB and was then divided into 300 µl aliquots. One aliquot at a time was 
diluted into 3 ml pre-warmed (37 oC) TB in the reaction cell, maintained with continual 
stirring. 250 µl of cells were removed from the reaction cell for every time point taken 
and filtered through a 0.22 µm syringe driven filter, followed by washing with 2.5 ml 
cold wash buffer (WB: 10 mM EDTA, pH 8.0). 2 ml of filtrate (cellular supernatant) 
were added to 4 ml Ultima Gold XR scintillant (Perkin Elmer) and inverted until mixed. 
All samples were left for 24 h to allow for a reduction in background chemi-
luminescence, before liquid scintillation counting for 3 min per sample across the 10–
300 nm channels (0.2–6.2 KeV) with a Beckman LS-6500 multi-purpose scintillation 
counter.  Additionally, to provide standardised results, diluted cells were removed from 
the reaction cell and the total protein concentration determined via a Bradford assay. 
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Figure 6.10: Growth of E. coli MG1655 in iron supplemented L broth.  
Optical density growth curve of 24 h aerobic growth in L. broth of complemented E. 
coli LC106 with pBADmbfA, or vector control.  Data shown are the means of three 
independent experiments conducted in triplicate.  Rhamnose was included at 0.1 mM. 
 
 
6.6: Induction of mbfA is required for maximal export of iron 
Initially, transformant with pBAD (vector control) and pBADmbfA were assayed for 
export of 55Fe into the supernatant in response to induction with rhamnose. 100 µM 
rhamnose was added to a culture of E. coli MG1655 transformed with pBAD or 
pBADmbfA after 2 h growth, but was omitted from two equivalent cultures.  Exported 
55Fe (pmol/mg) was measured every 5 min for 30 min (Figure 6.11A). Maximum export 
of 55Fe (704.38 pmol mg-1) was observed for pBADmbfA with addition of rhamnose, 
resulting in a significant difference (p = 0.0004) at 15 min after initiation of the assay 
compared to that achieved without addition of rhamnose.  55Fe export was far greater 
(>14-fold) upon mbfA induction, with 700 pmol mg-1 total export c.f. <50 pmol mg-1 
without inducer (and also for the vector control) at 15 min. 
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Additionally, minimal export of 55Fe was observed pmbfA without addition of 
rhamnose, resulting in a significant difference (p = 0.003) at 30 min after initiation of 
the assay compared to pBAD, which demonstrates no export of 55Fe with and without 
addition of rhanmose (Figure 6.11B). This observation is supported by a Western blot in 
which 55Fe was changed to 56Fe allowing manipulation outside the Radiation 
Laboratory (Figure 6.11C). 1 OD of cells were harvested after 1 hour induction with 
and without addition of rhamnose; expression of MbfA (36.2 kDa) is observed 
maximally with addition of rhamnose, however, minimal expression is observed 
without addition of rhamnose.  No expression is observed in the vector control samples, 
observations that are fitting with those of Figure 6.11. 
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Figure 6.11: Export of iron is dependent upon MbfA expression.   
Measurement of 55Fe in cellular supernatant from E. coli MG1655 pBADmbfA and 
pBAD transformants via liquid scintillation counting in the presence and absence of 
rhamnose. The data presented represents the means ± standard deviations obtained from 
three separate experiments.  A: 55Fe exported by E. coli MG1655 pBADmbfA with and 
without addition of rhamnose (0.1 mM), statistically significant differences as 
determined by Students t-test (p < 0.01) at T = 15 min are indicated. B: Expanded view 
taken from A showing 55Fe exported by E. coli MG1655 pBADmbfA without addition 
of rhamnose and E. coli MG1655 pBAD, statistically significant differences as 
determined by Students t-test (p < 0.01) at T = 30 min are indicated. C: Western blot 
showing the presence of the mbfA translation product in E. coli MG1655(pBADmbfA) 
with addition of rhamnose for cultures grown as in A. MbfA, 36.2 kDa.  
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6.7: Provision of hydrogen peroxide enhances export of iron by MbfA 
Export of iron by MbfA is hypothesised to be combined with reduction of hydrogen 
peroxide at the erythrin domain; an electron is taken from ferrous iron prior to export 
across the inner-membrane, oxidising it to ferric iron, which is then used to reduce 
hydrogen peroxide at the erythrin domain, driving the export process. To investigate 
this proposed mechanism, hydrogen peroxide was added exogenously to the reaction 
cell upon initiating the 55Fe export assay. The expectation was that increased hydrogen 
peroxide concentrations would increase iron export.  
 
Addition of 100 µM H2O2 at T0 resulted in a significant increase in 55Fe export (629.00 
pmol mg-1 to 856.25 pmol mg-1– difference of 227.25 pmol mg-1) until T20 (p = 0.0248) 
compared to no hydrogen peroxide addition, whereupon, export rate was not 
significantly different to that with 0 µM H2O2 addition (Figure 6.12). To further explore 
this effect, the converse experiment was conducted; in place of peroxide, an addition of 
100 U of a haem catalase from Micrococcus lysodeikticus was made to the reaction cell 
at T0.  Addition of catalase was expected to decrease endogenous hydrogen peroxide 
concentrations (given the non-polar nature of hydrogen peroxide, concentrations outside 
the cell are expected to be approximately equal to those within the cell) which would 
inhibit 55Fe export (presuming that export is peroxide dependent). A significant ~2.5-
fold reduction of 392 pmol mg-1 (p = 0.0026) in exported 55Fe was observed at T20 when 
compared to no addition of catalase. The amount of 55Fe exported did not reach that 
observed with no addition, over the duration of the assay, but remained ~2.5-fold lower.  
This effect is presumably due to the catalase-mediated degradation of H2O2 which 
would be expected to maintain very low levels of H2O2 within the culture.  However, 
55Fe export was still significantly (sixfold) more than that of the vector control (p = 
0.0034) throughout the assay.  In combination, these results strongly suggest that MbfA 
is indeed an iron exporter and that its export activity is promoted biochemically by 
H2O2.  
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Figure 6.12: Addition of hydrogen peroxide increases export of iron.  
Measurement of 55Fe in cellular supernatant of E. coli MG1655 pBADmbfA and pBAD 
transformants via liquid scintillation counting in the presence/absence of hydrogen 
peroxide or catalase. The data presented represents the means ± standard deviations 
obtained from three separate experiments. Statistically significant differences as 
determined by Students T-test (p < 0.01) at T = 20 min are indicated. 
 
The N-terminal erythrin domain of MbfA is predicted to facilitate the reduction of 
hydrogen peroxide; previously generated N- and C-terminal mutant constructs of mbfA 
(pBADery and pBADvit) were compared to 55Fe export by MbfA. Removal of the 
erythrin domain and expression of the membrane embedded VIT1 domain only, and 
conversely, expression of only the erythrin (peroxide reductase) domain, without the 
VIT1 domain, resulted in no significant difference in 55Fe export to that of the vector 
control (pBAD) (Figure 6.13A/B).  This shows that iron export by MbfA requires the 
combination of both domains and is consistent with the findings made earlier in this 
chapter showing that redox-stress resistance conferred by MbfA requires both domains 
(Figure 6.6C).  This finding thus further supports the suggested mechanism of iron 
export by MbfA where hydrogen peroxide reduction is hypothesized to drives iron 
export.  
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Figure 6.13: Both domains of MbfA are required for export of iron.  
Measurement of 55Fe in cellular supernatants from E. coli MG1655 pBADery and 
pBADvit transformants via liquid scintillation counting. The data presented represent 
the means ± standard deviations obtained from three separate experiments. A: 55Fe 
exported by E. coli MG1655 pBADmbfA (data from Figure 6.11) compared to E. coli 
MG1655 pBADery, statistically significant differences as determined by Students t-test 
(p < 0.01) at T = 15 min are indicated. B: Expanded view taken from A, 55Fe exported 
by the vector control, E. coli MG1655 pBADery and E. coli MG1655 pBADvit, no 
statistically significant differences are observed. 
 
An extension to this experiment was conducted in which the erythrin and VIT domains 
were expressed in trans from two separate plasmids within the same cell. In this way, 
an attempt was made to complement the lack of iron export observed with the domains 
expressed in isolation, through the supply of both protein domains.  Two distinct origins 
of replication, inducible promoters and antibiotic resistance markers are required on 
each plasmid to allow compatibility within the same cell. The pBADHisA plasmid 
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alongside the current pBADrham plasmid (p15A origin, CmR, rhamnose inducible).  
Initially, experimentation was conducted to ensure that the pBADara plasmid 
harbouring the B. suis mbfA sequence yielded similar observations of iron export to that 
seen previously with the pBADmbfA (rhamnose) expression plasmid (Figure 6.14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.14: Expression of MbfA and erythrin and VIT1 domains in trans from 
arabinose inducible vector results in export of iron.  
Measurement of 55Fe in cellular supernatants from E. coli MG1655 pBADrham and 
pBADara transformants. The data presented represent the means ± standard deviations 
obtained from three separate experiments. A: 55Fe exported by E. coli MG1655 
pBADmbfA(ara), pBADery(ara)/pBADvit(rham), pBADery(rham)/pBADvit(ara) 
pBADara and pBADrham, rhamnose and arabinose included at 0.1 mM. B: Expanded 
view taken from A.    
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Expression of MbfA from the arabinose inducible plasmid resulted in very similar 
concentrations of iron export from E. coli MG1655, also, as was previously noted, the 
expression of either the erythrin or Vit domain in isolation resulted in no export of iron.  
Next, examination of iron export was monitored from E. coli MG1655 transformed with 
a combination of either pBADery(ara) and pBADvit(rham) or pBADery(rham) and 
pBADvit(ara) (Figure 6.14).  
 
Expression of the two MbfA domains in trans resulted in export of iron from E. coli 
MG1655 reaching an average maximum of 216.3 pmol mg-1, however this represented a 
67.5% reduction in the amount of iron exported after 30 min compared to the native 
MbfA system. This result is significant as is shows that interactions between the two 
MbfA domains are possible, permitting iron export, even when both are supplied inside 
the cell, despite no physical linkage.  Export rate is significantly reduced compared to 
the native MbfA system; this likely relates to the dilution of interactions between the 
two domains through the loss of the physical connection. 
 
  
Chapter 6 
 
 
140 
In line with the experiments described previously, additions of hydrogen peroxide and 
catalase were conducted with the in trans MbfA expression system (Figure 6.15). 
Addition of 100 µM hydrogen peroxide resulted in a 20.0% increase in export, whilst 
addition of 100U haem catalase resulted in a 37.3% decrease in export compared to a no 
addition control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15: Addition of hydrogen peroxide increases in trans MbfA iron export 
rate.  
Measurement of 55Fe in cellular supernatants from E. coli MG1655 pBADrham and 
pBADara transformants in the presence/absence of hydrogen peroxide or catalase. The 
data presented represent the means ± standard deviations obtained from three separate 
experiments. 
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Another experiment supporting the involvement of hydrogen peroxide driving iron 
export by MbfA was conducted by washing cells with degassed transport buffer. De-
gassing, removal of dissolved oxygen, was achieved through the bubbling of nitrogen 
gas through required solutions for 20 min.  3 ml of degassed transport buffer was used 
within the reaction cell, which was also sealed with an o-ringed plunger to maintain a 
decreased oxygen environment. The removal of oxygen ensured the cessation of 
oxidative respiration, therefore preventing hydrogen peroxide generation – thus 
removing the oxidation substrate thought to be required for iron export.  Removal of 
oxygen resulted in a significant reduction in 55Fe export compared to that seen in 
aerobic conditions, 84% reduction (115.84 pmol mg-1 after 30 min), although export 
was still present and significantly more than that of the vector control (p = 0.011) after 
15 min (Figure 6.16A/B). To increase iron export under depleted oxygen conditions, 
100 µM hydrogen peroxide (vacuum degassed) was introduced via a hypodermal 
syringe injection through the O-ringed sealed plunger at T15 (Figure 6.16A).  At T20, T25 
and T30 (5, 10 and 15 min after H2O2 introduction respectively) detection of 
significantly increased 55Fe (nearly fivefold at T30) in the supernatant was measured 
compared to no H2O2 introduction (p = 0.015, p = 0.004 and p = 0.009 respectively).   
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Figure 6.16: Removal of oxygen limits MbfA-mediated export of iron.   
Measurement of 55Fe in cellular supernatant from E. coli MG1655 pBADmbfA 
transformants under decreased oxygen conditions. The data presented represents the 
means ± standard deviations obtained from three separate experiments. A: 55Fe exported 
by E. coli MG1655 pBADmbfA under decreased oxygen conditions with addition of 
100 µM hydrogen peroxide at T = 15 min, statistically significant differences as 
determined by Students t-test (p < 0.01) at T > 15 min are indicated. B: Expanded view 
taken from A.   
0.00	
100.00	
200.00	
300.00	
400.00	
500.00	
600.00	
700.00	
800.00	
0.0	 5.0	 10.0	 15.0	 20.0	 25.0	 30.0	
Ex
po
rte
d	
55
	Fe
	(p
m
ol
/m
g)
	
Time	(min)	
20.00	
40.00	
60.00	
80.00	
100.00	
120.00	
140.00	
160.00	
180.00	
0.0	 5.0	 10.0	 15.0	 20.0	 25.0	 30.0	
Ex
po
rte
d	
55
	Fe
	(p
m
ol
/m
g)
	
Time	(min)	
pmbfA	+	H2O2	
p	=
	0.0
015
	
A	
pmbfA	
pBAD	
pBAD	+	H2O2	
100	μM	H2O2	
p	=
	0.0
04	 p
	=	0
.00
9	
pmbfA	+	H2O2	
pmbfA	
pBAD	
pBAD	+	H2O2	
p	=
	0.0
11	
B	
Chapter 6 
 
 
143 
6.8: Identification of conserved amino acids required for iron transport by MbfA. 
The VIT1-like domain of the MbfA protein is conserved across both prokaryotes and 
eukaryotes and can be presumed to act universally to transport iron and/or related 
metals across a single membrane.  To identify conserved residues in the coding 
sequence of the VIT domain, the amino acid sequence of the B. suis 1330 MbfA Vit 
domain was aligned with VIT1 proteins of plant, yeast and mammalian parasites 
(Figure 6.17).  The location of trans-membrane helices was determined through trans-
membrane domain analysis (Phobius - (Kall et al. 2004)) and was over-laid on the 
alignment data to allow contextual information of amino acid location to be given to 
conserved residues across species.  With respect to iron transport, four amino acids 
(D191, M228, E232 and Y268) were identified as potential iron ligands due to their high 
conservation, location within membrane helices or cytoplasmic loops and known iron-
binding capacity. 
 
Site directed mutagenesis (SDM) was used as an investigative tool to gain insight to the 
mechanism of iron transport across the inner membrane in Gram-negative bacteria. 
SDM (Primers D191G F/R, M228G F/R, E232G F/R and Y268G F/R; Table 2.4) was 
used to change the nucleotide sequence of the D191, M228, E232 and Y268 codons of 
B. suis mbfA to glycine. In this way, modified pBADmbfA constructs with a targeted 
mutated residue can be assayed for ability to promote export of iron and thus assess 
residue involvement in MbfA/VIT1 iron-export function.   To ensure that mutation of 
the mbfA nucleotide sequence resulted in efficient expression of the MbfA protein, 
Western blot analysis was conducted on each variant (Figure 6.18).  Immuno-blotting 
identified that MbfA was present from each mutated variant, allowing valid assessments 
of iron export potential to be determined. 
 
Impaired iron transport was assessed using two assays: first, via measurement of optical 
density of E. coli JC28 transformants. The essentiality of the amino acid for iron 
transport will be measured by the relative increase in E. coli JC28 growth compared to 
that of E. coli JC28 growth with non-mutated MbfA construct expressed.  Secondly, the 
ability of mutated constructs to facilitate iron export was measured quantitatively via 
the radioactive iron export assay.  
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Figure 6.17: Alignment of VIT1 and Vit domain amino acid sequences with over-
laid trans-membrane helix locations.  Mutated residues indicated with arrow.   
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Figure 6.18: Western blot analysis of expression of SDM pBADmbfA variants. 
Immuno-detection of expression of mbfA from pBADmbfA SDM variants (D191, M228, 
E232 and Y268)  in E. coli MG1655, lanes from left to right: pBADmbfA without and 
with induction with 0.1 mM rhamnose. pBADmbfAD191, pBADmbfAM228, 
pBADmbfAE232 and pBADmbfAY268 without then with induction with rhamnose. MbfA 
36.4 kDa indicated with arrow.  
 
Bacterial growth curves were generated for a negative and positive control (pBADrha 
and pBADmbfA). Transformants carrying putative iron export mbfA mutants were then 
monitored for improvements in growth in iron restricted minimal medium compared to 
the wild type mbfA expressed in JC28 cells (Figure 6.19).   
 
 
 
 
 
 
 
 
 
 
Figure 6.19: Assessment of effect of MbfA SDM variants on growth of E. coli 
JC28.   
Growth after 48 h aerobic growth in 10 µM iron citrate supplemented minimal medium 
of complemented E. coli JC28 with pBADmbfA, vector control (pBAD) and the 
indicated SDM variants of pBADmbfA. Data shown are the means ± standard deviation 
of three independent experiments conducted in triplicate and analysed using an 
unpaired, two tailed Student’s t-test; * P<0.05, ** P<0.01 *** P<0.001. 
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Expression of the pBADmbfAD191 and pBADmbfAY268 MbfA mutant constructs resulted 
in a significant increase in growth compared to the growth of E. coli JC28 with 
expression of the non-mutated mbfA after 48 h.  This increase in growth suggests that 
more iron is available to the cell for these strains due to a detrimental mutation in the 
VIT domain of MbfA preventing iron removal.  The transformant with mutation in the 
D191 mbfA codon yielded an optical density after 48 h most similar to E. coli JC28 
vector control, suggesting a key role in iron transport for this residue. D191 is located in 
the centre of trans-membrane helix 1 (Figure 6.20) and may act as a key binding ligand 
for iron during passage across the inner membrane. Mutation of Y268 provides a 
significant increase in growth compared to the non-mutated mbfA, but less than that of 
D191. Y268 is located in the periplasmic-facing end of trans-membrane helix 3 and act as 
a binding ligand for iron during release into the periplasm.  
 
 
 
 
 
 
 
 
 
 
Figure 6.20: Schematic representation of B. suis 1330 Vit domain of MbfA.  
Schematic representation of the structure of the VIT domain of MbfA. Locations of 
trans-membrane helices, periplasmic and cytoplasmic loops and SDM targets are 
displayed (blue residues represent the location of the erythrin domain). 
 
In addition to assessment of E. coli JC28 growth, the ability of the mbfA SDM variants 
to export 55Fe from E. coli (MG1655) was also determined (Figure 6.21).  Mutation of 
M228/E232/Y268 resulted in no significant difference in supernatant accumulation of 55Fe 
after 15 min compared to the non-mutated mbfA construct.  Although no significant 
difference was apparent for M228/E232/Y268, the M228 and E232 variants gave lower export 
than the Y268 variant. However, mutation of D191, located in the centre of trans-
membrane helix 1, resulted in 41% less 55Fe export than the positive control.  Although 
the results for exported iron are not in complete agreement with the results obtained 
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with E. coli JC28, regarding mutations which present the greatest attenuation in iron 
transport, D191 presented in both cases as the most important of the four residues tested. 
This may suggest a central role in D191 acting as a transporting ligand during iron efflux 
through MbfA, as well as VIT1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.21: Assessment of effect of mbfA SDM variants on export of iron from E. 
coli MG1655.   
Measurement of 55Fe in cellular supernatants from E. coli MG1655 pBADmbfA site 
directed mutant transformants. The data presented represent the means ± standard 
deviations obtained from three separate experiments. A: 55Fe exported by E. coli 
MG1655 pBADmbfA compared to E. coli MG1655 pBADmbfA SDM variants, 
statistically significant differences as determined by Students T-test (p < 0.01) at T = 15 
min are indicated. B: Comparison of 55Fe export as a percentage of non-mutated MbfA 
at 15 min (data from A), statistically significant differences as determined by Student’s 
t-test; * P<0.05, ** P<0.01 *** P<0.001. 
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6.9: Iron export by Arabidopsis thaliana vacuolar iron transport 1 
With the phenotypic evidence of iron export collected from the complementation of the 
oxidative stress sensitive E. coli LC106 strain with pBADAt_VIT1, a more thorough 
examination of iron export by Arabidopsis thaliana vacuolar iron transport 1 was 
conducted. The 55Fe export assay was repeated as described previously but with 
replacement of E. coli MG1655 pmbfA transformants for E. coli MG1655 
pBADAt_VIT1 transformants (Figure 6.22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.22: Iron export by VIT1 from A. thaliana.   
55Fe accumulation in E. coli MG1655 supernatant during iron export through expression 
of VIT1 from pBADAt_VIT1 with no addition (A), 100 µM H2O2, 100 U catalase (B), 
anaerobic propagation or anaerobic propagation followed by 100 µM H2O2 injection 
(C). D: Summary of data expressed as the percentage of 55Fe export.  Vector control is 
also included.  Data shown are the means ± standard deviation of three independent 
experiments conducted in triplicate and analysed using an unpaired, two tailed Student’s 
t-test; * P<0.05, ** P<0.01 *** P<0.001.  Rhamnose was present at 0.1 mM.   
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Export of 55Fe by VIT1 was observed to reach a maximum of 542 pmol mg-1 after 30 
min (162 pmol mg-1 lower than form MbfA).  Iron accumulation in cellular supernatants 
only occurred with addition of 100 µM rhamnose, inducing gene expression, during 
bacterial propagation. This demonstrates that the VIT1 protein, without an N-terminal 
erythrin domain as present in MbfA, is able to export iron out of E. coli.  
 
In contrast to the hydrogen peroxide dependent export of iron observed in MbfA, 
manipulation of H2O2 through addition or removal of H2O2, or anaerobic culture, did not 
influence supernatant accumulation of 55Fe directed by VIT1 (Figure 6.22B/C).  This 
provides evidence to both the hypothesis that the erythrin domain drives the H2O2-
dependent export of iron in MbfA, and also indicates that a different mechanism of iron 
transport must be present and functional in Vit1 proteins lacking an erythrin domain.  
 
Due to the location of VIT1 in the vacuole and artificially within the inner membrane of 
E.coli, it is likely that energetically the VIT1 domain is acting as a Fe2+/H+ antiporter. 
To elucidate this mechanism of iron translocation across the vacuolar and inner 
membranes, the effect of addition of the proton ionophore carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) was examined upon export activity of VIT1 and MbfA 
(Figure 6.23).  
 
1, 10 and 100 µM concentrations of CCCP all resulted in a decrease in 55Fe export in 
both VIT1 and MbfA transformant strains.  However, disruption of the proton gradient 
was less marked in terms of iron export for MbfA (10 µM CCCP gave a 74.5% 
reduction for VIT1 but just a 5.3% reduction for MbfA), presumably because MbfA 
iron export is peroxide, not proton motive force, dependent.  The slight decrease in iron 
export could be due to disruption of cellular respiration, which might reduce 
endogenously generated H2O2.  It is likely that CCCP effectively prevents iron 
translocation by VIT1 through the disruption of the proton motive force across the inner 
membrane, which strongly suggests that VIT1 uses a Fe2+/H+ antiporter mechanism. 
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Figure 6.23: Effect of CCCP on iron export by MbfA and VIT1.   
55Fe export by E. coli MG1655 transformed with pAt_VIT1 (A) or pmbfA (B) with 0-
100 µM CCCP. C: Summary of data expressed as the percentage of 55Fe export.  Data 
shown are the means ± standard deviation of three independent experiments conducted 
in triplicate and analysed using an unpaired, two tailed Student’s t-test; * P<0.05, ** 
P<0.01 *** P<0.001. 
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6.10: MbfA exports ferric iron, Vit1 exports ferrous iron. 
Given the current hypothesis of iron export by MbfA, where ferrous iron in the cytosol 
is oxidised to ferric iron during export into the periplasm, exported iron will present in 
the ferric oxidation state.  In contrast, due to the lack of an erythrin domain and 
capability to reduce ferrous iron, Vit1 systems are thought to export ferrous iron in to 
the periplasm in the E. coli model.  
 
To determine experimentally the oxidation state of the exported iron by MbfA and 
VIT1, a colorimetric assay using the specific ferrous iron chelator ferrozine was 
conducted.  An adaption was made to a standard ferrozine assay to allow determination 
of the redox state of the exported iron. Ferrozine specifically binds ferrous iron, the 
inclusion of acetic acid and 750 mM sodium sulphite within the assay converts all 
available iron to the ferrous form, allowing the quantitation of total iron from the 
generation of the colorimetric ferrous-ferrozine complex (extinction coefficient: 27.9 
mM-1 cm-1 at 562 nm).  To determine specifically if MbfA/VIT1 export ferric or ferrous 
iron, first a ferrozine assay with acetic acid and sodium sulphite omitted was conducted, 
followed by the assay of the same sample with acetic acid and sodium sulphite 
included.  The difference in iron concentration between the two assays will give the 
concentration of ferric iron in solution.  The 55Fe transport assay protocol was used to 
facilitate collection of cellular supernatant samples (55Fe was substituted for non-
radioactive 56Fe).   
 
Preliminary studies collecting supernatant from 3.3 ml and 50 ml of cultured cells after 
20 min incubation at 37 °C provided inconclusive evidence of the redox state of the 
exported iron due to iron concentrations beneath the limit of detection for the assay. 
Increasing the number of cells within the assay through using 1 litre of culture reduced 
to a volume of 50 ml, thus increasing the concentration of iron exporting cells, resulted 
in detectable concentrations of iron.   
 
Minimal detection of either ferric or ferrous iron was observed within the supernatant of 
E. coli MG1655 pBADrham (vector control).  The detection of ~25 µM of ferric iron 
was detected in the supernatant from E. coli MG1655 pBADmbfA with induction, whilst 
~30 µM of ferrous iron was detected in the supernatant from E. coli MG1655 
pBADAt_VIT1 (Figure 6.24).   
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The cloned mbfA construct specifically exported ferric iron supporting the hypothesis 
that the erythrin domain removes an electron from the exported cytosolic ferrous iron 
during export.  Conversely, due to the lack of an erythrin like domain in the VIT1 
system, VIT1 transports specifically ferrous iron.  These observations support those 
made by Cockrell et al (Cockrell et al. 2014) who determine by Mossbauer and EPR 
spectroscopy that ferrous iron is translocated into the seed vacuole and is subsequently 
oxidised. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.24: Oxidation state of iron exported by MbfA and VIT1.   
Accumulation of exported ferric (A) and ferrous iron (B) through colorimetric ferrozine 
assay from E. coli MG1655 pBADmbfA or pBADAt_VIT1 compared to vector control 
(VC). Data shown are the means ± standard deviation of three independent experiments 
conducted in triplicate.   Rhamnose was present at 0.1 mM.   
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6.11: MbfA iron export is up-regulated under high iron conditions. 
To examine the mechanisms of regulation of mbfA in iron replete and limited conditions 
the 55Fe export assay was used to measure export of 55Fe by Burkholderia multivorans. 
This organism was employed as it naturally possesses an mbfA gene, is a pathogen and 
can be used under level 2 containment conditions.  Experimentation with mbfA in 
Brucella is complicated due to the requirement for both containment level three 
facilities combined with a radiation laboratory. B. multivorans is an example of a 
containment level 2 organism encoding mbfA (AA sequence identity 16.2% to B. suis 
MbfA), on which iron export experimentation can be conducted at the University of 
Reading radiation laboratory.  In addition, an mbfA mutant in this organism was already 
available (F. Issa, 2015). There are notable differences in the regulatory regions 
upstream of the mbfA coding sequences in B. multivorans and Brucella spp.. mbfA in 
Brucella is regulated by the iron response regulator (Irr), as evidenced from the location 
of the iron control element (ICE) box and the observed up-regulated in response to high 
iron (Figure 3.10).  Control of iron related genes in B. multivorans could possibly be 
achieved by the ferric uptake regulator (Fur), but investigation regarding this is 
required.  
 
To determine if B. multivorans mbfA exports 55Fe under conditions of high iron 
concentrations, and is hence up-regulated (expression or activity levels), wild-type B. 
multivorans, B. multivorans ΔmbfA and B. multivorans ΔmbfA complemented with a 
pBBR series vector harbouring mbfA (generated by F. Issa, 2015) were grown in 
minimal medium with 1 µM iron. The iron export assay as described previously was 
conducted with the following modifications, minimal medium with and without 10 µM 
ferric chloride was used in place of L broth, and rhamnose was omitted.  Export of 55Fe 
was observed with both high (10 µM) and low (1 µM) ferric chloride concentrations, 
from the wild-type and complemented mutant strains of B. multivorans, but not from 
the B. multivorans ΔmbfA strain (Figure 6.25A/B).  For the strains in which iron export 
is present, a 2.3 fold increase in export was observed when B. mulitvorans was 
propagated in a high iron environment compared to a minimal iron environment.  This 
suggests that upon exposure to iron, MbfA activity is enhanced allowing the increased 
removal of toxic iron from the cytosol preventing generation of ROS and associated 
redox stress. 
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Figure 6.25: Burkholderia multivorans MbfA exports iron.   
Measurement of 55Fe export in B. multivorans, B. multivorans ΔmbfA (BM) and 
complemented B. multivorans ΔmbfA (BM pmbfA). The data presented represents the 
means and standard deviations obtained from three separate experiments. A: 55Fe 
exported by B. multivorans compared to B. multivorans ΔmbfA (complemented and 
uncomplemented) under high iron conditions, statistically significant differences as 
determined by Students t-test (p < 0.01) at T = 10 min are indicated. B: 55Fe exported as 
above but under minimal iron conditions, statistically significant differences as 
determined by Students t-test (p < 0.01) at T = 15 min are indicated. 
 
In line with experimentation conducted for the pBADmbfA and pBADAt_VIT1 
constructs transformed into E. coli, examination of the effect of hydrogen peroxide 
upon iron export rate was conducted with B. multivorans (Figure 6.26A). Addition of 
100 µM H2O2 at T0 resulted in a significant increase in 55Fe export by 505 pmol mg-1 
(55.7 %) at T10, compared to no hydrogen peroxide addition, whereas reduction of 
hydrogen peroxide concentrations though addition of 100 U catalase over the same time 
period decreased 55Fe export by 294 pmol mg-1 (53.8 %).   
 
To conduct an examination of iron export by B. mulitvorans MbfA under anaerobic 
conditions, modification to the propagation of the bacteria was made through addition 
of 20 mM sodium nitrate.  B. mulitvorans is a facultatively anaerobic ß-proteobaceria 
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and requires addition of nitrate as a terminal electron acceptor to promote anaerobic 
growth.  Anaerobic propagation prevented the export of 55Fe, presumably through 
elimination of endogenous hydrogen peroxide production as a by-product of aerobic 
metabolism.  Subsequent injection of 100 µM H2O2 at T15 resulted in the immediate 
export of 55Fe at a comparable rate to that observed without H2O2 addition under 
aerobic culture (Figure 6.26B).  These observations are consistent with those obtained 
from the B. suis 1330 MbfA expressed in E. coli and further demonstrate that iron 
export by MbfA is hydrogen peroxide dependent, for both the B. suis MbfA expressed 
in E. coli as well as MbfA of B. multivorans.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.26: Hydrogen peroxide drives Burkholderia multivorans MbfA iron 
export.   
Measurement of 55Fe export from B. multivorans and B. multivorans ΔmbfA. The data 
presented represent the means and standard deviations obtained from three separate 
experiments. A: 55Fe exported by B. multivorans in the presence of hydrogen peroxide 
and catalase, statistically significant differences as determined by Students t-test (p < 
0.01) at T = 10 min are indicated. B: 55Fe exported by B. multivorans under anaerobic 
conditions and with addition of 100 µM hydrogen peroxide at T = 15 min (arrow), 
statistically significant differences as determined by Students t-test (p < 0.01) at T = 25 
min are indicated.  
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6.12: Export of iron potentiates disproportionation of hydrogen peroxide. 
The ability MbfA, through the export of ferric iron, to elicit the disproportionation of 
H2O2 was assayed with Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) 
(ThermoFisher). A transformant E. coli MG1655 colony was inoculated into 5 ml LB 
(starting OD of 0.05), induced for 1 h once the OD reached 0.5 with 100 µM rhamnose, 
washed once with 10 ml cold WB then twice with TB and diluted to 1 OD ml-1. For 
each measurement of H2O2 concentration, 100 µl of cells were added to 100 µl Amplex 
Red reagent and absorbance at 560 nm determined, then compared to a standard curve 
generated with known concentrations of H2O2. For each assay a measurement prior to 
addition (Pre) of 15 µM H2O2 (T0) was made to ensure endogenous H2O2 concentrations 
were minimal, then every two minutes after H2O2 addition during the assay.  
 
To ensure spontaneous disproportionation of hydrogen peroxide would not influence 
observed results, a control observation of 15 µM hydrogen peroxide in a 1 ml transport 
buffer solution (50 mM MES/TAPS pH 7.0) was conducted. The absorbance at 560 nm 
of Amplex Red remained stable over the 10 min assay period, enabling experimentation 
to progress without the need to consider spontaneous disproportionation.  The addition 
of 1 OD E. coli LC106 to 15 µM H2O2 resulted in no significant reduction in H2O2 
concentration (lack of catalase and alkyl hydroperoxidase, primary H2O2 scavengers in 
E. coli (Seaver and Imlay 2004)), whereas, addition of the parental wild type E. coli 
MG1655 resulted in rapid degradation of H2O2 (Figure 6.27A).  Addition of E. coli 
LC106 pBADmbfA to 15 µM H2O2 resulted in degradation of H2O2 at a constant rate 
until 4 min and there-after levels dropped slightly reaching a steady, low level.  This 
rate of degradation was significantly greater than that of the vector control, but less 
effective than wild type E. coli.  This demonstrates that MbfA is able to potentiate the 
disproportionation of H2O2, but the relative contributions afforded by Fenton reactions 
from exported iron and the erythrin domain peroxide reductase are unknown.  To 
resolve this, 200 µM desferrioxamine were added to the assay, prior to addition to cells, 
allowing chelation of exported ferric iron, preventing disproportionation of H2O2 
(Figure 6.28).  In this way, the contribution of the peroxidase reaction at the erythrin 
domain could be quantified and subtracted from the total degradation, allowing 
determination of the contribution afforded by Fenton reactions (Figure 6.27B).   
 
 
 
Chapter 6 
 
 
157 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.27: Disproportionation of hydrogen peroxide by MbfA.   
A: Quantitation of the disproportionation of 15 µM H2O2 by E. coli LC106 transformed 
with pBADrham (vector control, VC) or pBADmbfA with/without 200 µM 
desferrioxamine (DFOA) and E. coli MG1655. B: Relative H2O2 levels for VC minus 
those seen for pmbfA+DFOA, compared to levels for pmbfA+DFOA minus pmbfA-
DFOA.  This represents the relative loss of peroxide due to extracellular iron-induced 
Fenton chemistry and that driven by other MbfA mediated reactivity (i.e. peroxide 
reduction). Data shown are the means ± standard deviation of three independent 
experiments conducted in triplicate   
0	
2	
4	
6	
8	
10	
12	
14	
16	
18	
-2	 0	 2	 4	 6	 8	 10	
H 2
O
2	(
μM
)		
Time	(min)	
Pre	
H2O2		
pmbfA	
pmbfA	DFOA	
VC	
MG1655	
	
0	
51.78%	
36.77%	 41.44%	
49.28%	 55.01%	
48.22%	
63.23%	 58.56%	
50.72%	 44.99%	
0%	
20%	
40%	
60%	
80%	
100%	
0	 2	 4	 6	 8	 10	
Time	(min)	
Erythrin	
Fenton		
B 
A 
Chapter 6 
 
 
158 
Control reactions were conducted to demonstrate the effective protection of hydrogen 
peroxide disproportionation by ferrous and ferric iron when iron is chelated with the 
ferrous iron chelator 1,10–phenanthroline and the ferric iron chelator desferrioxamine 
(Figure 6.28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.28: Disproportionation of hydrogen peroxide by iron is inhibited upon 
chelation.   
Quantitation of the disproportionation of 15 µM H2O2 through exposure to 30 µM ferric 
and ferrous iron.  Prevention of disproportionation through prior addition of 200 µM 
desferrioxamine or 1,10-phenanthroline, respectively.  Data shown are the means of 
three independent experiments conducted in triplicate. 
 
To determine if this novel mechanism for degradation of hydrogen peroxide could be 
physiologically relevant to Brucella spp. within the acidified BCV (pH 4.0 - 4.5 (Porte 
et al. 1999)), the assay was repeated at acidic pH. Adjustments in pH were made to TB. 
Results show no difference in hydrogen peroxide disproportionation under acidic 
conditions (Figure 6.29).  
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Figure 6.29: Effect of pH on disproportionation of hydrogen peroxide by MbfA.  
H2O2 disproportionation by E. coli LC106 pmbfA at pH 4.0, 5.0, 6.0 and 7.0. Data 
shown are the means ± standard deviation of three independent experiments conducted 
in triplicate. 
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6.13: MbfA protects from nitric oxide sensitisation to oxidative stress. 
The phagolysosomal-like niche in which Brucella spp. are located during early stages of 
intracellular infection is characterised by the presence of both reactive oxygen and 
nitrogen species.  Within the phagosome nitric oxide is generated from arginine and 
oxygen by inducible nitric oxide synthase (iNOS) (Fang 2004), nitric oxide (NO) is then 
able to react with superoxide (O2-) to generate toxic peroxynitrite (ONOO-) (Radi et al. 
1991). In addition to the generation of toxic byproducts, NO is also able to liberate 
stored iron from bacterioferritin (Le Brun et al. 1997). As well as inhibit catalase 
through the conversion of catalase compounds II and III to ferricatalase (Kim et al 
2002); effectively stalling its catalytic activity, allowing lower concentrations of 
hydrogen peroxide to become toxic to the invading bacterium (Pacelli et al. 1995).   
 
In addition, the physical properties of hydrogen peroxide, specifically its non-polar 
nature, allows it to freely diffuse across all biological membranes.  It is important to 
note that not only can hydrogen peroxide diffuse into the invading organism, eliciting 
the redox stress required for bactericidal action, but also hydrogen peroxide will equally 
diffuse out of the phagolysosome.  This results in hydrogen peroxide concentrations 
within the phagolysosome being low (4 - 30 µM) as it is impossible to concentrate it in 
any biological compartment.  With this in mind, the requirement for nitric oxide, 
sensitizing invading bacteria to low concentrations of hydrogen peroxide becomes 
apparent. The synergism of NO and H2O2 mediated bacterial killing is highlighted by 
experimentation conducted by Ann Woodmansee; (Woodmansee and Imlay 2003).  
Nitric oxide was observed to accelerate the killing of E. coli through NO/H2O2 initiated 
Fenton reactions.  However, it was of note that the killing of E. coli was protected by 
the addition of a cell permeable iron chelator.  
 
Experimentation was conducted to examine the effect that NO has upon MbfA function 
and to determine whether MbfA is able to elicit a protective response to NO generated 
oxidative stress.  Initially, the effect on cellular viability, measured by aerobic growth of 
a bacterial culture over 18 h, was determined with addition of up to 1 mM H2O2 or 50 
µM NO (Figure 6.30).  Nitric oxide was introduced into L broth as DEA NONOate (2-
(N,N-diethylamino)-diazenolate-2-oxide). DEA NONOate is a nitric oxide donor, 
which is soluble in PBS and dissociates into a free amine and nitric oxide in a pH-
dependent manner.  At pH 7.4 and 37 °C, DEA NONOate has a half-life of 2 min and 
liberates 1.5 moles of NO per mole of parent compound. No deleterious effect was 
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observed upon the viability of E. coli MG1655 as optical densities were equivalent for 
cultures with no addition and with H2O2 or NO, at all concentrations, in the presence 
and absence of mbfA.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.30: Growth of E. coli MG1655 with addition of H2O2 or NO.   
Optical densities after 18 h aerobic growth of E. coli MG1655 pBADmbfA or vector 
control (VC) in L broth with addition of 1 mM H2O2 or 5-50 µM NO.  Data shown are 
the means ± standard deviation of three independent experiments conducted in 
triplicate.  Rhamnose was present at 0.1 mM.  
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In contrast, when 5 µM NO was combined with 1 mM H2O2 this resulted in sensitivity 
of E. coli MG1655, but this effect was ameliorated with the expression of mbfA (Figure 
6.31).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.31: Growth of E. coli MG1655 with addition of H2O2 and NO in 
combination.   
Growth of E. coli MG1655 pBADmbfA (black circles) or vector control (VC, grey 
circles) in L broth with 1 mM H2O2 and 0, 5, or 50 µM NO.  Data shown are the means 
of three independent experiments conducted in triplicate. Rhamnose was present at 0.1 
mM. 
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Addition of 5 µM NO resulted in an increase in E. coli lag phase by ~6 h, compared to 
when no NO was added.  When E. coli was transformed with pBADmbfA, lag phase 
was reduced by ~3 h in the presence of 5 µM NO; this implies that expression of mbfA 
protects against the combined action NO and peroxide, and thus reduces losses in 
cellular viability.  Similar, but more marked effects were observed with higher 
concentrations of NO. The synergistic effect of increased toxicity through combination 
of NO and H2O2 is most likely combated by MbfA mainly through the export of cellular 
iron which will degrade external H2O2.  It is likely that the catalases and alkyl 
hydroperoxidases of wildtype E. coli fail to effectively combat peroxide stress when 
NO is present since NO would inhibit these haem-containing enzymes, as indicated 
above, whereas MbfA is haem-independent and so can be expected to be NO inert.  
Thus, MbfA is able to compensate for the inhibition of endogenous peroxidase and 
catalase activity by NO. Further, exported iron might also bind NO and thus limit its 
toxicity (Cooper 1999).  
 
To further explore the combined impact of NO and H2O2, the effect of these two 
compounds on the E. coli catalase/alkyl-hydroperoxidase mutant (LC106) was 
examined (Figure 6.32A).  NO caused a major increase in LC106 sensitivity to 
peroxide, which shows that the enhanced sensitivity of the wildtype to peroxide induced 
by NO is not simply a result of catalase/alkyl-hydroperoxide inhibition (in contrast to 
what was suggested above).  In addition, MbfA was able to reverse this sensitivity.  As 
suggested before, this is likely to be caused by MbfA increasing extracellular free iron 
concentration resulting in disproportionation of peroxide.  However, NO may also act to 
enhance peroxide toxicity through binding to, and mobilization of, cellular iron (e.g. 
from Bfr) (Winstedt and von Wachenfeldt 2000) and/or through a range of direct NO 
toxicity activities within the cell (Beckman and Koppenol 1996).  The potential action 
of NO in mobilization of cellular iron resulting in raised free cytosolic iron levels, is 
supported through the effect of NO on the streptonigrin (SNG) sensitivity of E. coli K-
12 (MG1655) with and without MbfA.  The results show that NO raises sensitivity to 
SNG for the vector control, but MbfA appears to reverse or even decrease sensitivity for 
the pBADmbfA strain (Figure 6.32B).  This is consistent with NO mobilization of iron 
which in turn enables its removal from the cell by MbfA; without MbfA this iron 
mobilisation would result in enhanced free-iron levels in the cytosol raising SNG 
toxicity, as observed.   
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Figure 6.32: Protection of nitric oxide sensitisation to oxidative stress in E. coli by 
MbfA.   
A: Optical density after 18 h aerobic growth of E. coli LC106 pBADmbfA or vector 
control (VC) in LB with addition of 50 µM NO and/or 100 µM H2O2.  B: Optical 
density after 18 h aerobic growth of E. coli MG1655 pBADmbfA or vector control (VC) 
in LB with addition of 0 or 50 µM NO and streptonigrin (1-4 µg/ml).  Data shown are 
the means ± standard deviation of three independent experiments conducted in triplicate 
and analysed using an unpaired, two tailed Student’s t-test; * P<0.05, ** P<0.01 *** 
P<0.001. Rhamnose was present at 0.1 mM. 
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To determine whether the presence of NO has an impact on the rate of extracellular 
hydrogen peroxide disproportionation (as suggested above), H2O2 consumption by 
E. coli MG1655 and LC106 pBADmbfA transformants was assessed with and without 
NO. The assay was conducted as described previously, however, 5 min before addition 
of hydrogen peroxide, DEA-NONOate was added to allow dissociation into NO.  
 
Similar to previously observations, the E. coli LC106 vector control failed to degrade 
15 µM H2O2; because of this, provision of 50 µM NO had no notable effect on H2O2 
levels (Figure 6.33).  Again, as before, E. coli LC106 (pBADmbfA) showed rapid 
disproportionation of hydrogen peroxide, and addition of nitric oxide gave a slight 
increase in the initial (2 min) level of disproportion of hydrogen peroxide (Figure 6.33), 
although the difference was not significant.  Thus, NO appears to have little impact on 
the extracellular degradation of hydrogen peroxide as mediated by MbfA. Thus, it can 
be assumed that MbfA is not inhibited by NO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.33: Effect of NO on disproportionation of hydrogen peroxide by MbfA in 
E. coli LC106.   
Quantitation of the disproportionation of 15 µM H2O2 with Amplex Red. Samples were 
(as indicated): H2O2 only; E. coli LC106 vector control (VC) with 50 µM NO and H2O2 
; LC106 VC with H2O2 only; LC106 (pBADmbfA) with 50 µM NO and H2O2; LC106 
(pBADmbfA) with H2O2 only.  NO indicated by dashed lines. Data shown are the means 
of three independent experiments conducted in triplicate. Rhamnose was present at 0.1 
mM.  
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In contrast, addition of nitric oxide to E. coli MG1655 resulted in a reduction in the rate 
of hydrogen peroxide disproportionation, although over a 10-min period total 
disproportionation was not dissimilar (Figure 6.34).  In the absence of nitric oxide, 
E. coli MG1655 was able to disproportionate approximately 85-90% of total hydrogen 
peroxide within 2 min and 99% by 4 min.  In comparison, for the vector control, nitric 
oxide addition led to decreased hydrogen peroxide disproportionation such that just 33 
and 47% of total H2O2 was consumed at 2 and 4 min, respectively, which represents a 
greater than twofold decrease in consumption compared to the condition without NO 
(Figure 6.34).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.34: Effect of NO on disproportionation of hydrogen peroxide by MbfA in 
E. coli MG1655.   
As above, except E. coli MG1655 was used in place of LC106.  
 
For E. coli MG1655 with pBADmbfA, the presence of NO again decreased the rate of 
hydrogen peroxide disproportionation but not to the same degree as seen for the vector 
control (Figures 6.34 and 6.35).  Thus, expression of mbfA decreased hydrogen peroxide 
degradation, raising levels by ~threefold from by 7.8 to 2.6 µM at 4 min (compared to 
the VC). This suggests that, firstly, NO blocks the degradation of H2O2 by wildtype 
E. coli (presumably by inhibition of catalases and alkyl hyroperoxidases), and secondly, 
that MbfA is able to promote disproportionation of hydrogen peroxide in the presence 
of nitric oxide and thus compensate for catalase/alkyl hydroperoxidase inhibition by 
NO.  Crucially, the data from Figure 6.33 show that MbfA is not negatively impacted 
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by NO (unlike catalases/alkylhyroperoxidases) which explains its ability to assist 
peroxide degradation in the wildtype when endogenous mechanisms are subject to NO 
inhibition. This ‘resistance’ of MbfA to NO could be important for survival of Brucella 
within the eBCV where combined exposure to NO and H2O2 is likely (Gross et al. 
2004). 
 
A comparison of the disproportionation of hydrogen peroxide after 4 min for E. coli 
MG1655 and LC106, +/-NO and +/-mbfA reveals that MbfA provides a significant 
increase in hydrogen peroxide degradation in all but one condition. No significant 
difference is observed for MbfA provision in E. coli MG1655 without NO addition 
(Figure 6.35). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.35: Comparison of effects of NO and endogenous catalases/peroxidase on 
hydrogen peroxide degradation by MbfA.   
Data are derived from Figures 6.34-6.35 4 min.  Data shown are the means ± standard 
deviation of three independent experiments conducted in triplicate and analysed using 
an unpaired, two tailed Student’s t-test; * P<0.05, ** P<0.01 *** P<0.001 
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6.14: MbfA depletes the labile iron pool and iron stores. 
To examine the effect of expression of mbfA on the intracellular concentration of iron 
within E. coli, measurement of total cellular iron was conducted using a ferrozine 
colorimetric assay. Strains were grown to mid-log phase before lysis by heating to 
90 °C in the presence of an acidic ferrozine solution to allow determination of total iron 
content (Methods 2.5.2).  Samples were standardized per mg of protein, as determined 
by Bradford assay (Methods 2.4.9).  
 
Expression of mbfA in E. coli MG1655 resulted in significant reduction of total cellular 
iron at log phase (Figure 6.36) and this effect was reproduced in E. coli Δfur, ΔryhB and 
Δfur ΔryhB mutants.  The expression of mbfA in E. coli MG1655 resulted in a reduction 
in total iron content by 5.3 µmoles/mg (23.5 %); larger decreases in total iron content 
were observed in E. coli Δfur, ΔryhB and Δfur ΔryhB strains: 8.1, 9.8 and 11.2 
µmoles/mg (40.2, 46.8 and 53.8 %), respectively, compared to the wildtype.  In the case 
of the fur mutant, the increased reduction in cellular iron levels mediated by MbfA 
could be related to the increased level of labile, free cytosolic iron caused by the 
deregulation of iron homeostasis (Nandal et al. 2010).  For the ryhB mutant, an increase 
in Bfr levels is anticipated (Masse and Gottesman 2002) that might provide an increased 
source of intracellular iron for MbfA export (see below).  
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Figure 6.36: MbfA depletes cellular iron in E. coli with an increased effect seen for 
iron regulation mutants.   
Total cellular iron was determined by colorimetric Ferrozine assay. Data shown are the 
means ± standard deviation of three independent experiments conducted in triplicate 
following growth to mid-log phase.  Data was analysed using an unpaired, two tailed 
Student’s t-test; * P<0.05, ** P<0.01 *** P<0.001. Rhamnose was present at 0.1 mM.    
 
Deletion of fur results in de-regulation of iron uptake and storage; iron-uptake 
mechanism are constitutively expressed, whereas iron storage is repressed, as is 
incorporation of iron into proteins; these effects result in increased free intracellular iron 
concentrations compared to wild-type E. coli.  This would make more free iron 
available for export which is reflected in the observed decreased iron content caused by 
expression of mbfA in the fur mutants with respect to levels observed for the wildtype. 
In contrast, deletion of ryhB, encoding a small 90-nucleotide non-coding RNA which 
acts to down-regulate iron-storage (bacterioferritin, Bfr) when iron is limited, results in 
constitutive expression of Bfr (Masse and Gottesman 2002).  Provision of MbfA within 
the ryhB mutants, where this mutation is expected to result in less free iron due to 
excess Bfr iron storage capacity and raised expression of iron-protein genes, also 
resulted in reduction of total iron content in a similar fashion as seen for the fur 
mutants.  This would be consistent with MbfA acting to drive the removal of iron from 
Bfr (note that FtnA is not RyhB controlled; (Nandal et al. 2010), suggesting that Bfr 
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might act as a source of intracellular iron for MbfA-mediated iron export; this 
possibility is further addressed below).   
 
To further explore the hypothesis that MbfA not only depletes the labile iron pool but 
can also access cellular iron stores, examination of the total iron content of pBADmbfA 
transformants of E. coli ftnA, bfr, bfd and dps mutants was conducted upon induction of 
mbfA expression (Figure 6.38).  Examination of the total iron contents of E. coli ΔftnA, 
Δdps and ΔftnA Δdps mutants showed a significant reduction in total iron content with 
pBADmbfA in all cases under inducing conditions.  In contrast, deletion of bfd or bfr, or 
bfr and bfd, with or without ftnA, dps, and dps plus ftnA, gave no significant reduction 
in total iron content with pBADmbfA (Figure 6.37).  Thus, the MbfA-dependent 
reductions in total iron content were only seen when Bfr was present with Bfd. Deletion 
of the bfr gene or the adjacent ‘bacterioferritin-associated ferredoxin’ (Bfd) encoding 
gene (bfd) resulted in failure of MbfA to elicit a significant reduction in total iron 
content.  This suggests that MbfA is able to deplete cellular iron stores in the form of 
Bfr (but not FtnA), presumably through an indirect mechanism, in a manner that 
depends also on Bfd. It is likely that iron removed from the cytoplasm by MbfA results 
in mobilization of iron from Bfr (as a homeostatic response to cytosolic free-iron 
depletion) which is then subject to MbfA-mediated export.  It should be noted that Bfr 
is the sole recognized iron-storage protein within Brucella (Almiron and Ugalde 2010), 
so this mechanism would be expected to be applicable to most Brucella species.  Also, 
bfd is induced by low iron (Fur dependent) and is considered to be involved in release 
of iron from Bfr through a reductive mechanism (Garg et al. 1996, Quail et al. 1996) 
 
It is also possible that expression of mbfA prevents the accumulation of iron within Bfr 
(such that few iron stores are built up by Bfr) by reducing free intracellular iron 
availability, rather than by driving the removal of iron stores from Bfr.  However, the 
higher iron content of the bfd mutant is not consistent with this theory although does 
match the hypothesis that MbfA is able to promote removal of iron from Bfr in a Bfd-
dependent fashion.  It is possible that both processes contribute to the role of Bfr in 
enabling an MbfA-dependent reduction in total-cellular iron. 
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Figure 6.37: MbfA fails to significantly deplete cellular iron in E. coli Bfr and Bfd 
iron-storage defective strains.   
A: Quantitation of total cellular iron in log phase by colorimetric Ferrozine assay. B:  
Difference in iron content with expression of MbfA (pBAD Fe/mg – pBADmbfA 
Fe/mg) Data shown are the means ± standard deviation of three independent 
experiments conducted in triplicate and analysed using an unpaired, two tailed Student’s 
t-test; * P<0.05, ** P<0.01 *** P<0.001. Rhamnose was present at 0.1 mM.  
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In addition to examination of the total iron status of E. coli strains, assessment of time 
dependent ferric-iron export was conducted to determine the concentrations of iron 
exported when bfr is either present or absent.  
 
Iron export for E. coli MG1655 and E. coli Δdps ΔftnA, which both encode bfr, were 
compared to E. coli Δbfr and Δbfr Δdps ΔftnA, which both lack bfr, as well as a non-
exporting control (E. coli MG1655 VC) (Figure 6.38, Table 6.1). Bfr+ strains exported 
significantly more (~35 % at 16 min) iron over the time period assayed than Bfr- E. coli 
strains, further supporting a role for Bfr in providing a source of iron available for 
export by MbfA. It is noteworthy that the absence of Bfr resulted in only an ~33% 
reduction in MbfA-dependent iron export, yet MbfA-dependent depletion of total 
cellular iron was decreased by 70%, from ~5 to 1.5 µmol/mg, through absence of Bfr 
(Figure 6.38).  This discrepancy is likely to relate the longer time course for the 
experiments measuring cellular iron levels, where mbfA expression was induced 
throughout growth until the mid-log phase sampling point.  The resulting cellular iron 
levels would reflect the combined action of iron uptake and MbfA-mediated release 
during the entire period of growth.  In contrast, for the iron release experiments, assays 
were performed for just 32 min, one hour after mbfA induction, and are expected to 
represent the initial rates of iron export without influence of iron uptake.  
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Figure 6.38: Time dependent export of cellular iron content by MbfA.   
Export of iron as determined by ferrozine assay by E. coli MG1655 and mutant strains 
(Δbfr, Δdps ΔftnA and ΔftnA Δbfr Δdps) carrying pBADmbfA compared to E. coli 
MG1655(pBADrham) vector control (VC) following growth to mid-log phase.  Data 
shown are the means of three independent experiments conducted in triplicate and 
analysed using an unpaired, two tailed Student’s t-test; * P<0.05, ** P<0.01 *** 
P<0.001. Rhamnose was present at 0.1 mM.  
 
Table 6.1: Iron export rates   
Strain (pBADmbfA) Iron export rate (µmol/min/mg) 
MG1655 1.60 
Δbfr 1.54 
Δdps ΔftnA 1.05 
ΔftnA Δbfr Δdps 1.03 
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Finally, the effect of various iron-metabolism defects on MbfA-induced resistance to 
2 µg/ml streptonigrin resistance was tested to determine whether enhanced SNG toxicity 
resulting from increased cytosolic-free iron levels can be reversed by MbfA.  As 
detailed previously, E. coli Δfur has a high free iron content due to constitutive iron 
import and repressed iron storage, rendering this strain more sensitive to 2 µg/ml 
streptonigrin than the corresponding parental wild-type strain (Figure 6.39).  
Transformation of E. coli Δfur with pBADmbfA rescued the SNG-sensitive phenotype 
persumably through export of reactive iron resulting in lower cytosolic levels. 
Conversely, an E. coli mutant deficient (JC28) in all known high-affinity iron import 
systems was more resistant to 2 µg/ml strepotnigrin than the corresponding parental 
wild-type strain, such that the presence/absence of pBADmbfA had no notable effect on 
growth.  
 
Next, the effect of MbfA on the SNG-sensitivity of E. coli iron-storage mutants (Δdps 
ΔftnA Δbfr, Δbfr and Δdps ΔftnA) was tested. Strains lacking Bfr showed no significant 
increase in resistance to streptonigrin with expression of mbfA, but E. coli Δdps ΔftnA 
(bfr only) displayed a significant increase in resistance (Figure 6.40).  This supports the 
hypothesis that Bfr stores iron that is readily available for release into the cytosol to 
provide free iron for metabolic purposes, thus raising susceptibility to killing by 
streptonigrin.  The presence of Bfr in the wildtype did not result in MbfA-mediated 
enhancement of SNG-resistance, this effect was only seen in the dps ftnA mutant. The 
reason for this is unclear, but might be related to an increased SNG sensitivity resulting 
from Dps and FtnA absence. 
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Figure 6.39: Effect of MbfA on resistance to streptonigrin dependent killing in 
E. coli iron-metabolism mutants.   
Resistance of E. coli strains (as indicated, with pBADrham or pBADmbfA) to 2 µg/ml 
streptonigrin. Data shown are the means ± standard deviation of three independent 
experiments conducted in triplicate and analysed using an unpaired, two tailed Student’s 
t-test; * P<0.05, ** P<0.01 *** P<0.001.  
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6.15: Discussion:  
The experiments described in this chapter focus upon the characterization of Brucella 
suis MbfA, but also examines the MbfA system in Burkholderia multivorans as well as 
VIT1 from Arabidopsis thaliana. The aim was to characterize the function of MbfA and 
how it might contribute to redox-stress resistance and virulence of Brucella spp..   
 
Transformation of a plasmid expressing MbfA into an E. coli strain deficient in all high 
affinity iron uptake mechanisms (JC28) resulted in a reduction in growth in iron replete 
medium. Further MbfA-dependent growth reductions were observed when available 
iron was depleted through chelation.  This phenotype provides evidence that expression 
of mbfA allows for export of cellular iron.  Further to this, phenotypes were also 
observed which are consistent with iron export when MbfA was expressed in an E. coli 
peroxidase mutant (LC106). The transformed mutant and vector control were exposed 
to hydrogen peroxide, organic peroxide or redox mediators (methyl viologen) and 
differences in lag phase and final optical density were observed.  In all cases, expression 
of mbfA resulted in an increase in cellular growth and decreased time to achieve log 
phase compared to the vector control.  Although the erythrin domain of the MbfA 
protein is hypothesized to act as a peroxide reductase, the protection to the cell afforded 
by MbfA, in the presence of these redox active chemicals, cannot be directly attributed 
to this domain.  It is possible that peroxides act as oxidants and are reduced at the 
erythrin domain, but also it is possible that exported iron is able to engage in Fenton 
reactions with these chemicals outside of the cell, affording cellular protection. It is of 
note that the activity seen in vivo for mbfA in E. coli indicates that low-level expression 
must result in good occupancy of the erythrin domain with a di-iron centre, thus, the 
high zinc content observed in the over-expressed domain results from its high 
abundance which appears to result in insufficient iron availability for di-iron site 
formation, enabling zinc occupation instead.    
 
To aid in the resolution of how resistance to peroxides was achieved, the VIT1 gene was 
cloned from A. thaliana into an inducible expression vector and transformed into E. coli 
LC106.  VIT1 is known to act as an iron transport protein in A. thaliana, but has no 
erythrin domain therefore no peroxide reductase functionality. Expression of VIT1 in 
the presence of hydrogen peroxide in E. coli LC106 resulted in equivalent resistance to 
that achieved by MbfA, suggesting that resistance to peroxide induced stress may 
originate from reduction of the peroxides extracellularly through interactions with 
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exported iron.  To add further to this observation, when the Vit1 domain of the MbfA 
protein was expressed in isolation, no resistance to peroxide was observed.  This 
suggests that the erythrin domain is necessary to enable iron export by MbfA. 
 
The predicted functionality of MbfA acting as an iron exporter was further supported by 
the results observed when E. coli wildtype and mutant strains were exposed to the iron 
dependent antibiotic streptonigrin. Exposure of E. coli strains to streptonigrin resulted 
in varying decreases in cellular growth, dependent upon the levels of free intracellular 
iron. The E. coli fur mutant (H1941) was more sensitive to streptonigrin than wildtype 
E. coli (MG1655), which in turn was more sensitive than the E. coli iron import mutant 
(JC28).  In all cases, expression of MbfA, exporting intracellular iron, resulted in 
increases in resistance to streptonigrin. These results suggest that expression of mbfA 
drives export of cytosolic free iron which protects against the bactericidal action of 
streptonigrin through lowering concentrations of available iron able to interact with 
streptonigrin. 
 
The development of a method for the quantitation of iron released from bacteria via 
resulted in the first direct quantitation of iron export by MbfA.  Characterisation of the 
Brucella suis MbfA and Arabidopsis thaliana VIT1 were conducted in E. coli as a 
surrogate, whereas characterization of Burkholderia multivornas MbfA was conducted 
within the native host organism.   Initial experiments provided reinforcement of 
previous observations that mbfA expression is controllable, on the pBADrham plasmid, 
with addition of 0.1 mM rhamnose; observation of iron export was only observed with 
addition of inducer.  To characterize the mechanism of iron export by MbfA, exported 
iron was monitored as increased and decreased (catalase addition) hydrogen peroxide 
concentrations were applied. Addition of hydrogen peroxide increase export rate, 
whereas, addition of catalase reduced export rate. Further to this, anaerobic propagation 
of E. coli MG1655, preventing in vivo hydrogen peroxide generation, resulted in 
complete cessation of iron export, which could be resumed immediately upon direct 
injection of de-gassed hydrogen peroxide.   
 
To add further evidence for the requirement of both MbfA domains (erythrin and Vit1) 
to enable export of iron, quantitation of exported iron was determined when either 
domain was expressed in isolation.  No iron export was observed in either case, 
however, expression of isolated domains in trans from two different plasmids in the 
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same cell resulted in a restoration of iron export, but at a fraction of that observed with 
native MbfA.  Additionally, site-directed mutagenesis was used to selectively mutate 
four amino acids (D191, M228, E232 and Y268), which present as potential iron 
coordinating ligands, to glycine. Mutagenesis allowed for the comparison of each MbfA 
variant’s ability to export iron to the native MbfA.  Mutation of M228, E232 and Y268 
resulted in no statistically significant differences in iron export to the un-edited MbfA, 
however mutation of D191 within TMH1 of the Vit1 domain resulted in significant 
reductions in export of iron.  This observation was supported by a phenotypic 
observation in E. coli JC28 (iron uptake mutant).  E. coli JC28 expressing 
pBADmbfAD191 presented with significantly increased growth compared to the same 
strain expression pBADmbfA. The increase in cellular growth can be attributed to a 
reduction in iron export with mutation of D191. 
 
The same series of hydrogen peroxide manipulation experiments was conducted with a 
comparison of wildtype B. multivorans to B. multivorans ΔmbfA, as well as with the 
VIT1 protein of A. thaliana expressed in E. coli MG1655.  B. multivorans MbfA 
behaved in a very similar way to the MbfA from B. suis as iron was exported in a 
hydrogen peroxide dependent manner.  However, advantages could be gained by 
observing MbfA within a native host, experimentation could be conducting regarding 
the expression of mbfA from its native promoter.  The rate of iron export by B. 
multivorans MbfA was greatest when excess iron was supplied to the growth medium.  
In this way the B. multivorans cell is iron replete and suggests that mbfA is induced in 
response to high intracellular iron concentrations, allowing for the reduction in cellular 
iron content.  Experimentation with A. thaliana VIT1 resulted in the observation that 
manipulation of hydrogen peroxide concentration did not influence the rate of iron 
export; leading to the determination that the VIT1 system exports iron in a hydrogen 
peroxide independent manner.  This was to be expected due to the lack of an erythrin-
like domain within the VIT1 protein.  Experimentation with CCCP (proton ionophore) 
suggested that the VIT1 system, unlike MbfA, relies upon the proton motive force to 
enable iron translocation. Lastly, the dependence on hydrogen peroxide as an oxidant 
driving export influenced the redox state of the exported iron.  H2O2 dependent systems 
lost an electron in the process of export and the exported iron was released to the 
medium as ferric iron, where as the H2O2 independent system maintained the ferrous 
iron oxidation state.   
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Final experimentation characterizing the function and mechanism of action of MbfA 
determined that the export of iron by MbfA results in numerous, beneficial effects.  
Export of iron from the cell results in the rapid disproportionation of external hydrogen 
peroxide though engagement of iron in Fenton reactions.  This finding underpins the 
phenotypic observations that were conducted through the complementation of E. coli 
LC106 with MbfA and VIT1.  Secondly, the export of cellular iron by MbfA protects 
the cell from nitric oxide sensitization to hydrogen peroxide (MbfA activity appears to 
be little affected by NO).  Future work should be performed on the relative ability of the 
two separated domains (solo and in trans) to provide resistance to hydrogen peroxide in 
the presence and absence of nitric oxide. Lastly, the removal of iron from the cytoplasm 
by MbfA results in the mobilization of iron reserves from Bfr, which are in turn 
exported.  
 
From the experiments described in this summary it was evident that the resistance to 
peroxide stress afforded to the cell through expression of mbfA is primarily conferred by 
export of iron from the cell which then engages in Fenton reactions that decompose 
peroxide externally in a fashion that is not harmful to the sensitive cellular machinery.  
To quantitate this, an assay was used to determine the effect of MbfA on the 
concentration external hydrogen peroxide over time.  The E. coli strain lacking 
peroxidases (LC106) was unable to measurably degrade hydrogen peroxide over a 10 
min period, but when complemented with MbfA, a rapid loss of hydrogen peroxide was 
observed.  However, the issue was still apparent that the percentage contribution of 
peroxide degradation from the erythrin domain and Fenton reactions remained 
unresolved.  To determine peroxide reduction at the erythrin domain in isolation, an 
extracellular iron chelator was added prior to the addition of hydrogen peroxide, this 
allowed the chelation of exported iron, preventing it from undertaking Fenton reactions.  
Hydrogen peroxide degradation under these conditions related to that solely occurring 
at the erythrin domain, which equated to ~20% of total hydrogen peroxide 
disproportionation.  Therefore, as described in previous experiments, the majority of 
resistance to peroxides was achieved through the exported iron engaging in Fenton 
reactions outside of the cell.  
 
With a detailed understanding gained of the mechanism that MbfA utilizes to export 
iron, experimentation was conducted to examine the role that nitric oxide plays within 
the phagosome of the macrophage.  It was previously reported that NO and H2O2 act 
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synergistically in accelerating the killing of E. coli through a Fenton reaction 
mechanism (Woodmansee and Imlay 2003), and that this effect was reversed through 
the addition of a cell permeable iron chelator.  This effect was examined with relation to 
mbfA expression.  In isolation, addition of either 1 mM H2O2 or 50 µM NO gave no 
growth effect for E. coli MG1655, however when added together a synergistic killing 
effect was observed which was reduced with the expression of mbfA.  The potential 
reasons for the increased sensitivity to hydrogen peroxide were postulated as being 
attributable to NO liberating stored iron from bacterioferritin and/or that NO binds the 
haem residues of catalase preventing detoxification of H2O2 (Hoshino et al. 1993, 
Brown 1995).  In both cases, NO acts to sensitize the cell to hydrogen peroxide either 
by increasing available iron to engage in Fenton reactions within the cell, or by 
prevention of detoxification of H2O2. 
 
To assess whether the presence of bacterioferritin (Bfr) and to a wider extent other iron 
storage proteins in E. coli (ferritin; FtnA and DNA-binding protein from starved cells; 
DPS) influenced the ability of MbfA to export iron from E. coli, quantitation of total 
iron content was performed for wildtype and mutant strains.  Significant reductions in 
cellular iron content with expression of mbfA were only observed with deletion of bfr 
from the E. coli genome.  In addition to this, the same E. coli iron storage mutants were 
assessed for their resistance to streptonigrin with mbfA expression.  Deletion of all three 
iron storage mutants rendered E. coli more resistant to 2 µg/ml than wildtype E. coli 
with and without expression of mbfA.  When Bfr was the sole iron storage protein in E. 
coli, sensitivity was comparable to that of wildtype E. coli, but MbfA expression 
resulted in significant protection.  This suggests that Bfr acts as a reversible store of iron 
in E. coli.  
 
The findings obtained suggest that MbfA acts as an NO-resistant, hydrogen peroxide 
dependent iron exporter.  The biologically relevant consequences of exporting iron by 
Brucella are three-fold. First, MbfA specifically depletes intracellular ferrous iron 
concentrations, reducing the propensity for Fenton reactivity within the bacterial 
cytosol. Second, during export of ferric iron, the erythrin domain uses intracellular 
hydrogen peroxide as an oxidant, therefore further depleting the capacity for radical 
generation and ensuring that iron export only occurs when peroxides are present.  
Lastly, export of iron enables disproportionation of hydrogen peroxide outside of the 
bacterial cell, greatly limiting peroxide toxicity. This latter ability would be expected to 
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be particularly relevant in the macrophage where export of iron into the tight luminal 
space of the BCV should be highly effective in increasing iron concentration 
surrounding the Brucella in turn cell leading to efficient H2O2 decomposition. Thus, this 
relocalisation of H2O2-induced radical formation from the inside to the outside the 
bacterial cell provides a high degree of redox-stress resistance.  Indeed, previous work 
has shown that high extracellular iron protects against peroxide, whereas high 
intracellular iron raises sensitivity (Cao et al. 2007, Nandal et al. 2010).  
 
With respect to the use of hydrogen peroxide as a driving force for iron translocation in 
bacteria, this is not limited to the MbfA system.  The efeUOB operon in E. coli 
O157:H7 and other bacteria encodes a high affinity ferrous iron transport system which 
is proposed to employ hydrogen peroxide as an oxidant facilitating iron translocation 
(Cao et al. 2007). This system and homologues thereof, are all thought to function to 
oxidise ferrous iron, located in the periplasm, to ferric iron at the periplasmically 
located EfeO protein, the electron generated during this oxidation step is transferred to 
the peroxide-reductase-like EfeB where it is used to reduce hydrogen peroxide. The 
ferric iron, bound to EfeO, is believed to pass its iron on to the ferric iron permease 
(EfeU), which then translocates the ferric iron into the cytosol.  The substrates 
employed by EfeUOB are identical to those proposed for MbfA system, although the 
components involved in mediating the transport processes are quite distinct and the 
directionality of translocation is opposite. It both cases, hydrogen peroxide is used as an 
electron sink, to facilitate the oxidation and translocation of ferrous iron, whether this is 
for export or import is dependent upon the system.  
 
From selected examples (Table 6.2) it is notable that organisms encoding EfeUOB-like 
iron importers do not encode MbfA-like iron export systems.  The notion that both 
systems would be present in a single organism is counter intuitive as each employs 
peroxide to drive iron across the cytosolic membrane, but in reverse directions, and so 
their combined activities could result in a pointless futile cycle whereby peroxide 
promotes recycling of iron across the membrane. However, it is of interest that the 
Brucella spp. do encode a homologous, high affinity iron import system to EfeUOB, 
specified by the ftrABCD operon (Elhassanny et al. 2013).  However, FtrABCD lacks 
any peroxide reductase component and is therefore unlikely to be peroxide dependent.  
This may, in part at least, explain the use of FtrABCD rather than EfeUOB in the 
Brucellae. Additionally, it is of note that when Vit-only versions of mbfA are observed 
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which lack an erythrin domain such as within Neisseria flavescens, the EfeUOB system is 
present.  
 
Table 6.2: Gene identifiers of selected bacterial examples carrying either mbfA 
with ftrABCD, or efeUOB without mbfA. 
MbfA Sub-
family 
Phyla Organism mbfA (AA 
Identity) 
ftrABCD (AA 
Identity) 
efeUOB (AA 
Identity) 
Ib/c 
α-proteobacteria Brucella suis BS1330_I1673 
(100%) 
BS1330_II0378 
(100%) 
N/A 
α-proteobacteria Bradyrhizobium 
japonicum  
BJS_07869 
(58%) 
N/A N/A 
α-proteobacteria Agrobacterium 
tumefaciens 
ATCH_17048 
(69%) 
N/A N/A 
β-proteobacteria Burkholderia 
multivorans 
BMULJ_05750 
(16%) 
BMULJ_02190 
(66%) 
N/A 
β-proteobacteria Paraburkholderia 
terrae 
WQE_38914 
(17%) 
WQE_37547 
(71%) 
N/A 
Actinobacteria Micrococcus luteus Mlut_04290 
(15%) 
N/A N/A 
Bacteroidete Bacteroides 
fragilis 
BF9343_1281 
(17%) 
N/A N/A 
Bacteroidete Fusobacterium 
ulcerans 
FUAG_02346 
(21%) 
N/A N/A 
IIp 
β-proteobacteria Neisseria 
flavescens  
NEIFLAOT_00
744 (10%) 
N/A NEIFLAOT_01
857(50%) 
γ-proteobacteria Serratia 
marcescens  
SMDB11_1764 
(8%) 
N/A SMDB11_RS10
755 (74%) 
γ-proteobacteria Acinetobacter 
baumannii 
J504_1793 (7%) N/A A1S_1621 
(26%) 
Actinobacteria Mycobacterium 
tuberculosis  
K875_03682 
(10%) 
N/A K875_03222 
(37%) 
N/A 
γ-proteobacteria Escherichia coli  N/A N/A ECs1263  
(100%) 
γ-proteobacteria Yersinia 
enterocolitica  
N/A N/A CH49_1371 
(73%) 
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FtrABCD functions similarly to that of EfeUOB, in that ferrous iron is the transport 
substrate and is presumed to be oxidised during the uptake process.  Also, like EfeUOB, 
FtrABCD carries a cupredoxin protein (FtrA) as well as an Ftr1-like ferric iron 
permease (FtrC) to import the ferric iron atom (Brickman and Armstrong 2012, 
Elhassanny et al. 2013).  Differences arise in the way that the electron, generated from 
the ferrous iron oxidation, is dealt with.  For FtrABCD, ferrous iron is believed to 
initially bind to the Cu-containing and periplasmic FtrB, where an electron is removed 
(possibly via FtrA) and then passed on to FtrD, a membrane-embedded polyferredoxin, 
where the electron is thought to be disposed of via unknown mechanism (Brickman and 
Armstrong 2012, Elhassanny et al. 2013). FtrABCD therefore, does not appear to rely 
upon the reduction of hydrogen peroxide and instead makes use of the polyferredoxin 
located within the inner membrane, as a sink for electrons.  As indicated above, that 
hydrogen peroxide is not likely used as an oxidant for iron uptake in Brucella spp. is 
consistent with its use by MbfA for iron export instead (Figure 6.40).   
 
 
 
 
 
 
 
 
 
 
 
Figure 6.40: Schematic representation of the MbfA, EfeUOB and FtrABCD iron 
translocation mechanisms.   
A: Intracellular ferrous iron is oxidised, the resulting released electron reduces the di-
iron centre of the erythrin domain, allowing reduction of hydrogen peroxide. The 
resulting ferric iron atom is translocated to the periplasm. B: Extracellular ferrous iron 
is oxidised at the EfeO protein M75 domain, the electron passes to the EfeO cupredoxin 
domain (cup), and then on to the ferryl-haem group of EfeB, returning the haem group 
back to its resting state and enabling subsequent re-oxidation during reduction of 
hydrogen peroxide. The resulting ferric iron atom is translocated to the cytosol by EfeU.  
C: Extracellular ferrous iron is oxidised at the iron-binding site of the P19 protein 
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(FtrB), the released electron passed on to the periplasmic cupredoxin and is then 
shuttled to the iron-sulphur clusters of the membrane-bound polyferridoxin, FtrD, which 
may in turn feed the electron to the electron transport chain. The resulting ferric atom 
on FtrB is translocated to the cytosol via FtrC. 
 
The above observation raises the hypothesis that bacterial spp. encoding MbfA-like iron 
export systems will encode FtrABCD-like rather than EfeUOB-like iron import 
systems, preventing opposing iron translocation process occurring upon exposure to 
H2O2.  The converse should therefore be true, that bacterial spp. encoding EfeUOB-like 
iron import systems do not encode MbfA. 
 
Chapter 7 
 
 
185 
Chapter 7: Characterization of mbfA in Brucella suis 1330 and Brucella melitensis 
16M 
 
7.1: Rationale for the creation of Brucella spp. deletion mutants  
 
To explore the role that MbfA plays with regards to intracellular survival and virulence 
in Brucella spp., the mbfA gene was deleted from the Brucella suis 1330 and Brucella 
melitensis 16M chromosomes by a targeted approach.  
Given that Brucella spp. are hazard group three pathogens as defined by the Advisory 
Committee on Dangerous Pathogens (ACDP), as well as hazard group three Specified 
Animal Pathogen Order (SAPO) pathogens as defined by the Department for 
Environment, Food and Rural Affairs (DEFRA) and Overlap Select Agents as classified 
by the Center for Disease Control (CDC); all manipulations of Brucella spp. were 
conducted within the Defense Science and Technology Laboratory (DSTL) 
ACDP/ACGM containment level (CL) three laboratories.   
To remove the target gene from the genomes of Brucella suis 1330 and Brucella 
melitensis 16M a non-polar unmarked gene excision approach was used in which the 
target gene was removed and an antibiotic resistance determinant (kanamycin) inserted 
in its place.  This was achieved through the insertion of a suicide plasmid, via 
electroporation, into the Brucella spp. and recombination of that suicide plasmid with 
the Brucella genome via selective pressure applied by kanamycin. Integrants were cured 
through a second recombination event, selected for by resistance to sucrose, promoting 
the removal of the suicide plasmid backbone that encodes sacB. Upon the creation of 
Brucella mbfA mutants, a single clone was complemented with a replicating plasmid 
(limited to ten copies per cell in Brucella spp.) carrying the mbfA gene expressed from 
its native promoter.  
 
To determine if mbfA aids in the intracellular survival and virulence of Brucella spp. the 
growth of wild-type and mutant derivative strains was assessed for their ability to grow 
under oxidative stress inducing conditions, as well as survival within cultured murine 
macrophages and in vivo within a mouse model.  
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7.2: Creation of mbfA deletion mutants in Brucella suis 1330 and Brucella 
melitensis 16M 
 
Prior to the electroporation of plasmid DNA into Brucella suis 1330 and Brucella 
melitensis 16M it was ensured that stocks of the bacteria held at DSTL at -80C were 
viable and of smooth LPS phenotype.  The virulence of the classical Brucella strains; 
Brucella melitensis, Brucella abortus and Brucella suis is associated with presence of 
the O-polysaccharide, with smooth LPS phenotypes generally being virulent and rough 
ones not. Smooth Brucella spp. colonies present as moist glistening circular convex 
colonies entire edges of 2-4 mm in diameter after growth for 2 days on TSA.  However, 
spontaneous transition to the rough LPS phenotype is possible and is encouraged by the 
use of media with excessive moisture, unnecessary holding of cultures at room 
temperature and extended incubation periods. Rough cell phenotypes present with dry 
granular opaque and more brittle colonies that auto-agglutinate rapidly in broth culture, 
compared to smooth cultures which sediment slowly over time. A more comprehensive 
assessment of the smooth and rough phenotype on agar plates is achieved through 
flooding the plate with a 1:4 mixture of 10% crystal violet in ethanol and 1% 
ammonium oxalate in distilled water; smooth cells do not stain, whereas rough cells 
stain deep purple. Physical examination of Brucella melitensis after 3 days incubation at 
37 °C on Brucella agar reveals small (approx. 1 mm diameter) moist circular colonies 
with entire edges.  Additionally, Brucella suis colonies appear on average 3 mm in 
diameter with the same physical characteristics.  This observation confirms the smooth 
LPS phenotype of these strains. 
 
To prepare competent Brucella cells for receiving DNA by electroporation, one 10 µl 
loop of cells was scraped from a confluent TSA plate, which had been incubated at 37 
°C for 3 days, and was re-suspended in 1 ml of room temperature H2O.  The cells were 
washed three times with 1 ml H2O via centrifugation (3 min, 20 °C, 13,000 rpm), re-
suspended in 200 µl of water before dividing into 50 µl aliquots. 5 µl of plasmid DNA 
was added to 50 µl of competent Brucella cells in a cooled 0.2 mm electroporation 
cuvette and electroportated (BioRad XCell electroporation system) at 400 Ω, 25 µF and 
2.5 kV for 10 ms.  Electroporated cells were allowed to recover in 1 ml SOC-B at 37 °C 
overnight before plating onto TSA with appropriate antibiotics and incubated at 37 °C 
for up to 5 days.  
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Prior to the construction of deletion mutants though the electroporation of the suicide 
plasmid construct into the Brucella species, the transformation efficiency of 1 µg of the 
replicating plasmid pBBR1-MCS4 (AmpR) via the electroporation protocol described 
above into Brucella melitensis 16M and Brucella suis 1330 was determined.  A 
transformation efficiency of 2.3x103 cfu/µg was achieved with B. melitensis whilst an 
approximate one log higher transformational efficiency was achieved with B. suis; 
1.4x104 cfu/µg.  This observation is consistent with the greater enumeration of B. suis 
bacteria present on Brucella agar plate cultures compared to B. melitensis after 3 days 
incubation at 37 °C. 
 
Suicide and complementation plasmids (pEXΔmbfA::KnR, pBBR4mbfAmelitensis, 
pBBR4mbfAsuis) were extracted from E. coli Top10 (Qiagen Plasmid Midi Prep) and 
concentration via ethanol precipitation to approx. 200 ng/µl DNA in H2O and stored at -
20 °C.  Electroporation was repeated with pEXΔmbfA::KnR and integrant B. melitensis 
and B. suis colonies were selected for through plating recovered cells on to TSA with 45 
µg/ml kanamycin.  Two presumptive B. melitensis integrants were recovered whilst B. 
suis yielded 25 colonies.  The increased number of single homologous recombinations 
in B. suis was not unexpected due to the increased transformational efficiency.   
 
To confirm the presence of a single homologous recombination of the suicide plasmid 
into the Brucella melitensis genome, colony PCR was conducted. To conduct this 
analysis the two kanamycin resistant B. melitensis colonies where taken into 100 µl of 
H2O then heated and maintained at 96 °C for 10 minutes, ensuring complete loss of 
cellular viability.  cPCR with primers specific to the kanamycin cassette (mbfAKn F/R) 
could then be undertaken at CL3 prior to the PCR samples being removed to a CL2 
laboratory for agarose gel electrophoresis analysis (Figure 7.1) (Method 2.6.1). The 
presence of a 796 bp band indicates the single homologous recombination event within 
the integrant genome. Brucella suis colony boilates were unable to be created at the 
time of analysis, due to a Proof of Principle heat killing study on B. suis not having 
been undertaken – preventing the removal of all B. suis PCR materials from the CL3 
laboratory.  
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Figure 7.1:  Brucella melitensis cPCR integrant confirmation 
1% agarose gel electrophoretic analysis of cPCR of B. melitensis pEXΔmbfA::KnR 
single homologous recombination integrants (primers specific to inserted kanamycin 
cassette). Tracks left to right: 1/7, molecular weight marker; 2, B. melitensis integrant 1 
(796 bp); 3, B. melitensis integrant 2 (796 bp); 4, B. melitensis wild-type (negative 
control); 5, pEXΔmbfA::KnR (positive control); 6, blank (PCR without DNA). 
 
Both B. melitensis colonies and the positive control (pEXmbfA::kn plasmid) exhibited 
the expected 796 bp PCR band, whilst PCR from wild type B. melitensis did not exhibit 
any PCR product.  This indicates that kanamycin resistant B. melitensis colonies result 
in 100% positive integrant selection.  This can be taken as true for the B. suis colonies, 
which were unable to analyzed at the same time, that KnR colonies are integrants (later 
confirmed as integrants by PCR from extracted genomic DNA).  
 
One B. melitensis and one B. suis integrant were inoculated into 1 ml of Brucella broth 
and incubated overnight at 37°C.  The broth cultures were diluted ten-fold and 100 µl 
plated onto TSA with 10% sucrose and 45 µg/ml kanamycin and incubated at 37°C for 
3 days to select for double homologous recombinants.  
 
Eight single, isolated colonies, presumptive cured B. melitensis mutants, were selected 
for a second cPCR analysis with primers specific to the flanking region of DNA outside 
the 1kb flanking DNA used to allow for recombination (mbfA 1 kb F/R). A 154 bp 
larger PCR product was expected for mbfA mutants compared to the wild-type strains 
(Figure 7.2). The presence of a 3467 bp band rather than a 3313 bp indicates a double 
homologous recombination event. 
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Figure 7.2: Brucella melitensis cPCR mutant confirmation 
1% agarose gel electrophoretic analysis of cPCR of cured Brucella melitensis 
mbfA::KnR mutants with flanking primers. Tracks left to right: 1/15. molecular weight 
marker, 2-9. presumptive B. melitensis mbfA mutants (3467 bp), 10/11. B. melitensis 
integrants (negative control), 12. blank (PCR reaction without DNA), 13. B. melitensis 
wild-type (positive control – 3313 bp), 14. pEXΔmbfA::KnR (negative control). 
 
Two of the eight presumptive cured mutants presented with 3467 bp PCR products, 
suggesting a 25% success rate. With an mbfA mutant confirmed by cPCR in B. 
melitensis, genomic DNA preparations (Qiagen Gentra Puregene) were prepared from 
the eight presumptive cured mutants, one presumptive integrant and one wild-type B. 
melitensis and B. suis colonies.  The DNA preparations were tested for sterility before 
removal to a CL2 laboratory via the inoculation of 10% of the DNA preparation in 10 
fold excess Brucella broth and incubation for 7 days at 37 °C, followed by the 
incubation of 100 µl of broth on Brucella agar for a further 7 days at 37 °C.  Plates 
presenting with no presumptive Brucella colonies were deemed sterile (Method 2.6.2).   
 
The PCR reactions used to identify and confirm integrants and cured Brucella 
melitensis mutants were repeated for both Brucella melitensis and Brucella suis in a 
CL2 laboratory using the extracted genomic DNA (Figure 7.3A). To highlight the small 
increase in base pairs (154 bp), which determined the strain as a mutant rather than the 
wild type, the PCR products were analyzed after electrophoretic separation on an 
agarose gel directly adjacent to each other (Figure 7.3B). The presence of the 3467 bp 
band indicates a double homologous recombination event. 
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Figure 7.3: B. melitensis and B. suis genomic DNA PCR 
A: 1% agarose gel electrophoretic analysis of PCR with gDNA of cured B. melitensis 
and B. suis mbfA::KnR mutants with flanking primers. Tracks left to right: 1/12. 
molecular weight marker, 2-9. presumptive B. melitensis mbfA mutants (3467 bp), 10. 
B. melitensis integrant (3467 bp), 11. B. melitensis wild-type (positive control – 3313 
bp). 13-20. presumptive B. suis mbfA mutants (3467 bp), 21. B. suis integrant (3467 bp), 
22. B. suis wild-type (positive control – 3313 bp). B: 1% agarose gel electrophoretic 
analysis of PCR with gDNA of B. melitensis ΔmbfA3, B. suis ΔmbfA1 and respective 
wild-type strains with flanking primers. Tracks left to right: 1/6. molecular weight 
marker, 2.  B. melitensis ΔmbfA3 (3467 bp), 3. B. melitensis WT (3313 bp), 4. B. suis 
ΔmbfA3 (3467 bp), 5. B. suis WT (3313 bp). 
 
Reproduction of the PCR reactions with B. melitensis genomic DNA resulted in five of 
the eight presumptive cured mutants presenting with 3467 bp (62.5 % successful cured 
mutants) compared to the two when analysed by cPCR.  It is of note, that both cPCR 
positive cured integrants were both PCR positive when genomic DNA was analysed. 
Severn of the eight B. suis genomic extractions presented as PCR positive (87.5 %), 
with all PCR products separating to larger molecular weights than the respective wild-
type control, indicating all isolates are mbfA deficient.  
 
The genomic DNA from B. melitensis ΔmbfA3 and B. suis ΔmbfA1 was taken forward 
for a further confirmation of the mutant genotype by PCR using a combination of 
primers which would only yield a PCR product if a double recombination event had 
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taken place (mbfA F with mbfAkn R and mbfA R with mbfAKn F). The 5’ flanking 
primer was paired with the 3’ KnR primer for the left-hand reaction and the 3’ flanking 
primer was paired with the 5’ KnR primer for the right-hand reaction, allowing a 
comprehensive evaluation of the presence of the double recombination event and 
creation of the deletion mutant (Figure 7.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4: B. melitensis and B. suis mutant confirmation PCR 
1% agarose gel electrophoretic analysis of PCR with gDNA of B. melitensis ΔmbfA3, B. 
suis ΔmbfA1 and respective wild-type strains with kanamycin and flanking primers. 
Tracks left to right: 1/8. molecular weight marker, 2. B. melitensis ΔmbfA3 LHS (2328 
bp), 3. B. melitensis ΔmbfA3 RHS (2032 bp), 4. B. melitensis WT (negative control), 5. 
B. suis ΔmbfA1 LHS (2328 bp), 3. B. suis ΔmbfA1 RHS (2032bp), 4. B. suis WT 
(negative control). 
 
The presence of 2328bp and 2032bp bands amplified from the mutant genome, and 
simultaneous absence from the wild-type genome indicate the removal of the target 
gene and replacement with the kanamycin cassette within the mbfA gene. 
 
In addition to confirmation by PCR, the DNA sequence containing the mbfA deletion 
was sequenced.  This would confirm that both, the mbfA gene had been removed and 
preplaced by the kanamycin cassette, as well as, ensuring that the B. melitensis wild-
type strain encode the mbfA pseudogene through acquisition of the t55c SNP 
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The mbfA coding sequence and flanking regions of B. melitensis ΔmbfA3, B. suis 
ΔmbfA1 and their respective wild-type parental strains were amplified by PCR (mbfA 1 
kb F/R) from the respective genomic DNA isolates.  The amplified DNA was removed 
from residual oligonucleotides and free bases, and blunt end ligated into the pCR4-
TOPO vector.  The Brucella originating DNA was sequenced from the M13 forward 
and reverse sequencing primers (Figure 7.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: Sequence confirmation of mbfA Brucella mutants 
Sanger sequencing reads of B. melitensis 16M WT, B. melitensis ΔmbfA, B. suis 1330 
WT and B. suis ΔmbfA with M13 forward and reverse sequencing primers. Sequencing 
primers indicated with open arrows, mbfA and kanamycin genes indicated with yellow 
arrows. 
 
The sequencing results confirmed that the mutant strains have deletions to the mbfA 
gene and replacement with the kanamycin gene and kanamycin promoter sequence.  
Additionally, confirmation of the t55c point mutation (glutamate to stop codon 
mutation) in the mbfA gene of B. melitensis 16M WT was observed, whilst this was 
absent in the B. suis strain, as expected. 
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Upon full confirmation of the deletion of the mbfA coding sequence from the genomes 
of Brucella melitensis 16M and Brucella suis 1330 complementation with pBBR4 series 
vectors was conducted.  
 
Both B. melitensis and B. suis ΔmbfA strains were complemented with both the 
functional B. suis mbfA, or non-functional B. melitensis mbfA (pBBRmbfAsuis and 
pBBRmbfAmelitensis) as well as empty vector control (pBBR4).  Electroporations were 
conducted as described previously with selection of transformant strains conducted 
through plated onto Brucella agar (100 µg/ml ampicillin).  Ampicillin resistant colonies 
were stored in glycerol stocks at -80 °C. 
 
Table 7.1 lists the Brucella strains that have been created to characterize the function of 
mbfA in Brucella suis 1330 and Brucella melitensis 16M.  
 
Table 7.1: Wild type and engineered Brucella spp. strains.  
Brucella spp Strain Genotype Antibiotic resistance 
B. melitensis 
16M WT - 
ΔmbfA ΔmbfA Kn 
pmbfAsuis ΔmbfA pmbfAsuis Kn, Amp 
pmbfAmel ΔmbfA pmbfAmel Kn, Amp 
B. suis 
1330 WT - 
ΔmbfA ΔmbfA Kn 
pmbfAsuis ΔmbfA pmbfAsuis Kn, Amp 
pmbfAmel ΔmbfA pmbfAmel Kn, Amp 
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7.3: Characterisation of mbfA deletion mutants of Brucella suis 1330 and Brucella 
melitensis 16M 
 
To characterize the effect that the deletion of mbfA has upon the ability of Brucella suis 
1330 and Brucella melitensis 16M to withstand loss of cellular viability through 
exposure to oxidative stress, three main experiments were proposed.  First a growth 
curve monitoring the optical density over a 48 hour time period would be conducted in 
the presence of the two major factors contributing to oxidative stress experienced within 
the phagolysosome; hydrogen peroxide and ferrous iron (supplied as ferrous sulphate). 
Secondly, macrophage survival assays will be conducted and a comparison the number 
of intracellular bacteria determined during a time course experiment.  Lastly, an in vivo 
study using a chronic infection mouse model will be conducted to identify if a 
significant difference is present between wild type and mutant Brucella suis strains.  
Individually and in combination these three assays will allow for a comprehensive 
review into the requirement of mbfA in Brucella spp. in terms of resistance to oxidative 
stress, intracellular survival and ability to maintain infection in a mammalian host, 
therefore determining if mbfA acts as a virulence factor in Brucella spp.  
 
First an analysis of aerobic growth of Brucella suis 1330 and Brucella melitensis 16M 
wild type and mbfA mutants was monitored over a 48 hour time period at 37 °C 20 µl of 
0.5 OD adjusted cells from an overnight Brucella culture was inoculated into 180 µl of 
Brucella broth with either hydrogen peroxide, ferrous sulphate or left with no addition 
as a control and optical densities at 620 nm were measured every 30 minutes for 48 
hours with the Thermo Multiskan FC (Figure 7.6). Brucella broth (10.0 g/L pancreatic 
digest of casein, 10.0 g/L peptic digest of animal tissue, 2.0 g/L yeast extract, 5.0 g/L 
sodium chloride, 0.1 g/L sodium bisulphite, 1.0 g/L dextrose) was used as the base 
media in all experimentation; with supplementation of either with either 10 mM 
hydrogen peroxide or 5 mM ferrous iron made to examine resistance to oxidative stress.  
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Figure 7.6. 48-hour growth curve of B. suis 1330, ΔmbfA and pmbfA.  
All growth curves were conducted in 96 well plates in Brucella broth, supplementations 
are noted. A: Average optical density achieve for each strain after 48 hr growth. B: 48 
hr growth curve. The data presented represents the means obtained from three separate 
experiments, the asterisk (*) denotes a statistically significant difference, between the 
data obtained for B. suis 1330 and B. suis ΔmbfA via a Students T-test (P < 0.01) at T = 
48 h.   
A 
B D 
C 
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Figure 7.7. 48-hour growth curve of B. melitensis 16M, ΔmbfA and pmbfA. 
As figure 7.6, B. melitensis in place of B. suis.  
  
A 
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Aerobic growth over a 48 hour time course of B. melitensis in non-supplemented 
Brucella broth identifies growth to ½ maximal OD (0.42 OD units ~ 18 h) was achieved 
5 h after that of B. suis (0.62 OD units ~ 13 h).  As well as a reduced ½ maximal OD, a 
reduced optical density after 48 h (0.41 OD units) was visualized.  This growth profile 
is consistent with the observation of smaller and less numerous B. melitensis colonies 
on Brucella agar compared to B. suis.  Additionally, the less avid growth phenotype was 
apparent in both wild-type and ΔmbfA B. melitensis strains, suggesting that the 
reduction in B. melitensis growth is not mbfA dependent.  
 
Supplementation of Brucella broth with 5 mM FeSO4 resulted in a reduction in final 
optical density in all Brucella strains and derivatives. A greater reduction in optical 
density after 48 hr is observed in B. suis strains than B. melitensis (B. suis 1330 39.9% 
reduction; B. melitensis 16M 26.4% reduction) when comparing growth in 
supplemented and non-supplemented media. This suggests a greater resistance of B. 
melitensis 16M to iron associated oxidative stress than B. suis 1330.  A hypothesis for 
greater redundancy in mechanisms relating to oxidative stress resistance is plausible 
although the mechanism for this resistance is unknown, and is not obvious upon 
examination of the B. melitensis genome.  
 
B. suis ΔmbfA experienced greatest reduction in optical density – 0.452 OD units, 
compared to WT under the same iron supplemented condition, demonstrating an 
involvement of MbfA in protection against iron induced oxidative stress in B. suis.  This 
effect was reversed with complementation of mbfA on a pBBR series vector.  Deletion 
of mbfA in the cryptic B. melitensis 16M strain presented with no difference in optical 
density, but complementation with a functional copy of B. suis mbfA increased optical 
density by 0.124 OD units, suggesting that removal of mbfA via targeted mutation or 
through acquisition of SNP is detrimental to the protection against iron initiated 
oxidative stress in B. melitensis.   
 
Supplementation of Brucella broth with 10 mM H2O2 resulted in similar observations to 
supplementation with ferrous iron; B. suis ΔmbfA experienced greatest reduction in 
optical density – 0.477 OD units and was complementable with pmbfA.  B. melitensis 
16M and ΔmbfA strains exhibit no significant difference in optical density, but 
complementation with a functional mbfA gene results in an increased resistance to H2O2 
(0.268 OD unit increase). 
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Taken together these results suggest that in vitro, mbfA serves a role in protecting 
Brucella spp. from oxidative stress supplied via hydrogen peroxide and Fenton 
chemistry.  As elucidated in previous chapters the mechanism for resisting oxidative 
stress by MbfA is likely due to the export of intracellular free iron, preventing the 
accumulation of hydroxyl radical damage generated as a byproduct of ferrous iron and 
hydrogen peroxide interactions.  Exported iron will also function to engage in Fenton 
chemistry outside the cell preventing hydoxyl radical formation within the cell.   
 
Given that B. melitensis strains are naturally cryptic for mbfA, suggestive of an 
evolutionary step away from its requirement in virulence, the results of this in vitro 
experimentation are unlikely representative of the interactions the Brucella spp. 
undertake in vivo. However, they do present evidence that MbfA provides measurable 
protective effects against iron and hydrogen peroxide initiated oxidative stress.   
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7.4:  Immuno-detection of MbfA in Brucella suis 1330 and Brucella melitensis 16M 
To further characterize the cryptic nature of the B. melitensis mbfA sequence and 
therefore lack of MbfA translation, Western blotting of whole cell extracts of B. suis, B. 
melitensis and derived mutants was conducted.  Anti-rabbit, polyclonal antibodies were 
previously generated to the soluble N-terminal cytosolic erythrin domain of the MbfA 
protein, enabling probing for MbfA expression in Brucella strains.  
 
To enable the collection of whole Brucella cells expressing mbfA, B. suis, B. melitensis 
and derived mutants were propagated in 5 ml Brucella broth over-night, before sub-
culture into a further 5 ml Brucella broth supplemented with 10 mM hydrogen peroxide 
or 5mM ferrous sulphate.  The cultures were incubated for 8 hr and 1 OD of cells 
pelleted by centrifugation at 13,000 rpm in a benchtop microfuge before re-suspension 
in 1 ml H2O. The 1 ml suspensions were heat inactivated at 60 °C for 2 hrs, before the 
sterility of the suspension was assessed prior to removal to a CL2 laboratory (Method 
2.6.2). The total protein content of the heat-killed cells was determined by a Bradford 
assay, using lysozyme to generate a standard curve. 10 µl of a 0.1 mg/ml normalized 
preparation was used to separate the isolated proteins by SDS-polyacrylamide gel 
electrophoresis and conduct a Western blot (Figure 7.8). 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: Western blot identification of MbfA 
Immuno-detection of MbfA (anti-erythrin) from B. suis and B. melitensis whole cell 
extracts after 2 hour exposure to 10 mM H2O2 or 5 mM FeSO4. MbfA: 36.4 kDa. 
 
The Western blot highlights the absence of MbfA translation in response to hydrogen 
peroxide and ferrous iron in B. melitensis as well as engineered B. suis mbfA mutants, 
and B. suis mutant complemented with the B. melitensis pseudogene.  MbfA is 
translated in the B. suis WT strain and when complemented with the mbfA sequence in a 
complementation plasmid.  
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7.5: Intracellular survival and replication of B. suis and B. melitensis mbfA 
mutants in J774.A1 murine macrophage 
Building on the results observed in vitro, in which the presence of mbfA in Brucella spp. 
confers resistance to oxidative stress, the role that MbfA plays in regards to the 
intracellular survival of Brucella spp. will be elucidated through experimentation with 
J774.A1 murine macrophages.  The relative survival of B. suis 1330, B. melitensis 16M 
and derivative ΔmbfA mutants will be compared to provide insight into MbfA function.  
 
J774.A1 murine macrophages are an immortalized monocyte macrophage cell line 
isolated from the reticulum cell sarcoma of BALB/c mice. To enable maintenance and 
growth classical cell culture techniques are employed; J774.A1 macrophages were 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) with 5% fetal bovine 
serum (FBS) and 2 mM L-glutamate and were incubated at 37 °C under a 5% CO2 
atmosphere. Upon 70-80% confluent growth in tissue culture flasks cells are split into 
fresh media to allow renewed propagation.  
 
To conduct intracellular survival assays, 1x105 J774.A1 macrophages were seeded per 
well in a 24 well plate in supplemented DMEM.  After 24 hours growth at 37 °C and 
5% CO2, which provides sufficient time for attachment of macrophages to the 24-well 
plate and upon visualization of cellular monolayers, spent culture media was removed. 
Culture medium was replaced with 0.5 ml Leibovitz’s L15 media containing 
approximately 1x107 CFU/ml of the test organism, resulting in a multiplicity of 
infection (MOI) of 100:1.  Leibovitz’s L15 media was used in replacement of DMEM 
during intracellular survival assays conducted at CL3 due to the absence of an incubator 
supplying a 5% CO2 atmosphere, through the requirement of containing CL3 pathogens 
in sealed containers during all manipulations outside the specified safety cabinet.  
Leibovitz’s L15 media enables to buffering of pH to within required limits in the 
absence of CO2. After 1.5 hours of infection, extracellular bacteria were killed by 
treatment with gentamicin (50 µg/ml) and maintained in Leibovitz's L-15 medium with 
gentamicin (2 µg/ml).  
 
After removal of non-internalized Brucella via treatment with gentamycin, at pre-
determined time points (0, 4, 24 and 48 hrs) macrophages were washed with PBS and 
lysed with 0.1% (vol:vol) triton X-100 in H2O. To enumerate viable intracellular 
Brucella cells at each time point, macrophage cell lysates were serially diluted and 
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plated onto Brucella agar, then incubated for 3 days at 37 °C.  CFU were counted and 
data was presented as CFU per well.  
 
Prior to experimentation, preliminary studies were conducted to ensure 50 µg/ml 
gentamycin was bactericidal to all experimental Brucella strains.  Gentamycin is an 
aminoglycoside, bactericidal antibiotic and functions through binding to the 30S subunit 
of the bacterial ribosome, interrupting bacterial protein synthesis.  Studies have 
determined that the minimal bactericidal concentration (MBC), (the minimal 
concentration at which growth after 72 hours at 37 °C inhibited growth in broth and 
yielded no colonies for the corresponding agar subculture after 72 hours at 37 °C) of 
Brucella melitensis, and Brucella suis strains are between 4 and 32 µg/ml (Olsen and 
Carlson 2015).  In line with this methodology, the effectiveness of the bactericidal 
action of 50 µg/ml gentamycin on B. melitensis and B. suis strains was examined.  An 
overnight culture of B. suis and B. melitensis WT and ΔmbfA mutants was diluted to a 
standardized optical density of 0.5 OD units in Brucella broth.  100 µl of each Brucella 
culture was spread onto Brucella agar containing 50 µg/ml gentamicin; plates were 
incubated for 3 days at 37 °C then examined for colony forming units.  In all cases, no 
Brucella colonies were observed.  With confirmation of the bactericidal effect of 
gentamycin on Brucella survival, analysis of the intracellular survival of B. suis 1330, 
B. melitensis 16M and ΔmbfA mutants in J774.A1 murine macrophages was conducted 
(Figure 7.9).  
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Figure 7.9: Intracellular survival and replication of B. suis 1330, B. melitensis 16M 
and derivative strains in J774.A1 murine macrophages.  
1 x 105 J774.A1 macrophages were infected at an MOI of 100:1, at indicated times 
post-infection macrophages were lysed and the number of intracellular brucellae 
determined by serial dilution, plating and culture.  (A) Survival and replication of B. 
suis 1330 and ΔmbfA and (B) B. melitensis 16M, ΔmbfA and pmbfA. The results are 
averages of n = 3 technical replicates and n = 3 biological replicates ± the standard 
deviation at each time point and analysed using an unpaired, two tailed Student’s t-test.  
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Analysis of the intracellular survival profiles of B. suis and B. melitensis reveals that all 
strains exhibit an initial reduction in viable bacteria with in the first hours of 
macrophage infection.  This is consistent with published literature; it is noted that up to 
90% of ingested bacteria can be killed rapidly by the macrophage within the first 4 
hours of infection (Celli et al. 2003), and represents the association with in the early 
Brucella containing vacuole (eBCV).  In all wild type cases, after initial reductions in 
viable intracellular numbers, bacterial replication commences and increases in 
recoverable viable intracellular bacteria are observed. 
 
B. suis 1330, mbfA expressing, is able to replicate at a greater rate and sooner during 
macrophage infection than the ΔmbfA mutant, which results in significantly less 
intracellular bacteria after 24 and 48 h. The deletion of mbfA from the B. suis 1330 
genome results in an increased reduction (47%) of intracellular bacteria during 
residence within the eBCV (4-24 hours).  This observation is consistent with MbfA 
providing protection against the respiratory burst generated by the macrophage during 
this period.  
 
In comparison to B. suis, B. melitensis 16M, ΔmbfA or pmbfA strains all exhibit an 
increased number of bacteria entering macrophage at T0 compared to B. suis strains; but 
present with differing percentage survival during the association within the eBCV 
depending upon mbfA genotype.  mbfA defective strains experience an average 149% 
decrease in cellular viability after 4 h infection, whereas, mbfA expressing B. melitensis 
only suffers a 20% decrease in viable cell count over the same period, supporting the 
role of MbfA providing protection against oxidative stress.   
 
It is of interest that mbfA expression during later macrophage infection is detrimental to 
B. melitensis viability. Post 24 h, mbfA defective B. melitensis strains begin replication 
but the mbfA expressing strain maintains a decreasing rate of reduction in cellular 
viability, this suggests that mbfA expression, although beneficial during early stage 
infection, is detrimental throughout the entire macrophage infection cycle.  Removal of 
reactive free iron by MbfA protects against oxidative stress, but may disadvantage 
replication when environmental conditions are favourable. This suggests that mbfA in 
Brucella melitensis strains may act as an anti-virulence factor. The presence of MbfA, 
exporting iron during early stages of phogolysosomal localization is detrimental to the 
intracellular survival of B. melitensis at later time points.  It is after 24 h that B. 
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melitensis is localized within the endoplasmic reticulum and when the requirement for 
iron to allow cellular replication is apparent. With the removal of iron by MbfA to 
counter oxidative stress, the propensity for replication is reduced.   
 
A second interpretation of this data may suggest that the expression of mbfA in Brucella 
melitensis is completely advantageous. The assay conducted specifically identifies 
intracellular bacteria; the gentamycin in this assay specifically kills extracellular 
bacteria.  We are therefore unable to enumerate bacteria that have completed their 
intracellular transition and have exited the macrophage as they will contact gentamycin.  
If mbfA is advantageous to B. melitensis, mbfA encoding strains may be able to transit 
through the macrophage quicker and exit the macrophage at a sooner time point. Under 
the conducted assay this would manifest as a reduction in intracellular bacteria, as is 
observed.  Although this second conclusion can be drawn from the data, counter 
evidence exists which suggests that mbfA is not advantageous to B. melitensis strains.   
 
Other lines of evidence counter the principle that mbfA is advantageous to B. melitensis.  
Firstly, from genetic analysis it is apparent that B. melitensis is currently in the process 
of genomic decay and mbfA is being lost from the genome as was detailed in the 
bioinformatics chapter. Clade I B. melitensis strains (including B. melitensis Ether) have 
acquired SNP’s within the mbfA gene, two of which encode for stop codons and 
subsequently render the gene cryptic.  If mbfA were advantageous to B. melitensis is it 
unlikely that a single point mutant resulting in a stop codons introduction would be 
maintained, let alone two.  
 
Secondly, the results from these experiments are based upon the principle that the 
intracellular survival assay is based upon a model.  To this fact, murine macrophages 
are being used as a representative model of human or in wider settings ruminant 
infections. The murine macrophage cell line J774.A1 possesses the G169D point 
mutation within the Slc11a1 (NRAMP1) gene rendering it non-functional, within 
humans and ruminants this mutation is not present and NRAMP is functional. Slc11a1 
represents the major mechanism for host derived nutritional immunity directed towards 
the invading host.  In the absence of Slc11a1 iron is not actively removed from the 
phagolysosome generating an altered environment as to that which is observed in 
humans and ruminants.  Therefore results observed for the requirement of mbfA in 
intracellular survival of both B. suis and B. melitensis may not be a representative 
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model.  
 
To address this concern, RAW264.7 murine macrophages, originally isolated from 
Slc11a1 non-functional BALB/c mice were obtained from Prof. Gunter Weiss (Medical 
University - Innsbruck) (Atkinson and Barton 1999) which have been transfected with 
the pHβA-1-neo plasmid containing either the full-length Slc11a1 cDNA (RAW-37) or 
an antisense-Slc11a1 construct (RAW-21).  
 
The transfection of the functional Slc11a1 gene, with expression driving from the 
human β-actin promoter, will recreate conditions within the murine macrophage more 
representative of that observed in humans and ruminants.  In the presence of 
Slc11a1/NRAMP1 – the requirement for MbfA to maintain cellular viability may be of 
greater requirement.  	
Laurence A. Guilloteau et al. (Guilloteau, Dornand et al. 2003) compared the 
intracellular survival of Brucella melitensis H38S (smooth virulent strain) within the 
RAW264.7 transfectant cell lines R21 (Nramp1 deficient) and R37 (Nramp1 
expressing) provided by C. H. Barton.  Their examinations revealed that there was no 
difference in the replication rates of B. melitensis H38S in the RAW264 transfectants, 
leading them to conclude that “In contrast to infections with Salmonella, Leishmania, 
and Mycobacterium, the expression of the Nramp1 gene appears to be of limited 
importance for the natural resistance of mice to Brucella.” Their work further noted that 
it was only during initial stages (first week) of B. melitensis H38S infection of a 
NRAMP1 resistant mouse that spleen and liver counts were increased compared to a 
NRAMP1 sensitive mouse.  By the second week of infection, no differences were 
observable in bacteria isolated from spleens or livers.  
 
Although this study determined that NRAMP1 was of little importance to the resistance 
of B. melitensis infection in mice, the importance of NRAMP1 in influencing the 
intracellular survival of mbfA encoding Brucella spp. (B. suis or B. abortus) has not 
been examined.  To address this, intracellular survival assays with the	 RAW264.7	transfectant	cell	 lines	R21	and	R37	were	conducted	with	B.	suis	1330	and	B.	suis	ΔmbfA.		
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7.6: Intracellular survival and replication of B. suis and B. melitensis in RAW264.7 
NRAMP1 transfectant murine macrophage RAW264.7	-R21	and	-R37	macrophage	cell	lines	were	generously	supplied	by	Prof.	G.	Weiss,	whilst	anti-NRAMP1 antibodies were supplied	by	Dr. H. Barton.  Prior to 
conducting macrophage survival assays with Brucella, the NRAMP1 status of the 
transfectant cell lines was determined via Western blotting.  The anti-NRAMP1 
antibodies supplied were generated to amino acids 1-54 of the murine NRAMP1 
(Slc11a1) protein sequence, and were routinely used at a dilution of 1:1000 (Atkinson 
and Barton 1999). 1x106 macrophage cells were collected from RAW264.7 R21 and 
R37 cell lines, as well as from the J774.A1 macrophage cell line used previously.  
Whole cell lysates were prepared for each cell line through passage of the cell solution 
in SDS-PAGE buffer through a syringe (advise was given not to boil samples before 
analysis as NRAMP1 would aggregate and not separate during electrophoresis), before 
separation by SDS-PAGE and immuno-blotting (Figure 7.10).  It is of note that 
NRAMP1 is glycosylated, and hence results in a non-distinct band upon immuno-
detection.  
 								
 
Figure 7.10: Western blot identification of NRAMP1  
Immuno-detection of NRAMP1 from J774.A1, RAW264.7-R21 and RAW264.7-R37 
macrophages.  NRAMP1: 90-100 kDa. 
 
An approx. 100 kDa product, consistent with the presence of NRAMP1 was only 
observed from RAW264.7-R37 macrophage.  This confirms the genotype of both 
J774.A1 and RAW264.7-R21 as NRAMP1 deficient, whilst RAW264.7-R37 as 
NRAMP1 expressing.  
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Macrophage survival assays conducted with transfectant	 RAW264.7	 murine	macrophages	 where	 conducted	 in	 the	 same	 way	 as	 was	 described	 for	 J774.A1 
macrophages assays, with one exception; geneticin G418 was included at a 
concentration of 0.5 mg/ml within DMEM during propagation of macrophages to 
provide selective pressure to ensure the maintenance of the pHβA-1-neo harboring the 
antisense- or sense-Slc11a1 cDNA.  
 
Analysis of the intracellular survival of B. suis 1330, ΔmbfA and pmbfA, as well as B. 
melitensis 16M and pmbfA were compared in RAW264.7 R21 and R37 macrophages 
simultaneously (Figure 7.11).   
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Figure 7.11: Intracellular survival and replication of B. suis 1330, B. melitensis 
16M and derivative strains in RAW264.7 R21 and R37 macrophages.  
1 x 105 RAW264.7 R21 and R37 macrophages were infected at an MOI of 100:1, at 
indicated times post-infection macrophages were lysed and the number of intracellular 
brucellae determined by serial dilution, plating and culture. (A) Survival and replication 
of B. suis 1330 ΔmbfA and pmbfA in R21 macrophage, (B) B. suis 1330 ΔmbfA and 
pmbfA in R37 macrophage, (C) B. melitensis 16M and pmbfA in R21 macrophage and 
(D) B. melitensis 16M and pmbfA in R37 macrophage, (E) B. suis 1330 and ΔmbfA in 
R21 and R37 macrophages. The results are averages of n = 3 technical replicates and n 
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= 3 biological replicates ± the standard deviation at each time point and analysed using 
an unpaired, two tailed Student’s t-test. 
 
The replication profiles of all B. suis, B. melitensis and derived mbfA mutant and 
complemented strains examined in RAW264.7-R21 macrophages were directly 
comparable to those observed in J774.A1 macrophages.  This is expected, as both cell 
lines are Nramp1 deficient – this observation acted as a control as it ensured that the 
results observed in RAW264.7-R37 macrophages was comparable with previous 
intracellular survival observations.  In contrast, the intracellular survival of B. suis, 
derived mbfA mutant and complemented mutant strains, when examined in RAW264.7-
R37 macrophages (Nramp1 encoding) were significantly hampered compared to that of 
Nramp1 deficient macrophages. 
 
Comparing the number of viable B. suis cells, from all strains, that entered R21 and R37 
macrophages (survival at T0) revealed no significant difference in Brucella infectivity. 
At T0, R21 macrophages presented with 9.3 x 103 bacterial cells/well compared to 8.5 x 
103 cells/well with in R37 macrophage, a difference of 8.8%.  This demonstrates that 
Nramp1 genotype does not alter Brucella entry into macrophage and all strains present 
with the same infectivity.  
 
The presence of NRAMP1, within the phagolysosome, decreases B. suis intracellular 
survival in all wild-type and derived strains compared to when NRAMP1 is absent, 
during early phases of macrophage infection (T4 and T24).  Significantly, the largest 
reduction in viable intracellular cells resulted when mbfA is absent from B. suis (Figure 
7.11 E).   
 
A reduction of 16.8 % in viable B. suis 1330 cells (p = 0.0241) is observed when 
comparing R21 to R37 macrophages after 4 hours; this increases to a 33.9 % reduction 
(p = 0.0642) after 24 hours.  No significant difference is observed after 48 hours, as 
numbers of viable B. suis differ only by 6.67 %.  This is suggestive that the presence of 
NRAMP1 is detrimental to the survival of Brucella cells during transit of the bacterium 
from the phagolysosomal-associated eBCV to the ER-associated rBCV, as is observed 
through decreases in viable Brucella between 4 and 24 hours, time points when 
Brucella are known to be associated with this cellular compartment.  It is of note that 
wild-type and complemented B. suis mbfA mutant present equivalent intracellular 
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survival from four hours after engulfment, 6.7 x 103 and 5.6 x 103 respectively (16.8 % 
difference) to 48 hours after engulfment, 3.9 x 104 and 4.2 x 104 respectively (6.7 % 
difference).  This displays effective expression of mbfA in trans from the pBBR-4 
plasmid, functionally complementing the deletion of mbfA in the constructed mbfA 
mutant.  
 
When mbfA is removed from the B. suis genome, much larger decreases in viable cell 
counts are observed when comparing R21 to R37 macrophages throughout the assay, 
from T4 to T48.  After 4 hours a 63.7 % reduction (p = 0.0004) in B. suis ΔmbfA viable 
cells is observed when comparing counts from R21 to R37, this decreases to a 46.3 % 
reduction by 24 hours (p = 0.0294) and 43.8 % by 48 hours post infection (p = 0.0378).  
Taken together these viable cell counts display a significant reduction in B. suis 
intracellular survival when located in the phagolysosome with Nramp1 expression in 
the absence of mbfA.  This bactericidal effect is mediated by NRAMP1; exporting iron 
from the phagolysosome promotes conditions where hydrogen peroxide is able to 
accumulate to a concentration where sufficient quantities can ingress into the Brucella 
cell. The subsequent creation of free radicals leads to cellular damage and loss of 
cellular viability, this effect is exasperated by the deletion of mbfA from B. suis as 
NRAMP1-dependent export of iron progresses without competition from the export of 
iron by MbfA. .This therefore, provides evidence for the hypothesis that MbfA 
functions to aid B. suis viability within the phagolysosome though export of iron and 
acts as a virulence factor for B. suis. 
 
This observation is not repeated in B. melitensis however.  As with B. suis, there is no 
significant difference with the number of B. melitensis able to enter macrophages.  But 
as with observations made with J774.A1 macrophage, more B. melitensis bacteria were 
able to enter RAW264.7 cells than B. suis strains, at an average of half a log increase.  
In contrast to B. suis, the presence of NRAMP1 within RAW264.7 macrophages was 
not detrimental to the intracellular survival of B. melitensis 16M (smallest p value over 
four time points comparing R21 to R37 B. melitensis 16M viable cells = 0.451). This 
observation is in agreement with those collected by Guilloteau et al. (Guilloteau et al. 
2003) who determined that “there was no difference between in vitro replication rates of 
B. melitensis H38S in Nramp1 RAW264 transfectant macrophages”.  The authors 
conclude that the Nramp1 gene of little importance for the natural resistance of mice to 
Brucella melitensis, this is in contrast infections with Salmonella, Leishmania, and 
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Mycobacterium where the presence of Nramp1 is detrimental to intracellular survival. 
 
 
 
The complementation of B. melitensis 16M with B. suis mbfA (pBBRmbfA) yielded 
significant increases in the survival of intracellular bacteria at T4 and T24 in both R21 
and R37 macrophages when compared to wild-type B. melitensis (naturally cryptic 
mbfA).  No differences were present when comparing across macrophage strains, 
suggesting that MbfA provides a growth advantage during early macrophage infection 
which is not NRAMP1 dependent.   
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7.7: Role of mbfA during B. suis infection of mouse  
 
To determine if the reduced intracellular survival of B. suis ΔmbfA within cultured 
murine macrophages results in a reduction in virulence, an in vivo study was conducted. 
The mouse model is widely used to assess the virulence of Brucella spp. and derived 
mutants, and was employed in this instance.  The colonization of the spleen, liver and 
blood was compared within mice infected with either B. suis 1330 or B. suis ΔmbfA 
over an 8 week period.  
 
Experimental infection in the murine model with Brucella spp. results in a chronic 
infection that can routinely be maintained for up to 12 weeks (Nymo et al. 2016) but 
can persist for up to 6 months (Enright et al. 1990). In general, Brucella infection can 
occur via the digestive or inhalation routes, and upon crossing the respective mucosal 
barrier the organisms are able to reach regional lymph nodes.  Bacterial replication 
occurs within macrophages and a bacteremic phase of infection must follow to allow 
colonization of the spleen and liver, establishing a systemic and persistent infection.  
Experimental infection of mice occurs mostly through three routes: intraperitoneal, 
digestive and nasal (aerosol), with the intraperitoneal (IP) route being the most 
frequently used in published literature. The IP route of infection establishes a persistent 
infection with rapid systemic distribution and high bacterial loads in the liver and spleen 
(Grillo et al. 2012), this method of bacterial delivery was used in this study.  
 
The replication profile of a Brucella infection in the mouse model can be divided into 
four separate and distinct phases (Grillo et al. 2012). First, the onset of the infection is 
marked by colonisation of the animal in the first 48 h post infection.  Secondly, an acute 
phase of infection presents, extending from approximately the third day post infection 
to the time point at which colony forming units (CFU) reach a maximum, generally 
between 2 and 3 weeks.  Next, a chronic infection phase, which correlates to a plateau 
in CFU that can last up to 8 weeks.  Finally, a chronic-declining phase, which as 
previously stated may last up to 6 months post infection; during this period a slow 
elimination of the bacteria occurs.  
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To evaluate the role that MbfA plays in resistance to bacterial killing during 
macrophage engulfment, a comparison between organ colonisation profiles of forty 6 to 
8 week old female BALB/c mice was conducted.  BALB/c mice were obtained from 
Charles River Laboratories UK, and all work was conducted according to the Animal 
(Scientific Procedures) Act 1986.  
 
Mice which had undertaken a 5 day acclimatisation period were challenge by the IP 
route with 5 x 104 cells of the wild type or mutant Brucella suis strains. Five mice per 
group were culled at 1, 2, 4 and 8 weeks post infection. To prepare the inoculum of B. 
suis strains for challenging the BALB/c mice via the IP route, both wild type and 
mutant strains were grown on Brucella agar for 2 days at      37 °C. Trial inoculums 
were prepared to determine a relationship between the optical density of suspended cells 
against CFU/ml (Figure 7.12).  It was determined that Brucella cells harvested into PBS 
and adjusted to a standardized optical density of 0.005 would correspond to a challenge 
dose of approx. 5 x 104. Enumeration of the final challenge dose revealed that 7.0 x 105 
CFU/ml were present for B. suis 1330, and 7.9 x 105 CFU/ml for B. suis ΔmbfA.  
Optimum challenge dose was 5 x 105 CFU/ml (5 x 104 CFU/0.1 ml). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.12: Standardisation of colony-forming unit numbers to optical density. 
Enumeration of CFU from decreasing optical densities of B. suis 1330 (black) and B. 
suis ΔmbfA (red) cultures. Black dot, B. suis 1330 (black line) challenge dose; red dot, 
B. suis ΔmbfA (red line) challenge dose; blue dot, target challenge dose.   
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Following inoculation, five mice per experimental group were culled at 1, 2, 4 and 8 
weeks post-infection. Each mouse was terminally anaesthetised by inhalation of 
halothane prior to collection of blood via cardiac puncture followed by culling by 
cervical dislocation, a schedule 1 method.  Subsequently, post-mortems were conducted 
to allow for the collection of the spleen and liver. Each organ was weighed then 
homogenized in PBS with 0.1% Triton X-100, serially diluted and plated to enumerate 
viable Brucella at each time point.  
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Figure 7.13: Spleen, liver and blood bacterial counts and organ weights.   
Log bacterial counts per organ per gram for B. suis 1330 (black) and B. suis ΔmbfA 
(red) in spleens, livers and blood of BALB/c mice after intraperitoneal (IP) inoculation 
of 5x104 colony forming units (CFU) of bacteria, along with organ weights for 
corresponding samples. The asterisk (*) denotes a statistically significant difference as 
determined by a Student’s t-test (P < 0.01).  Dotted horizontal line indicates ‘normal’ 
weights for uninfected controls, and horizontal bars indicate average (mean) values.  
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Figure 7.14: Comparison of bacterial counts and organ weights for spleen and 
liver.   
Data are derived from the figure above. Average organ weights (broken lines) and 
average log bacterial counts (solid lines) for B. suis 1330 (black) and B. suis ΔmbfA 
(red) in spleens and livers of BALB/c mice.  Results are expressed as means ± one 
standard deviation. The asterisk (*) denotes a statistically significant difference as 
determined by a Students T-test (P < 0.01) for average log bacterial counts. 
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The number of ΔmbfA bacteria recovered from the spleen, liver and blood were 
consistently significantly less than the numbers obtained for the wild-type strain from 
14 days post-infection onwards.  This therefore suggests that mbfA is required for 
virulence of B. suis in the murine model. It should be noted that the reduced B. suis 
ΔmbfA survival after 14 weeks compared to the wild-type was achieved despite a 
slightly higher inoculum used for ΔmbfA (11.4% higher CFU count) than that for WT.  
 
Supplementary to this primary observation, the organ weight data gathered reveals a 
peak in both liver and spleen weights at 14 days post infection, with a 9.1 times increase 
in mean spleen weight for B. suis 1330 and 7.4 times increase for B. suis ΔmbfA 
compared to the average, uninfected spleen weight (0.08 g).  Similar observations were 
made for the liver, an increase in weight of 1.73 times was observed with infection with 
B. suis 1330 and 1.60 times increase for B. suis ΔmbfA compared to the average, 
uninfected liver weight (1.1 g).  The inflammation of the liver was accompanied by a 
pale colouration, compared to normal healthy tissue.  It should be noted that there is a 
greater likelihood of variation between liver weights due to difficulties in isolating the 
entire organ during post-mortem.  The multi-lobed nature of the liver renders it difficult 
to ensure that all lobes are excised, generating the possibility that the whole liver will 
not have been removed.  Despite this technical limitation, the standard error between 
samples was not excessively high.  
 
Over the first two weeks post-infection, the B. suis ΔmbfA strain gave a lower number 
of recoverable cells from the spleen, with respect to those recovered for the wild-type 
strain (B. suis ΔmbfA 2.495 log reduction with respect to the inoculum; B. suis 1330 
1.688 log reduction).  Over the 4 and 8 weeks post infection period, the numbers of 
recoverable viable cells from the spleen remained relatively constant for both strains, 
although reductions in CFU’s were still seen in the liver, with the B. suis ΔmbfA strain 
again displaying a greater reduction which culminated in clearance of this strain from 
the liver by 8 weeks post infection, whereas the wildtype remained present at 1.9x102 
cells/g.  The infection pattern seen in the spleen resembles that previously reported with 
an initial ‘acute phase’ giving a peak recovery (seen at 7 days here), followed by a 
chronic phase with a CFU plateau that lasts ~10 weeks.  A final ‘chronic decline phase’ 
can last more than 36 weeks and so would not be observed in the data provided here 
which does not extend beyond 8 weeks (High et al. 2007). 
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Previous reports have shown that the spleen and liver are the most infected organs in 
mice following challenge with virulent smooth Brucella species (Grillo et al. 2012), 
with one-two logs lower CFU/g in the liver than the spleen (Cheers and Cone 1974), as 
seen above.   The infection level is reported to be consistently higher in the spleen and 
infection is usually cleared from the liver after 3-4 weeks (Pardon and Marly 1976), 
although here the wildtype remained associated with the liver even at 8 weeks.  It is 
thought that the spleen protects the liver from major infection since the level of liver 
infection is greatly increased when the spleen is removed (Braude and Spink 1951). 
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In addition to the examination of CFU’s within murine organs, recordings were made of 
individual mouse weights (g) on each day post-infection (weekdays only) as well as one 
day prior to infection (Figure 7.15).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.15: Average change in mouse weight following infection with wildtype 
and MbfA-deficient B. suis.   
Average increase in whole animal weight of B. suis 1330 and B. suis ΔmbfA infected 
BALB/c mice (n = 40) over the 8 week post infection period. Five mice from each 
group were culled at day 7, 14, 28 and 56. Results are expressed as means ± one 
standard deviation.  
 
The average animal weight increase for B. suis 1330 and B. suis ΔmbfA infected 
BALB/c mice was not significantly different, despite the significantly decreased 
recovery of B. suis ΔmbfA from infected mice.  This result represents the chronic and 
non-lethal model that the mouse represents in terms of Brucellosis disease.  Infection 
with wild type, virulent B. suis did not cause weight loss or significant decreasing in 
weight increase over time.  The average absolute weight of mice infected with B. suis 
1330 one day prior to infection was 19.57 g whilst mice infected with B. suis ΔmbfA 
was 19.70 g, with the average weight after 8 weeks post infection being 21.84 g for B. 
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suis 1330 and 22.64 g for B. suis ΔmbfA (Figure 7.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.16: Average absolute mouse weight following infection with wildtype and 
MbfA-deficient B. suis.   
Average increase in absolute whole animal weight of B. suis 1330 and B. suis ΔmbfA 
infected BALB/c mice (n = 40) over the 8 week post infection period. Five mice from 
each group were culled at day 7, 14, 28 and 56. Results are expressed as means ± one 
standard deviation.  
 
Absolute average animal weights reflect those of changes in animals weights, with a 
steady increase over the 8-week infection period.  However, it is of note that on 
average, B. suis ΔmbfA infected mice was consistently heavier than B. suis 1330 
infected mice. This observation indicates that, despite randomisation of mice receiving 
inocula, heavier mice were inoculated with B. suis ΔmbfA, rather than any effect of the 
mbfA mutation on body weight. 
 
Supplementary to the recording of whole animal weights, the animal’s general condition 
was examined for indications of distress and clinical signs indicative of disease.  A 
score was assigned to each animal each day post-infection; if observations indicated that 
the animal was succumbing to the infection, actions could then be taken to cull the 
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animal at a humane end-point.  During this study, 16 animals displayed minor clinical 
signs (visible starring around the neck) for a maximum of 1 day only during the entire 
course of the infection.  These minor symptoms further support the chronic and non-
lethal infection that Brucellosis presents in the murine model.  
 
Taken together, the data collected from whole animal weights, clinical signs, organ 
weights and CFU’s per organ, support the hypothesis that mbfA is required for optimal 
virulence of B. suis in the murine model.  
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7.8: Discussion 
 
In summary, experiments reported in this chapter included the creation of B. suis 1330 
and B. melitensis 16M mbfA deletion mutants, in vitro growth assays, macrophage 
survival assays and in vivo virulence assays.  Together these experiments have provided 
evidence that mbfA is required for efficient intracellular survival of B. suis 1330 in 
macrophages and for full virulence of this organism in mice.   
 
The creation of B. suis 1330 and B. melitensis 16M mbfA deletion mutants was achieved 
via the delivery of a suicide plasmid harboring an in frame deletion of the mbfA gene, 
substituted with a kanamycin resistance cassette. Targeted PCR and Sanger sequencing 
techniques were then used to confirm the genotypes of the deletion mutants.  Upon 
confirmation of the B. suis 1330 and B. melitensis 16M ΔmbfA strains, in vitro 
characterisation of the resistance to hydrogen peroxide and ferrous sulphate was 
conducted through comparison of growth curves.  The deletion of mbfA from the B. suis 
genome resulted in significant reduction in culture optical density upon exposure to 
H2O2 or FeSO4 when compared to the wildtype strain or a complemented mutant strain. 
In contrast, deletion of mbfA from the B. melitensis genome did not result in any 
attenuation in growth compared to the wildtype strain highlighting the cryptic nature of 
mbfA in B. melitensis strains.  Complementation of either wildtype B. melitensis (cryptic 
mbfA) or the engineered mutant (ΔmbfA) with the functional mbfA from B. suis resulted 
in significantly increased resistance to both to H2O2 and FeSO4.  It was observed that B. 
melitensis strains are slower growing in broth culture, but are more resistant to ferrous 
iron related oxidative stress than mbfA-encoding B. suis.  To support these observations, 
immuno-detection of MbfA was conducted; MbfA was detected with exposure to H2O2 
or FeSO4 in strains with functional MbfA, but was absent when H2O2 or FeSO4 was 
removed or when mbfA was deleted or cryptic.  
 
To determine if mbfA contributed to the intracellular survival within macrophages of 
Brucella spp., enumerations of viable Brucella cells over 48 h were made in J774.A1 
(NRAMP1-) as well as RAW 264.7 (NRAMP1+/-) murine macrophages.  In summary, 
deletion of mbfA from B. suis resulted in significant attenuation of intracellular survival 
in NRAMP1- macrophages (J774.A1/RAW 264.7 - R21).  Despite the natural lack of 
mbfA expression in B. melitensis intracellular growth was observed but was increased 
when a functional copy of mbfA was supplied.  When enumerations of viable cells were 
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conducted from NRAMP1+ macrophage (RAW 264.7 - R37), a greater attenuation in 
intracellular growth was observed with the deletion of mbfA in B. suis compared to 
NRAMP1- macrophages.  This experiment demonstrated that the deletion of mbfA from 
B. suis results in an attenuation of survival and replication within macrophages. The 
observation that B. suis ΔmbfA yields significantly fewer CFU at 24 and 48 h post-
infection in both NRAMP1+/- macrophages (with significantly fewer in NRAMP1+ 
macrophages) suggests that MbfA protects B. suis 1330 from succumbing to the 
oxidative stress encountered within the eBCV.  Interestingly, the presence of NRAMP1 
is more detrimental to cellular survival in an mbfA mutant than when NRAMP1 is 
absent.  This is consistent with the suggestion that NRAMP1 and MbfA have 
antagonistic roles in moving iron out of, and into, the lumen of the eBCV.  This finding 
suggests that nutritional immunity plays a large role in Brucella survival within the 
phagosome than previously suggested: in the absence of NRAMP1, H2O2-quenching 
iron is not exported from the phagosome lumen and can therefore disproportionate 
hydrogen peroxide, rendering the phagosome less bactericidal. An mbfA mutant strain is 
therefore able to replicate to higher numbers in NRAMP1- than in an NRAMP1-
expressing macrophages since luminal iron levels are higher which in part compensates 
for lack of MbfA activity.  The ability of MbfA to lower H2O2 exposure within the 
eBCV of macrophage by countering the action of NRAMP1, correlates with the reduced 
virulence observed for B. suis ΔmbfA in the murine model.  Experimental infection of 
BALB/c mice with B. suis ΔmbfA resulted in a significant reduction of viable bacteria 
isolated from spleen, liver and blood over time in comparison to wildtype B. suis.  
Notably mbfA deficient B. suis were eliminated from the blood by day 14 post infection 
compared to day 56 for wildtype B. suis, in addition to a reduced splenic colonization 
throughout the infection period.  This highlights the reduced ability mbfA deficient B. 
suis has in surviving intracellularly within splenic macrophages, resulting in fewer 
extracellular Brucella entering the blood.  
 
The murine infection model for Brucellosis research represents a good model of 
infection compared to that seen in the natural host (pig/goat/cow).  However, there are 
differences between experimental infection of mice and disease observed in animal 
hosts and humans, the most notable being that Brucella are not significantly shed during 
infection of mice – reducing horizontal transmission (Grillo et al. 2012).  
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Consideration of the temporal and spatial recruitment of host proteins to the BCV 
during Brucella intracellular life identifies rationales for the requirement of MbfA. 
After phagocytosis of Brucella by the macrophage, Brucella shapes the BCV from a 
phagosomal-like vesicle into an autophagosome/ER-like vesicle where replication 
ultimately takes place.  The BCV interacts with the early endosome characterised by the 
presence of early endosomal markers (Pizarro-Cerda et al. 1998) late endosome (Starr et 
al. 2008) and ER, whilst preventing lysosome fusion (Pizarro-Cerda et al. 1998).   
During initial stages of BCV transit, internalised Brucella experience the respiratory 
burst generated by NADPH phagocyte oxidase (PhoX) as well as exposure to NO 
generated by inducible nitric oxide synthase (iNOS) which produce an antimicrobial 
activity (Jiang et al. 1993) (Figure 7.17). Evidence that Brucella experience the 
respiratory burst was determined by treating macrophages with methylene blue 
(enhances respiratory burst activity). Treated cells experienced increased intracellular 
killing but was reversible through the addition of catalase or superoxide dismutase 
(Jiang et al. 1993). Many intracellular bacteria experience early exposure (minutes to 
hours post infection) to the respiratory burst and NO. In experimental Salmonella 
infections, the respiratory burst and NO radical production contribute significantly to 
the anti-Salmonella activity of the macrophage (Mastroeni et al. 2000, Vazquez-Torres 
et al. 2000), whilst early recruitment of iNOS is also observed in macrophages infected 
with Mycobacterium spp. (Miller et al. 2004). But, NADPH oxidase-dependent killing 
of Salmonella was limited to the initial phase of infection, whereas RNS, generated by 
iNOS, exhibited an extended role in limiting residual bacterial replication through a 
sustained bacteriostatic effect (Vazquez-Torres et al. 2000).  The co-localisation of 
NADPH oxidase and iNOS in the early phagosome (eBCV) enables interaction between 
ROS and RNS which play a synergistic role in bacterial killing as NO can potentiate 
H2O2 killing of bacteria (Pacelli et al. 1995). It is of notable interest that Burkholderia 
cenocepacia, which do not encode mbfA, may combat this synergistic effect by delaying 
the association of NADPH oxidase by approx. 6 h within the B. cenocepacia containing 
vacuole (BcCV) (Keith et al. 2009). 
The NRAMP1 protein is expressed in the membranes of late endosomes of 
macrophages (Blackwell et al. 2000, Forbes and Gros 2001) (Figure 7.17) and is 
thought to function by removing iron into the cytoplasm, conferring resistance to 
intracellular pathogens including Salmonella typhimurium in mice (Fritsche et al. 2012) 
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by reducing available iron for growth. Nramp1 expression was first associated with 
decreased phagosomal iron content by Gomes and Appelberg; 1998 who determined 
that this activity influenced the growth of Mycobacterium avium within the macrophage 
through starvation of the pathogen of iron (Gomes and Appelberg 1998), additionally 
Nramp1 expression resulted in decreased cellular iron loads (Atkinson and Barton 
1998). Since Brucella does not replicate in the eBCV, any lack of iron imposed by 
NRAMP1 is unlikely to exert any starvation effect, instead the removal of iron is 
presumed to favour the preservation of H2O2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.17:  Schematic representation of Brucella intracellular trafficking in 
mammalian cells 
Brucella spp. reside within a vacuole termed the Brucella containing vacuole (BCV) 
which traffics along the endocytic pathway interacting with early endosome (EE), late 
endosomes (LE) and lysosomes (Lys).  Interaction with the lysosome provides cues for 
induction of the VirB T4SS, from which VirB type IV effector proteins redirect the 
BCV to fuse with the endoplasmic reticulum (ER) creating the rBCV.  
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The distinct separation of the recruitment of NADPH oxidase and iNOS before 
NRAMP1 to the BCV may play an important role in the survival of Brucella.  MbfA 
exporting iron in response to Irr-sensed redox stress, as generated by NADPH oxidase, 
allows degradation of peroxide in the BCV lumen, thus enhancing catalase mediated 
disproportionation of H2O2 in the Brucella cytoplasm, which in the presence of iNOS-
generated NO may be inhibited.  As the BCV matures and NRAMP1 is recruited, 
MbfA-dependent iron release will reduce peroxide levels and raise luminal iron levels 
such that the withdrawal of iron by NRAMP1 would be less effective in preserving 
peroxide.  Additionally, iron released by MbfA into the lumen of the BCV could be 
later reabsorbed by Brucella through induction of FtrABCD, once in the rBCV, when 
peroxide levels are diminished, enabling growth to progress.  
 
Despite a proposed rationale for the requirement of MbfA in Brucella spp. it is clear 
that B. melitensis strains are mbfA deficient, but remain virulent.  One explanation for 
the maintenance of virulence of B. melitensis strains is that they transit to the ER faster 
than other Brucella spp..  Experimental infection of JEG-3 trophoblasts with B. abortus 
and B. suis showed residence within single membrane, acidic, LAMP1 inclusions 24 h 
post infection, whilst B. melitensis was located within BCVs positive for calnexin (ER 
marker) (Salcedo et al. 2013).  These observations suggest that B. melitensis may be 
able to move through the phagosomal pathway at an accelerated rate compared to other 
Brucella spp. reaching the replicative niche within the ER sooner.  In addition, B. 
abortus replication rate was slower than that of B. melitensis – suggesting that the ER-
derived BCVs are a more suited niche for Brucella intracellular replication (Salcedo et 
al. 2013). These observations are supported by the experiments displayed in Figure 7.9, 
where B. melitensis 16M was observed to be more infectious in J774.A1 macrophages 
where the bacteria replicated to higher numbers within macrophage than their B. suis 
1330 and B. suis ΔmbfA counterparts. 
 
The lack of mbfA expression in B. melitensis as well as the accelerated transit to the ER-
associated replicative niche compared to B. abortus and B. suis points towards a 
different strategy for redox stress avoidance in B. melitensis.  A quicker transit through 
the eBCV stages within the macrophage allows for a reduced exposure to NADPH 
oxidase, iNOS and NRAMP1, preventing loss of cellular viability.  Additionally, the 
maintenance of cellular iron (lack of export of MbfA) prevents the requirement of iron 
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acquisition before cellular proliferation enabling faster initiation of replication. The loss 
of mbfA does not present a burden to B. melitensis strains, which is the most infectious 
of the Brucella species, possibly because this species possesses other mechanisms for 
countering the redox-stress imposed by macrophages.  
 
Examination of literature detailing the characterization of redox stress relief and iron 
uptake mechanisms allows additional context to be given to role that MbfA plays within 
Brucella and the BCV.  Brucella spp. encode a single periplasmic catalase, a homolog 
of the katE gene of E. coli (haem catalase) (Sha et al. 1994), which is dispensable. 
Although the catalase protects against hydrogen peroxide supplied in vitro, a B. 
melitensis deletion mutant retains full virulence in the natural host (Gee et al. 2004).  As 
NO is expected to inhibit haem catalases during Brucella localization in the BCV, 
rendering it non-functional, deleting the gene may have no impact on virulence.  
However, in vitro experiments, conducted in the absence of NO, show that catalase 
functions as expected.  In addition, the examination of a katE and ahpC double mutant 
in B. abortus (Steele et al. 2010) suggests that B. abortus can degrade hydrogen 
peroxide without the expression of the major respiratory antioxidants, catalase and alkyl 
hydroperoxidase.  This therefore suggests that additional enzymes are present within 
Brucella spp. that are able to degrade hydrogen peroxide, thus providing speculative 
evidence for MbfA activity. 
 
In addition to catalase, Brucella spp. express two superoxide dismutase, a cytoplasmic 
Mn-SOD (sodA) (Sriranganathan et al. 1991) as well as, a periplasmic Cu-Zn SOD 
(sodC) (Stabel et al. 1994).  Both SodA and SodC were identified independently as 
being required for intracellular survival of B. abortus during early stages of infection in 
macrophages (Gee et al. 2005) (Martin et al. 2012), but in isolation were not required 
for full virulence in vivo (Latimer et al. 1992, Tatum et al. 1992).  This suggests that 
redundancy between the two SODs is experienced, masking the effect of a single 
deletion in vivo, but also that SOD is required primarily during the early stages of BCV 
inhabitation due to the temporal recruitment of NADPH oxidase to the BCV; once 
within the rBCV exposure to redox stress is limited. 
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Chapter 8:  Discussion 
 
8.1:  Summary of experimental observations 
In summary, the experimental findings of this thesis detail the role that a novel iron 
transport system, MbfA, plays in Brucella pathogenicity and intracellular survival.  
 
Bioinformatical analysis of the mbfA sequence from Brucella suis 1330 identified that 
the protein was organized into an N-terminal erythrin domain and a C-terminal, 
membrane embedded (vacuolar iron transporter) Vit1 domain.  Examination of 
additional bacteria phyla for examples of MbfA-like sequences revealed that four 
distinct variants of the MbfA protein were encoded by both prokarya and eukarya, and 
that the five transmembrane helix organization of the VIT domain was extensively 
conserved.  A closer examination of the mbfA sequence from Brucella spp. identified 
that B. melitensis strains had acquired one or, in some cases, two SNPs, introducing stop 
codons to the sequence rendering mbfA in these strains cryptic. Analysis of the upstream 
region of DNA from the mbfA start codon showed high sequence similarity to the iron 
control element (ICE) box, allowing predictions to conditions in which mbfA is 
expressed in Brucella.  
 
The first experimental steps taken were to clone the mbfA gene from B. melitensis 16M 
into a high copy number plasmid for further manipulations.  Due to the presence of 
interfering SNPs in the B. melitensis mbfA sequence, site directed mutagenesis (SDM) 
was used to revert the mutations regenerating the mbfA sequence found in B. suis.  The 
B. suis variant of the mbfA gene was cloned into controllable expression vectors 
(rhamnose, arabinose and IPTG) to enable the observation of phenotypes in E. coli 
strains.  Additionally, suicide and complementation vectors were generated to enable 
the deletion of mbfA from the B. suis and B. melitensis genomes by replacement with a 
kanamycin cassette. The soluble erythrin domain was cloned into a T7 RNA 
polymerase promoter containing plasmid to enable the overexpression and subsequent 
extraction of recombinant protein. 
 
Creation of the pET plasmid harboring the erythrin domain from mbfA enabled the 
generation of sufficient quantities of recombinant erythrin protein to facilitate its 
purification by chromatographic methods.  The incorporation of a C-terminal His-tag 
enabled initial purification of erythrin by nickel affinity chromatography, which was 
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followed by anion exchange chromatography to yield high concentrations and 
homogeneity of erythrin.  The purified homogenous erythrin protein allowed further 
experiment, including: the generation of polyclonal antibodies in rabbits, facilitating the 
immune-detection of MbfA in E. coli and Brucella. Also, the formation of apo-erythrin 
(metal free) through the chelation of bound metals, which were subsequently removed 
by dialysis, enabling the recreation of a di-iron form of erythrin through the titration of 
ferrous iron.  The di-iron centre of the erythrin was first characterized by ICP-OES and 
ESI-MS spectroscopy techniques, which confirmed the association of two iron atoms 
per protein monomer. This in turn allowed the examination of the reduction (sodium 
dithionite) and oxidation (hydrogen peroxide) of the di-iron centre spectroscopically at 
360-480 nm. Thermal shift assays indicated that, in addition to iron, zinc, manganese 
and cadmium were also able to bind the di-iron binding site.  This knowledge facilitated 
directed attempts to generate protein crystals; crystallization trials were conducted on 
iron, manganese and zinc centred erythrin. 
 
The first experimentation conducted with B. suis mbfA was with the controllable 
expression vector pBADrham transformed in E. coli. Phenotypes were observed, 
consistent with the export of iron through the expression of mbfA, in an E. coli strain 
deficient in all iron acquisition mechanisms (E. coli JC28), an E. coli fur mutant (E. coli 
H1941) and an E. coli catalase/alkyl hydroperoxidase mutant (E. coli LC106).  This 
supported the notion that MbfA affords Brucella spp. increased intracellular survival 
capacity through exporting iron to counter redox stress.  To determine whether mbfA 
expression influenced the intracellular iron content of the E. coli strains, resistance to 
streptonigrin was used as a probe.  Streptonigrin is an iron dependent antibiotic, thus, 
increased resistance to streptonigrin upon mbfA expression would represent a removal 
of reactive intracellular iron.  In all examined E. coli strains, expression of mbfA 
increased resistance to streptonigrin highlighting the proposed function of MbfA.  
 
To quantitatively measure the efflux of iron by MbfA, a protocol was developed to 
utilize the sensitivity of detection of the radioisotope 55Fe by liquid scintillation 
counting.  The presence of 55Fe in cellular supernatants collected after expression of 
mbfA from wildtype E. coli represented effluxed intracellular iron by MbfA.  The rate of 
iron efflux of iron was observed to be biochemically controlled by the presence of 
hydrogen peroxide.  During aerobic respiration H2O2 is generated which then facilitates 
iron export by MbfA, however, when additional H2O2 was introduced the iron export 
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rate increased, conversely, when an additional catalase was added, consuming H2O2, the 
rate of iron export reduced. This was further demonstrated by culturing E. coli 
anaerobically, which prevented the generation of hydrogen peroxide thus eliminating 
iron export. This series of experiments highlighted the combined roles that the erythrin 
and Vit1 domains play in MbfA, facilitating iron export.  Results suggest that an 
electron from intracellular ferrous iron is likely removed to facilitate the reduction of 
hydrogen peroxide at the di-iron centre of the erythrin domain; the oxidized iron atom is 
then translocated across the membrane.  In the absence of hydrogen peroxide, the 
electron flow from the iron waiting to be exported is interrupted and export is 
prevented.  This biochemical control ensures that the scares iron resources of the cell 
are maintained in the absence of redox stress and that export is only initiated when 
damaging H2O2 is present.   
 
To investigate this system in more detail, the erythrin and Vit1 domains of MbfA were 
separated from one another and expressed in isolation.  No iron export was observed in 
either case, supporting the evidence acquired previously that both domains are required 
for iron transport.  Despite this, the vacuolar iron transport system (VIT1) of A. thaliana 
and P. falciparum are reported, as well as hypothetically, type II mbfA like proteins, to 
facilitate iron transport whilst lacking an erythrin domain. To examine the mechanism 
of iron transport by VIT1, A. thaliana VIT1 was codon optimized and cloned into an 
inducible vector, enabling expression in E. coli, and thus quantitation of 55Fe export.  
No biochemical control of VIT1 was observed as iron was exported constitutively 
during all manipulations of hydrogen peroxide concentrations.  The proton motive force 
was found to facilitate the translocation of iron by this system as titration of the 
protonophore CCCP greatly reduced iron export, whilst little impacting MbfA activity.  
Colorimetric quantification with the ferrous iron specific chelator ferrozine enabled 
determination of the redox state of the exported iron; ferric iron was exported by MbfA 
but ferrous iron by VIT1, reflecting the involvement of an oxidation step in export of 
iron by the MbfA system.  
 
From initial phenotypic examinations of mbfA expression it was observed that MbfA 
was able to protect against hydrogen peroxide induced redox stress. A colourmetric 
Amplex Red hydrogen peroxide assay was used to monitor the rapid disproportionation 
of H2O2 by wildtype E. coli and lack of such activity in a catalase/alkyl 
hydroperoxidase deficient strain (E. coli LC106).  This formed the experimental basis to 
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examine the ability of MbfA to facilitate H2O2 degradation.  Expression of mbfA in E. 
coli LC106 resulted in H2O2 degradation, but the relative contributions afforded by 
reduction at the erythrin domain and the degradation of extracellular peroxide by 
exported iron were unknown.  To resolve this, the extracellular ferric iron chelator 
desferrioxamine was added to quench extracellular iron allowing quantitation of 
hydrogen peroxide reduction at the erythrin domain to be calculated; up to 80% of 
hydrogen peroxide disproportionation was facilitated by exported iron Fenton reactions.  
 
With a detailed understanding gained of the mechanism that MbfA utilizes to export 
iron and afford resistance to hydrogen peroxide, the role that nitric oxide plays within 
the phagosome of the macrophage in inhibiting bacterial catalase/hydroperoxidase was 
investigated.  In isolation, addition of either H2O2 or NO presented with no growth 
reduction for E. coli MG1655, however when added together a synergistic killing effect 
was observed possibly through the inhibition of catalase/hydroperoxidase; this effect 
was markedly reduced with the expression of MbfA.  This observation demonstrates a 
mechanism for intracellular survival within the phagosome as NO inhibition of catalase 
can be circumvented by expression of mbfA, reducing hydrogen peroxide that would 
otherwise accumulate and cause cellular damage.  
 
Although export of iron by MbfA is unique in terms of mechanism and biochemical 
control, it is of acknowledgement that recent work conducted with the Gram-positive 
bacteria Bacillus subtilis and Listeria monocytogenes has identified an ATPase system 
specific for export of iron (Guan et al. 2015 and Pi et al. 2016).  The B. subtilis PfeT 
protein functions as a ferrous iron efflux pump that protects the cell against iron toxicity 
as measured by resistance to the iron dependent antibiotic, streptonigrin.  This evidence 
was supported by the examination of an engineered pfeT deletion mutant, which 
accumulated elevated levels of intracellular iron as determined by ICP-OES (Guan et al. 
2015). Similarly, the L. monocytogenes FrvA protein was shown in vitro to function as 
a divalent cation specific ATPase that was induced with exposure to ferrous iron and 
that complementation of the B. subtilis pfeT deletion strain (Guan et al. 2015) with frvA 
increased resistance to iron (Pi et al. 2016). 
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The first experimentation directly upon Brucella was to generate mbfA deletion mutants 
within B. suis 1330 and B. melitensis 16M; this was conducted by a targeted approach 
removing the mbfA gene and replacing it with a kanamycin resistance cassette. The 
resistance of wildtype and mbfA deficient Brucella spp. to ferrous sulphate and 
hydrogen peroxide was assessed through examination of growth curves and this 
revealed that B. suis ΔmbfA is more susceptible to redox mediated killing than wildtype. 
However, ΔmbfA B. melitensis grew equivalently to the wildtype due to the naturally 
cryptic mbfA encoded by this strain. Complementation of B. melitensis with a functional 
copy of mbfA from B. suis increased resistance to redox stress suggesting that the loss of 
MbfA function in B. melitensis is deleterious under the conditions employed.  Next, the 
intracellular survival of the Brucella stains was examined within NRAMP1- 
(J774.A1/RAW264-R21) and NRAMP1+ (RAW264-R37) murine macrophages.  
Deletion of mbfA from B. suis resulted in significant attenuation of intracellular survival 
in all examined macrophages, but greatest attenuation was observed for the deletion of 
mbfA in B. suis in NRAMP1+ macrophages.  In support of this, experimental infection 
of BALB/c mice with B. suis ΔmbfA resulted in a significant reduction of viable 
bacteria isolated from spleen, liver and blood over time in comparison to wildtype B. 
suis.   
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8.2: MbfA promotes Brucella intracellular survival and is required for virulence 
Many bacterial species, including Brucella, have an absolute requirement for iron; its 
acquisition during host colonization is paramount in enabling virulence and 
propagation.  Brucella spp. are able to acquire iron from multiple sources, including: 
ferric iron – acquisition mediated by the siderophores 2,3-dihydroxybenzoic acid 
(DHBA) and Brucebactin, as well as ferric chelates; ferrous iron - acquisition via the 
high affinity FtrABCD system; and haem, via BhuATUV.  In vivo studies have 
elucidated that the high-affinity ferrous iron and haem transport systems which are fully 
expressed during stationary phase during location in the rBCV are absolutely required 
for virulence during chronic infection; deletion of ftrA (periplasmic ferrous iron binding 
protein) or bhuA (OM haem transporter) in Brucella abortus result in attenuation in 
macrophage and mouse models (Paulley et al. 2007, Elhassanny et al. 2013).  However, 
ferric iron acquisition systems are dispensable as siderophore-iron import systems are 
not required for replication in macrophages or for chronic infection of BALB/c mice 
(Bellaire et al. 1999), as was demonstrated with an entC (isochorismate synthase – 2,3-
DHBA synthesis) mutant.  This lack of requirement for ferric-iron import can be 
attributed to the niche that Brucella species occupy within the host; the reduced nature 
of the intracellular environment and the low pH of the BCV (Gonzalez Carrero et al. 
2002) would be expected to favour the ferrous iron oxidation state over the ferric state, 
rendering ferric uptakes systems redundant.  
 
Iron homeostasis is regulated by the iron response regulator (Irr) in Rhizobiales of the 
alpha-proteobacteria including Brucella spp.; Irr promotes the transcription of iron-
uptake genes in response to low iron concentrations, and represses their expression in 
response to high intracellular iron and oxidative stress (Yang et al. 2006).  During iron 
replete conditions, expression of iron storage (bfr) and export (mbfA) genes is 
stimulated to maintain iron concentrations within tight parameters (Jaggavarapu and 
O'Brian 2014).   The ability for Brucella spp. to not only store iron, but also to export 
excess free intracellular iron, represents a novel mechanism for maintaining iron 
homeostasis and combating redox stress.  The export of iron by MbfA allows rapid 
counteraction of oxidative stress imparted though the processes such as the respiratory 
burst of the macrophage, thus promoting survival.  This mechanism enables utilisation 
of intracellular iron to directly combat the toxicity exerted by H2O2 in the external 
environment, increasing likelihood of survival under redox-stress conditions.  
 
Chapter 8 
 
 
234 
The results described in this thesis have enabled a new hypothesis for the function of 
MbfA in Brucella spp. to be established.  MbfA acts to export intracellular iron from 
the Brucella cell in a hydrogen peroxide dependent manner.  The MbfA-mediated 
export of iron is controlled both genetically and biochemically. The genetic control is 
through the de-repression of mbfA expression by Irr, which is degraded when cellular 
iron concentrations are high or upon exposure to hydrogen peroxide (Yang et al. 2006); 
the biochemical control is achieved as iron export is driven by hydrogen peroxide 
reduction at the erythrin domain (Chapter 6.7).  These two levels of control would be 
expected to allow Brucella to exert great control over the rate at which iron, an essential 
micronutrient, is released from the cell.   
 
Iron export by MbfA involves oxidation of intracellular ferrous iron to the ferric form; 
this redox reaction is believed to involve the release of an electron from Fe2+ (during 
export to the periplasm) which is then used for the reduction of hydrogen peroxide to 
water.  This mechanism would be expected to lower the concentration of both total 
intracellular iron and free cytosolic iron, which has the propensity to initiate Fenton 
chemistry generating damaging radicals, when hydrogen peroxide is present.  MbfA’s 
action of exporting iron further aids redox-stress resistance during the intracellular 
survival of B. suis in macrophages through several additional means. Exporting iron 
into the eBCV lumen acts as a direct counter to the function of NRAMP1.  NRAMP1 
removes divalent metal cations from the phagosomal lumen; the reason for this activity 
is reported to be to generate conditions of nutritional immunity, restricting invading 
bacteria of essential nutrients.  However, as suggested here, the removal of redox active 
metals would also enhance the preservation of hydrogen peroxide within the luminal 
space.  Generation of hydrogen peroxide in the phagosome (and related intracellular 
bodies such as the eBCV) is one of the primary mechanisms of attack against the 
invading bacterium.  As hydrogen peroxide is non-polar it diffuses across all biological 
membranes, therefore its synthesis cannot lead to high concentrations inside cells which 
are found at 2-50 µM in phagosomes (Slauch 2011), a concentration which is below that 
required for bactericidal action (E. coli 15 mM) (Pericone et al. 2000).  Such sub-lethal 
concentrations are maximized through the release of nitric oxide, which acts as a 
potentiator of redox stress through two means: firstly, it stalls haem 
catalases/peroxidases, preventing the degradation of hydrogen peroxide; secondly, it 
reacts with hydrogen peroxide to create toxic peroxynitrite. The removal of iron by 
MbfA can be considered to counter both of these macrophage mechanisms.  Iron 
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removed from Brucella would limit free-radical generation by hydrogen peroxide in 
proximity to sensitive cellular components (e.g. DNA), it would also re-populate the 
phagosomal (or eBCV) luminal space with iron, driving disproportionation of hydrogen 
peroxide (Chapter 6.12).  In summary, the H2O2-driven export of iron into the 
phagosomal/eBCV lumen by MbfA would be expected to directly counter the 
respiratory burst activities of the macrophage by: 
• Reducing intracellular H2O2, 
• Lowering intracellular iron levels, 
• Counteracting the action of NRAMP1 by raising extracellular iron levels, 
• Promoting the disproportionation of hydrogen peroxide outside of the cell, 
preventing ingress into the cell, and 
• Compensating for the inhibition of catalases/peroxidase by NO.  
The above mechanism represents a novel approach for thwarting the innate-immune 
system by a pathogen. It is paramount to the successfulness of Brucella spp. 
pathogenesis that cellular viability is maintained as it transits through its intracellular 
niches in the host macrophage (phagolysosome to ER).  It is evident from in vitro and in 
vivo experimentation that the presence of mbfA in Brucella suis 1330 confers significant 
protection to macrophage-associated killing and survival in the host, allowing greater 
numbers of bacteria to disseminate and maintain infection. 
 
8.3: MbfA contribution to Brucella spp. pathogenesis. 
The primary requisite of a bacterial organism is to propagate.  Although Brucella is able 
to survive and replicate within macrophages, to maximize this propagation, infection of 
the greatest numbers of hosts is desirable, therefore an ability to disseminate to new 
hosts is required.  In the case of Brucella infection, despite significant symptoms, 
pathogenesis of Man is limited and appears to be a “dead-end” in terms of bacterial 
transmission and dissemination.  This is primarily due to the lack of infectivity of 
trophoblasts of the placenta in pregnant individuals and hence ineffective mechanisms 
of transmission from host to host (the major mechanism of spread in animals is by 
contact with infected birthing fluids and tissues).   
 
Brucella utilizes MbfA to survive the ‘nutritional immunity’ and redox stress that are 
imparted as a consequence of inhabiting the phagolysosome (eBCV) of a macrophage.  
Since Brucella does not replicate in the eBCV, any lack of iron imposed by NRAMP1 is 
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unlikely to exert any starvation effect.  The type-4 secretion system (T4SS), a major 
virulence factor of Brucella, allows release of Brucella from the endosomal niche and 
establishment of an ER niche (the rBCV).  During infection of human or non-pregnant 
ruminants, Brucella persists within macrophages of the spleen and represents a chronic 
infectious state (Hanot Mambre et al. 2015).  It is only when a ruminant host becomes 
pregnant that Brucella is able to infect the trophoblasts of the placenta.  The same 
mechanisms of intracellular survival as used in the macrophage are required to transit 
Brucella to the ER of the trophoblast (Salcedo et al. 2013).  However, within the ER of 
trophoblasts (the rBCV), T4SS-induced ER stress causes release of the pathogen, which 
are able to grow to concentrations approaching 1011/g extracellularly, causing acute 
inflammation, resulting in abortion of the foetus.  As a result, dissemination of the 
bacterium is promoted and transmission through the herd is most likely achieved 
through licking of the foetus by other animals (Byndloss and Tsolis 2016). 
 
With this assessment of the pathogenesis of Brucella, the role that MbfA plays in the 
survival of the bacteria during early stages of infection is highlighted.  Encountering 
oxidative stress upon engulfment by professional macrophages during host infection 
represents a preliminary barrier to Brucella establishing a replicative niche in the 
phagosome leading to a chronic infection; the results presented herein show that MbfA 
plays a role in limiting such oxidative stress and promoting the chronic infectious state.  
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Figure 8.1: Schematic representation of Brucella survival in eBCV and rBCV 
Brucella spp. reside within a vacuole termed the Brucella containing vacuole (BCV) 
which traffics along the endocytic pathway interacting with early endosome (EE), late 
endosomes (LE) and lysosomes (Lys) characterizing the eBCV, before T4SS effector 
proteins facilitate fusing with the endoplasmic reticulum (ER) generating the rBCV. 
Top insert depicts interactions between Brucella and the macrophage within the eBCV, 
which is dominated by redox stress imposed by the respiratory burst of the macrophage. 
MbfA acts to compensate for NO-inhibited catalase/alkylhydroperoxidase by exporting 
iron to catalyse peroxide disproportionation in the eBCV lumen. Bottom insert depicts 
switch of iron metabolism from export to import via FtrABCD and BhuATUV, upon 
relief of redox stress within the rBCV.  Note the role of Irr in reciprocal regulation of 
both MbfA and FtrABCD expression in response to iron and peroxide levels. 
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8.4: Inclusion of MbfA in future vaccine development 
There are currently several licensed live attenuated Brucella vaccines that are available 
for use in livestock.  S19 and RB51 for Brucella abortus, Rev 1 for Brucella melitensis 
and S2 for Brucella suis.  The effectiveness of these vaccines is dependent upon the 
host species and all are virulent in humans.  These limitations present the requirement 
for the development of a vaccine that meets all ideal vaccine characteristics. The ideal 
Brucella vaccine would:  
• be live and induce a strong type 1 helper immune response, would not induce 
antibodies, that interfere with current serological tests, and  
• would be attenuated sufficiently so as not cause disease to animals or humans 
(Ko and Splitter 2003).  
 
The current B. abortus vaccine strain, S19, is a live attenuated strain, but maintains a 
smooth LPS phenotype which induces antibodies that interfere with serological 
examinations of Brucella herd prevalence.  Attenuation is primarily achieved through a 
702 bp deletion located within the erythritol metabolism locus.  Failure of Brucella to 
metabolise erythritol (an energy source found mainly within the placenta of livestock), 
prevents replication of Brucella to extremely high concentrations and thus avoids 
abortion of the foetus. Despite this, immunisation of pregnant cattle by the 
subcutaneous route can result in up to a 3.2% abortion rate (Beckett and MacDiarmid 
1985) and 100% when immunised intravenously (Taylor and MacDiarmid 1949).  To 
avoid complications with serological tests the RB51 vaccine was developed and 
replaced the S19 vaccination in the USA in 1996.  RB51 was developed through 
passage of B. abortus 2308 on sub-inhibitory concentrations of rifampicin and selection 
of rough colony phenotypes.  RB51 was found to be safer to administer to pregnant 
cows intravenously, with a 25% abortion rate, but does not protect cattle against B. suis 
infection (Olsen and Hennager 2010), and is still infectious to humans (Ashford et al. 
2004). 
 
Vaccination against B. melitensis is conducted with the B. melitensis Rev 1 vaccine, a 
live attenuated vaccine created through passage on streptomycin medium until resistant 
clones developed (Elberg and Faunce 1957).  Unlike the RB51 vaccine, Rev 1 
maintains the smooth LPS phenotype and hence interferes with serological diagnosis.  
However, the Rev 1 vaccine is effective in preventing Brucella infection in goats and 
sheep, but this strain is still virulent to humans (Blasco and Diaz 1993).  In addition, the 
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B. suis S2 vaccine, like the Rev 1 vaccine, was developed through serial passage and 
retains the smooth LPS phenotype, yet it remains effective at vaccinating sheep, goats, 
sows and cows against B. suis infection.   
 
Recent vaccine development has focused upon introducing targeted deletions to 
characterised virulence factors followed by testing for loss of virulence in mice. Efforts 
in B. abortus have focused on mutation of purine biosynthesis genes (purL purD and 
purE) (Alcantara et al. 2004), however these deletions did not sufficiently attenuate B. 
abortus.  In contrast, mutation of the lipid A fatty acid transporter (bacA) (Ferguson et 
al. 2004), ferrochelatase (hemH) (Almiron et al. 2001) and type 4 secretion system 
(virB) (den Hartigh et al. 2004) resulted in high attenuation in mice, but efficacy in 
cattle is yet to be assessed.  Similarly, in B. suis, deletion of the aromatic amino acid 
biosynthesis gene (aroC) (Foulongne et al. 2001) results in loss of virulence in mice, 
but efficacy is yet to be determined.  In contrast, deletion of the erythritol metabolism 
gene eryC in B. suis (Burkhardt et al. 2005) did not reduce virulence, therefore this 
mutant is not sufficiently attenuated for investigation in pigs. Lastly, the development of 
rough B. melitensis mutants through the deletion of core and O-polysaccaride synthesis 
genes (wbkF, per and waa) was less effective than Rev1 in sheep. 
 
These efforts summarise the difficulty in establishing a safe and effective vaccination 
against Brucellosis, and highlights the requirement for the identification of addition 
virulence factors which can be targeted during vaccine development. It appears that, in 
isolation, the deletion of a single virulence factor does not yield vaccine efficacy that is 
equivalent or greater than that achieved by a vaccine generated 50 years ago.  It is 
therefore likely that a combination of targeted deletions would be required to increase 
the efficiency of any newly developed vaccine.  With this in mind, the reduced 
virulence that is exhibited through infection of mice with B. suis ΔmbfA could be 
combined with additional mutants such as erythritol metabolism to generate a 
sufficiently attenuated live Brucella vaccine. Clearly, such a strategy would not be 
applicable to B. melitensis. 
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8.5: mbfA phylogeny - rationale for the cryptic nature of mbfA in Brucella 
melitensis strains 
The presence of mbfA is not restricted to Brucella spp., MbfA is widely conserved 
across the alpha-proteobacteria, in particularly the Rhizobiales order. The function that 
MbfA plays within these bacterial species is likely to bear relationship to that indicated 
by this study in Brucella spp..  Many bacteria of the Rhizobiales order play an important 
role in the development of the root nodule of leguminous plants; a symbiotic 
relationship is established between the plant root and the bacteria, in which the bacterial 
enzyme nitrogenase fixes atmospheric nitrogen generating ammonium, which is 
consumed, by the plant. 
 
During development of the plant root nodule before development of the mature root 
bacteroid, the bacterial species activates the plant immune system, triggering release of 
redox active chemicals.  The expression of mbfA under these environmental conditions 
is therefore likely to aid in survival of bacteria in the mature root bacteroid through the 
same iron export mechanism as described for Brucella.  Not only do many alpha-
proteobacteria encounter conditions of oxidative stress (although many bacteria 
encounter oxidative stress but do not encode mbfA), the intracellular niches that these 
bacteria inhabit are characterised by very small luminal spaces.  This spatial restriction 
allows for maximum benefit of redox detoxification by export of iron, as exported iron 
is not diluted throughout a large luminal space.  
 
A search of MbfA-like amino acid sequences across both the Prokarya and Eukarya 
identified four distinct variants of MbfA-like sequences, denoted Ia, Ib, Ic and II 
(Chapter 3.2). Variant Ib denotes the abundant MbfA variant present in the alpha-
proteobacteria consisting of an N-terminal erythrin domain, characterised by the 
presence of four iron-binding motifs (2 x ExxH and 2 x E-6-Y), and a C- terminal, five 
transmembrane helix bearing, vacuolar iron transporter domain.  Ia MbfA variants 
exhibit a C-terminal VIT domain but no N-terminal erythrin domain; these variants 
were only observed in Bartonella spp..  MbfA of B. quintana and B. bacilliformis both 
have N-terminal domains but these domains do not resemble erythrin, nor are they 
similar to other Bartonella MbfA N-terminal domains.  Bartonella represent an 
interesting bacterial genus, they are opportunistic pathogens that reside primarily within 
erythrocytes and are transmitted via fleas, ticks and mosquitoes.  The residence within 
erythrocytes is reflected in the iron uptake capabilities of these pathogens, many iron 
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transport systems present in closely related Brucella spp. have been lost in the 
Bartonella genome through the process of genome reduction.  Examination of the B. 
quintana genome reveals that a haem uptake system (hutABC) and a ferrous iron uptake 
system (sitABCD) remain the only mechanisms for iron assimilation.  In addition to 
minimal iron uptake machinery, they lack the traditional iron-storage proteins FtnA, 
Dps and Bfr and no not encode catalase (Nijssen et al. 2009, Liu and Biville 2013). 
Taken together, these genetic traits suggest that mbfA may play a significant role in both 
iron homeostasis and oxidative stress resistance in Bartonella spp..  Thus, the Ia mbfA 
variants are most likely fulfilling a function to mitigate redox stress through the 
alteration of iron homeostasis via iron export.  
 
In addition to Ia mbfA variants, Ic variants encode an N-terminal erythrin domain; in 
addition to this they have an approximate 85 amino acid insertion between 
transmembrane helix 2 and 3, which translates to a large cytoplasmic loop in the VIT 
domain.  This cytoplasmic loop is also present in type II MbfA variants but it differs 
from that of type Ic variants due to the complete absence of an N-terminal erythrin 
domain.  In this way, type II MbfA variants are directly comparable to the CCC1 
system described in S. cerevisiae and VIT1 in A. thaliana. Examples of type Ic variants 
are present in both Gram-negative (beta-Proteobacteria) and Gram-positive bacteria 
(Actinobacteria).  The additional cytoplasmic loop within these variants is well 
conserved but its purpose is unknown.  
 
In contrast, the type II MbfA variants (CCC1/VIT1-like proteins) are conserved across 
not only Gram-negative (beta/gamma/delta-Proteobacteria) and Gram-positive bacteria 
(Actinobacteria/Firmicutes) but also eukaryotic domains including: alveotata/euglenoza 
(Plasmodium falciparum/Toxoplasma gondii), fungi (S. cerevisiae/A. niger), plantae (A. 
thaliana) and amoebozoa.  
 
Although prokaryotes and eukaryotes encode a well-conserved type II MbfA 
(CCC1/VIT1), which in strict terms is a VIT1 protein, the mechanism in which the 
transport of iron is utilised the role of these proteins in oxidative stress and regulation of 
iron homeostasis would be expected to differ from that of classical bacterial MbfAs.  It 
is assumed that MbfA will be located in the inner membrane of all bacteria and would 
function to export iron out of the cell, however, in eukaryotes, evidence is present to 
suggest that VIT1 is utilised to transport iron into a storage vacuole.  Such a mechanism 
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cannot be deployed by prokaryotes since they lack internal, membrane-bound 
organelles, although the use of iron-storage proteins provides a similar capacity.  The 
reason for the use of iron-storing vacuoles in yeast, plants and protozoa in place of 
ferritin molecules is unclear, although yeast lacks ferritins so has not alternative option.  
Experimentation on VIT1 systems has focus primarily on the CCC1 iron transport 
system in S. cerevisiae and VIT1 system in A. thaliana, but more recently, 
experimentation has characterised the function of the VIT1 system in P. falciparum 
where a role in regulating iron homeostasis in response to oxidative stress was 
described (Slavic and Krishna 2016).  Iron was determined to be transported into a 
cytoplasmic vacuole, as is also seen in S. cerevisiae and A. thaliana (Li et al. 2001, Kim 
et al. 2006). P. falciparum, like Brucella, is an intracellular parasite.  However, the iron 
exporting processes mediated by VIT1 and MbfA, respectively, are quite distinct in that 
in one case the iron is sequestered and the other the iron is externalised. Additionally, 
the niche that each intracellular parasite resides differs, Plasmodium within erythrocytes 
whilst Brucella within macrophage. This suggests quite different purposes for these 
proteins in assisting the virulence within their respective hosts. The work reported 
herein provides added detail to such studies at it confirms the iron export capacity of 
VIT1, shows that the exported iron is in the form of ferrous iron, and indicates that the 
process is driven by the PMF (Chapter 6.9). 
 
As outlined above, the expression of mbfA appears to present as a beneficial mechanism 
for bacterial survival through efficient regulation of iron homeostasis to prevent excess 
damaging oxidative stress.  However, examination of the B. melitensis mbfA sequence 
and subsequent in vitro experimentation reveals that all B. melitensis strains have 
acquired at least one (and in some cases two) SNP’s rendering mbfA cryptic.  This 
observation is puzzling as B. melitensis strains are very pathogenic to humans and 
induce abortions in a wide range of animal hosts, yet lack MbfA which is shown in this 
thesis to be a B. suis as a virulence factor. Further, provision of function MbfA to B. 
melitensis provides little advantage during redox stress and may even be detrimental in 
the macrophage (Chapter 7.5), acting as an anti-virulence factor which might favour 
selection against its expression through the acquisition of point mutations. This poses 
the question, why isn’t MbfA beneficial to virulence in B. melitensis?  
 
MbfA in B. melitensis may be acting in several ways; one possibility is that it promotes 
the initial survival of B. melitensis, as is observed, but this increased virulence is 
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detrimental to the “stealthy” nature of Brucella pathogenesis.  Perhaps MbfA makes B. 
melitensis too successful resulting in a greater immune response to infection – providing 
a less favourable niche for colonisation.  Another possibility is that removal of iron 
during the eBCV stage resulting in detoxification of peroxide in the eBCV could be 
detrimental to the survival of B. melitensis due to the loss of bacterial iron stores that 
might reduce subsequent replication in the rBCV phase. In either case, B. melitensis 
remains an effective pathogen in the absence of mbfA, and a precise reason for the loss 
of the gene is unclear.  
 
In summary, the work reported in this thesis shows that MbfA provides a new 
mechanism by which iron homeostasis can be adjusted to combat oxidative stress.  In 
addition, the results provided here represent the first characterisation of a dedicated 
prokaryotic iron export system with a clear physiological purpose.  Further, this work 
contributes towards current knowledge on eukaryotic intracellular iron trafficking.  
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Chapter 9: Appendix 
 
9.1: DNA and Protein molecular markers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1: DNA (A) and Protein (B) molecular markers 
 
 
 
  
A B 
Chapter 9 
 
 
245 
9.2: Brucella suis 1330 nucleotide and amino acid sequences 
 
Table 9.1: mbfA nucleotide sequence 
Brucella suis 1330 chromosome I - 1622586-1621603 complement (984 bp). Locus tag: 
BS1330_I1673  
Position	 Sequence	
1 ATGTTCAGCC GATTCTTCCG TAATGACCGA CGCTCTTTCG ATTCGCTTTC TGAACAGGAA 
61 ATTCTGGCGC TTGCCATATC CTCCGAGGAG GATGATGCCC GCATCTATCT GGCTTATGCC 
121 GATGGCCTGC GCGACGAGTT TCCGCAATCG GCGAAGATTT ACGAGCAGAT GGCCGCAGAG 
181 GAACACGACC ACCGCGCAGC ACTGATTGAG CGGCATAAGG CCCGCTTTGG CGACCGGATT 
241 CCGCTGATCC GCCGCGAGCA TGTCAGTGGC TATTATGATC GCAAGCCGGA CTGGCTGGTG 
301 CGTCCGCTCG GCATCGACAA GGTGCGTGAG GCCGCCTCCG AGATGGAGGA ACAGGCTTAT 
361 CGTTTCTATG TCGAGGCGGC CAAGCGCGTC AGCGATGCAG ACACGCGCAA ACTGCTGGGT 
421 GACCTTGCCC AGCAGGAAAA ACAGCACGAA GCCAAGGCTG AATCGCTGGA ACACACGCTG 
481 ACACCGGATA ATGTGCAGGA TGAGGAACGC GCCGCCGAGC GCAAGCAATT CATCCTCACC 
541 TATATCCAGC CTGGCCTTGC GGGCCTGATG GACGGCTCCG TCTCGACACT CGCACCGATC 
601 TTTGCCGCCG CCTTTGCCAC GCAGGATACA TGGCAGACCT TTCTGGTTGG CCTTTCCGCC 
661 TCGGTCGGCG CCGGTATTTC GATGGGCTTT ACAGAAGCCG TGCATGACGA CGGCAAGCTG 
721 TCGGGACGCG GCTCGCCGAT CAAGCGCGGC ATTTCATGCG GCGTCATGAC GACGCTGGGC 
781 GGGCTTGGTC ACAGCCTGCC CTATCTGATC AAGGATTTCT GGACTGCGAC AAGCATCGCC 
841 GTGATCCTTG TCTTCTTCGA GCTCTGGGCC ATTGCCTTCA TTCAGAACCG CTATATGGAA 
901 ACGCCCTTCT TCCGCGCCGC ACTCCAGGTC GTTTTTGGCG GTGCGCTCGT CCTGGCGGCG 
961 GGCATATTGA TCGGCAGCGC CTGA 
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Table 9.2: MbfA amino acid sequence 
Hypothetical membrane protein (327 AA); Locus tag: WP_004690452 
 
Position Sequence 
1 MFSRFFRNDR RSFDSLSEQE ILALAISSEE DDARIYLAYA DGLRDEFPQS AKIYEQMAAE 
61 EHDHRAALIE RHKARFGDRI PLIRREHVSG YYDRKPDWLV RPLGIDKVRE AASEMEEQAY 
121 RFYVEAAKRV SDADTRKLLG DLAQQEKQHE AKAESLEHTL TPDNVQDEER AAERKQFILT 
181 YIQPGLAGLM DGSVSTLAPI FAAAFATQDT WQTFLVGLSA SVGAGISMGF TEAVHDDGKL 
241 SGRGSPIKRG ISCGVMTTLG GLGHSLPYLI KDFWTATSIA VILVFFELWA IAFIQNRYME 
301 TPFFRAALQV VFGGALVLAA GILIGSA 
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Table 9.3: MbfA amino acid frequency  
Molecular weight: 36.433 kDa 
Isoelectric point: 5.27 
Amino Acid Frequency Percentage (%) 
A 41 12.5 
C 1 0.3 
D 21 6.4 
E 25 7.6 
F 19 5.8 
G 24 7.3 
H 8 2.4 
I 21 6.4 
K 12 3.7 
L 31 9.5 
M 7 2.1 
N 3 0.9 
P 10 3.1 
Q 14 4.3 
R 24 7.3 
S 22 6.7 
T 14 4.3 
V 16 4.9 
W 4 1.2 
Y 10 3.1 
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9.3: MbfA multiple sequence alignments 
 
 
 
 
 
 
 
Figure 9.2: Alignment of prokaryotic and eukaryotic MbfA erythrin domain  
Multiple sequence alignment of prokaryotic and eukaryotic MbfA erythrin domains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.3: Alignment of prokaryotic and eukaryotic MbfA transmembrane 
helices  
Multiple sequence alignment of prokaryotic and eukaryotic MbfA transmembrane 
helices 
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Clostridium pasteurianum
Sequence Logo
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Arcobacter butzleri
Campylobacter curvus
Fusobacterium ulcerans
Desulfovibrio fairfieldensis
Bacteroides fragilis
Acidiphilium multivorum
Nitrobacter hamburgensis
Gluconacetobacter diazotrophicus
Bradyrhizobium japonicum
Bartonella quintana
Pseudomonas bauzanensis
Methylobacterium extorquens
Ochrobactrum anthropi
Brucella canis
Brucella suis 1330
Agrobacterium fabrum
Rhizobium leguminosarum
Sinorhizobium meliloti
Rhizobium meliloti
Fusarium oxysporum
Aspergillus niger 
Saccharomyces cerevisiae
Penicillium oxalicum
Bacillus coagulans
Theobroma cacao
Ricinus communis
Arabidopsis thaliana
Capsella rubella
Brassica rapa 
Eutrema salsugineum
Vibrio mytili
Dictyostelium discoideum
Leishmania donovani
Trypanosoma brucei
Toxoplasma gondii
Cryptosporidium parvum
Plasmodium falciparum
Streptomyces auratus
Anaeromyxobacter dehalogenans
Corynebacterium diphtheriae
Actinomyces coleocanis
Microbacterium hominis
Micrococcus luteus
Mycobacterium smegmatis
Streptomyces cattleya
Chloroflexus sp. isl-2
Pseudomonas aeruginosa 
Burkholderia multivorans
Paraburkholderia terrae
Burkholderia xenovorans
Acinetobacter baumannii
Acinetobacter baylyi
Acanthamoeba castellanii
Schizosaccharomyces pombe 
Neisseria flavescens
Serratia marcescens
Klebsiella pneumoniae
Pseudomonas fluorescens 
Bdellovibrio bacteriovorus
Sulfurimonas autotrophica 
Desulfocapsa sulfexigens
Bifidobacterium mongoliense
Propionibacterium acnes
Mycobacterium tuberculosis
Lactococcus lactis
Listeria aquatica
Lactobacillus bifermentans
Streptococcus pneumoniae
Streptococcus agalactiae
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Figure 9.4: Alignment of prokaryotic and eukaryotic MbfA cytoplasmic loop 
Multiple sequence alignment of prokaryotic and eukaryotic MbfA cytoplasmic loop. 
Clostridium pasteurianum
Sequence Logo
1 10 20 30 40 50 60 70 80 90 93
Fusarium oxysporum
Aspergillus niger 
Saccharomyces cerevisiae
Penicillium oxalicum
Bacillus coagulans
Theobroma cacao
Ricinus communis
Arabidopsis thaliana
Capsella rubella
Brassica rapa 
Eutrema salsugineum
Vibrio mytili
Dictyostelium discoideum
Leishmania donovani
Trypanosoma brucei
Toxoplasma gondii
Cryptosporidium parvum
Plasmodium falciparum
Streptomyces auratus
Anaeromyxobacter dehalogenans
Corynebacterium diphtheriae
Actinomyces coleocanis
Microbacterium hominis
Micrococcus luteus
Mycobacterium smegmatis
Streptomyces cattleya
Chloroflexus sp. isl-2
Pseudomonas aeruginosa 
Burkholderia multivorans
Paraburkholderia terrae
Burkholderia xenovorans
Acinetobacter baumannii
Acinetobacter baylyi
Acanthamoeba castellanii
Schizosaccharomyces pombe 
Neisseria flavescens
Serratia marcescens
Klebsiella pneumoniae
Pseudomonas fluorescens 
Bdellovibrio bacteriovorus
Sulfurimonas autotrophica 
Desulfocapsa sulfexigens
Bifidobacterium mongoliense
Propionibacterium acnes
Mycobacterium tuberculosis
Lactococcus lactis
Listeria aquatica
Lactobacillus bifermentans
Streptococcus pneumoniae
Streptococcus agalactiae
LLID-------MLDEERLKYVGAIVLGLNDALVEITGSLAGFTLSMANTRVIALAGLITGI--SATLSMAASEYIAE----KTEGTKN-----
Q------------AGKKEFAVQNRPGDERTGVYDVLEKY-SVSRSAAAPLVDELCK----NPTEWVRFMMDFELKLE-----EPNVHR-----
T------------VREAKELIDTSPAETSSIVQSIFASY-RLPEDVINQINMSLHS----SEDRLLDFLVSFHHKES-----EPDCNQ----A
E-----------VKKEKRK-FYDNSNLINREIEDILLE---INPNFSDETIVSFIKDLQRTPELMVDFIIRYGRGLD-----EPAENR-----
T------------LKETENQTMVDPASVSTTIEDIFEPY-ELPAELVSQLTNHLSA-----SPMLPSFLMNFHHTLP----EPSDSRA-----
E-----------LKREYRE-VEEVPEREKDEVRDVFKAY-DLKPEQIEAIVDKMAE----NPDKWVDFMMKFELGLE-----KPEKGR-----
E-----------LRREEEE-IISVPDTEAAEVAEILAGY-GIEPHEYAPVVNALRK----RPQAWLDFMMKFELGLE-----KPDPRR----A
E-----------LKREQEE-IVTVPDTEAAEVAEILAQY-GIEPHEYQPVVNALRK----QPQAWLDFMMKFELGLE-----KPDPRR----A
E-----------MKREQEE-IVAVPETEAAEVAEILAQY-GIEPHEYSPVVNALRK--NPQ--AWLDFMMRFELGLE-----KPDPKR-----
E-----------MKREQEE-IVAVPETEAAEVAEILAQY-GIAPHEYSPVVNALRK----NPPAWLDFMMRFELGLE-----KPDPKR-----
E-----------VKREQEE-IKTIPETEAAEVAEMLSDY-GVEPREYSPVVNALRK----NPQAWVDFMMRFELGLE-----KPEPKR-----
E-----------MKREQEE-IVAVPETEAAEVAEILAQY-GIEPHEYSPVVNALRK--NPQ--AWLDFMMRFELGLE-----KPDPKR-----
A------------ERTEREHIRAVPEGEREEIRQLFQAK-GFDGELLEQVVEAISRNPD----VWVATMLREEYGLS-----GAGLS------
E------------YKKLEQDIDSNPDEQKSILIEIYEKK-GFTNSQASRIVELLFP----YRKTVTSIMMMEEHGATV-DDDDDEEGGGGTDY
E-----------RRREEWE-VENSFDLEIDEMVQIYMAK-GLSFDDAHTIVGIISK----DPKMFVDFMMVEELGLLV---DIDDAHG-----
E-----------RRREEWE-VENAFDMEVDEMVQIYEMK-GLSHEDATTIVNIISK----DPKLFVDFMMTEELGIII---DTEDTHG-----
E-----------KQREEWE-VENCPEEEKREMVEIYTEKYGFSRADAQSMVDITFK----YKKFFVQHMMVEELGLMY---GFDEPT------
E-----------QEREKWE-VENCPEEEISEMYNLYQLKYGFSEEDAQKMVDLTFK----YKDFFISNMMFEELGLII---EQGDSSQ----P
E-----------KKREEWE-IENCPSEEKQEMIDIYMNKYKFDSEDARNLVEITFR----NKNFFLEHMMSEELGLIV---TNEDKNE-----
E-----------LAVERAE-LRTHPKDELDELAALYVSR-GVEPALARQVAEQLSS----DPEQALEIHAREELGID-----PSDLPS-----
VASQRDLLAR-QIALEKRE-IEEAPEEEAAELALIFKQK-GLSTEQASRTAAEILK----NPESALDTLVREELGLD-----PEDLG------
VKSQNELLEASTPHPGTKNHIPQL-DVDANELALVYRAR-GMSEADAEQKAAEVFA----NLRNAEDQAIIDEPRN-------DEPSS-----
VASQRDLLEASDPAPEVHRALTKL-DLHANELELVFRAR-GDSPEQAAAHAQMLFAAMSRPANDTSTGPLVTRMSMMGAQYQGRNSDEHLSVG
VRSQRELLDA-TEPSDYADHVLPDLDLDANELALVYRAR-GLGERDAHERARQIIAAAQAA-DRSQPYRLHRAAGAD------HEVVG-----
VRSQRELLEASSPTQITLE-AAQHLDLDHNELTLVYLAR-GMTPEDAEHRALERLGYLTCDCNPKFSARPDGSQGPVDHSDSFAEIG------
MRSQQESYQR-EIALEEEE-LRDDPEAETEELALIYRAK-GLDQDEAERVAITIMK----DRESALDTMAREELGLD-----PDELG------
MRSQREAYER-EIALEADE-LRDDPEAEAEELALIYRAK-GLPADEAERVAATIMK----DQETALETMAREELGLD-----PEELG------
VQSSRELYER-QIAIEREE-LEQNPSEEQTELALIYQAK-GLPADQAQALAARLIA----DRPAALDTLSREELGVD-----PEELGG-----
R------------IAEEERLLRLCPNTETQELIDIFTAK-GLSEVSARRVALQLMN----DGRGALDTLSREALGID-----PTELGG----N
VTNAYEL-AQTQIARENEE-LQRTPKAELRELALIYQAK-GLDRDDARRVAEEMMRNRD----KALDTLTREELGLD-----PEELGG-----
VTNAREL-ARTQIAKEADE-IEHTPEAEQHELALIFQSK-GIDADEAKRVAAQIMR----DKQKALDTLTREELGLD-----PAELGG-----
VTNAREL-ARTQIAKEAQE-IKETPEAEEHELTLIYRAK-GLDANEAKRVASQMMR----DPDKALDTLTREELGLD-----PAELGG-----
D-----------LAMEERE-LNLHPVHELRELKNIYIKR-GLEDDLAEEVAKQLTA------HNALDAHARDEIGIL-----EQTAAR-----
D-----------LKFEARE-LEKNPHLELDELTIIYIRR-GLAPELAREVAIQLTE------KDALEAHARDEIGIL-----EQTAAR-----
D-----------LEKERWE-LENNPEGELEELSLLYQER-GVDPVTATEVARQLMA------KDALQAHAIEELGI-------RDFSQ----A
D-----------LQLERRE-MDADWDAEVDELAAIYRGR-GLDEELSRTVAVQLME------YNALEAHARDELGIN-----IHTTAK-----
D-----------LHKERYE-LANNPDAELEELTEIYRRR-GLSDPLAAEVAKALME------HDALAAHARDEIGIT-----ETSAAQ-----
A-----------LAEEQAELLEDYP-GEFRELTSIYVHR-GLDPALARQVAEKLMA------HDALEAHARDELGIS-----SATRAR-----
A-----------LAEEKSE-LDADYQGEVRELTSLYIQR-GVEPALARQVAEQLMA------KDALEAHAREELGLT-----DTHSAR-----
D-----------LSRERAE-LASDPKAEHLELANIYMHR-GVSPELAHQVADQLMA------HDALGSHARDELGIS-----ATLTAK-----
D-----------LEREKSE-LESNVDFERDELAQIYVGR-GLEPRLASQVAEQLMA------HDALGAHARDELGIN-----EVLSAR-----
D-----------LELEKKA-LQENEAYEKEELAQIYEAR-GIKPELAKEVASQLME------HDALDAHARDELGIT-----EGGKSN-----
D-----------ITLEKRS-LENDFEFEKDELAQIYQNR-GLDPDLARTVAEQLMA------HDALGAHTRDEIGIS-----ENAGAQ-----
L-----------LTKERWE-LTNLPAEELNELAQIYETK-GMTASTATQAAAEAMN------HDALRAHAIDELQID-----PDDLTN-----
VSSQRDI-EKTVMAKEAAE-LRDFPDEELEELTEIYTEK-GLSRGTARQVALELTA------HDPLRAHAEAELGLD-----PDEYT------
L-----------LRQERRE-LREDPVAELDELATLYEAK-GLTPATARTVAEELTD------HNPLLAHAEVELGIN-----PEELTN-----
I------------IQEQKVALATNYQNEFDFVYQKYRAD-GISNELAHKATDEMMK------KDALATTVRERHGFTI----GQELSA-----
L------------VKKERESLKTDYEGELQKLIEIYKAK-GLSDESAHQVASELMK------KDALGVQAQEVLGFK-----LNDYAN-----
V------------VAEEERLLATNYELELDRVVAYYEAR-GVTSETAHEIATELMA------QDALGTVVRVKYDLE-----LGHYMS-----
A------------VSQEKLLLDQDRELAKKSLYAAYIQN-GECKTSAQLLTNKIFL------KNPLKALVEEKYGIE-----YEEFTN-----
A-----------VAREEKL-LENNPELAKKSLVDIYLAK-GESHEHAQWLVDKAFS------KNAIEHLVEEKYGIE-----FGEYTS-----
Ic 
IIe 
IIp 
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 9.4: B. suis 1330 iron metabolism and redox stress genes  
Table 9.4: B. suis 1330 iron metabolism and redox stress genes 
 
Product	 Gene	Symbol	 Start	 End	
Base	
Pairs	 AA		
Catalase		 katA	 336392	 337915	 1524	 507	
Ferric	iron	ABC	transporter,	permease	protein	 sfuC1	 676714	 678432	 1719	 572	
Ferric	iron	ABC	transporter,	iron-binding	protein	 sfuA1	 678504	 679520	 1017	 338	
Ferric	iron	ABC	transporter,	ATP-binding	protein	 sfuB1	 679646	 680680	 1035	 344	
Ferric	iron	ABC	transporter,	ATP-binding	protein	 sfuC2	 698847	 699908	 1062	 353	
Ferric	iron	ABC	transporter,	permease	protein	 sfuA2	 699905	 702130	 2226	 741	
Ferric	iron	ABC	transporter,	iron-binding	protein	 sfuB2	 702265	 703290	 1026	 341	
Periplasmic	protein	p19		 ftrA	 362050	 362598	 549	 182	
putative	exported	protein	 ftrB	 362626	 363000	 375	 124	
High-affinity	iron	permease	 ftrC	 363007	 363843	 837	 278	
Polyferredoxin	 ftrD	 363804	 365237	 1434	 477	
Heme-degrading	monooxygenase	 bhuQ	 541582	 541896	 315	 104	
ATP-binding	component	 bhuV	 735357	 736154	 798	 265	
Permease	component	 bhuU	 736151	 737149	 999	 332	
Periplasmic	substrate-binding	component		 bhuT	 737191	 738225	 1035	 344	
TonB-dependent	siderophore	receptor	 bhuA	 1192352	 1194337	 1986	 661	
Hypothetical	transmembrane	iron-regulated	protein	 mbfA	 1621603	 1622586	 984	 327	
Bacterioferritin	 bfr	 542630	 543115	 486	 161	
Non-specific	DNA-binding	protein	Dps		 dps	 2071065	 2071547	 483	 160	
Manganese	transport	protein		 mntH	 1399842	 1401131	 1290	 429	
alkyl	hydroperoxide	reductase	D	 ahpD	 687040	 687567	 528	 175	
Alkyl	hydroperoxide	reductase	protein	C		 ahpC	 687647	 688201	 555	 184	
Manganese	uptake	regulation	protein		 mur	 1603397	 1603867	 471	 156	
Iron-responsive	regulator	 irr	 2097917	 2098321	 405	 134	
Iron-responsive	repressor		 rirA	 541004	 541465	 462	 153	
Zinc	uptake	regulation	protein		 zur	 1116283	 1116720	 438	 145	
Enterobactin	synthetase	 entD	 9684	 10316	 633	 210	
2,3-dihydroxybenzoate-2,3-dehydrogenase	 entA	 10399	 11175	 777	 258	
Isochorismatase	[brucebactin]		 entB	 11175	 12047	 873	 290	
2,3-dihydroxybenzoate-AMP	ligase	[brucebactin]		 entE	 12099	 13718	 1620	 539	
Isochorismate	synthase	[brucebactin]	 entC	 13825	 15000	 1176	 391	
Siderophore	biosynthesis	non-ribosomal	peptide	synthetase	modules	 entF	 15141	 16481	 1341	 446	
Iron	compound	ABC	transporter,	periplasmic	iron	compound-binding	
protein	 fatB	 653662	 654591	 930	 309	
Iron	compound	ABC	transporter,	permease	protein	 fatD	 654648	 655610	 963	 320	
Iron	compound	ABC	transporter,	permease	protein	 fatC	 655603	 656556	 954	 317	
Iron	compound	ABC	transporter,	ATP-binding	protein	 fatE	 656553	 657311	 759	 252	
TonB-dependent	receptor	 fiu	 986784	 988814	 2031	 676	
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Vitamin	B12	ABC	transporter,	ATPase	component		 fepD	 1304414	 1305190	 777	 258	
Vitamin	B12	ABC	transporter,	permease	component		 fepC	 1305187	 1306188	 1002	 333	
Vitamin	B12	ABC	transporter,	B12-binding	component	 fepB	 1306181	 1307020	 840	 279	
Outer	membrane	vitamin	B12	receptor		 cir	 1307034	 1309019	 1986	 661	
Superoxide	dismutase	[Fe]		 sodA	 561022	 561621	 600	 199	
Superoxide	dismutase	[Cu-Zn]		 sodC	 682572	 683093	 522	 173	
Biopolymer	transport	protein	 exbB	 1611752	 1612630	 879	 292	
Biopolymer	transport	protein		 exbD	 1612636	 1613130	 495	 164	
TonB-dependent	receptor	 tonB	 1613127	 1614053	 927	 308	
Periplasmic	zinc-binding	protein	 znuA	 1113345	 1114349	 1005	 334	
Zinc	ABC	transporter,	ATP-binding	protein	 znuC	 1114576	 1115472	 897	 298	
Zinc	ABC	transporter,	permease	protein	 znuB	 1115426	 1116286	 861	 286	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.5: B. suis 1330 genome map 
Genome map of B. suis 1330. Chromosome I: 2.11 Mp Chromosome II: 1.21 Mp.  
Annotations from outside to inside: coding sequences - sense strand, (dark green), 
coding sequences - antisense strand (light green), tRNA’s (red), GC% plot (orange), 
iron and redox stress related genes (purple).  
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9.5: Thermal shift assay screen matrix 
 
Actual screen stocks contain concentrations twice that of which is displayed.  The 
concentration is halved by the addition of the protein and the SYPRO orange probe. 
 
Table 9.5: pH screen 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9.6: Salt screen 
 
 
 
 
 
 
 
 
 
 
  
  
1 2 3 4 5 6 7 8 9 10 11 12
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
citric	acid citric	acid citric	acid acetic	acid acetic	acid acetic	acid succinic	acid succinic	acid succinic	acid
pH	4.1 pH	4.6 pH	5.1 pH	4.2 pH	4.7 pH	5.2 pH	4.4 pH	4.9 pH	5.4
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
malic	acid malic	acid malic	acid tartaric	acid tartaric	acid tartaric	acid propionic	acid propionic	acid propionic	acid malonic	acid malonic	acid malonic	acid
pH	4.3 pH	4.8 pH	5.3 pH	4.3 pH	4.8 pH	5.3 	pH	4.3 	pH	4.8 	pH	5.3 pH	5.2 pH	5.7 pH	6.2
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
citric	acid citric	acid citric	acid succinic	acid succinic	acid succinic	acid MES MES MES maleic	acid maleic	acid maleic	acid
pH	5.5 pH	6.0 pH	6.5 pH	5.6 pH	6.1 pH	6.6 pH	5.6 pH	6.1 pH	6.6 pH	5.7 pH	6.2 pH	6.7
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
sodium	cacodylate sodium	cacodylate sodium	cacodylate ADA ADA ADA bisTRIS bisTRIS bisTRIS ACES ACES ACES
pH	5.7 pH	6.2 pH	6.7 pH	6.1 pH	6.6 pH	7.1 pH	6.1 pH	6.6 pH	7.1 pH	6.3 pH	6.8 pH	7.3
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
phosphate phosphate phosphate PIPES PIPES PIPES imidazole imidazole imidazole MOPS MOPS MOPS
pH	6.3 pH	6.8 pH	7.3 pH	6.3 pH	6.8 pH	7.3 pH	6.6 pH	7.1 pH	7.6 pH	6.6 pH	7.1 pH	7.6
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
bisTRIS	propane bisTRIS	propane bisTRIS	propane HEPES HEPES HEPES tricine tricine tricine EPPS EPPS EPPS
pH	6.6 pH	7.1 pH	7.6 pH	7.0 pH	7.5 pH	8.0 pH	7.5 pH	8.0 pH	8.5 pH	7.5 pH	8.0 pH	8.5
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
TRIS TRIS TRIS bicine bicine bicine TAPS TAPS TAPS bisTRIS	propane bisTRIS	propane bisTRIS	propane
pH	7.7 pH	8.2 pH	8.7 pH	7.7 pH	8.2 pH	8.7 pH	7.9 pH	8.4 pH	8.9 pH	8.5 pH	9.0 pH	9.5
100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM 100	mM
boric	acid boric	acid boric	acid CHES CHES CHES glycine glycine glycine CAPS CAPS CAPS
pH	8.6 pH	9.1 pH	9.6 pH	8.8 pH	9.3 pH	9.8 pH	9.2 pH	9.7 pH	10.2 pH	9.9 pH	10.4 pH	10.9
C
D
E
F
G
H
A Water	 Water	 4	M	urea
B
1 2 3 4 5 6 7 8 9 10 11 12
3.0	M 1.0	M 0.8	M 0.6	M 0.4	M 0.2	M 5	mM 0.5	M 0.2	M
Gu-HCl Gu-HCl Gu-HCl Gu-HCl Gu-HCl Gu-HCl Gu-HCl Na3	citrate Na3	citrate
1.5	M	 1.0	M	 0.8	M	 0.6	M	 0.4	M	 0.2	M	 1.5	M 1.0	M 0.8	M 0.6	M 0.4	M 0.2	M
Na2	malonate Na2	malonate Na2	malonate Na2	malonate Na2	malonate Na2	malonate (NH4)2SO4 (NH4)2SO4 (NH4)2SO4 (NH4)2SO4 (NH4)2SO4 (NH4)2SO4
1.5	M 1.0	M 0.8	M 0.6	M 0.4	M	 0.2	M 1.5	M 1.0	M 0.8	M 0.6	M 0.4	M	 0.2	M	Na2
NaCl NaCl NaCl NaCl NaCl NaCl NH4Cl NH4Cl NH4Cl NH4Cl NH4Cl NH4Cl
1.0	M 0.8	M 0.6	M 0.4	M	 0.2	M 1.0	M 0.8	M 0.6	M 0.4	M	 0.2	M 0.5	M 0.2	M	
MgSO4 MgSO4 MgSO4 MgSO4 MgSO4 Na2SO4 Na2SO4 Na2SO4 Na2SO4 Na2SO4 KCl KCl
0.5	M 0.2	M	 0.5	M 0.2	M	 0.5	M 0.2	M	 0.4	M 0.1	M	 1.5	M 0.4	M 0.1	M 0.4	M
LiCl LiCl RbCl RbCl CsCl CsCl NaF NaF NaBr NaBr NaBr NaI
0.1	M 0.4	M 5	mM	 5	mM 5	mM 1	mM 0.1	mM 1	mM 0.1	mM 5	mM 0.5	mM 1	mM
NaI MgCl2 MgCl2 CaCl2 SrCl2 ZnCl2 ZnCl2 NiCl2 NiCl2 MnCl2 MnCl2 CoCl2
0.1	mM 1	mM 0.1	mM 1	mM 5	mM	EDTA 5	mM	EGTA magic 2	mM 2	mM 2	mM 2	mM 2	mM
CoCl2 CuSO4 CuSO4 CdSO4 pH	7.5 pH	7.5 triangle La(NO3)3 PrCl3 NdCl3 SmCl3 EuCl3
2	mM 2	mM 2	mM 2	mM 2	mM 5	mM 5	mM 5	mM 5	mM 5	mM 5	mM 5	mM
GdCl3 DyCl3 HoCl3 YbCl3 LuCl3 Na2HPO4 Na3VO4 Na2WO4 Na2MoO4	 DTT TCEP β-mercapto
ethanol
D
E
F
G
H
A Water	 Water	 4	M	urea
B
C
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Table 9.7: Metal screen 
 
 
 
 
 
 
 
 
  
1 2 3 4 5 6 7 8 9 10 11 12
A H2O 1	μM	MnCl2 1	μM	FeCl3
1	µM	
Fe(NH4)2(SO4)2
1	μM	CoCl2 1	μM	NiSO4 1	μM	CuCl2 1	μM	ZnSO4 1	μM	MoO3 1		μM	CdCl2
1	μM	
Pb(NO3)2
1	μM	VOSO4
B H2O 5	μM	MnCl2 5	μM	FeCl3
5	µM	
Fe(NH4)2(SO4)2
5	μM	CoCl2 5	μM	NiSO4 5	μM	CuCl2 5	μM	ZnSO4 5	μM	MoO3 5	μM	CdCl2
5	μM	
Pb(NO3)2
5	μM	VOSO4
C 4M	Urea 10	μM	MnCl2 10	μM	FeCl3
10	µM	
Fe(NH4)2(SO4)2
10	μM	CoCl2 10		μM	NiSO4 10	μM	CuCl2 10	μM	ZnSO4 10	μM	MoO3 10	μM	CdCl2
10	μM	
Pb(NO3)2
10	μM	VOSO4
D 4M	Urea 50	μM	MnCl2 50	μM	FeCl3
50	µM	
Fe(NH4)2(SO4)2
50	μM	CoCl2 50		μM	NiSO4 50	μM	CuCl2 50	μM	ZnSO4 50	μM	MoO3 50	μM	CdCl2
50	μM	
Pb(NO3)2
50	μM	VOSO4
E 20	mM	MES 100	μM	MnCl2 100	μM	FeCl3
100	µM	
Fe(NH4)2(SO4)2
100	μM	CoCl2 100	μM	NiSO4 100	μM	CuCl2 100	μM	ZnSO4 100	μM	MoO3 100	μM	CdCl2
100	μM	
Pb(NO3)2
100	μM	
VOSO4
F 20	mM	MES 500	μM	MnCl2 500	μM	FeCl3
500	µM	
Fe(NH4)2(SO4)2
500	μM	CoCl2 500	μM	NiSO4 500	μM	CuCl2 500	μM	ZnSO4 500	μM	MoO3 500	μM	CdCl2
500	μM	
Pb(NO3)2
500	μM	
VOSO4
G Dithionite 1mM	MnCl2 1	mM	FeCl3
1	mM	
Fe(NH4)2(SO4)2
1	mM	CoCl2 1	mM	NiSO4 1	mM	CuCl2 1	mM	ZnSO4 1	mM	MoO3 1	mM	CdCl2
1	mM	
Pb(NO3)2
1mM	VOSO4
H Dithionite 2	mM	MnCl2 2	mM	FeCl3
2	mM	
Fe(NH4)2(SO4)2
2	mM	CoCl2 2	mM	NiSO4 2	mM	CuCl2 2	mM	ZnSO4 2	mM	MoO3 2	mM	CdCl2
2	mM	
Pb(NO3)2
2mM	VOSO4
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9.6: Crystallisation screening conditions  
 
Table 9.8: PACT premier HT-96 – Conditions A1-D12 
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Table 9.9: PACT premier HT-96 – Conditions E1-H12 
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Table 9.10: JCSG-plus HT-96 – Conditions A1-D12 
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Table 9.11: JCSG-plus HT-96 – Conditions E1-H12 
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